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Abstract 
The principal objectives of the study presented in this thesis were to study the changes of 
milk  proteomes,  peptidomes  and  metabolomes  during  the  course  of  bovine  mastitis  in 
comparison with normal milk samples and to discover new bovine mastitis biomarkers 
using various modern and up-to-date methodologies such as proteomics, peptidomics and 
metabolomics. 
Bovine mastitis caused by bacterial infection of the mammary gland of dairy cows is often 
associated with loss of milk production due to a reduction in milk composition and quality 
which in turns, lead to negative economic impact on dairy industry. 
Two important acute phase proteins (APPs) which serve as valuable biomarkers in bovine 
mastitis were investigated in every chapter using developed and validated enzyme linked 
immunosorbent assay (ELISA) for bovine milk haptoglobin and commercially available 
ELISA  for  bovine  milk  serum  amyloid  A3  (M-SAA3).  These  APPs  were  quantified 
alongside somatic cell counts (SCC) and California Mastitis Test (CMT) to confirm the 
disease status of each animal used in this study. 
Proteomic  methodologies  were  applied  including  1D  gel  electrophoresis,  2D  gel 
electrophoresis, MALDI-TOF analysis and difference gel electrophoresis to investigate the 
changes  of  milk  proteome  in  both  subclinical  and  clinical  mastitic  milk  samples  in 
comparison with healthy milk samples.  However these investigations did not reveal novel 
biomarkers for mastitis. 
Next, peptidomic methodologies were used to study the changes in milk peptidome and to 
detect the presence of any significant disease biomarkers in the presence of bovine mastitis 
by  using  CE-MS  and  LC-MS/MS.  A  total  of  31  and  14  polypeptides  can  be  used  to 
discriminate  control  from  infected  groups  and  E.  coli  from  S.  aureus  infected  groups 
respectively. 
Lastly, metabolomic methodology was applied with an intention to study the changes in 
milk  metabolome and ultimately to  detect  the  presence of novel  biomarkers in  bovine 
mastitis. Di- and tri-peptides were found higher in S. aureus than in E. coli infected groups 
and based on metabolic pathways, arachidonic, arginine and galactose metabolites were 
seen increased in mastitic milk samples in comparison to healthy milk samples. 3 
 
Overall, the findings detailed in this thesis indicate that the use of advanced proteomic and 
metabolomic methodologies could deliver on their promise of the discovery of potential 
significant bovine mastitis biomarkers. Further studies are needed for validation of these 
proposed biomarkers and it was hoped that better prevention and treatment methods for 
bovine mastitis can be achieved in the future. 
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amu  atomic mass unit 
AP  alkaline phosphatase 
APP  acute phase protein 
APR  acute phase reaction/response 
AQUA  absolute quantification 
Arg  arginine 15 
 
ASAT  aspartate aminotransferase 
ASG  acid-soluble glycoprotein 
Asp  aspartic acid 
ATP  adenosine triphosphate 
ATPase  adenosine triphosphatase 
AUC  area under curve 
BCA  bicinchoninic acid 
bcSCC  Box-Cox transformed somatic cell count 
BH  Benjamini-Hochberg 
BHB   beta-OH butyrate 
BHBA  beta hydroxybutyrate 
bHp  bovine haptoglobin 
BMC  buttermilk concentrate 
BMSCC  bulk milk somatic cell counts 
BSA  bovine serum albumin 
C  complement 
CATHL1  cathelicidin 1 
CD  cluster of differentiation 
CE  capillary electrophoresis 
cells/ml  cells per millilitre 
CE-MS  capillary electrophoresis mass spectrometry 
CFB  complement factor B 
CHAPS  3-[(3-cholamidopropyl)dimethylammonio] propanesulfonate 
CHCA  cyano-4-hydroxy cinnamic acid 
Chem  chemical 
cIEF  capillary isoelectric focusing 
Cl
-  chloride ion 
CL-43  collectin-43 
CLU  Clusterin 
CM  clinical mastitis 16 
 
CMT  California Mastitis Test 
CN  Casein 
co.  corporation 
ConA-  Concanavalin A 
COX-2  cyclooxygenase-2 
CRP  C-reactive protein 
CPLL  combinatorial peptide ligand library 
Cu  copper 
CV  Coefficient of variance 
Cy  cyanine 
CyDye  cyanine dye 
Cys  cysteine 
Da  Dalton 
DiGE  difference gel electrophoresis 
DIM  days in milk 
Dm  error difference between the theoretical mass value of the peptide and the 
experimental mass 
DNA  deoxyribonucleic acid 
DTT  dithiothreitol 
E.coli  Escherichia coli 
e.g  example 
EB  Equilibration buffer 
EC  electrical conductivity 
ELISA  enzyme-linked immunosorbent assay 
ESI  electrospray ionization 
ESI-MS  electrospray ionization mass spectrometry 
EU  European Union 
FA  fatty acid 
Fe  iron 
FFFA  free fatty acid 
FGF  fibroblast growth factor 17 
 
FGFBP  fibroblast growth factor binding protein 
FTICR  fourier transform ion-cyclotron resonance 
FTMS  Fourier transform mass analyzer 
g/litre  gram per litre 
GC-MS  gas chromatography mass spectrometry 
Gly  glycine 
GlyCAM-1  glycosylation-dependent cell adhesion molecule 1 
Glu  glutamic acid 
GSH  glutathione 
GSHPx  glutathione peroxidase 
H  histidine 
H2O2  hydrogen peroxide 
Hb  haemoglobin 
HbCN  cyanmethaemoglobin 
HDL  high density lipoprotein 
Hb-Hp  haemoglobin-haptoglobin 
HCl  acid hydrochloride 
His  histidine 
HMW  high molecular weight 
HNMR  proton nuclear magnetic resonance 
Hp   haptoglobin 
Hp-HbCN  haptoglobin-cyanmethaemoglobin 
HPLC  high-performance liquid chromatography 
Hp-MMP9  haptoglobin-matrix metalloproteinase 
HSA  human serum albumin 
ICAT  Isotope-coded affinity tag 
ID  identification 
IEF  isoelectric focusing 
IEX  ion exchange chromatography 
Ig  immunoglobulin 18 
 
Ile  isoleucine 
IL-1  interleukin-1 
IL-10  interleukin-10 
IL-12  interleukin-12 
IL-19  interleukin-19 
IL-1β  interleukin-1 beta 
IL-6  interleukin-6 
IL-8  interleukin-8 
IMI  intramammary infection 
Inc.  incorporation 
iNOS  inducible nitric oxide synthase 
IPG  immobilized pH gradient 
IQR  inter-quarter ratio 
IRT  infrared thermography 
iTRAQ  isobaric tags for relative and absolute quantitation 
K  lysine 
K
+  potassium ion 
kDa  kilo Dalton 
KEGG  Kyoto Encyclopaedia of Genes and Genomes 
kV  kilo volt 
LAB  lactic acid bacteria 
lb  pound 
LBP  lipopolysaccharide binding protein 
LC  liquid chromatography 
LC MS  liquid chromatography mass spectrometry 
LC-HSRM-MS  liquid chromatography-high-resolution selected reaction monitoring- mass 
spectrometry 
LC-MRM-MS/MS  liquid chromatography-multiple reaction monitoring-tandem mass 
spectrometry 
LC-MS/MS  liquid chromatography tandem mass spectrometry 
LDH  lactate dehydrogenase 19 
 
Leu  leucine 
Lf  lactoferrin 
LKA4  leukotriene A4 
LKB4  leukotriene B4 
LMW  low molecular weight 
logSCC  logarithmic somatic cell count 
logNAGase  log N-acetyl-beta-D-glucosaminidase 
Lp  lactoperoxidase 
L-PGDS  lipocalin-type prostaglandin D synthase 
LPL  lipoprotein lipase 
LPS  lipopolysaccharide 
LTA  lipotechoic acid 
LTB4  Leukotriene B4 
Lys  lysine 
m or M  methionine 
M  molar 
MALDI  matrix-assisted laser desorption ionization 
MALDI TOF MS  matrix-assisted laser desorption ionization-time of flight mass spectrometry 
MALDI-TOF 
MS/MS  
matrix-assisted laser desorption ionization-time of flight tandem mass 
spectrometry 
Met  methionine 
MFGE8  milk fat globule EGF factor 8 
MFGM  milk fat globule membrane 
mg/ml  milligram per millilitre 
MH+  protonated mass of peptide 
MHC  major histocompatibility complex 
MHp  milk haptoglobin 
min  minute 
ml  millilitre 
mM  millimolar 
MPO  myeloperoxidase 20 
 
Mr  relative molecular mass 
mRNA  messenger ribonucleic acid 
MS   mass spectrometry 
MS  mass spectrometry 
mS/cm  milliSiemens per centimetre 
MS/MS  tandem mass spectrometry 
M-SAA3  mammary-associated serum amyloid A3 
Mud-PIT  multidimensional protein identification 
MUFA  monounsaturated fatty acid 
MWCO  molecular weight cut off 
m/z  mass to charge ratio 
n  total 
Na
+  sodium ion 
NaCl  sodium chloride 
NAD  nicotinamide adenine dinucleotide 
NADH  reduced nicotinamide adenine dinucleotide 
NAGase  N-acetyl-β-D-glucosaminidase 
NaHCO3  sodium bicarbonate 
NaOH  sodium hydroxide 
NCBI  National Centre for Biotechnology Information 
NEB  negative energy balance 
NEFA  non-esterified fatty acid 
nESI-MS/MS  nanoelectrospray-tandem mass spectrometry 
NET  neutrophil killing mechanism 
ng/ml  nanogram per millilitre 
NH4  ammonium 
NH4OH  ammonium hydroxide 
NH4SO4  ammonium sulphate 
NHS  N-hydroxysuccinimidyl 
NHS-PEO4  N-Hydroxysuccinimide polyethylene oxide 4 21 
 
NK-κB  nuclear factor kappa-light-chain-enhancer of activated B cells 
nm  nanometre 
NMR  nuclear magnetic resonance 
NO  nitric oxide 
NOS  nitric oxide synthase 
NPN  non-protein nitrogen 
O2
-  superoxide anion 
OD  optical density 
OH  hydroxyl radical 
P or p  proline 
P4  progesterone 
PAGE  polyacrylamide gel electrophoresis 
para-κ-CN  para-kappa casein 
PBS  phosphate buffered saline 
PCM  milk prostacyclin 
PCR  polymerase chain reaction 
PGD2  prostaglandin D2 
PGE2  Prostaglandin E2 
PGF1ʱ  prostaglandin F1 alpha 
PGF2ʱ  prostaglandin F2 alpha 
PGI2  prostacyclin 
PGJ2  prostaglandin J2 
PGLYRP1  peptidoglycan recognition protein 1 
pH  power of hydrogen 
PHA-  phytohaemagglutinin 
pI  isoelectric point 
Pm  probability of misclassifying 
PMF  peptide mass fingerprinting 
PMN  polymorphonuclear 
PMNL  polymorphonuclear leukocyte 22 
 
pmol/μl  picomol per microlitre 
ppm  parts per million 
PPV  positive predictive value 
Pro  proline 
PSD  post-source decay 
psi  pounds per square inch 
PTM  post transitional modification 
PUFA  polyunsaturated fatty acid 
p-value  probability that null hypothesis is true 
Px  peroxidase 
Q  quadrupole 
Q-TOF MS/MS  quadruopole-time of flight tandem mass spectrometry 
r  correlation 
R  arginine 
RAM  restricted access media 
RP  reversed phase 
RP-HPLC  reversed phase-high performance liquid chromatography 
RSNO  S-nitrosothiols 
RT  rectal temperature 
RT-PCR  reversed transcription polymerase chain reaction 
RBP  retinol binding protein 
S. agalactiae  Staphylococcus agalactiae 
S. aurues  Staphylococcus aureus 
S. epidermidis  Staphylococcus epidermidis 
S. uberis  Streptococcus uberis 
S. dysgalactiae  Streptococcus dysgalactiae 
SAA  serum amyloid A 
SCC  somatic cell counts 
SCX  strong cation resin 
SD  Standard deviation 23 
 
SDPP  short-day photo period 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Se  selenium 
SELDI-TOF  Surface-enhanced laser desorption ionization-time of flight 
Ser  serine 
SFA  saturated fatty acid 
SHp  serum haptoglobin 
SILAC  Stable isotope labelling with amino acids in cell culture 
SNF  solid non-fat 
SOD  Superoxide dismutase 
spp  species 
SPE  solid phase extraction 
SPME  solid phase microextraction 
SPR  surface plasmon resonance 
SRID  single radial immunodiffusion 
SST  skin surface temperature 
SVM  support vector machine 
T  trace 
TBS  Tris-buffered saline 
TCA  citric acid cycle 
TFA  trifluoroacetic acid 
TLR  toll-like receptor 
TMB  Tetra methyl benzidine 
TNF-ʱ  tumour necrosis factor-alpha 
TOF  time-of-flight 
Tris-HCl  Tris-hydrochloride 
TrpRS  tryptophanyl-tRNA-synthetase 
TTR  transthyretin 
TXA2  thromboxane A2 
TXB2  thromboxane B2 24 
 
UFA  unsaturated fatty acid 
UK  United Kingdom 
UPLC  ultra-high pressure liquid chromatography 
USA  United States of America 
utlIEF  ultra-thin layer isoelectric focusing 
UV  ultra violet 
UV/VIS  ultra violet visible 
V  voltage 
Val  valine 
vs  versus 
v/v  volume over volume 
w/v  weight over volume 
WPC  whey protein concentrate 
WST  Whiteside test 
X  times 
XCorr  cross correlation value from the search 
x g  centrifugal force in gravity 
Zn  zinc 
z-value  standard score 
ʱ1-AGP  alpha 1 acid glycoprotein 
ʱ1-PI  alpha 1-acid proteinase 
ʱ-CN  alpha casein 
ʱ-LG  alpha lactoglobulin 
ʱS1-CN  alpha S1 casein 
ʱS2-CN  alpha S2 casein 
β-CN  beta casein 
β-Gase  β-glucuronidase 
β-LA  beta lactalbumin 
γ  gamma 
 γ1-CN  gamma 1 casein 25 
 
 
 
γ2-CN  gamma 2 casein 
 γ3-CN  gamma 3 casein 
 ʴ-12-PGJ2  delta-12-prostaglandin J2 
ʴ-CN  delta casein 
κ-CN  kappa casein 
μg  microgram 
μg/ml  microgram per litre 
μl  microlitre 
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Chapter I. Introduction 
1.1   Bovine Mastitis and its Impact on the Dairy Industry 
   
Mastitis is an inflammation of mammary gland parenchyma which is characterized by a 
range of physical and chemical changes of the milk and pathological changes in the udder 
tissues (Radostits et al. 2000). Significant milk changes that can be observed in bovine 
mastitis are the presence of clots in milk, milk discolouration and high numbers of 
leukocytes in affected milk. Furthermore, apparent clinical signs in bovine mastitis 
comprise swelling, heat and pain in the udder. 
Mastitis is usually caused by bacterial pathogens which can be classified into two groups; 
the contagious pathogens which include Streptococcus agalactiae, Staphylococcus aureus 
and Mycoplasma bovis as well as environmental pathogens which include Streptococcus 
species  (Streptococcus  uberis  and  Streptococcus  dysgalactiae)  and  environmental 
coliforms  (Gram  negative  bacteria  Escherichia  coli,  Klebsiella  spp.,  Citrobacter  spp., 
Enterobacter  spp.,  Enterobacter  faecalis  and  Enterobacter  faecium.,  and  other  gram 
negative bacteria such as Serratia, Pseudomonas and Proteus (Radostits et al. 2000) 
The  bovine  mammary  gland  is  protected  by  innate  and  specific  immune  responses 
(Sordillo & Streicher 2002). However, factors such as environmental and physiological 
could compromise the defence mechanism of the mammary gland (Hopster et al. 1998; 
Waller 2000). Milking by using machines can also contribute to teat damage which in turn 
increases  the  susceptibility  of  mastitis-causing  pathogen  colonization.  Poor  housing 
environment, increased cow densities per unit and low ventilation can also increase the 
susceptibility to bovine mastitis. Nevertheless, the most important factor in contributing to 
increase bovine mastitis susceptibility is the lactation stage of a cow. It is known that 
during  the  periparturient  period,  the  immunity  of  the  udder  is  compromised  due  to 
physiological changes that happen in preparation for lactation (Oliver & Sordillo 1988). 
Mastitis is one of the most prevalent diseases in dairy cows. It is an endemic disease and 
happens to be the most frequent and most costly disease affecting dairy herds worldwide 
(Halasa et al. 2007; Miller et al. 1993). It affects the quality of the milk through changes in 
milk  composition  and  in  return,  affects  the  economy  of  dairy  industry.  The  United 
Kingdom (UK) is the third largest milk producer in the EU after Germany and France and Chapter 1, 31 
 
ninth largest producer in the world (Defra, Agriculture in the United Kingdom 2009, April 
2010, Table 9.1). Around one million cases of bovine mastitis occur each year in the UK 
with £200 million of losses in production and treatments every year (Science Daily 2008). 
Various papers have discussed the economic impact of bovine mastitis. To simplify their 
conclusions, economic losses due to mastitis can be caused by milk production losses, use 
of treatments, discarded milk, veterinary services, labour, product quality, materials and 
investments,  diagnostics,  other  diseases  and  culling  (Halasa  et  al.  2007).    Persistent 
decrease in milk production is the main detrimental effect that contributes to the economic 
impact  of  mastitis  (Seegers  et  al.  2003).  However,  it  is  quite  difficult  to  estimate  the 
economic losses caused by bovine mastitis as they are influenced by various factors.  
According to Bhikane & Kawitkar (2000), this most important disease in dairy cattle can 
cause up to 70% of reduced milk production, 9% of milk discard after treatment, 7% of the 
cost of veterinary services and 14% of premature culling.  
Traditionally,  the  control  of  mastitis  has  involved  the  use  of  chemical  disinfectants, 
antiseptic or herbal teat dips (Maiti et al. 2004) and antibiotic therapy.  Antibiotic therapy 
has  been used in  mastitis  control  for  about  50  years  (Sharma 2007). However, it was 
suggested  that  antibiotic  therapy  was  not  actually  helping  to  reduce  the  incidence  of 
mastitis. In fact, several problems arise from the use of antibiotics for example, developing 
resistance to antibiotic, questionable drug efficacy and presence of antibiotic residues in 
the  milk.  Thus,  Sharma  (2003)  suggested  the  use  of  alternative  approaches  to  control 
mastitis  that  enhance  the  immunity  of  mammary  gland  by  using  immunoregulatory 
micronutrients (Vitamin E and selenium), vaccines and cytokines.  
1.1.1  Bovine Milk 
Milk  is  one  of  the  important  biological  fluids  and  contains  considerable  amounts  of 
nutrients. All types of milk contain proteins in colloidal dispersion as micelles, fats in 
emulsified globules coated with a membrane and easily digested, minerals, vitamins and 
other components (Jensen et al. 1991, 1995). Each of these components plays beneficial 
roles to the host.  
Colostrum is another type of milk that is produced by cows during the first several days 
postpartum. It is important for the growth and health of the neonates as it contains antibody 
(immunoglobulins) and complement that provide antimicrobial properties against different 
types of pathogens which can be detrimental to the newborn especially during early age Chapter 1, 32 
 
(Korhonen  et  al. 2000). Thus, colostrum provides nutrients  to  the newborn as  well  as 
conferring passive immunity to them. However, in this thesis, we will focus only on milk 
protein of bovine.  
1.1.2  Milk Protein 
Proteins are arguably the most important nutritional factors in the milk. In bovine, six 
major gene products of the mammary epithelial cells have been identified which include 
ʱS1-, ʱS2-, β-, κ-caseins, β-lactoglobulin and ʱ-lactalbumin (Swaisgood 1982, 1993). Apart 
from the presence of blood plasmin and plasminogen in the milk, small peptides (e.g; 
proteose-peptone which is largely derive from the N-terminus of β-casein and from fat 
globule membrane glycoproteins) and large peptides (e.g; γ-caseins are derived from the 
C-terminus of β-casein) are also present in milk with varying concentrations (Swaisgood 
1993) as well as a number of low abundance minor proteins and enzymes (plasmin and 
lipoprotein lipase). 
Protein is one of the milk compositions known to affect more of the properties of milk and 
most dairy products than any other constituent, thus considerable amounts of research have 
been performed to investigate their unique properties and technological importance.  
Milk  contains  acid-precipitated proteins  known as  casein  (CN) which are converted to 
curds by rennin (Kinsella et al. 1984). The liquid left after casein precipitation of skim or 
whole milk is called whey proteins. Another two groups of proteinaceous materials are 
proteose  peptones  and  non-protein  nitrogen  (NPN)  which  was  discovered  by  Rowland 
(1938). 
Pedersen and Mellander (McMeekin 1970) successfully resolved isoelectric casein into 
three proteins namely ʱ-, β-, γ- caseins depending on their electrophoretic mobility. Alpha-
casein was further resolved by Waugh and van Hippel (1956) into ʱs-casein which contains 
two  types  of  proteins  ʱs1-  and  ʱs2-  caseins  as  well  as  κ-casein.  According  to  Fox  & 
Brodkorb (2008), ʱ s1-casein, ʱ s2-casein, β-casein and κ -casein represent approximately 
38, 10, 35 and 12% respectively of whole bovine casein. 
As  for  the  whey  proteins,  they  are  globular  molecules  in  which  the  acidic/basic  and 
hydrophobic/hydrophilic amino acids are evenly distributed along their polypeptide chains 
(Evans 1982). Whey proteins comprise of β-lactoglobulin (β-LG), ʱ-lactalbumin (ʱ-LA), 
immunoglobulins  (Igs),  lactoferrin  and  lactoperoxidase,  together  with  other  minor 
components (Madureira et al. 2007). Chapter 1, 33 
 
Other proteins that are present in bovine milk comprise metal-binding proteins (glutathione 
peroxidase),  β-microglobulin,  osteopontin  and  vitamin-binding  proteins,  angiogenins, 
kininogen, glycoproteins, proteins in the milk fat globule membrane and growth factors. 
Milk Proteins  Examples 
Caseins  ʱS1-casein, ʱS2-casein, β-casein, κ-casein 
Whey proteins  β-lactoglobulin,  ʱ-lactalbumin, 
immunoglobulins, lactoperoxidase 
Others  metal-binding  proteins,  β-microglobulin, 
osteopontin,  vitamin-binding  proteins, 
angiogenins,  kininogen,  glycoproteins, 
proteins of milk fat globule membrane and 
growth factors 
Table 1-1: Examples of caseins, whey and other proteins present in bovine milk 
composition 
1.2  Diagnostic Methods for Bovine Mastitis 
These  traditional  diagnostic  methods  discussed  below  are  the  most  common  ways  of 
diagnosing bovine mastitis at the farm level worldwide. They are known to be used widely 
in detecting bovine mastitis. Despite of several major drawbacks in these methods, they 
still are widely used in diagnosing bovine mastitis in dairy herds. 
1.2.1  Somatic Cell Counts 
Somatic cell count (SCC) has proved to be one of the most useful diagnostic techniques to 
detect the presence and occurrence of bovine mastitis and especially for bovine subclinical 
mastitis  (Dohoo  &  Meek  1982;  Schukken  et  al.  2003).  According  to  Shook  (1989), 
currently,  the  dairy  industry  relies  on  this  method  for  milk  quality  payment  schemes 
(Viguier  et  al.  2009)  where  elevated  levels  of  somatic  cells  result  in  low  payments. 
Automated devices have been developed recently so that rapid determination of somatic 
cell counts can be performed by using the Coulter Milk Cell Counter; where the particles 
are counted through an electric field and the Fossomatic; where the cells are stained using 
fluorescent dyes before counting the fluorescent particles (Dohoo & Meek 1982). 
Normally, in a non-infected mammary gland, the SCC is low and macrophages are the 
predominant cells in the milk, which account for 60% of the total somatic cells with 12% Chapter 1, 34 
 
consisting of neutrophils and 28% of lymphocytes (Burvenich et al. 1995; Napel et al. 
2009). However, following microbial infection, approximately within 6 hours after the 
release of bacterial endotoxin, the somatic cells increase dramatically from fewer than 10
5 
cells/ml of milk to an excess of 10
6 cells/ml (Kehrli and Shuster 1994). At this stage, the 
majority of cell populations are neutrophils (>90%), which remain the main cell type up to 
59 hours following infusion (Saad & Ostensson 1990). However, according to Van Werven 
et al. (1997), it may take about 3 weeks for the SCC to return to its normal concentration 
following successful bacterial elimination. Thus, the levels of neutrophils as the percentage 
of the SCC can be used as a mastitis indicator (Hamann and Kromker 1997). Leukocytes, 
primarily  neutrophils  are  recruited  from  the  blood  in  order  to  fight  against  bacterial 
colonization  and  thus  making  neutrophils  the  cells  predominant  in  milk  somatic  cells 
during mastitis (Leitner et al. 2000). 
 
The presence of increased somatic cell counts can be explained by the pathogenesis of 
bovine mastitis. Following microbial establishment in the mammary gland, the bacteria 
will stimulate both the cellular and humoral defence mechanisms of the udder and will 
further deteriorate its condition by multiplying and liberating toxins. Endotoxin released by 
the bacteria induces  leukocytes  and epithelial  cells  to  release chemoattractants  such as 
cytokines, interleukins (IL-1, IL-8), eicosanoids (PGF2ʱ), oxygen radicals and acute phase 
proteins (APPs). Polymorphonuclear cells (PMNs) are attracted to the site of inflammation 
to engulf and destroy the invading bacteria and in turn, release intracellular granules which 
contain  bactericidal  peptides,  proteins,  enzymes,  and  neutral  and  acidic  proteases.  The 
apoptotic  PMNs  are  later  engulfed  and  ingested  by  macrophages  and  the  dead  and 
sloughed off mammary epithelial cells together with dead leukocytes give rise to high 
somatic cell counts in the milk 
 
To correctly interpret the SCC, several factors need to be considered. First, is the infection 
status of the quarter of the mammary gland. The SCC depends on the causal organisms 
(commensal  organisms;  Corynebacterium  bovis  or  coagulase  negative  streptococci  or 
major pathogens; Streptococci species, Staphylococcus aureus and coliforms) as different 
types  of pathogens,  result in  different  ranges  of SCC. Second, the number of quarters 
infected is particularly important in composite (cow) SCC as the high cell count milk from 
infected quarters is diluted with low cell count milk from uninfected quarters. Increased 
age of a cow has been reported to be associated with an increase of cellular content of milk 
due  to  increased  prevalence  of  disease  in  older  cows  (Marshall  &  Edmondson  1962; Chapter 1, 35 
 
Reichmuth 1975; Dohoo & Meek 1982). After calving, there is a possibility of the somatic 
cell counts rising in uninfected quarters and then decreasing to the normal level 4-5 days 
postpartum (Dohoo & Meek 1982; Barkema et al. 1999). Some authors have reported that 
the somatic cell counts increase as the lactation progresses (Schultz 1977). Towards the 
end of lactation, SCC is seen to be elevated (Brolund 1985; Miller & Paape 1988) but 
return  to  a  low  level  if  the  quarter  is  uninfected.  However,  if  there  is  a  presence  of 
infection,  the  SCC  remains  high  and  this  can  be  used  to  detect  a  new  intramammary 
infection  postpartum  (Barkema  1999).  Thus,  stage  of  lactation  seems  to  affect  the 
interpretation of SCC. 
Milking frequency also seems to affect the SCC. Increasing the frequency of milking (from 
two times a day to three times a day) decreased the SCC of the bulk milk (Hogeveen et al. 
2001).  Cell counts were seen to be elevated in the afternoon rather than in the morning 
(Kukovics 1996) and also they appeared to be highest in the milk strippings. These cell 
count concentrations could persist for up to 4 hours before return to low levels (Smith & 
Schultze 1967).  Other factors that should be considered include season, stress, day to day 
variation, technical aspects and management (Dohoo & Meek 1982). 
The  type  of  sample  taken  for  SCC  analysis  (quarter,  composite  or  bulk  tank)  is  an 
important  factor  when  interpreting  the  results.  One  should  remember  that  there  are 
possibilities of having false-positive or false-negative results.  Infected cows sometimes 
have low cell counts and vice versa. Second, cell counts are only an indication of the 
presence of infection within the mammary gland, rather than indicating the presence of 
pathogen.  Finally,  the  evaluation  of  herd  averages  is  better  than  the  evaluation  of 
individual quarter, cow or bulk tank level (Dohoo & Meek 1982). 
With quarter milk samples, the threshold of 200 000 cells/ml has been recommended to 
classify the quarter as being infected (with a major pathogen) (Hillerton 1999a). When 
interpreting the composite SCC, the dilution effect of milk from uninfected quarters on the 
elevated  counts  from  infected  quarters  should  be  taken  into  consideration.  It  has  been 
suggested that the logarithmic transformation of the SCC can be done before the average of 
cell count is calculated (Dijkman 1975). Bulk tank SCCs seem to be a good indicator of the 
general state of udder health and levels below 250 000 cells/ml indicate a good state of 
udder health and over 500 000 cells/ml indicate the presence of severe mastitis in a herd 
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High  somatic  cell  counts  affect  the  milk  quality  and  milk  production  as  well  as  milk 
composition. Due to high SCC, the quality of milk is altered as it causes deterioration in 
the flavour quality and the shelf life of the milk. These effects result from the breakdown 
of milk protein and fat and an increase in acid degree value (Ma et al. 2000). High levels of 
whey protein and low casein levels lead to lower cheese yields (Sharif & Muhammad 
2008) because an elevation of rennet to cutting time and reduced curd firmness are found. 
In  turn,  severity  of  mastitis  affects  the  value  of  food  in  terms  of  low  protein  and  fat 
contents in milk (Ullah et al. 2005). Thus, an increase in SCC is an indicator of losses in 
milk production due to subclinical mastitis.  However, it must be remembered that other 
factors associated with mastitis could also lead to production losses such as discarded milk, 
drug  costs,  veterinary  fees,  extra  labour,  increased  cow  replacement  costs  and  loss  of 
genetic potential (Dijkman 1975). An intramammary infection during mastitis can cause 
considerable  impact  on  the  mammary  gland  of  a  cow.  Permeability  of  the  blood-milk 
barrier is disrupted and results in increased leakage of blood components into milk such as 
serum albumin and immunoglobulins (Haenlein et al. 1973). Furthermore due to infection, 
the synthetic activity of mammary tissue seems to be affected, thus decreasing lactose fat 
and ʱ-lactalbumin level in milk (Harmon 1994). 
1.2.2  California Mastitis Test (CMT) 
A  rapid,  simple  test  to  detect  mastitis  called  the  California  Mastitis  Test  (CMT)  was 
developed  by  Schalm  and  Noorlander  in  1957.  In  this  test,  a  mixture  of  the 
reagent/detergent and milk caused precipitation and gel formation which reflected the cell 
count of the milk (Barnum & Newbould 1961). According to Carroll and Schalm (1966), 
deoxyribonucleic acid (DNA) originating from the nuclei of somatic cells constituting the 
inflammatory exudates cause this CMT reaction. Jensen (1957) reported that this CMT 
reaction was due to the formation of a gel of leukocyte proteins and the reaction was 
negative until the level of cell count exceeded 500 000 cells/ml. Thus, CMT is one of the 
popular cow-side mastitis tests to indicate the presence of mastitis based on the leukocyte 
count in the infected milk. 
Detergents  used  in  the  CMT  decrease  the  surface  tension,  change  the  structure  and 
conductivity of cell membranes and the nucleus of the cells. Other than that, it disturbs the 
osmotic  balance,  blocks  oxidizing  reactions  and  stimulates  proteolytic  enzymes  and 
increases  milk  viscosity,  leading  to  gel  formation  (Sargeant  et  al.  2001;  Ruegg  & 
Reinemann 2002; Middleton et al. 2004). According to Barnum & Newbould (1961), the 
test was performed by pouring the well-mixed milk to a volume of 3ml in one part of a Chapter 1, 37 
 
partitioned  plastic  paddle  before  adding  approximately  3ml  of  the  commercial  CMT 
reagent. The paddle can hold 4 samples at one time and is rotated quickly by hand 10 times 
and graded as either negative, trace (T), 1+, 2+ and 3+. The description is as follows: 
 
CMT reactions  Description 
Negative  No change in consistency. 
T-Trace  No visible change in consistency, but when 
paddle is tipped a slime is momentarily seen on 
the bottom. 
1+  A gel or thick slime forms, but when the paddle 
is swirled the solution does not move into the 
centre. 
2+  A thick lumpy gel forms, which, when swirled, 
quickly moves toward the centre 
3+  A distinct gel forms which tends to adhere to 
the paddle, and during swirling a distinct 
central peak forms. 
Table 1-2: Description on the changes of milk after adding the CMT reagent and 
their CMT scores. (Barnum & Newbould 1961) 
 
Although SCC estimation is a reliable tool to be used to screen and identify intramammary 
infection (IMI) (Sargeant et al. 2001), determining SCC requires sample submission to a 
laboratory and is not readily accessible to on-farm use. Thus, CMT serves as an important 
method of diagnosis that is readily accessible to on-farm use and its scores correlate well 
with the SCC (Hogan et al. 1999). The CMT and Modified Whiteside (Murphy 1942; 
Murphy et al. 1941) tests are useful diagnostic tests to identify subclinical mastitis and 
evaluate its severity (Forster et al. 1966). According to Middleton et al. (2004), if CMT is 
a reliable test to identify subclinical infected mammary quarters, then it could be used in 
selecting  quarters  for  cessation  of  lactation.  This  therapeutic  cessation  of  lactation  in 
infected mammary quarters can help in decreasing individual cow SCC and thereby bulk 
tank SCC (Middleton et al. 2004; Middleton & Fox 2001). 
Because the CMT reaction is an indication of leukocyte counts, various studies have been 
performed  to  correlate  the  relationship  between  CMT  and  leukocyte  content  of  milk. Chapter 1, 38 
 
Barnum  &  Newbould  (1961)  reported  that  CMT  showed  close  association  with  the 
leukocyte count as 71.7% of samples with positive CMT were from quarters classified as 
infected mammary quarters. More samples with less than 500 000 cells/ml gave a trace 
reaction of CMT. Furthermore, only 2.7% of samples showed a false positive result but 
indicated that the paddle method of CMT needed experience in both the method of testing 
and interpretation of the reactions to achieve uniformity and accuracy of the results. 
The understanding on the effects of milk composition and yield caused by the varying 
levels of subclinical mastitis is important in dairy industry. Thus a study by Daniel et al. 
(1966) determined the effects of subclinical mastitis (as determined by CMT on samples of 
24-hour milk production) on milk composition and yield. This study indicated that by one 
unit  of  difference  in  CMT  value,  the  average  changes  were  a  decrease  in  lactose 
concentration by 0.1%, increased protein level by 0.042%, reduced solid non-fat (SNF) 
levels by 0.046% and most importantly, reduced milk production by 4.9lb per cow. 
One study on the relationship between CMT reaction and milk production and composition 
of milk from opposite quarters were done by Forster et al. (1966). Before CMT became 
available,  the  opposite-quarter  comparisons  of  milk  production  was  established  by 
Crossman  et  al.  (1950) based on that subclinical  mastitis was  actually  associated with 
decreased  milk  production.    Based  on  comparisons  made  from  1258  opposite-quarter 
milkings from 763 cows, average decreases in milk production were seen according to the 
CMT reactions (on total quarter milk). The biggest changes of milk production were seen 
at test reaction of 3 with 43.4% decrease in milk production. 
The relationship between CMT reaction and bacteriological analyses has also been studied 
by Wesen et al. (1967) as it seems probable that both the type of pathogens involved and 
leukocyte numbers should be considered in diagnosing mastitis. It appeared that there was 
a relationship between CMT and the type of pathogens identified in a particular quarter as 
there was at least one type of pathogen found in quarters with different type of CMT 
reactions. The non-pathogenic pathogens were identified more frequently in quarters with 
low mastitis test reactions (negative, trace and 1) than in quarters with high mastitis test 
reactions (2 and 3). 
Miller & Kearns (1966) studied the effectiveness of CMT to measure the leukocyte content 
of quarter milk samples and found that the CMT was reliable for the low leukocyte count 
milk when the CMT score is 0 with the percent of correct was 90.7. They concluded that as 
the CMT score increased, the leukocyte content can be expected to increase materially and Chapter 1, 39 
 
that CMT was a reliable tool to estimate leukocyte content from a herd of cows under 
normal management practices. 
To determine the effectiveness of CMT in identifying subclinical mastitis, Middleton et al. 
(2004) found that the sensitivity of the CMT with a trace result as the cut off for a positive 
result, was low (<0.61) which indicated CMT was not useful as a screening test as only 
50% of infected mammary quarters would yield a positive test result. An ideal screening 
test should have maximal sensitivity to minimize the false-negative results. Differences on 
specificity  and  sensitivity  between  this  study  and  previous  studies  are  due  to  the 
characteristics of the individual pathogens and the prevalence of these pathogens in the 
herds studied. Staphylococcus aureus for example has different pathogenicity from other 
bacterial  infection  which  lead  to  variation  in  the  severity  of  mastitis  they  induced 
(Brookbanks 1966). 
Dingwell et al. (2003) indicated that early detection of IMI during early lactation may have 
significant economic benefits. This author agreed on the idea that a screening test with a 
high sensitivity (no false-negative CMT reactions) would be ideal to discriminate between 
non-infected and infected quarters. Although the highest calculated sensitivity and positive 
predictive value (PPV) were on days in milk (DIM) 4 at a cut-off point of >0, it cannot be 
concluded that DIM 4 is the best day to perform the CMT because samples were not taken 
from  every  cow  on  every  day  in  this  study.  Nevertheless,  CMT  can  still  be  a  rapid, 
accurate and economically feasible test for fresh cows to identify specific pathogens. 
Reports by Sharma et al. (2010) were in accordance with other previous studies (Reddy et 
al. 1998; Tanwar et al. 2001; Goswani et al. 2003) that SCC was the most accurate test to 
diagnose subclinical mastitis followed by the modified CMT and the modified Whiteside 
Test (WST) based on the sensitivity and specificity values. They suggest that CMT could 
be useful as a regular mastitis screening test in dairy herd monitoring programmes even by 
less trained dairymen as supported by Sargeant et al. (2001). 
1.2.3  Enzyme levels  
 
One enzyme that is known to be a reliable and sensitive mastitis indicator is N-acetyl-β-D-
glucosaminidase (NAGase) (Kitchen 1976) which has been shown to originate from the 
cytosol of mammary gland secretory cells (Kitchen et al. 1978). It was first reported by 
Mellor (1968) that bovine NAGase is derived wholly from leucocytes and its concentration 
might  be  convenient  to  indicate  the  presence  of  bovine  mastitis.  During  mastitis,  an Chapter 1, 40 
 
increase in cytoplasmic material being shed into milk happens as a result of permeability 
change  in  the  plasma  membranes  of  the  secretory  cells  together  with  extensive  tissue 
damage (Chandler et al. 1974).  
 
It has been found that the level of NAGase in milk can be used to estimate the SCC in milk 
using  spectrophotometric  measurement  (Kitchen  &  Middleton  1976;  Kitchen  1976). 
However, an improved assay procedure using a fluorimetric substrate has been proposed to 
facilitate automation of the method (Kitchen et al. 1978). NAGase is one of the indigenous 
enzymes which found was to be increased in milk during inflammation which originates 
from phagocytes (Pyorala 2003). 
 
According to Kitchen et al. (1978), the fluorimetric procedure used to analyse NAGase is 
superior to the previously spectrophotometric assay due to greater sample throughput and 
ability to get an absolute measure of the level of the product released without problem of 
sample turbidity problem. Besides, this procedure is suitable for an automated method. 
They  also  found  good  correlation  coefficient  value  between  the  SCC  of  243  quarter 
foremilk  samples  determined  by  the  Fossomatic  instrument  and  the  fluorimetric  assay 
(r=0.86).  This  study  also  concluded  that  the  level  of  NAGase  in  milk  is  significantly 
influenced by the integrity of the mammary gland secretory cells as the level of NAGase 
from the mammary gland tissue was the highest compared with other sources listed. Thus, 
NAGase level in milk could serve as a sensitive indicator of pathological and physiological 
changes in the mammary gland. 
 
Fitz-Gerald et al. (1981) reported that both NAGase and SCC increased markedly in the 
milk of first milking after infusion of endotoxin (9-hour interval) in line with a similar 
increase in the blood component blood serum albumin (BSA) and in Na
+/K
+. Furthermore, 
NAGase levels took longer to return to normal than did SCC and BSA and this can be 
explained due to a healing of injured tissue is a slower process compared with the reversal 
of other changes.  
 
However,  Obara  and  Komatsu  (1984)  found  that  NAGase  activity  in  milk  is  a  better 
indicator to grade the severity of inflammation than estimating the level of SCC based on 
the higher correlation between NAGase and chloride (r=.88) and lactose (r = -.80) than 
correlation  between  NAGase  and  SCC  (r=.72).  In  the  healthy  udders,  low  levels  of 
NAGase  are  secreted  from  the  cytosol  of  secretory  cells  but  during  IMI,  NAGase  is Chapter 1, 41 
 
released from the cells into milk according to intensity of the inflammation. Thus, NAGase 
provides a useful indicator of the severity of udder inflammation and the injury implicated 
on the mammary gland.  They also found close correlation (r=.91) between NAGase and 
lactoferrin  which  is  also  known  to  increase  in  milk  from  injured  epithelial  cells  after 
initiation of udder inflammation. 
 
Although  the  range  of  NAGase  activities  were  found  to  be  low  in  bulk  milk  samples 
compared with the composite and quarter milk samples (Kitchen et al. 1984a), there was a 
significant variation of NAGase activities in the bulk milk samples. The NAGase test is 
more versatile than other alternative mastitis diagnostic methods (BSA, conductivity) as it 
can be applied to all levels of milk sampling (quarter, composite and bulk), it is rapid and 
has a simple procedure. The combined use of SCC and NAGase provides a promising and 
meaningful interpretation of mastitis diagnosis so that herds could be classify according to 
their level and extent of infection (Pyörälä & Pyörälä 1997). 
 
Previous  studies  have  observed  the  significance  relationship  between  NAGase  and  its 
reference test SCC to assess the inflammatory responses in the mammary gland. However 
further research work by Kitchen  et al. (1984b) has observed the relationship between 
NAGase and the presence of isolated pathogenic bacteria causing mastitis as the growth of 
bacterial  pathogen  in  the  udder  caused  secretory  disturbances  as  a  results  from  tissue 
damage (Schalm et al. 1971; Giesecki 1975). The presence of udder pathogens during 
mastitis was seen to have a definite relationship with NAGase activities in the infected 
quarters (Kitchen et al. 1984b). Udders that were infected with minor pathogens had only a 
slight increased in NAGase activity compared to major pathogens causing mastitis which 
caused  marked  increased  in  NAGase  activity.  Furthermore,  little  variation  in  NAGase 
activity in the infected milk made it more meaningful in assessing the infection severity 
than SCC.  NAGase levels  are also  useful  in  diagnosing bovine subclinical  mastitis  by 
applying  the  composite  NAGase  analyses  on  regular  monthly  basis.  However,  as 
previously  mentioned,  the  combination  between  NAGase  and  SCC  provide  a  more 
definitive interpretation on secretory disorders in affected quarters.  
 
Nagahata  et  al.  (1987)  have  studied  the  activities  of  two  different  enzymes  in  severe 
mastitic milk samples NAGase and β-glucuronidase (β-Gase). Beta-glucuronidase was also 
derived  from  leukocytes  and  seems  to  be  a  further  useful  marker  in  bovine  mastitis 
(Kiermeier  &  Güll  1966).  From  their  study  (Nagahata  et  al.  1987),  they  have  found Chapter 1, 42 
 
remarkable  increases  in  both  NAGase  and  β-Gase  levels  in  milk  samples  from  acute 
clinical mastitis cases but only a slight increase in these enzyme levels was observed in 
milk samples from chronic mastitis. They also assumed that most of NAGase and β-Gase 
activities found in mastitic milk derived from blood serum, neutrophils and macrophages 
associated with inflammatory process apart from mammary secretory cells.  
 
Sandholm et al. (1984) proposed the use of milk antitrypsin as a sensitive indicator of 
bovine mastitis  because its  activity has  shown  to  be rapidly increased  during mastitis. 
Matilla et al. (1986) indicated that NAGase level was superior to any other tests (BSA, 
antitrypsin, SCC) when single threshold values were applied. However, when inter-quarter 
evaluation  was  applied  to  avoid  background  „noises‟,  the  differentiating  abilities  of 
antitrypsin  were  improved  equalling  that  of  NAGase.  NAGase  also  showed  highest 
deflection which is important in monitoring composite and bulk milk samples to minimize 
the dilution factor in mastitic quarters. The authors concluded that the use of combination 
between  NAGase  and  antitrypsin  to  achieve  optimal  diagnostic  potential  as  mastitis 
involves in different types of inflammatory reactions (increased leakage of plasma proteins 
such as antitrypsin and BSA and cell destruction as shown by NAGase).  
 
Teat canal infections can predispose the mammary gland to mastitis as the mammary gland 
infection is thought to be ascending infections started through the teat canals (Forbes & 
Herbert 1968). To differentiate between the teat canal infections and mastitic infections, 
analyses of both cultures of swabs of teat canals and milk samples drawn from lactiferous 
sinus by teat puncture were done (Murphy & Stuart 1954; Forbes & Hebert 1968; Giesecke 
& Viljoen 1974). However, Kaartinen & Jensen (1988) claimed that release of NAGase 
into teat canal secretions could be an indicator of teat canal infections. They found that in 
S. uberis infected quarter of mammary gland, the NAGase levels in teat sample fractions 
were significantly lower than in respective milk samples showing that the invasion of S. 
uberis  through  teat  canal  did  not  cause  inflammation  or  colonization. However,  if  the 
quarters were infected with either S. aureus or Micrococcus, NAGase levels in teat sample 
and in the respective milk samples were at the same level. Thus, these pathogens initially 
colonize  the  teat  canal  before  attacking  the  upper  part  of  milk  compartment  with  the 
constant  bacterial  irritation  within  the  streak  canal.  Analysing  the  NAGase  gradients 
between  teat  canals  and  milk  showed  a  promising  evaluation  on  the  inflammatory 
condition of the teat canal. 
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Chagunda et al. (2006) found an increased activity of NAGase in clinically mastitic cows 
as compared with healthy cows but that other factors should be taken into consideration 
before interpreting the level of this enzyme. The origins of NAGase have been discussed as 
some authors claimed that the contribution of NAGase from plasma into milk was not 
important (Timms & Schultz 1985). However, there has been a report on the increased of 
NAGase level during dry period in the mammary gland compared with plasma indicating 
that the enzymes originated from mammary gland (Timms & Schultz 1985). 
 
The  presence  of  PMN  leucocytes  and  macrophages  in  the  mammary  gland  during 
subclinical  and  clinical  mastitis  induced  the  phagocytic  process  with  secretion  of 
hydrolytic  enzymes  and  as  the  consequence,  tissue  degradation  occurred.  Among  the 
enzymes found are both nonlysosomals (lactate dehydrogenase and 2-naphthylamilase) and 
lysosomals (NAGase, β-Gase, β-galactosidase and ʱ-manosidase) (Perdigon et al. 1985). 
However, β-Gase proved to be the most significant selectively released enzyme in the 
inflammatory  process  (Schnyder,  &  Bagglioni.  1978;  Schorlemrner  1977).  Studies 
performed by Perdigon et al. (1985) indicated a high correlation between the SCC and the 
presence of enzymes β-Gase (76%). This enzyme was also related to the presence of both 
major pathogens such as S. agalactiae, E. coli, Klebsiella pneumonia, S. aureus as well as 
minor pathogens (e.g; S. epidermidis). The reaction of β-Gase is very sensitive and because 
of its high specificity and simplicity, the detection of this enzyme could be applied for 
mastitis detection.   
 
L-lactate dehydrogenase (LDH) is another type of enzyme that can be used as mastitis 
indicator. It is involved in the glycolytic pathway and found in the cytoplasm of all cells 
and tissues in the body (Chagunda et al. 2006). It has 5 isotypes (LDH1 to LDH5) and in 
milk is known to increase in quantity with mastitis (Bogin et al 1977; Harmon 1994). 
Chagunda et al. (2006) found that the activity of LDH increased in milk during clinical 
mastitis  compared  with  healthy  cows.    However,  the  enzyme  level  was  influenced  by 
parity,  stage  of  lactation  and  month  of  production.  Thus,  it  is  important  to  take  these 
factors into consideration before classifying cows as sick. The association between LDH 
levels  and  SCC  was  stronger  in  clinically  mastitic  cows  than  in  healthy  cows.  It  was 
thought that the origin of elevated LDH was from leukocytes (Bogin 1977) but Kato et al. 
(1989) found that granulocytes and lymphocytes in mastitic milk might partly contribute to 
the  displacement  of  LDH  isoenzymes  into  milk.  However,  Chagunda  et  al.  (2006) 
indicated  that  the  somatic  cells  (neutrophils)  might  contribute  to  the  presence  of  this Chapter 1, 44 
 
enzyme.  When  comparing  between  NAGase  and  LDH,  LDH  seem  to  be  better  in 
classifying mastitic cows than NAGase as LDH is a more sensitive indicator in predicting 
the clinical mastitis. 
 
Another type of enzymes that can be used to detect bovine mastitis is myeloperoxidase 
(MPO). This enzyme is a lysosomal enzyme which is found in the primary granules of 
neutrophils  (Cooray  1994).  Due  to  its  important  role  in  the  oxygen-dependent 
antimicrobial system of neutrophils (Nauseef et al. 1988; Klebanoff, 1991and Cooray et al. 
1993), it can be used to estimate neutrophil number as one of the indirect estimator in 
bovine mastitis. Cooray (1994) found a high correlation between MPO levels in elevated 
numbers  of  neutrophils  with  SCC  (r=0.91).  Due  to  its  presence  in  high  quantities  in 
mastitic milk, this enzyme has the potential to be an important indicator of bovine mastitis. 
 
1.2.4  Electrical Conductivity 
 
Electrical conductivity (EC) is a measure of the resistance of a particular material to an 
electric current (Nielen et al. 1992). Normally, milk has a resistance of between 4.0 and 5.5 
mS/cm at 22ºC (Wong 1988) and is measured in log normal (Knudsen & Jensen 1990). 
The  concentration  of  sodium  chloride  (NaCl)  is  often  expressed  as  milk  electrical 
conductivity  (Kitchen  et al.  1980;  Linzell & Peaker 1972;  Linzell  et  al.  1974;  Peaker 
1978).  
 
Conductivity is thus used in diagnosing bovine mastitis, and cow-side tests and on-line 
measurements have been developed (Nielen et al. 1992). As for on-line measurements, the 
EC was measured using an electrical cell placed in the milking equipment (Maatje et al. 
1983; Puckett et al. 1984). Another system has been developed without electrodes being in 
contact with the milk but using two toroidal ferromagnetic cores and a milk loop in the 
system (Onyango et al. 1988).  
 
During mastitis, the destruction of blood capillary permeability, the destruction of tight 
junctions as well as the failure of the active ion-pumping system causes changes in ion 
composition in milk. Na
+ and Cl
- which have high concentrations in extracellular fluid 
pour  into  the  lumen  of  mammary  gland.  In  contrast,  lactose  and  K
+  leaked  into  the 
extracellular  fluid  and  blood  (Kitchen  1981;  Oshima  1977).  These  changes  caused  an 
increased  of  EC  in  mastitic  milk  (Kitchen  1981).  However,  several  other  factors  also Chapter 1, 45 
 
influenced the ionic content of milk such as temperature, fat concentration, milk solids and 
milk fraction (Woolford et al. 1998). These are important factors that should be taken into 
consideration  when  interpreting  the  EC  in  the  diagnosis  of  bovine  mastitis  as 
intramammary infection induces a 15-50% of elevation in EC (Greatrix et al. 1968; Wolfe 
et al. 1972; Linzell et al. 1974; Fernando et al. 1982). 
 
Electrical  conductivity  was  once  assumed  to  be  a  difficult  method  as  there  was  no 
established value for normal milk making it impossible to interpret the results directly 
(Little et al. 1968). However, this problem can be overcome if simultaneous comparison 
was made for all 4 quarters (Greatrix et al. 1968; Wolfe et al.1972) as first proposed by 
Davis in 1949. 
 
It is thought to be less sensitive than the measurement of sodium (Linzell & Parker 1971, 
1972),  through  daily  measurement  of  foremilk  conductivities.  Furthermore,  it  is  more 
practical to automate reading than milk sodium concentrations (Linzell et al. 1974) and it 
was hoped that daily monitoring of milk conductivity, would allow  subclinical mastitis to 
be detected using this method. 
 
A study by Linzell et al. (1974) indeed indicated that under normal herd management, the 
use of electrical conductivity can be used as indicator in subclinical mastitis. This study 
also made it possible to distinguish a value of milk conductivity (56.5mM) above which it 
referred to severely infected quarters.  
 
Fernando  et  al.  (1982)  found  that  in  mastitis  caused  by  major  pathogens  (S.  aureus, 
coliforms),  the  conductivity  of  stripping  milk  was  higher  than  foremilk  conductivity. 
Furthermore,  conductivity  of  post-milking  strippings  was  more  sensitive  indicator  in 
intramammary  infection  than  those  of  foremilks  with  3.8%  false  negative  value.  In 
identifying  infected  and  uninfected  quarters,  a  combination  of  both  differential  and 
absolute conductivity provides the most accurate methods. Electrical conductivity (EC) 
with  an  in-line  system  in  milking  parlour  is  known  to  be  a  rapid  and  easily  obtained 
measurement. 
 
Further study by Fernando et al. (1985) confirmed that increases of EC, Cl
-, Na
+, BSA and 
logSCC were related to intramammary infection. Marked changes were more pronounced 
in infection caused by major pathogens. It was also confirmed that the EC were higher in Chapter 1, 46 
 
strippings milk than in foremilks. Furthermore, the accuracy of EC was found to be higher 
in strippings milk than in foremilks. Their results however were in contrast with results of 
Linzell et al. (1974) as they found accurate results from foremilks. This difference was 
thought to be due to variation in sampling techniques. Tests for EC, Na
+ and Cl
- contents 
were more accurate in detection of infection variables than other predictors. However, their 
results were in accordance with Woolford & Williamson (1982) and Yamamoto (1982) 
who  found  increased  sensitivity  of  strippings  to  udder  infection.  Due  to  increased 
intramammary  pressure  from  accumulation  of  milk,  there  is  a  possibility  of  higher 
concentration of ions in the mastitic milk. Thus it was suggested that EC has the potential 
as a screening test in bovine mastitis as its accuracy to detect mastitis compared favourably 
with other indirect mastitis tests (SCC, BSA, Na
+, Cl
-, etc) 
 
However, EC  also  showed to  be influenced by  herd variation. Sheldrake  et  al.  (1981) 
claimed that the accuracy of EC varied considerably between herds. Because SCC in this 
study showed similar sensitivity and specificity between herds, SCC appeared to be a more 
accurate method at detecting infected quarters than EC. It was then suggested that overall, 
EC is unsuitable cow-side test to detect the presence of intramammary infection.  
 
EC was also influenced by stage of lactation as well as the number of lactations (Sheldrake 
et  al.  1983a)  as  the  concentration  of  chloride  increased  during  lactation  (Caufield  & 
Riddell  1935)  and  changes  in  EC  were  seen  due  to  physiological  factors  in  all  four 
quarters. However, in mastitis, changes of EC occurred only in infected gland (Linzell et 
al. 1974). Sheldrake et al. (1983a) observed that as lactation advanced, there was little 
effect of EC seen in uninfected mammary quarters whereas gradual increase of EC was 
seen in quarters infected with minor or major pathogens.  
 
Sheldrake et al. (1983b) found that the probability of misclassifying (Pm) quarters for EC 
ranged between 22 to 32%. Pm reduced the apparent distortion of percentages caused by 
unequal  numbers  of  infected  and  uninfected  quarters  as  it  is  the  point  at  which  false 
negative and false positive diagnoses are equal. However, this study was in conflict with 
Davis (1947) in which the comparison within cow by differences and ratios from different 
quarters yielded little advantage over absolute estimations. However, the finding was in 
accordance with studies by Linzell et al. (1974) and Fernando et al. (1982). 
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EC has been proposed to detect the presence of clinical mastitis earlier than by inspection 
by herdsmen to detect the physical changes of the milk (Milner et al. 1996). In 55% of 
cases, the diagnosis of mastitis by EC can be made at an average 2 milkings before any 
visible clinical changes occurred. In about 34% of cases, diagnosis was made at the same 
time  as  clots  appeared  in  the  milk.  Thus,  changes  in  EC  as  detected  using  automated 
sensors could be applied as early as or earlier than visible changes in milk detection to 
diagnose clinical mastitis. 
 
Differences in the EC values between milk fractions in infected quarters have been studied 
by Woolford et al. (1998). In infected quarters, decreased EC values (p<0.05) were seen 
from first foremilk to main flow milk fractions. Meanwhile, in quarters infected with S. 
aureus,  conductivity  was  increased  (p<0.05)  from  main  flow  milk  to  stripping  milk 
fraction. In contrast, in uninfected quarters, the conductivity decreased with successive 
milk  fractions  due  to  elevated  fat  levels.  However,  variation  in  electrical  conductivity 
values in infected quarters was not due to fat levels but may be the result from the mixing 
of milk from infected to uninfected areas of the gland. Localized infection and differential 
drainage  from  the  infected  area  of  secretory  cells  were  the  factors  which  caused  the 
variation  change  in  EC  from  first  foremilk  to  stripping  milk  fraction.  The  authors 
suggested that using the foremilk fraction provided the highest sensitivity when EC was 
used to diagnose subclinical intramammary infection. 
 
Various EC traits have been used to study its association with the udder health (Norberg et 
al. 2003). Four EC traits defined as the inter-quarter ratio (IQR) between the highest and 
lowest quarter EC values, the maximum EC level for a cow, IQR between the highest and 
lowest quarter EC variation, and the maximum EC variation for a cow were calculated for 
every milking throughout lactation. All EC traits were increased markedly (P<0.05) in 
subclinical and clinical mastitis. The IQR performed best in classifying cows correctly 
with 80.6% of clinical and 45% of subclinical cases were classified correctly. About 74.8% 
were correctly classified as healthy. This is due to the fact that this trait reflected the level 
of EC rather than variation of EC. 
 
Biggadike et al. (2002) suggested that an assessment of changes in EC should be made on 
an  individual  quarter  basis  to  minimise  other  factors  such  as  stage  in  lactation  that 
influenced the changes in a whole udder. However, the authors found that the conductivity 
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predictor due to low sensitivity (54%) and positive predictor value (55%). It was suggested 
that cows with high EC values in their individual quarters, additional evidences are needed 
before initiating any treatment such as NAGase test or ATPase test. 
 
1.2.5  Infrared Thermography (IRT) 
 
Infrared thermography (IRT) has been employed as a diagnostic method in bovine mastitis 
based on heat detection generated from the udder. The thermal camera used in this method 
absorbs  infrared  radiation  and  based  on  the  amount  of  heat  generated,  the  images  are 
produced and generated (Eddy et al. 2001; Mazur & Eugeniusz-Herbut 2006). The ability 
of IRT in detecting increased body temperature has made it possible to assess many aspects 
in animal industry. In animal production, it has been used to assess meat quality (Schaefer 
et al. 1989) and detecting oestrus in animals (Hurnik et al. 1984). Furthermore, it also can 
be  used  to  assess  animal  welfare  (Stewart  et  al.  2005)  that  is  associated  with  stress 
(climate, managerial practices) (Kimmel et al. 1992; Eicher et al. 2006). Lastly, it has 
shown to have an advantage over other methods of  diagnosis in diseases such as bovine 
viral diarrhoea in calves (Schaefer et al. 2004, 2007) and bovine lameness in dairy cows 
(Head & Dyson 2001; Nikkhah et al. 2005). 
 
In bovine mastitis, inflammation induced by the pathogens increased the temperature of the 
animal. Hurnik et al. (1984) identified 4 out of 6 cases of mastitis using IRT. Endotoxin 
infusion into the mammary gland caused an increase of 2.3ºC of temperature as measured 
by the IRT (Scott et al. 2000). 
 
Colak  et  al.  (2008)  studied  the  relationship  between  CMT  score  and  skin  surface 
temperature (SST) of the udder as well as the rectal temperature (RT). During mastitis, 
increased  vascularisation  at  the  infected  site  and  tissue  metabolism  increased  the  SST 
(Berry et al. 2003) which can be detected by  IRT. At cow average, strong correlation 
(r=0.93; P<0.0001) was seen between CMT score and udder SST but weak correlations 
between CMT score and RT (r=0.27; P<0.01) and between udder SST and RT (r=0.24; 
P<0.02). Nevertheless, IRT has shown that it was sensitive enough to detect an increase in 
udder temperature. 
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Although Barth (2000) claimed that IRT was not suitable to detect early stage of mastitis, 
Berry et al. (2003) developed a predictive model for the temperature of the udder surfaces 
and suggested that IRT has the potential to diagnose early stage of mastitis.  
 
Furthermore,  Hovinen  et  al.  (2008)  found  an  increase  in  udder  temperature  of  both 
experimental and control quarters 4 hours post-inoculation which was in line with a rise in 
rectal temperature. In contrast, mild physical changes in udder and milk which occurred 2 
hours post-inoculation were not detected by IRT. Swelling of the udder caused by the 
plasma leakage into the interstitium (McGavin & Zachary 2007) may result in undetected 
increases in udder surface temperature. The equal temperatures seen in both experimental 
and control quarters were caused by the systemic effects of LPS (Hovinen et al. 2008). 
Although this method might bring additional value in detecting mastitis with continuous 
monitoring of a herd, the authors concluded that more studies should be conducted in 
naturally occurring mastitis in field conditions where the systemic inflammatory reactions 
might be less pronounced. 
 
Polat et al. (2010) however successfully found high predictive diagnostic ability (positive 
predictive value of 95.0) of IRT similar to CMT (positive predictive value of 99.2) thus 
making it a sensitive tool in detecting early onset of subclinical mastitis. However, several 
cow factors such as parity, milk production and time relative to feeding and milking cows 
under different environmental conditions (air temperature, humidity and velocity) should 
be taken into account before analysing the reliability of IRT in diagnosing early onset of 
subclinical mastitis. 
1.3  Biomarkers in bovine mastitis 
The discovery of disease biomarkers has become a major research interest in recent years 
especially  with  the  development  of  new  technologies.  Biomarkers  are  indicators  of 
biological processes and pathological state that can reveal a variety of health and disease 
traits (Biomarkers Definitions Working Group, 2001). They are important analytes that can 
be used to predict the progress and outcome of a disease. In bovine mastitis, the search for 
biomarkers has been underway since the late 1990‟s. Traditional methods that are still used 
to diagnose bovine mastitis may have their technical drawbacks that affect their efficiency 
(Chagunda  et  al.  2006).  For  example,  somatic  cell  counts  (SCC)  as  described  above 
appears to be a less sensitive and less specific indicator when assessing milk quality in the 
bulk  tank  milk  level  (Le  Roux  et  al.  2003)  than  for  individual  cows.  In  contrast, Chapter 1, 50 
 
bacteriology using culturing techniques to detect the micro-organisms that cause mastitis 
has disadvantages of lacking in speed, is very labour-intensive and expensive (Labohm et 
al.  1998;  Hillerton  2000;  Viguier  et  al.  2009).  Detection  of  mastitis  using  electrical 
conductivity or pH is inexpensive and easy to monitor but has been shown to be relatively 
insensitive  (Nielen  et  al.  1995;  De  Mol  &  Ouweltjes,  2001,  Viguier  et  al.  2009). 
Furthermore, results  from  California Mastitis  Test  (CMT)  can often be mis-interpreted 
especially when diagnosing a subclinical mastitis case that can lead to false positive or 
negative  (Chagunda  et  al.  2006;  Viguier  et  al.  2009).  Thus,  the  discovery  on  specific 
mastitis  biomarkers  is  needed  for  an  early  diagnosis  of  bovine  mastitis  so  an  early 
therapeutic intervention can be applied to reduce the severity of the disease. 
 
Following  mammary  gland  infection,  various  chemoattractants  are  released  which  are 
induced by liberation of toxins from the bacteria. These mediators include various types of 
cytokines attract circulating immune effector cells mainly PMN on the site of infection. 
The  proteins  of  PMN  have  been  studied  for  biomarker  potential.  The  PMN  cells  are 
involved in destroying invading bacteria by releasing their intracellular granules which 
contain bactericidal peptides, proteins, enzymes and neutral and acidic proteases such as 
elastase, cathepsin G, cathepsin B and cathepsin D.  
 
A reliable indicator has become an important interest and several criteria have been set so 
that a serious and prolonged period of subclinical and clinical mastitis can be avoided. A 
mastitic biomarker should have a fast response to infection so that the treatment course can 
be  initiated  as  soon  as  possible.  The  response  towards  infection  should  also  be 
distinguishable from the basic milk values as it is an important factor in early warning 
procedure. The presence of indicator only in the infected quarters and not spreading in 
other neighbouring quarters is essential if the intended mastitis parameter is adapted to be 
used at the single quarter level or composite milk level (Larsen et al. 2010).  
 
An alteration in the permeability of the microvasculature due to inflammatory responses 
has led to the identification of blood proteins leaking from the intravascular compartments 
into milk through the separated tight junctions between endothelial and epithelium cells 
and have been examined as potential mastitis biomarkers. One of the better indicators is 
bovine serum albumin (BSA) which is one of the smaller molecular weight of protein of 
plasma (Giesecke & Viljoen 1974). However the determination of BSA concentrations in Chapter 1, 51 
 
milk  requires  immunochemical  procedures,  it is  difficult  to  automate and thus  has  not 
gained popularity.  
 
Barta et al. (1990) investigating blastogenesis inhibitory factors suggested that mastitis 
might be also associated with the presence of these inhibitory factors in milk whey. Bovine 
lymphocyte cultures were used to detect DNA synthesis inhibitory factors in whey and 
showed that these factors may be released from somatic cells or other tissue cells during 
inflammation.  In  this  study,  clinical  mastitis  was  associated  with  inhibition  of 
Concanavalin  A  (ConA-)  and  phytohaemagglutinin  P  (PHA-)  mitogen  induced  DNA 
synthesis  by  more  than  95  and  86%,  respectively.  A  positive  correlation  was  shown 
between such inhibitory activity, SCC and with electrical conductivity in samples from 
quarters with mastitis indicating that inhibitory factors in whey may be used as a novel 
indicator of subclinical mastitis.  However, this is relatively complicated and cannot be 
applied  in  daily  practice  although  it  can  be  simplified  by  isolation  of  the  molecules 
responsible for DNA synthesis inhibition. 
 
A study by Baeker et al. (2002) using a proteomic approach revealed the upregulation of 
lipocalin-type prostaglandin D synthase (L-PGDS) in quarters affected with subclinical 
mastitis which could be used as a marker in bovine mastitis. Prostanoids are known to have 
a role as inflammatory  mediators via  anti-inflammatory  effects  of this enzyme and its 
metabolites. Pro-inflammatory mediators which are induced by bacteria or their cell wall 
compartments as well as lipopolysaccharide (LPS) can activate several signalling pathways 
that leads to an expression of cyclooxygenase-2 (COX-2) and finally results in increased 
production  of  prostanoids.  Mammary  gland  and  mammary  epithelial  cells  are  able  to 
produce prostanoids and leukotrienes. The upregulation of L-PGDS suggested that there is 
a probability of coupling of this enzyme to COX-2 induction. As a result, increases in 
production of prostaglandin D2 (PGD2) and its metabolites such as PGJ2, ʴ-12-PGJ2 and 
15d-PGJ2 could be seen in the subclinically mastitic cows on this study. 
 
A study by Zeng et al. (2009) involved determining the level of lipopolysaccharide binding 
protein (LBP) in naturally acquired subclinical and clinical mastitic cows in comparison 
with the level of acute phase protein; haptoglobin (Hp) which is becoming accepted as a 
diagnostic marker in bovine mastitis.  However, milk and blood concentrations of LBP 
could  not  be  differentiated  between  subclinical  intramammary  infection  with  clinically 
healthy  cows.  In  contrast  to  LBP,  blood  and  milk  concentration  of  haptoglobin  were Chapter 1, 52 
 
significantly different between cows with clinical mastitis and subclinically infected as 
well as clinically healthy cows. Thus, LBP was not a suitable candidate in bovine mastitis 
and haptoglobin appeared to be a better biomarker in differentiating healthy and subclinical 
mastitic cows. 
 
Another  type  of  biomarker  which  has  been  studied  to  differentiate  between  acute  and 
chronic inflammatory diseases is Hp-matrix metalloproteinase 9 (Hp-MMP9) complexes. 
Although a study by Bannikov et al. (2010) did not focus specifically on bovine mastitis, it 
showed that this complex which was released from neutrophils upon degranulation might 
serve  as  an  important  indicator  during  acute  inflammation.  This  complex  has  shown 
significant difference in the serum of cattle with acute septic disease compared to those 
with chronic/metabolic inflammatory disease or healthy animals (Bannikov et al. 2010). 
However, neither individual Hp nor MMP-9 was suitable marker to differentiate between 
acute and chronic inflammatory diseases for example mastitis. Furthermore, it is common 
to find MMP-9 alone in the sera of clinically healthy animals while these proteins might 
have  dual  roles  in  inflammatory  process  either  pro-inflammatory  or  anti-inflammatory 
activity. Thus, the use of Hp-MMP 9 complexes to diagnose acute septic inflammation in 
cattle was more reliable when compared to free Hp or MMP-9. 
1.4   Acute Phase Proteins in Bovine Mastitis 
The measurement of acute phase proteins following infection has been used extensively in 
human patients as a part of monitoring disease progression and to evaluate the successful 
of treatment given. Following infection, a number of systemic events take place which 
include  the  acute  phase  response.  The  release  of  various  inflammatory  mediators  and 
cytokines  stimulates  the  hepatocytes  in  the  liver  to  produce  and  secrete  acute  phase 
proteins (APP). The released cytokines also able to produce a wide range of host responses 
including  pyrexia,  leucocytosis,  hormone  alterations  such  as  an  increase  in  circulating 
cortisol and a reduction in thyroid hormone levels and trace element disturbances with 
reductions in the serum iron and zinc concentrations (Eckersall 1995). This is part of the 
innate  immune  response  in  the  defence  against  pathogens  prior  to  full  activation  of 
immune response. 
In cattle, Hp and serum amyloid A (SAA) are the most sensitive APP during inflammatory 
or infectious conditions (Conner et al. 1986; Eckersall et al. 2001). Thus, evaluation of 
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detect inflammation. Haptoglobin is known to be one of the most reactive acute phase 
proteins in bovine and exhibits high relative elevated level during acute infection. It has 
been shown to protect the host from oxidative activity of haemoglobin by binding to the 
free  haemoglobin.  Thus,  decreased  levels  of  haptoglobin  in  any  sample  indicate  the 
presence of haemolysis of red blood cells. Serum amyloid A, another major APP in cattle 
is synthesized by the liver in different isoforms and released into the plasma following 
stimulation of inflammatory mediators such as interleukin-1(IL-1), interleukin-6(IL-6) and 
tumour necrosis factor (TNF-ʱ). 
It  has  been  demonstrated  that  the  concentration  of  Hp  is  low  and  often  undetected  in 
normal and healthy animals but can increase 50-100 times during inflammation. Although 
SAA is also known to be increased during the acute phase response, it seems to react faster 
during inflammation and produce higher differences between healthy and diseased animals 
compared to Hp. The use of SAA (which is a precursor of amyloid A protein) as a marker 
of  tissue  injury  in  cattle  was  originally  limited  due  to  its  difficulties  in  purifying  and 
quantifying as it is an apo-lipoprotein complexed in the high density lipoprotein fraction 
(Horadagoda et al. 1999), but commercial assays have been available for several years.  
The  value  of  using  Hp  and  SAA  as  important  markers  in  detecting  inflammation  has 
proved to be greater than the use of haematological analyses. Following on the successful 
measurement of the relative concentration of serum amyloid A in cattle using ELISA by 
Boosman et al. (1989) and purification of amyloid A from acute phase bovine serum by 
Horadagoda et al. (1993), the measurement of serum amyloid A (SAA) in the serum can be 
quantified using ELISA. Assessment of acute phase proteins is recommended compared to 
haematological analyses as these proteins are quite stable and the measurement can be 
performed  on  frozen  samples.  Haptoglobin  for  example,  has  proven  to  be  a  sensitive 
inflammatory indicator in both sheep and dogs (Skinner and Roberts 1994; Solter et al. 
1991). These findings were supported by work in cattle by Horadagoda et al. (1999) where 
it was found that acute phase proteins were able to discriminate between acute and chronic 
inflammation. However, due to differences in the release of cytokines following infection, 
variations  in  the  responses  of  acute  phase  proteins  might  occur.  For  example,  the 
concentrations of SAA increased significantly during the early course of disease compared 
to haptoglobin which indicated that SAA is more sensitive to stimulation than haptoglobin. 
Measurements  of  both  proteins  helped  to  determine  to  which  extent  the  inflammatory 
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Although  these  two  APP  are  known  to  be  elevated  in  bovine  serum  during  either  
spontaneous or induced mastitis, studies by Eckersall et al. (2001, 2006) have shown that 
serum amyloid A can be produced locally in the mammary gland making it a more reliable 
indicator of bovine mastitis.  This has suggested that measurement of acute phase proteins 
is more sensitive and less influenced by the physiological state of the cow. In order for the 
SAA to be increased in the milk during mastitis, an intramammary inflammatory stimulus 
is required.  
One study which confirmed the presence of mammary-associated serum amyloid A3 (M-
SAA3)  was  done  by  McDonald  et  al.  (2001)  in  which  they  found  high  levels  of  this 
extrahepatically produced SAA3 isoform in the colostrums of healthy cows. It may have a 
role in providing immunological benefits to the neonates. This is further confirmed by 
Molenaar et al. (2009) in which they found that bovine mammary gland epithelium was 
capable of expressing M-SAA3 and had a role in developing mammary gland immunity.  
Despite showing production of SAA in the mammary gland during mastitis, disruption to 
the permeability of blood-milk barrier is observed which could lead to leakage of serum 
proteins  in  milk  (Eckersall  et  al.  2006).  However,  because  no  correlation  was  found 
between concentrations of SAA in milk and serum, they suggested that SAA might be 
produced  locally  in  the  inflamed  mammary  gland.  It  has  been  be  concluded  the 
discrepancy that exists in the levels of acute phase proteins found in serum and milk is 
caused by a variation in the duration and severity of the udder infection (Nielsen et al. 
2004)   
In one study of APP in mastitis by Kovac et al. (2007), acute phase proteins were found to 
be more accurately detectable in milk rather in serum and thus may be a useful tool in 
diagnosing mastitis and a useful marker of milk quality. Hp and SAA milk levels were 
significantly higher in cows with the somatic cell counts exceeded 400 000 cells/ml than in 
cows  with  SCC  less  than  400  000  cells/ml.  Thus,  it  was  concluded  that  due  to  high 
correlation of acute phase proteins levels in milk and SCC, the analysis of APP in the milk 
may be useful in monitoring the health of the udder. 
1.4.1  Naturally occurring mastitis 
The dynamics of the acute phase response has been studied in naturally occurring coliform 
mastitis  (Ohtsuka  et  al.  2001;  Wenz  et  al.  2010).  The  changes  in  the  level  of  both 
haptoglobin (Hp) and ʱ1-acid glycoprotein (AGP) in serum were different in two groups of 
coliform mastitis; severe and moderate respectively. Serum ʱ1-acid glycoprotein (AGP) Chapter 1, 55 
 
was shown to be increased later in the course of disease in severe coliform mastitis cows 
whilst the concentration of Hp levels only peaked at 3 days after the onset of the disease 
(acute  inflammatory  condition).  Thus,  the  severity  of  the  inflammatory  processes  can 
affect the regulation of different APP.  
A comparison study on acute phase proteins; haptoglobin, SAA and ʱ1-acid glycoprotein 
(ʱ1-AGP)  was  done  to  evaluate  the  diagnostic  potential  of  these  proteins  as  mastitis 
indicators in both milk and serum (Eckersall et al. 2001). The result of this study revealed 
that there was no significant difference in terms of APP levels in the serum established 
between mild and moderate inflammation. Thus, acute phase proteins in the serum are not 
suitable indicator to discriminate between these groups. However, these APPs in the serum 
are able to differentiate between acute and chronic inflammatory condition in which Hp 
and SAA were both affected by acute conditions while AGP is a better indicator in chronic 
inflammation. AGP was not found in the milk as it is only a moderate acute phase protein 
in cows and that SAA and Hp might have an inherent advantage over AGP as well as ʱ1 
antitrypsin. In this study, the specificity of both SAA and Hp were 100% with no false 
positive  results.  Only  SAA  in  milk  showed  significant  differences  between  mild  and 
moderate inflammatory responses which suggest the production of SAA in milk was under 
different control mechanisms from that of Hp in the milk or the SAA in serum.  
Grönlund et al. (2004) also studied a naturally occurring chronic subclinical mastitis to 
evaluate the usefulness of acute phase proteins such as haptoglobin, serum amyloid A and 
adenosine triphosphate (ATP) enzyme in milk. The diagnosis of subclinical mastitis has 
always been challenging to diagnose due to an absence of observable clinical signs of 
mastitis.  Although  cow-side  test  such  as  CMT,  measuring  adenosine  triphosphate  or 
NAGase as well as electrical conductivity can be used to diagnose subclinical mastitis, 
these analyses are less efficient to detect subclinical mastitis and thus new disease markers 
and its methods of detection are needed. In this study, they found that APP level varied 
markedly  in  chronic  subclinical  mastitic  cows  but  there  were  significant  correlations 
between Hp, SAA and ATP. As compared to the previous study by the same author, Hp 
was  found  to  be  often  detected  than  SAA.  Different  amount  and/or  combination  of 
cytokines  involved  and  also  variation  in  host  response  towards  inflammation  might 
contribute to this result. The duration and different phases of inflammation also seem to 
affect the type of APP being produced. Lastly, it can be concluded that Hp and SAA 
analysed in udder quarter sample are preferable to evaluate the usefulness of these APP to 
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Safi et al. (2009) has proposed that M-SAA3 was the most accurate test for the diagnosis 
of subclinical mastitis followed by CMT, SCC, MHp, SAA and SHp. Tests on APP in milk 
generally were more accurate than tests on serum in the diagnosis of subclinical mastitis 
due to the significantly larger area under curves (AUCs) of the proteins in milk than those 
in serum. 
 
Another study on naturally occurring clinical mastitis (CM) investigated the factors that 
influenced the concentrations of selected acute phase proteins and cytokines on mastitis 
caused by different pathogens (Wenz et al. 2010). They found that the level of Hp, IL-19, 
IL-12, TNF-ʱ and IL-8 were greater in cows with moderate to severe versus mild systemic 
diseases. When analysing the season of the year when CM occurred, it appears that some 
proteins (APP and cytokines) increased during summer and others increased during winter. 
Thus, it possible that season does affect the immune response of the cows during mastitis. 
This result showed that with higher amount of proteins being expressed during winter, it 
was associated with the fact that the immunity is enhanced during short-day photo period 
(SDPP). Lower levels of IL-10, IL-12 and lactate dehydrogenase (LDH) in the first 60 days 
of milking are associated with low immunity in periparturient cows. Cows infected with 
gram-negative bacteria seemed to have higher level of IL-10 and IL-1β as compared to 
cows infected with gram-positive bacteria. Finally, this study provides a comprehensive 
background on the factors affecting the innate immune response of cows with naturally 
occurring clinical mastitis and their influences on proteins associated with infection. 
1.4.2  Experimental Induced Mastitis 
When evaluating the acute phase response in experimental induced mastitis, it was found 
in an early study that serum Hp was a good prognostic indicator based on its higher level in 
severely  affected  heifers  inoculated  with  Actinomyces  pyogenes,  Fusobacterium 
necrophorum  and  Peptostreptococcus  indolicus  (Hirvonen  et  al.  1996). Although acid-
soluble glycoproteins (ASG) were associated with severely affected heifers, it was less 
sensitive  than  Hp  as  ASG  is  comprised  of  several  acute  phase  reactants  (e.g:  ʱ1-acid 
glycoprotein  and  some  proteinase  inhibitors).  Meanwhile,  the  use  of  fibrinogen  as  a 
reliable marker was not found to be useful due to the insignificant differences between 
severe and moderately affected animals. As for ʱ1-acid proteinase (ʱ1-PI) activity, it was 
found  not  to  be  a  suitable  marker  to  predict  the  severity  and  outcome  of  the  disease. 
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significant. Fibrinogen and ʱ1-PI however, can be used as markers to detect the presence of 
inflammatory condition (Hirvonen et al. 1996). 
Following the revelation by Eckersall et al. (2001, 2006) on the discovery of APP in milk, 
a number of experimental studies have looked at the responses of the APP in milk.  A 
study by Suojala et al. (2008) used two consecutive experimentally induced mastitis by E. 
coli  studies  to  evaluate  the  possible  carry-over  effects  of  the  previous  intramammary 
infection. The result showed that the cows had a moderate systemic immune response 
towards E. coli inoculation in the first challenge but the clinical signs were milder and 
disappeared faster in the second challenge. The level of inflammation indicators (Hp and 
SAA) followed the same pattern producing significant difference in both milk and serum. 
Faster response towards infection and milder condition of the disease might be due to 
effective bacterial elimination by neutrophils through LPS recognition. Concentration of 
SAA in milk was higher as compared to the serum and this rapid response is due to local 
immune response in the mammary gland itself. However, the milk Hp concentration was 
only half of those in the serum and the response was less pronounced during the infection. 
As for the LBP, it is involved in the formation of LPS-CD14-complex which is known to 
increase the sensitivity of the host immune response towards gram-negative bacteria.  
One experimental study on Staphylococcal causing mastitis has been performed to describe 
the local and systemic acute phase response during acute and chronic phases of mastitis 
(Grönlund et al. 2003). Staphylococcus aureus is one of major pathogen causing bovine 
mastitis ranging from peracute to chronic form. However, the peracute form is rare but if 
the acute form is not successfully treated, it can progress into chronic, subclinical form. 
Chronically infected cows become source of infection where the bacteria are intermittently 
being  shed.  During  acute  clinical  mastitis,  APP  were  increased  in  infected  quarters 
suggesting the local production of proteins particularly SAA in the mammary gland. The 
rise of APP was correlated with the increase of SCC and the onset of clinical signs. The 
problem  arises  when  diagnosing  subclinical  chronic  form  of  mastitis.  SAA  has  shown 
significantly  higher  level  in  infected  quarters  than  pre-infection  and  healthy  control 
quarters. Also, the increase of APP in the serum might suggest a non-specific response due 
to other acute inflammatory response but chronic form of mastitis was found to be able to 
initiate the systemic acute phase response. Thus, SAA is an excellent indicator to diagnose 
chronic subclinical mastitis (Grӧnlund et al. 2003). 
One experimentally induced subclinical mastitis study (Eckersall et al. 2006) showed that 
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serum concentrations of both of these proteins. This demonstrated that blood was unlikely 
to be the source of the immediate increase in milk. A moderate increase of both APP, 
particularly  the  Hp  indicate  that  this  experimental  model  was  successful  to  induce 
subclinical mastitis in which only mild or moderate APR was stimulated. The authors also 
suggested that these APP can be use to  estimate the severity  of the mastitis condition 
because it showed a significant increase in APP level after second infusion of bacteria as 
compared to  the first  infusion.  Results  from  immunocytochemistry suggested that the 
origin of M-SAA3 in milk may be synthesis within secretory epithelial cells and cells 
lining the gland cistern of the mammary gland. Although Hp synthesis was not detected by 
immunocytochemistry in the mammary gland following S. aureus infusion, quantitative 
RT-PCR  has  supported  the  probability  of  local  production  of  both  M-SAA3  and  Hp 
mRNA in the mammary gland. M-SAA3 and Hp were thought to have similar activities as 
serum Hp and SAA and these could be useful to provide resistance to diseases as well as 
passive transfer of innate immunity to neonate and calf.  
 
Another study on cows following inoculation of LPS by Larsen et al. (2010) showed that 
Hp level is more reliable indicator to distinguish between moderate and severe cases of 
mastitis. However, the acute phase reactants (Hp and SAA) have their own drawbacks for 
having prolonged phase of decline and that the declining phase may last for several days. 
The use of ELISA-based principle to analyse the milk Hp is not suitable for in-line system 
but the application of biosensor to determine the Hp level might give a better value on 
practical purposes (Åkerstedt et al. 2006). As for the concentration of enzymes involved in 
mastitis, only LDH, NAGase and AP are known to increase in a faster rate upon LPS 
infusion. They also showed clear distinct between inflamed quarters with those placebo-
treated neighbouring quarters. This study also discussed the possible origin of some of the 
enzymes  during  mastitis.  For  example,  although  acid  proteinase  (AcP)  and  alkaline 
phosphatase (AP) are native constituents in bovine milk and the mammary gland is the 
source of these enzymes, enhanced expression of leukocytes lead to upregulation of these 
enzymes which can be seen during mastitis. Furthermore, LDH activity has shown not only 
originate from plasma but also from granulocytes and lymphocytes in mastitic milk. Thus, 
it can be concluded that AP, LDH and NAGase are the sensitive markers in mastitis as they 
were increased significantly as Hp, M-SAA3 and SCC during early phase of inflammation. Chapter 1, 59 
 
1.4.3  APP and Milk Quality 
One study that investigated (Åkerstedt et al. 2007) the relationship between APP and SCC 
in  all  clinically  healthy  animals  found  that  a  large  proportion  of  animals  (53%)  had 
detectable levels of Hp and/or SAA. Although the presence of both APP was significantly 
more  common  in  milk  at  higher  SCC,  SAA  was  found  more  frequently  in  the  milk 
regardless of the sample type (quarter, cow composite and bulk tank) and had a significant 
relationship with SCC in quarter and composite milk samples. The reason why there was 
no relationship between Hp and SCC in bulk tank milk might be due to the dilution effect 
from quarter to bulk tank level. However, although the SCC of the cow composite sample 
was normal, SAA seemed to be detected in all four quarters in the cow composite sample. 
During certain physiological conditions (dry-off and oestrus), the permeability of blood-
milk  barrier  is  altered  which  leads  to  leakage  of  blood  proteins  into  milk.  Thus,  the 
presence of APP in milk suggests the independent relationship between APP and SCC. 
Hp and SAA have been studied on their use to assess milk quality. Several parameters 
concerning  milk  quality  such  as  total  protein,  whey  protein  and  casein  levels,  casein 
number, proteolysis and levels of fat and lactose in cow composite sample were compared 
with the level of both APP (Åkerstedt et al. 2009). Healthy milk samples with detectable 
level of Hp showed lower total protein and casein levels but higher SCC. Healthy milk 
samples with detectable levels of SAA showed lower casein number, lower lactose level 
but also higher SCC. Although total protein level in the milk is commonly used as a milk 
quality  parameter,  casein  level  is  a  more  specific  quality  trait  since  total  protein  may 
include  less  valuable  serum  proteins  that  may  increase  during  mastitis.  It  is  said  that 
measuring casein instead of total protein level in the milk is more relevant because the 
degree of casein degradation also affects the processing properties of the milk other than 
yield and quality of the dairy products. No relationship was observed between APP and 
proteolysis found in this study might be due to insensitive fluorescamine method to detect 
small differences in proteolysis. Proteolysis might also cause decreased casein levels and 
lower casein numbers as proteases particularly plasmin, bind to casein and hydrolyse the 
proteins to soluble peptides. Lower lactose level with detectable SAA is due to the release 
of specific peptides during hydrolysis of casein by plasmin that may serve as regulators in 
lactose secretion. However, lactose is not sensitive and specific enough to be detected in 
the bulk tank milk and thus, not suitable to be used as milk quality parameter. Furthermore, 
in samples with both APP detected, reduced whey protein level was observed which might 
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no relationship was found between total proteins and casein levels/casein number with 
SCC but high SCC was found together with decreased lactose level and increased whey 
proteins (Åkerstedt et al. 2008). 
The assessment on the composition of bulk tank milk is done to determine the quality of 
raw milk sample (Åkerstedt et al. 2009). Subclinical mastitis often constitutes a problem as 
the  absence  of  macroscopic  changes  in  the  milk  goes  unnoticed  and  the  milk  from 
unaffected glands mixes with the milk from infected quarters. Bulk tank milk somatic cell 
count was reported as not a suitable predictor of raw milk quality especially for cheese 
production. Thus, investigation on Hp and SAA and their relationships with various raw 
milk quality parameters in bulk tank milk could be important to determine if the levels of 
APP can be related to the milk quality traits. In bulk tank milk samples with detectable Hp, 
lower casein content as well as lower casein number were found due to higher proteolytic 
activity in these samples. Proteolysis is seen in bulk tank milk but not in cow composite 
milk  samples  because  of  different  factors.  The  fact  that  bulk  tank  milk  consists  of 
commingled  milk  from  different  milkings  as  well  as  milk  from  non-infected  and 
subclinically infected quarters contribute to presence of proteolytic activity in bulk tank 
milk.  Furthermore,  the  longer  storage  time  before  collection  and  freezing  allows 
proteolysis to proceed for a longer time. Decreased levels of both APP were related to 
reduce lactose level as damaged epithelial cells contribute to decreased lactose synthesis. 
Proteolysis of β-casein released the peptides with a regulatory effect on lactose secretion 
(Silanikove et al. 2000). Thus, it can be concluded that APP can be serve as potential 
candidates to predict the raw bulk tank milk quality in relation to protein quality because 
the presence of APP in milk is related to disadvantageous changes in milk composition. 
1.5   General Proteomics Application 
Proteomics  has  become  one  of  the  most  significant  „post-genomic  era‟  tools  due  to 
advances in proteomic technologies which allowed an extended experimental approach to 
investigation of biological systems. Originally, the initial proteomic experiments which 
rely  on  two-dimensional  gel  electrophoresis  (O‟Farrell  1975)  and  application  of 
chromatography  techniques  (Neverova  &  Van  Eyk 2002)  could  not  be used for broad 
proteomic  application  due  to  difficulty  in  identifying  proteins  (Graham  et  al.  2005). 
However,  this  problem  is  overcome  by  an  introduction  of  mass  spectrometry  (MS)  in 
combination with developing genomics databases (Graham et al. 2005). Chapter 1, 61 
 
Proteomics  is  defined  as  the  study  of  the  proteome;  a  full  complement  of  expressed 
proteins  from  the  genome  of  a  given  tissue,  cell  or  biological  fluid  in  all  isoforms, 
polymorphisms and post-translational modifications (PTMs) at a particular point of time. 
(Wilkins et al. 1995; Graham et al. 2005; Manso et al. 2005; Hiendleder et al. 2005; 
Mitton & Kranias 2003). Proteomics provides a holistic and global approach to separate, 
identify,  characterize  and  quantify  proteins  and  their  PTMs  to  provide  information  on 
protein abundance, location, modification and protein-protein interaction in a proteome of 
a  given  biological  system  (He  &  Chiu  2003;  Stoughton  &  Friend  2005).  Principally, 
proteomics offers an inventory of the different proteins and their modifications within a 
defined biological state and comparison of proteomes derived from different biological 
states, e.g. normal in comparison to diseased states or with treatment to non-treatment 
(Hiendleder et al. 2005).  
According to Mitton & Kranias (2003), proteomics has advantages over genomics and 
transcriptomics because cellular protein composition and activity are positively correlated 
with  changes  in  overall  cellular  function.  Furthermore,  proteomic  methods  have  the 
potential to generate a bulk of data quickly and they are able to generate high-throughput 
systems which are useful to analyze a complex biological system. Furthermore, proteomics 
is able to determine the time course of protein behaviour and to characterize the presence 
and relevance of PTMs to a given process.  
While its potential usage is outstanding, proteomics faces three major challenges (Mitton 
&  Kranias  2003).  First,  cellular  proteomes  are  highly  dynamic  with  changes  in  the 
proteome occur at the same time as changes in cellular functions. Thus, great care needs to 
be taken to standardize and interpret the results. Second, proteomics has to deal with a 
variety  of  proteins  in  terms  of  its  molecular  weights,  partition  coefficients 
(hydrophobicity/hydrophilicity), electrostatic charges, ion chelation properties and PTMs 
(glycosylation, lipid conjugation and phosphorylation). This also complicates the detection 
of low-abundance proteins (Hiendleder et al. 2005). Finally, technically difficult and time-
consuming  proteomics  methods  have  been  considered  as  a  major  hurdle  although  vast 
improvements in the last decade have improved its reliability and efficiency. 
1.5.1 Proteomics in Animal Sciences 
The use of proteomic methods in animal sciences can help researchers to identify key 
proteins and their changed expression in response to different experimental conditions. 
Furthermore, it will provide data libraries of the abundant proteins expressed in a single Chapter 1, 62 
 
cell, cell compartments, tissues and body fluids (Lippolis & Reinhardt 2005; Cho et al. 
2006; Reinhardt & Lippolis 2006; Radosevich et al. 2007). These proteins derived from 
pathogens or hosts are important to examine the status of disease progression and recovery, 
organ  development  or  host  responses  to  stress.  Furthermore,  it  also  helps  with  the 
intervention of diagnostic tests, development of new therapies or even on a discovery of 
disease biomarkers (Lippolis & Reinhardt 2008).  
With the technologies of proteomics promised to provide the identification of proteins that 
are differentially expressed in normal and disease conditions, naturally occurring animal 
diseases  can  be  studied  to  improve  the  health  of  animals  which  in  turn  may  lead  to 
improvements  in  the  characterization,  clinical  management  and  treatment  of  human 
diseases through comparative medicines (Doherty et al. 2008). 
For  example,  dilated  cardiomyopathy  which  occurs  in  the  Simmental-Red  Holstein 
crossbreed of cattle has been studied to investigate its molecular pathogenesis (Weekes et 
al. 1999). This study revealed that poly-ubiquitination of proteins was increased in this 
disease and may play a role in heart disease. Paratuberculosis or Johne‟s disease has been 
implicated as a possible factor in the development of Crohn‟s disease in humans (Grant 
2005). Ten proteins have been identified as up-regulated proteins in naturally occurring 
Johne‟s disease which provide an important fact for the host-parasite relationship which 
can act as model system for the parallel Crohn‟s disease in human (Hughes et al. 2007). 
Proteomics has been applied to study the innate immunology pathways in stress-induced 
immunosuppression (Lippolis et al. 2006a; Mitchell et al. 2007). One of the bovine innate 
immunity proteins discovered was histone H2A.1 in bovine milk (Lippolis et al. 2006b) 
which  involved  in  neutrophil  killing  mechanism  (NET)  (Brinkmann  et  al.  2004).  
Additionally, proteomic investigation on milk fat globule membrane proteome (MFGM) 
revealed that mammary epithelial cells may be directly involved in signalling the early 
recruitment  of  innate  immune  cells  due  to  the  presence  of  innate  immune  signalling 
molecules, TLR2, TLR4 and CD 14 (Reinhardt & Lippolis 2006). This study on MFGM 
also provides new data on mammary development in early lactation. 
Proteomic analysis on bacterial-causing diseases helps in developing new diagnostic test 
from  new  protein  markers  and  also  development  of  vaccine  from  newly  identified 
candidate proteins. Examples of animal diseases which used similar proteomic approaches 
are Johne‟s disease (Radosevich et al. 2007), Brucella abortus (Connolly  et al. 2006), Chapter 1, 63 
 
Pasteurella multocida (Boyce et al. 2006) and Mycobacterium bovis (Mollenkopf et al. 
2004). 
The  proteomes  from  3  important  bacteria  used  in  the  production  of  dairy  products; 
Lactobacillus bulgaricus, Lactococcus lactis and Streptococcus thermophiles have been 
studied for any protein changes resulting from growth in laboratory medium or in milk 
(Rechinger et al. 2000; Derzelle et al. 2005; Gitton et al. 2005). This data provides new 
information to food scientists in modifying these bacteria to achieve good food production 
practices. 
Proteomic  approaches  also  been  widely  used  to  examine  post  mortem  changes  in 
slaughtered beef and pork that affect the quality of the meat (Jia et al. 2006a,b; Sayd et al. 
2006;  Laville  et  al.  2007;  Suman  et  al.  2007).  In  addition,  the  variation  in  types  and 
amounts or proteins in seminal fluid of bull has been studied using proteomic methods 
(Kelly et al. 2006). Although it is not known yet if these findings will lead to improvement 
of bull fertility, it is likely that such methods will have a good future in animal production 
profitability. 
Because  proteomics  is  able  to  screen  large  numbers  of  proteins  simultaneously,  it  has 
become  an  important  role  at  identifying  disease  biomarkers  from  the  thousands  of 
molecules present in a tissue of body fluid (Ilyin et al. 2004; Seo & Ginsberg 2005). In 
order  for  proteomics  to  be  used  effectively  in  biomarker  discovery,  a  combination  of 
efficient  and  stringent  separation  technologies  and  high-resolution  mass  spectrometry 
(Aebersold & Mann 2003;  Rifai  et  al. 2006) are needed. Cairoli  et  al. (2006) applied 
proteomics  to  study  the  changes  in  protein  expression  in  pregnant  cows  and  in  the 
peripartum periods in cows with or without postpartum uterine infections. They found that 
both haptoglobin and orosomucoid/ʱ1-acid glycoprotein fluctuated at the time of calving. 
Orosomucoid is also known to significantly decrease in cows with endometritis compared 
with healthy cows which hold promise as a prognostic biomarker in cattle health post-
partum. Proteomics has also identified PR-39 in pigs with respiratory disease as a potential 
disease biomarker at day 21 of infection (Hennig-Pauka et al. 2006). 
1.5.2 Milk Proteomics 
Although  milk  proteins  have  been  studied  for  well  over  50  years,  only  recently  have 
proteomic techniques been widely used to study milk and milk products by separation of 
major milk proteins including caseins (ʱs1-, ʱs2-, β- and κ-casein) and whey proteins (ʱ-Chapter 1, 64 
 
lactalbumin, β-lactoglobulin and bovine serum albumin) (O‟Donnell et al. 2004; Manso et 
al. 2005).  
The milk proteome is an extremely complex entity due to the presence of several molecular 
forms of many of the proteins as a consequence of different genetic variants, changes in the 
level  of phosphorylation or  glycosylation  as  well as  the localization of PTMs  of milk 
proteins (Eigel et al. 1984). Furthermore, there are a number of lower abundance proteins 
such as lactoferrin, immunoglobulins, glycoproteins, hormones and endogenous enzymes 
(Fox & Kelly 2003) present in the milk which may also be studied by means of proteomic 
approaches. 
An early observation on bovine and human milk proteins was first reported by Anderson et 
al. (1982) using high resolution 2 DE. Major milk proteins were demonstrated in this 2D 
mapping  study  which  included  ʱ-LA,  β2-LG,  ʱ-  and  β-caseins,  4  post-transitionally 
modified  κ-chains,  para  κ-casein,  Lf  and  albumin.  Studies  by  Galvani  et  al.  (2000) 
performed  on  powdered  and  fluid  milk  samples  using  MALDI  analyses  revealed  the 
electrophoretic position of common high abundance proteins (caseins, β-lactoglobulin, etc) 
that can be found in milk and with modifications such as proteolysis, glycosylation and 
phosphorylation. 
Normally, low-abundance proteins in milk are rarely seen on traditional 2DE maps due to 
high  amount of major  proteins  in  milk  which  obscure the detection of low-abundance 
proteins. Incomplete solubilization during sample preparation can also reduce the detection 
of low abundance proteins (Manso et al. 2005).  However, low-abundance milk proteins 
account for approximately 5% of the total milk proteins and a number of studies have been 
applied on these proteins to aid in the search of their biological role and impacts on animal 
and human health (Lippolis & Reinhardt 2005; Reinhardt & Lippolis 2006; Fong et al. 
2008; Smolenski et al. 2007; Reinhardt & Lippolis 2008). Low abundance proteins are 
frequently thought to have an important role as regulatory proteins, signal transduction 
proteins, receptors and enzymes (Fox & Kelly 2003). 
An early study of low-abundance milk  proteins  was  done using human colostrum and 
mature milk samples (Murakami et al. 1998). In total, 22 low-abundance proteins were 
identified using 2DE followed by microsequencing in both human colostrum and mature 
milk samples. Interestingly, no significant difference was found on 2DE patterns of low-
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Further study on milk proteins was carried out by Yamada et al. (2002) using the same 
proteomic methods (2DE and microsequencing) but with bovine colostrum and mature 
milk. In this study, 29 low-abundance proteins were identified with several proteins being 
present  only in  bovine  colostrum such as  gelsolin, chitinase3-like 1, apolipoprotein H, 
complement  C3  and  fibrinogen  β-chain.  There  may  be  important  in  the  health  and 
development of calves during early lactation. They also observed significant difference in 
2DE  patterns  of  low-abundance  proteins  between  bovine  colostrum  and  mature  milk 
samples. 
Another study by Baeker et al. (2002) demonstrated the expression of a group of proteins 
from  the  whey  from  inflamed  mammary  quarters.  These  proteins  were  identified  by 
MALDI-TOF as isoforms of lipocalin-type prostaglandin D synthase and suggested to be a 
new biomarker of bovine mastitis. 
Low-abundance proteins in human colostrum were studied by Palmer et al. (2006) using 
2D-LC MS/MS, who found around 151 proteins of which 83 proteins were not previously 
reported.  In  this  study,  immunoabsorbents  were  applied  to  remove  the  major  proteins: 
secretory IgA, lactoferrin, alpha-lactalbumin and human serum albumin (HSA). Most of 
the  newly  identified  proteins  exhibited  many  important  functions  for  the  newborn‟s 
immunity,  growth  and  nutrition  such  as  complement  C1r-like  proteinase,  complement 
factor  I,  calgranulin  A,  calgranulin  B,  cysteine-rich  secretory  protein-3,  mucin  5B, 
neutrophil gelatinase-associated lipocalin, and uteroglobinrelated protein 2. 
The whey proteins are the soluble part of protein fractions. Major components of whey 
proteins include Igs, ʱ-LA, β-LG, lactoferrin (Lf), serum albumin and lactoperoxidase (Lp) 
(Severin  &  Wenshui  2005).  According  to  Casado  et  al.  (2009),  whey  proteins  can  be 
further separated using ultrafiltration to concentrate the proteins or generates whey protein 
concentrates (WPC) respectively.  
Proteomic approaches have been used to study whey proteins particularly in relation to the 
beneficial  effects  of  these  whey  proteins  and  their  bioactive  peptides  as  functional 
ingredients in food (Michaelidou & Steijns 2006; Toba et al. 2000). Furthermore, many 
low-abundance proteins which arise from proteolytic activity from the major milk proteins, 
extrusion or leakage from the plasma or mammary epithelia (Hogarth et al. 2004; Larsen et 
al. 2006) or are products of the somatic cells (Kelly & McSweeney, 2003 ; Paape et al. 
2003) might contribute to the health benefits of whey proteins.  Chapter 1, 66 
 
Various fractionation methods have been employed to increase the resolution of such low-
abundance proteins in whey fraction such as isoelectric focusing (IEF) (Zuo & Speicher 
2002), affinity tagging (Holland et al. 2006) and immunoabsorption (Yamada et al. 2002). 
In one study by Fong et al. (2008), the use of semi-coupled anion and cation exchange 
chromatography to fractionate whey from late-lactation milk samples into acidic, basic and 
non-bound fractions has revealed a large number of minor whey proteins which have not 
been  found  previously  in  bovine  milk  such  as  factor  XIIa  inhibitor,  tetranectin,  CD5 
antigen-like,  complement  components  C4,  C8,  C9,  factors  I  and  D  as  well  as 
nucleobindins. 
In a recent work by D‟Amato  et al. (2009), the use of a combinatorial peptide ligand 
library (CPLL) has been shown to enhance the low-abundance protein species in milk. This 
work  which  comprised  of  IEF  in  gel  followed  by  immunoblotting  with  unambiguous 
detection of polymorphic IgG revealed 100 unique gene products in milk which were not 
previously  mentioned.  In  total,  about  149  proteins  were  presented  in  a  comprehensive 
whey proteins list under a combination of untreated and treated colostrum and mature milk 
with CPLL1 and CPLL2 (library 1 and 2 respectively). 
However, Le et al. (2011) demonstrated that by using ion exchange to fractionate milk 
proteins, higher sample load was allowed which in turn, allowed more whey proteins to  be 
identified. The total of whey proteins found was double the number of proteins identified 
using CPLL with 293 proteins found in bovine colostrum and mature milk. About 217 
proteins were found in both bovine colostrum and mature milk whilst 36 proteins were 
only found in colostrum and 40 proteins came only from mature milk. Semi-quantitative 
analysis also revealed several lower-abundance proteins being up-regulated in colostrum 
such as CLU (complement system), MFGE8 (antiviral activity), CATHL1 (antibacterial 
activity),  SAA3  (acute-phase  protein),  CD5L  (immune  system),  PGLYRP1  (innate 
immunity  and  antimicrobial)  and  CFB  (complement  system)  that  function  as  natural 
defence mechanism. 
A study on human whey proteome was performed by Liao et al. (2011) using LC-MS/MS 
with enrichment methods using Proteominer Protein Enrichment Technology. Major whey 
proteins such as Lf and ʱ-LA or even casein subunits were still detected when using this 
approach but a total of 115 proteins have been identified of which 38 proteins not being 
mentioned before in human milk. These proteins were known to perform a wide variety of 
physiological  functions  in  milk.  Relative  quantification  of  these  minor  proteins  also 
showed that ʱ -1-antitrypsin, ʱ –lactalbumin, carbonic anhydrase 6, chordin-like protein 2, Chapter 1, 67 
 
galectin-3-binding  protein,  lactadherin,  lactoferrin,  prolactin-inducible  protein,  and 
tenascin were significantly expressed in higher levels in both colostrum and 1-month milk 
whey with immune modulating functions. 
Proteomic studies on milk fat globule membrane (MFGM) provide an understanding on 
lipid synthesis and secretion in the milk. By characterizing its proteins associated with this 
membrane, one may be provided with information on signalling and secretory pathways of 
the mammary gland and eventually the cellular origin of the membrane (Casado  et al. 
2009). However, MFGM is known to be highly hydrophobic and thus, solubilization is 
difficult. To overcome such problems, various solubilization strategies (Quaranta  et al. 
2001;  Cavaletto  et  al.  2002)  have  been  employed  including  the  use  of  detergent  or 
reducing agent solution as well as by extraction using organic solvent that may help to 
improve the recovery of MFGM proteome (O‟Donnell et al. 2004). 
In  early  studies,  MFGM  proteins  were  identified  as  mucins,  xanthine  oxidase  and 
butyrophilin)  by  immunological  methods  and  N-terminal  sequencing  (Cavaletto  et  al. 
2004). Mather et al. (2000) also identified MFGM proteins using traditional biochemical 
methods which were slow, laborious and addressed only one protein at one particular time. 
In  humans,  multiple  forms  of  both  butyrophilin  and  lactadherin  were  found  after 
combining  SDS-PAGE  with  sequence  analysis  (Cavaletto  et  al.  1999).  Meanwhile,  in 
bovine, major proteins associated with MFGM were demonstrated by Mather (2000) which 
includes  mucin  1,  xanthine  oxidase,  CD36,  butyrophilin,  adipophilin,  lactadeherin  and 
fatty acid binding protein. 
Several studies on human MFGM proteins have been investigated. According to Quaranta 
et al. (2001), about 23 proteins identified by microsequencing and MS analysis confirming 
the presence of lactadherin and butyrophilin as the major glycoproteins in human MFGM. 
Other proteins that have been revealed include adipophilin, disulfide isomerase ER-60, 
apolipoprotein J as well as carbonic anhydrase which were not previously mentioned in 
human milk. 
Charlwood et al. (2002) further demonstrated the presence of previously resolved MFGM 
proteins which were ʱ-LA, Lf, lysozyme precursor, β-CN, clusterin, milk fat globule EGF-
factor  8  protein  and  polymeric  IG  receptor  precursor.  By  characterizing  the  N-linked 
glycans found in MFGM proteins, multiple fucosylation products can be studied which 
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The  development  of  2-DE  database  for  human  MFGM  proteins  has  led  to  the 
characterization and identification of 107 protein spots with multiple PTMs on lactadherin, 
butyrophilin, Lf, adipophilin and carbonic anhydrase. Of these proteins, 46% were known 
previously  as  MFGM  proteins  composition,  10%  involved  in  folding  and  protein 
destination  and  another  9%  involved  in  intracellular  transport  and/or  receptor  activity. 
Also, the discovery has been made of low-abundance proteins in MFGM which involved in 
cell development and differentiation, cell motility and signal transduction. 
Reinhardt & Lippolis (2006) first reported the proteomic study on bovine MFGM which 
aimed to provide a good research foundation on the secretory mechanism of mammary 
gland in this species. They applied an extraction of MFGM using carbonate to enrich the 
intrinsic membrane proteins of MFGM and found 120 proteins from bovine MFGM. Most 
of these proteins were associated with membrane/protein trafficking or cell signalling. The 
most significant findings of this study were the presence of CD14, TLR2, and TLR4 on 
MFGM suggesting a role of protecting the mammary gland against infection. 
Later, Reinhardt & Lippolis (2008) used a more advanced proteomic approach to identify 
and measure the level of protein expression changes in MFGM from colostrum to milk on 
day 7 of lactation. An amine-reactive isobaric tag (iTRAQ) was used to quantify protein 
changes in MFGM between colostrum and day 7 milk and revealed 138 MFGM proteins in 
which  26  proteins  were  upregulated  whilst  19  proteins  downregulated  in  d  7  MFGM 
compared with colostrum MFGM. Amongst proteins that were significantly upregulated 
individually in d 7 MFGM were mucin 1 and 15, the tripartite complex of proteins of 
adipophilin, butyrophilin, and xanthine dehydrogenase as well as proteins involved in lipid 
transport  synthesis  and  secretion  (acyl-CoA  synthetase,  lanosterol  synthase, 
lysophosphatidic acid acyltransferase, and fatty acid binding protein). 
Vanderghem et al. (2008) have established a simple and fast method to purify the MFGM 
by using Zwitterionic detergents (4% (w/v) CHAPS). This method proved to remove the 
majority of skim milk proteins as no caseins were found on their 2-DE gel. A total of 230 
proteins spots were excised and analysed by MALDI-TOF/TOF and further characterized 
by  PMF  and  MS/MS.  Amongst  the  proteins  identified  were  butyrophilin,  lactadherin, 
adipophilin, xanthine dehydrogenase/oxidase and fatty acid binding proteins as previously 
mentioned. 
Over the past few years, an increasing interest in quantification of proteins in MFGM has 
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benefits in human such as anti-cancer effects (Spitsberg & Gorewit 2002), anti-bacterial 
effects (Schroten et al. 1992; Wang et al. 2001) and anti-viral effects (Murgiano et al. 
2009).  Thus,  Fong  &  Norris  (2009)  have  used  the  absolute  quantification  (AQUA) 
technique to quantify the 6 major MFGM proteins in butter milk protein concentrate. The 
released  peptides  were  measured  at  the  same  time  using  liquid  chromatography-high-
resolution selected reaction monitoring-mass spectrometry (LC-HSRM-MS). 
 Due to the importance of the MFGM efforts have been made to increase the efficiency of 
sample preparation in the protein extraction and solubilization prior to proteomic analysis 
of MFGM protein, Bianchi  et al. (2009) compared 4 different types of lysis buffers with 
different  detergents  and  chaotropes  together  with  delipidation  to  maximize  the 
visualization of MFG protein expression profile. In conclusion, delipidation, urea/thiourea 
combination and CHAPS/TritonX100 application as surfactants resulted in a proper MFG 
protein pattern visualization. In all, 82 protein spots with 42 different polypeptides were 
identified by MS and a reference 2-D map of cow MFGM was produced in this study. The 
majority of proteins identified were involved in lipid synthesis or in fat globule secretion.  
Affolter et al. (2010) have used 3 different qualitative and quantitative analytical profiling 
on two MFGM enriched milk fractions (whey protein concentrate; WPC and buttermilk 
concentrate;  BMC).  An  LC-MS/MS-based  shotgun  approach  identified  244  proteins  in 
WPC and 133 in BMP with 4 main functional categories of proteins (signal transduction, 
proteolysis, immunity and defence and lipid metabolism). A second approach using label-
free  profiling  gave  a  rapid  and  efficient  semi-quantitative  comparison  of  the  top  34 
proteins  present  in  both  fractions.  Lastly,  the  application  of  stable  isotope  dilution 
combined with LC-MRM-MS/MS technology to quantify proteins gave a highly flexible 
and adaptable analysis for a large number of proteins in a complex mixture.  
The  complexity  of  milk  in  its  protein  heterogeneity  arises  from  significant  levels  of 
phosphorylation  and  glycosylation  together  with  genetic  variation,  proteomic  analyses 
have been used for the discovery, detection and characterization of these post translational 
modifications (Baeker et al. 2002; Charlwood et al. 2002). The majority of caseins exist as 
mixture of phosphoproteins. Mamone et al. (2003) identified more than 30 phosphorylated 
caseins  using  combined  polyacrylamide  gel  electrophoresis  with  MALDI-TOF  and 
nanoelectrospray-tandem mass spectrometry (nESI-MS/MS). Holland et al. (2004) in other 
hand identified 10 forms of κ-casein at different isoelectric point (pI) values as well as two 
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Glycosylation also occurs in numerous milk proteins particularly on both N- and O-linked 
glycoproteins.  As  described  by  Holland  et  al.  (2004),  The  O-glycosylation  sites  were 
identified  by  tandem  MS  with  10  different  glycoforms  of  κ-CN  were  resolved  and 
identified. Charlwood et al. (2002) on the other hand studied the N-linked glycosylation on 
four major proteins  of the human MFGM namely  clusterin, lactotransferrin,  polymeric 
immunoglobulin receptor and lactadherin which possess a wide range of different sugar 
motifs. Proteins were separated and identified by MALDI-TOF analysis while Tandem MS 
and nESI source were used to identify the sugar constituents of isolated glycans. 
1.5.3 Proteomics on Bovine Mastitis 
Changes in the milk proteome during bovine mastitis could provide a significant insight on 
variation in protein composition that could lead to the discovery of protein biomarkers for 
bovine  mastitis.  Furthermore,  by  applying  proteomic  analyses,  it  may  be  possible  to 
identify  specific  and  potential  protein  target  for  therapies  and  immune  manipulations 
against bovine mastitis (Yong et al. 2009). 
Hogarth et al. (2004) applied pre-fractionation to remove abundant caseins from milk so 
that  proteomic  analyses  of  mastitic  whey  in  comparison  with  normal  whey  could  be 
investigated. However, despite an attempt to remove caseins, many other higher abundance 
proteins were seen from the results of this study and few low abundance proteins were 
apparent  suggesting  an  alternative  approach  to  remove  these  high  abundance  proteins. 
Serum  albumin  and  serotransferrin  were  among  the  proteins  found  to  be  present  or 
increased in mastitic whey. It is interesting to see that normal major whey proteins such as 
β-LG, ʱ-LA and the casein remnants were absent from whey samples from cases of clinical 
mastitis. 
Smolenski et al. (2007) analyzed mastitic milk for the presence of minor milk proteins 
involved in host defence mechanism. By using direct liquid chromatography-tandem mass 
spectrometry  (LC-MS/MS),  and  two-dimensional  electrophoresis  (2-DE)  followed  by 
matrix-assisted  laser  desorption  ionization-time-of-flight  (MALDI-TOF)  mass 
spectrometry (MS), several proteins involved in host defence were identified in bovine 
milk such as chaparonins, proteins secreted from neutrophils, lymphocyte proteins, DNA-
binding proteins, enzymes, transport proteins and structural proteins probably present as a 
consequence of the shedding and subsequent lysis of somatic cells in milk. A number of 
host defence proteins were also found in MFGM and there were significant differences in 
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Furthermore, Boehmer et al. (2008) successfully identified complement factors C3 and C4 
and the apolipoproteins A-IT and C-Ill in mastitic whey samples inoculated with E. coli. It 
has proved that by using 2-DE and MALDI-TOF PSD, the identification of low-abundance 
proteins  can  be  achieved  without  prior  sample  clean-up.  In  addition,  a  wide  range  of 
differentially expressed proteins were identified in mastitis whey compared with normal 
whey due to larger sample size which improve the discovery of protein biomarkers in 
coliform mastitis.  
Proteomic approaches have also been applied to study protein expression of the mammary 
gland from both normal and clinical mastitic dairy cows as done by Yang et al. (2009). Six 
differentially expressed proteins were identified by tandem MS such as haemoglobin-beta, 
κ-CN  and  Tryptophanyl-tRNA-synthetase  (TrpRS)  which  can  be  found  from  healthy 
mammary  gland  tissues  as  well  as  cytochrome  C  oxidase  and  annexin  V  which  were 
identified from mastitic mammary gland tissues.  
 
Over  the  years,  an  interest  on  quantification  of  the  abundance  of  proteins  exists  in  a 
complex biological fluid has grown tremendously. In milk, Boehmer et al. (2010) have 
applied  an  LC-MS/MS  label-free  approach  to  quantify  relative  changes  in  identified 
proteins over a time course following E. coli infection of the udder. A number of medium- 
to high-abundance proteins such as ʱS1-, ʱS2- β-, and κ-caseins and whey proteins serum 
albumin, β-lactoglobulin, and ʱ-lactalbumin were found in all whey samples at all time 
points.  In  addition  to  that,  lower  abundance  proteins  of  potential  use  as  inflammation 
markers  were  also  characterized  such  as  lactoferrin,  transferrin,  apolipoprotein  AI, 
fibrinogen, glycosylation-dependent cell adhesion molecule-1, peptidoglycan recognition 
receptor protein and cyclic dodecapeptide-1. 
Danielsen et al. (2010) have also applied quantitative proteomic approaches to assess the 
protein  differential  expression  in  the  milk  proteome  of  individual  cows  before  and 
immediately after LPS challenge. In all, 49 proteins were found to be significantly up-
regulated during LPS challenge including apolipoproteins, complement C3 and C4 as well 
as other anti-inflammatory proteins.  
Pathway analysis can be incorporated when studying the enriched proteome that emerged 
during E. coli and S. aureus responses as done by Ibeagha-Awemu et  al. (2010). The 
proteomic  profiles  of  whey  milk  from  naturally  infected  E.  coli  and  S.  aureus  in 
comparison  to  whey  from  healthy  cows  were  revealed  by  one-dimensional,  liquid 
chromatography  tandem  MS  (LC-MS/MS).  A  total  of  73  proteins  were  found  to  be Chapter 1, 72 
 
differentially  expressed  between  normal  and  whey  from  quarters  infected  with  E.  coli 
appeared to cause more significant alteration in the concentration of the affected proteins 
than S. aureus itself. The acute phase response signalling pathway was the most significant 
enriched canonical pathway in this study. In addition, more lower abundance proteins were 
identified as compared to other previous studies such as the serpins and proteins with 
binding activities (glucose phosphate isomerizes and PFN1) 
Proteolysis of casein which is known to increase in bovine milk during mastitis has been 
studied  by  Larsen  et  al.  (2010)  after  infusion  of  lipoteichoic  acid  from  S.  aureus. 
According to 2-D gel electrophoretograms, hydrolysis of β- and ʱS1-caseins occurred in 
milk 6 hours after infusion with the toxin. Those peptides were subsequently separated by 
reversed-phase HPLC and C18 columns and further identified by MALDI-TOF MS/MS. 
About 20 different peptides were successfully characterized and confirmed to originate 
from ʱS1- and β-CN. 
Proteomic  study  on  different  pathogens  causing  bovine  mastitis  could  also  provide 
important data on the proteome of bacteria isolated from mastitis cases. This could aid in 
defining specific vaccine and therapeutic targets as suggested by Taverna et al. (2007). 
They produced a (2-DE) reference map of surface associated proteins of isolated S. aureus 
from a case of bovine mastitis with protein identification using MALDI-TOF MS.  
1.6   General Peptidomics 
Peptidomics is regarded as the sequel to the proteomic technologies and is one of the new 
branches of chemical biology based on post-genomic technological platforms. The term 
peptidome refers to the whole set of endogenous peptides present in a given biological 
sample  (Ivanov  et  al.  2009)  and  peptidomics  is  a  comprehensive  study  of  all  natural 
peptides in an organism, a tissue or a body fluid (Clynen et al. 2001; Schrader & Schultz-
Knappe 2001). In the previous discussion on proteomics, 2D-PAGE is often utilized to 
separate  and  visualize  the  protein  complement  present  in  any  cells,  tissues  and  fluids 
followed  by  identification  of  expressed  proteins  by  the  MS  (Baggerman  et  al.  2004). 
However, due to major limitation of 2D-PAGE in detecting molecules between 10kDa and 
200kDa,  these  standard  proteomics  approaches  are  unsuitable  for  the  analysis  of 
peptidomes (Ramström & Bergquist 2004). It is thought that the very important groups of 
peptides and neuropeptides are outside the range of this mass region (Baggerman et al. 
2004).  Furthermore,  according  to  Schulte  et  al.  (2005),  due  to  high  complexity  and 
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detect these important endogenous peptides especially as they are often present at very low 
concentrations.  
Peptides are referred to as low-molecular weight polypeptides molecules with the mass of 
<20kDa (Ramström & Bergquist 2004, Hu et al. 2009). They are often the products of 
proteins after proteolytic cleavage of the protein precursor by active proteases that have 
very specific functions as mediators and regulators of many physiological processes in 
nervous,  endocrine,  immune  and  other  systems  (Ivanov  et  al.  2009,  Hu  et  al.  2009). 
Peptides just like proteins change dynamically according to different physiological and 
pathological  conditions  and  are  influenced  by  metabolism,  disease  states,  stress,  drug 
intervention,  genetic  modifications  and  other  external  factors  (Ivanov  et  al.  2009; 
Ramström & Bergquist 2004). Although the circulating peptides in the body fluid or tissue 
may  reflect  the  biological  events,  the  real  function  of  specific  peptides  is  frequently 
unknown and further studies were needed (Petricoin et al. 2006). According to Hu et al. 
(2009), peptides in the peptidomes are divided into two groups; first, the bioactive peptides 
that  have  important  roles  in  biological  processes  such  as  cytokines,  hormones,  growth 
factors  and  MHC  class  1  peptides;  and  second,  the  degraded  peptides  arising  from 
proteolytic cleavage. 
Peptidomics was only introduced at early 2000s after several advances in the development 
of MS techniques coupled with the completion of the genome sequences in majority of 
living  species  (Ivanov  et  al.  2009).  Subsequently,  several  fields  of  studies  have 
successfully employed peptidomic approach such as neuroendocrine studies (Baggerman et 
al. 2002; Clynen et al. 2003), biomarker discovery (Yuan & Desiderio 2005; Schrader & 
Salle  2006)  and  therapeutic  development  against  oncology,  neurodegeneration, 
osteoporosis and others (Clynen et al. 2008). 
In earlier years, the study of peptides involved the purification of peptides from tissue 
extracts with the extracted peptides being characterized by Edman sequencing (Ramström 
& Bergquist 2004). As a result of the introduction of MS, hundreds of newly identified 
peptides  were  discovered  and  sequenced  (Ivanov  et  al.  2009;  Ivanov  et  al.  2005)  and 
termed as peptide profiles (Slemmon et al. 1997) or peptide pools (Karelin et al. 1998). It 
is not an easy task to analyse peptides in a real sample due to their low concentrations, the 
complexity of the sample together with the presence of other components in the sample in 
a wide range of concentration and the availability of the analytes at different chemical 
properties (hydrophobicity, size, pI) (Ramström & Bergquist 2004). Thus, a very sensitive, 
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and able to handle a great abundance of data. The different peptidomics approaches will be 
discussed in the final chapter.  
1.6.1  The presence of peptides in bovine milk and dairy 
products 
Milk  or  dairy  products  possess  an  important  role  in  providing  the  main  nitrogenous 
nutrients in human food as it has a high content of proteins. Many breakdown products of 
proteins upon ingestion of milk proteins are called bioactive peptides (Srinivas & Prakash 
2010; Schmelzer et al. 2004). The hydrolytic reactions of digestive enzymes present in the 
gastrointestinal  system  as  well  as  in  vitro  proteolysis  by  proteolytic  enzymes  such  as 
plasmin, (Bastian et al. 1991), cysteine proteases or acid proteases (Wedholm et al. 2008) 
lead to  the production of these bioactive peptides.  Bioactive peptides  in  milk  or dairy 
products  such  as  cheese  and  yoghurt  provide  a  health  enhancing  factor  that  can  be 
incorporated  into  functional  foods  and  /or  used  as  nutraceuticals  (Meisel  &  Fitzgerald 
2003). Most of the bioactivities of these peptides remain in a latent state within the protein 
sequence and to exert their functions, proteolytic processes must be initiated (Smacchi & 
Gobbetti 2000; Srivinas & Prakash 2010). However, some of bioactive substances in milk 
are fully active as proteins (Smacchi & Gobbetti 2000). These bioactive peptides in dairy 
products serve numerous biological and physiological functions. 
The functions of bioactive peptides in dairy products have been reviewed by Smacchi & 
Gobbetti (2000) which include opioid characteristics, antihypertensive, antimicrobial and 
antithrombotic effects. Examples of these peptides include peptides from ʱS1- and β-CN 
(Maruyama & Suzuki 1982), β-lactoglobulin (Mullaly et al. 1996), ʱ-lactalbumin (Parker 
et al. 1984), and lactoferricin (Yamauchi et al. 1993). Some of these milk-derived peptides 
exert  multi-functional  activities  such  as  β-casomorphins  and  casokinins;  both  are 
Angiotensin-1 Converting Enzyme (ACE)-inhibitory and immunostimulatory (Grant et al. 
1993; Meisel & Schlimme 1994). 
Smacchi  &  Gobbetti  (2000)  have  also  produced  lists  of  bioactive  peptides  present  in 
different types of dairy products such as milk and milk hydrolysates, fermented milks and 
cheese. Proteolytic bioactivities depended upon the differentiation, functional states as well 
as the intramammary inflammation of mammary gland (Schanbacher et al. 1997). Various 
peptides were also found in fermented milk which influenced by the type of bacteria starter 
used. The production of bioactive and non-bioactive peptides during proteolytic event of 
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In  another  study,  Srivinas  &  Prakash  (2010)  have  isolated  and  characterized  the 
multifunctional properties of bioactive peptides from ʱ-CN from bovine milk. To generate 
peptides from ʱ-CN, several proteolytic enzymes were employed such as aminopeptidase, 
carboxypeptidase,  fungal  and  bacterial  proteases  and  chymotrypsin.  However, 
chymotrypsin hydrolysates were chosen as they released smaller size of peptides. Peptides 
identified  in  this  study  showed  multifunctional  properties  such  as  ACE  inhibition, 
antioxidant  activity,  propyl  endopeptidase  inhibitory  activities  and  antimicrobial 
properties. 
In terms of technical determination and characterization of proteolytic products of dairy 
products,  numerous  methods  have  been  employed.  In  early  years,  these  include 
polyacrylamide  gels  with  urea  (urea-PAGE),  denaturing  agent  (SDS-PAGE)  or  IEF 
techniques (Molina et al. 2000). With time, the separation and identification of peptides 
has been successfully performed by coupling these previous analytical techniques with the 
MS. Details on the various analytical tools on peptide studies will be discussed in the final 
chapter. 
Most  of  the  studies  on  bovine  milk  peptides  revolved  around  proteolytic  activities  on 
casein,  the  major  milk  protein.  Plasmin  has  been  regarded  as  the  main  indigenous 
proteinase in bovine milk (Bastian et al. 1991; Somma et al. 2008) and it preferentially 
cleaves  Lys-X  and  Arg-X  residues  (Le  Bars  &  Gripon  1989).  This  enzyme  activity 
increases  with  the  stage  of  lactation,  lactation  number  and  severity  of  bovine  mastitis 
(Politis et al. 1989; Schar & Funke 1986) and it leads to detrimental effects on milk quality 
due to decreased amount of intact CN.  
Recio  et  al.  (1997)  have  employed  capillary  electrophoresis  (CE)  with  hydrophilically 
coated capillary and low pH buffer containing urea to  separate proteolytic activites  of 
plasmin  and  chymosin  on  caseins.  They  identified  several  casein  breakdown  products 
which include γ1-CN A1, γ1-CN A2, γ1-CN B, γ1-CN C, γ2- CN A, γ1- CN A3, γ2- CN B, 
γ3- CN A and γ3- CN B including proteose peptones derived from different genetic variants 
of β-CN. Breakdown products of ʱS1-CN and κ-CN were also found which were produced 
by chymosin proteolysis. 
Molina et  al.  (2000) employed CE to  study the fractions  of casein  and its  breakdown 
products treated with plasmin and chymosin from three different species of animals (cow, 
ewe and goat). It showed that hydrolysis of β-casein by plasmin gives rise to γ1-CN, γ2-CN 
and γ3-CN.  Additionally, they found a decrease in the peaks corresponding to ʱS2-CN as it Chapter 1, 76 
 
was also very susceptible to hydrolyse by plasmin due to its high lysine residues (Le Bars 
& Gripon 1989). Hydrolysis of casein in cheese by chymosin and rennet was also studied 
with its main degradation products include para-κ-CN and ʱS1-I-CN. 
Another study on peptides derived from bovine β-CN by peptic cleavage was studied by 
Schmelzer et al. (2004). By using two types of MS analysis; MALDI-TOF MS with post-
decay  source  and  LC-MS/MS,  they  successfully  identified  41  peptides  with  a  high 
sequence coverage (75%). The peptides identified had lengths of between 2 and 36 amino 
acids which originated from the C-terminus of the protein. 
Somma  et  al.  (2008)  compared  two  different  approaches  between  capillary  isoelectric 
focusing (cIEF) and ultra-thin layer isoelectric focusing (ultIEF) in combination with MS 
to characterize the products of β-CN digestion by plasmin from both bovine and water 
buffalo milk samples. The presence of a novel CN breakdown product was found from the 
hydrolysis of water buffalo β-CN which was not present in hydrolysis of bovine β-CN. 
They concluded that cIEF is faster, requires shorter processing times and does not involve 
staining when compared with ultIEF technique. 
Apart  from  proteolytic  activities,  studies  of  peptides  have  also  been  employed  to 
investigate the presence of adulteration in milk or other dairy products. The most common 
fraud observed was the addition of cow‟s or sheep‟s milk to goat‟s cheese due to seasonal 
fluctuations, availability and price (Guarino et al. 2010). Thus, the need of rapid, fast and 
reliable control methods to accurately determine the level of adulteration in milk or dairy 
products is increasing. Previously, the use of immunological technique (Levieux & Venien 
1994), PCR-techniques (Bottero et al. 2003) or slab gel electrophoresis (Addeo et al. 1990) 
have been used to detect the presence of bovine milk proteins in dairy products from other 
species. However, all these techniques only provide semi-quantitative results and failed to 
detect small amounts of bovine milk proteins in ovine or caprine products (Muller et al. 
2008). Other techniques include analysis of whey proteins, chromatographic techniques 
(De Frutos et al. 1991) and UV/VIS spectrophotometric detection (Cifuentes 2006) which 
allow quantitative analysis of milk proteins. 
The fraudulent addition of rennet whey solids to dairy products can be determined by the 
detection  and  quantification  of  caseinomacropeptide  (CMP),  the  fragment  of  κ-CN 
released by chymosin during milk clotting. It should be absent in normal milk but certain 
bacterial  proteases  that  degrade  κ-CN  milk  could  give  rise  to  the  similar  degradation 
products as CMP (Recio et al. 1997). Van Riel & Olieman (1995) successfully separated Chapter 1, 77 
 
the different forms (non-glycosylated forms) of CMP in their studies. It can be concluded 
that  adulterations  of  dairy  products  with  soya  or  milk  from  different  species  can  be 
detected based on CE patterns. 
Muller et al. (2008) demonstrated the use of CE coupled with ESI-MS to determine the 
adulteration  of  ovine/caprine  milk  by  bovine  milk.  This  technique  was  chosen  due  to 
electrophoretic  clean-up  of  the  milk  samples  and  subsequent  identification  and 
quantification of latoglobulins. It was concluded that CE-MS analysis was a rapid, simple 
and accurate technique to determine and quantify amounts of bovine milk in milk of other 
species. 
Another study on adulteration of dairy products was performed by Guarino et al. (2010) in 
which LC-MS/MS has been employed to identify and quantify the percentage of sheep‟s 
milk in cow‟s and goat‟s cheeses. Plasmin was chosen over other proteolytic enzymes for 
proteolysis due to simple chromatographic separation, mass spectra analysis and simple, 
fast and widely used protocol. This method appeared to be suitable to monitor adulteration 
as it allows quantitative detection of the use of sheep‟s milk in goat‟s or cow‟s cheeses. 
1.6.2  Peptidomics in Bovine Milk/Bovine Mastitis 
Due to the importance of peptides in animal physiology, various studies have dealt with 
this approach using a wide range of samples (cells, tissues or body fluids). In total, a very 
limited  number  of  peptidomic  studies  were  done  to  analyze  the  direct  effect  of 
intramammary inflammation on the changes of levels of peptides in bovine milk. However, 
an application of various techniques of protein/peptide separation coupling with MS (as 
described  above)  can  be  used  to  study  the  proteolytic  activity  in  milk  samples  as 
proteolysis is increased during mastitis (Verdi et al. 1987). 
Apart  from  plasmin,  a  principal  milk  enzyme  which  hydrolyses  β-CN  into  γ-CN  and 
proteose peptones and to a smaller extent hydrolyses ʱS1- and ʱS2-CNs; there are a number 
of native proteinases in milk derived from somatic cells or leaked out through the damaged 
somatic cells which also contributes to proteolytic activity in bovine milk (Larsen et al. 
2006).  PMN  which  are  the  main  cellular  immune  components  that  increase  during 
infection (Azzara & Dimick 1985) contain several enzymes including serine proteases, 
cathepsin G and elastase (Kirschke & Barrett 1987; Travis 1988; Owen & Campbell 1999). 
The lysosomes of somatic cells are also thought to contain cysteine proteases (cathepsin B, 
H, L and S) as well as acid proteases (cathepsin D) (Owen & Campbell 1999). Chapter 1, 78 
 
During  mastitis,  the  increase  of  somatic  cell  counts  is  one  of  the  important  disease 
manifestations. With increasing cell counts, it was estimated that the peptide count in milk 
was  also  increased  by  a  factor  of  100  (0.03  to  2.71mg/ml)  (Lindmark-Mansson  et  al. 
2006). It is also thought that in high SCC milk, proteolysis is caused more by proteases 
apart from plasmin (Larsen et al. 2004; Kelly et al. 2006).  In cheese production, higher 
SCC contribute to lower yield and poorer quality of cheese (Grandison & Ford 1986), 
increased moisture content  of cheese and the  activity of lysosomal  enzymes  in  cheese 
(Marino et al. 2005) and less elastic with soft cheddar cheese due to degradation of ʱS1-CN 
(Creamer & Olson 1982). 
Wedholm et al. (2008) have studied the presence of peptides produced from proteolytic 
activities of different level of SCC in milk and demonstrated the responsible proteases 
based  on  their  cleavage  sites.  Using  RP-HPLC  to  separate  the  peptides  and  further 
characterized by MALDI-TOF MS/MS, peptides that successfully identified were in the 
range of mass from 1023 to 2000 Da which originated from ʱS1-, ʱS2- or β-CN. It was 
concluded that plasmin, cathepsin B, D and leucocyte elastase were responsible for these 
proteolytic activities. 
Larsen et al. (2010) studied the proteolytic cascade in a model system which used the 
bacterial lipotechoic acid (LTA) or gram-positive S. aureus to mimic inflammation of the 
mammary gland. They have also employed RP-HPLC and MALDI-TOF MS/MS in this 
study and concluded that approximately 20 different peptides were identified originating 
from ʱS1- and β-CN. The responsible proteases were plasmin, cathepsin B and D, elastase 
and amino- and carboxypeptidases.  
In  summary,  by  employing  various  methods  of  peptidomic  analyses,  the  presence  of 
peptides  in  mastitic  bovine  milk  can  be  studied  and  characterized.  These  biological 
peptides  may  contribute  to  the  discovery  of  important  and  novel  mastitis  biomarkers. 
Furthermore,  identification  of  these  peptides  may  be  applied  in  the  development  of 
therapeutic interventions of bovine mastitis. 
1.7   Animal-applied Metabolomics 
Metabolomics  is  one  of  the  new  technologies  that  has  gained  interest  and  can  be 
considered as important as other “-omics” studies such as genomics, transcriptomics and 
proteomics.  The metabolome is a set of low-molecular weight metabolites that are present 
in  a  biological  fluid,  cell  or  organisms  under  different  physiological  states  (Alvarez-Chapter 1, 79 
 
Sanchez et al. 2010). According to Kell (2006), metabolomic analysis is more promising 
for several reasons. Metabolites appear to be in smaller sizes, thus the sample processing 
can be reduced as compared to genes and proteins. It is also evident that preparation for 
metabolic profiling is less expensive than proteomics and more samples can be analysed to 
provide a good and reliable results and finally metabolomic technology is more generic 
than any other analysis. 
A problem that the metabolomic analysis faced is lack of comprehensive and standardized 
methods. In order to make sure a generalized detection and identification of metabolites, an 
integration  of  various  analytical  approaches  is  being  made  [e.g.,  gas  chromatography 
combined with mass spectrometry (GC-MS), liquid chromatography combined with mass 
spectrometry (LC-MS) and nuclear magnetic resonance(NMR)]. 
The implementation of metabolomics in milk and investigations of the pathophysiology of 
animal diseases has not been the objective of much research. To date, there is no major 
study on the metabolomics in bovine mastitis but there are relevant publications. 
Metabolomic  analysis  has  been  used  in  milk  in  order  to  monitor  a  whole  range  of 
metabolic  processes.  One  classical  metabolomic  measurement  approach  is  by  using 
chromatography  (Martens  et  al. 2007) to  analyse the fatty  acid  profile  in  bovine milk 
sample where it was used to quantify with variation in their chain lengths and unsaturation 
properties.  
Another  study  by  Boudonck  et  al.  (2009)  revealed  the  use  of  liquid  and  gas 
chromatography  that  successfully  identified  over  223  metabolites  between  10  different 
milk varieties.  Metabolic profiling was shown to possibly provide a distinct biochemical 
signature in different types of milk and a specific marker could be assigned which could 
describe specifically for particular milk. 
Apart  from  examining  milk  metabolomics,  the  method  has  been  applied  to  a  few 
investigations  of  animal  models.  Metabolomic  analyses  have  been  used  to  study  the 
metabolic changes in canine liver disease (Whitfield et al. 2005). Plasma samples were 
analysed using LC-MS and metabolites that were identified to increase significantly with 
liver disease were the taurine conjugates of the bile acids, cholic and chenodeoxycholic 
acids  whilst  16:0-,  18:2-  and  18:0-lysophosphatidylcholine  were  decreased  in  diseased 
animals.  This  analysis  was  able  to  distinguish  animals  with  congenital  portovascular 
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Bertram et al. (2004) have studied splanchnic metabolism in cattle using proton nuclear 
magnetic resonance (H NMR) from arterial, portal and hepatic plasma. It was concluded 
that the methyl groups of propionate, 3-β-hydroxybutyrate and lactate were increased in 
spectral intensities in the H NMR portal plasma samples. As for hepatic plasma samples, 
due to hepatic uptake of short fatty acids (n-butyrate, propionate, iso-butyrate, valerate and 
iso-valerate),  there  was  reduced  in  spectral  intensities  of  these  regions.  In  addition,  a 
hepatic  excretion  of  β-hydroxybutyrate  and  glucose  resulted  in  increased  in  spectral 
intensities of these regions. These spectral differences can be used to describe changes in 
metabolites which could be supported by biochemical analyses. 
In  another  study  by  Bertram  et  al.  (2009),  they  have  used  the  similar  approach  to 
investigate  propylene  glycol  toxicosis  in  a  Holstein  cow.  However,  no  significant 
metabolite  differences  could  be  detected  in  the  biofluids  of  the  cow  which  developed 
toxicosis. It could be due to the vitality of the metabolites or they might be present below 
the  detection  limit  of  NMR.  Although  there  was  a  decreased  in  content  of 
isopropanol,isobutyrate, β-hydroxybutyrate, acetate, acetone and acetoacetate shortly after 
feeding with propylene glycol, it might be due to reduce in fermentation activity in the 
rumen as well as reduce absorption in ruminal atony. It can be concluded that shallow 
breathing manifested by the affected animal was due to pulmonary vasoconstriction from 
the  sulphur-containing  compounds  produced  during  fermentation  of  propylene  glycol. 
However, no sulphur-containing compounds were observed in the NMR spectra. 
The influence of different lactation stages on physiological and metabolic variables has 
been  studied  by  Klein  et  al.  (2010)  using  high  resolution  nuclear  magnetic  resonance 
(NMR) and mass spectrometry (MS). They have identified 44 milk metabolites in milk 
samples  from  individual  cows  during  early  and  late  lactation  with  an  emphasis  on 
metabolites related to energy metabolism. There was a large difference in the levels of 
acetone and β-hydroxybutyrate (BHBA) during early lactation. These two compounds are 
important  biomarkers for subclinical  ketotic conditions.  The large discrepancies values 
suggest that different individual animals cope very differently with the metabolic stress 
during this period and it is highly true for high-producing animals. 
In conclusion, the new technology of metabolomics has made it possible for researchers to 
study the effect of disease progression on the metabolome and could provide new, low 
molecular weight biomarkers to assess the health condition of animals. However, due to 
high diversity and variability of metabolome, there are no available analytical platforms 
that  can  define  metabolites  simultaneously  (Dettmer  et  al.  2007).  Thus,  an  efficient Chapter 1, 81 
 
sampling  and  separation  of  metabolites  should  be  achieved  so  that  low-abundance 
metabolites  can  be  detected  with  the  use  of  small  sample  volumes.  Furthermore,  data 
analysis  and  visualization  tools,  libraries,  and  databases  for  metabolomics  need  to  be 
developed so that standardization in data analysis can be achieved. 
1.7.1  Metabolites found in bovine milk 
A number of studies have been performed to evaluate the presence of metabolites in bovine 
milk with earlier, non-metabolomic methods. Investigations which compared the presence 
of metabolites between mastitic milk samples and healthy milk samples (assuming low 
somatic cell counts and negative microbiological culturing) will be discussed further in 
Chapter 5, Section 5.1.2.  
Amongst many metabolites found in bovine milk, fatty acids are one of the important 
molecules  in  milk.  About  96%  of  lipid  in  bovine  milk  are  triacylglycerols  and  were 
comprised of a molecule of glycerol and 3 esterified fatty acids (Jensen 1995). Fatty acids 
on the other hand are composed of 3 different groups based on the number of double bonds 
present in their chemical structure. They are saturated fatty acids (SFA), monounsaturated 
fatty acids (MUFA) and polyunsaturated fatty acids (PUFA). MUFA and PUFA form the 
unsaturated group of FA (UFA) (Soyeurt et al. 2011). Previously, the level of FA in milk 
was determined by GC after an extraction, followed by saponification and transmethylation 
but  this method was  expensive and time consuming. Thus, Soyeurt  et  al. (2011) have 
proposed to use mid-infrared spectrometry to quantify the individual content of FA in 
bovine milk. Ferrand et al. (2011) have also performed a mid-infrared spectrometry to 
estimate the main fatty acids in bovine milk by applying the genetic algorithm method to 
improve  the  quality  of  estimation.  The  variation  observed  in  the  milk  fatty  acid 
composition was determined by several factors such as diet; forage to concentrate ratio 
(Griinari et al. 1998) and intake of unsaturated fatty acids (Dhiman et al. 1999) as well as 
seasonal  which  consequently  affected  the  dietary  intake  of  the  cows  (Lock  and 
Garnsworthy 2003). 
An earlier study on the metabolite levels and enzyme activities in bovine mammary gland 
has  been  studied  by  Waldschimdt  and  Rilling  (1973)  at  different  stages  of  lactation. 
Previously, studies have been focussed on the mammary gland of laboratory animals for 
example rats (Wang 1960; Baldwin & Cheng 1969). This study however determined the 
level of metabolites in the udders of heifers and cows at peak and near the end of lactation 
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different stages of lactation but quantities of malate, ATP and ADP were higher in cows 
with high milk yields. Additionally, pyruvate levels showed variations with season whilst 
the NAD: NADH ratios in mammary cytoplasm showed no significant differences between 
different groups of cattle. ATP: AMP ratios in mammary gland tissues were highest in 
lactating animals. 
Hollis et al. (1981) studied the presence of vitamin D and its metabolites which include 25-
hydroxyvitamin  D,  24,25-dihydroxyvitamin  D,  25,26-dihydroxyvitamin  D  and  1,25-
dihydroxyvitamin D in both human and bovine milk using chromatographic purification 
method coupled with ligand-binding assay. It is known that these antirachitic sterols in 
milk were the same as those in plasma though the concentration in milk is much lower. 
They are secreted into the milk, bound to plasma and/or cytosol binding proteins (e.g. 
vitamin D binding protein). Eventually these sterols migrate from the aqueous portion to 
the fat portion of the milk. Furthermore the levels of anticharitic sterols appear to be linked 
with dietary intake of these sterols. 
With  the  use  of  reverse-phase  high-performance  liquid  chromatography  (RP-HPLC) 
Tiemeyer et al. (1984) determined all pyrimidine and purine compounds in milk to relate 
the  nucleic  acid  metabolites  to  different  rates  of  protein  biosynthesis.  Biosynthesis  of 
proteins in the mammary gland is often accompanied by nucleic acids biosynthesis and 
degradation  and consequently  a turnover of pyrimidine and purine compounds.  In this 
study,  it  was  established  that  bovine  milk  contains  nucleosides  (uridine,  cytidine, 
pseudouridine) and free bases (hypoxanthine) as well as ortic and uric acids. There are 
mainly  two  sources  of  metabolites  in  the  milk;  1)  derived  from  mammary  cell  and 
leukocytes or 2) possibilities of 5‟-nucelotidase activity on the cell surface as described for 
blood  cells.  There  are  also  two  groups  of  metabolites  based  on  the  influence  of  milk 
production;  1) metabolites  which are not  affected by milk  yield (hypoxanthine,uridine, 
cytidine and pseudoridine) and 2) decrease in amounts with increase in the rate of milk 
production (orotic acid, uric acid and allantoin). The close correlation between the milk 
yield and protein secretion showed that high milk production were also accompanied by 
increase rates of nucleic acid turnover which eventually lead to accumulation of nucleic 
acid metabolites in both mammary cells and in milk. This study showed rate-limiting steps 
in the catabolic pathways of pyrimidines and purines with its relationship with protein 
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1.8  Aims of study 
In the past few decades, it has been shown that various studies were employed for protein 
analysis in bovine milk as well as in bovine mastitis. Although clinical mastitis cases have 
been widely studied, it is important to take into account the subclinical cases of mastitis for 
the discovery of important protein biomarkers of mastitis. With the development of new 
and advanced non-gel approaches (peptidomics and metabolomics), a number of lower 
molecular weight molecules such as peptides and metabolites can be discovered which are 
significant in detecting the presence of bovine mastitis. Thus, the overall objective of this 
study is to apply various proteomic and other non-gel methodologies (peptidomics and 
metabolomics) to discover significant disease biomarkers in bovine mastitis. 
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 Chapter II: Acute Phase Proteins in Bovine 
Mastitis 
2.1  Introduction 
2.1.1  Bovine Acute Phase Proteins and Acute Phase 
Reactions  
As described in Chapter 1, Section 1.4, acute phase proteins (APP) are a group of blood 
proteins that are synthesized and change in concentration following various stimuli such as 
infection,  inflammation,  surgical  trauma,  stress,  neoplastic  growth  or  immunological 
disorders (Gordon & Koy 1985; Gruys et al. 1999, Murata et al. 2004) which initiate the 
acute phase reaction (APR) which is also part of non-specific innate immune responses 
that involves restoration of homeostasis and inhibits the growth of pathogens (Murata et al. 
2004; Eckersall & Conner 1988).  
Following  internal  or  external  challenges,  the  body  reacts  by  the  release  of  pro-
inflammatory cytokines as well as the activation of vascular system and inflammatory cells 
at the site of microorganism invasion (Gruys et al. 2005). The systemic reaction activated 
by cytokines caused an induction of hepatic metabolism which leads to the released of APP 
(Gruys et al.1994). Of the pro-inflammatory cytokines, interleukin-6 (IL-6), interleukin-8 
(IL-8), tumour necrosis factor α (TNFα) and interleukin-1β (IL-1β) are known to mediate 
the synthesis of APP (Nakagawa-Tosa et al. 1995; Alsemgeest et al. 1996; Yoshioka et al. 
2002). Some of the APPs are increased during the APR while others, such as albumin, 
transthyretin (TTR, formerly called prealbumin), retinol binding protein (RBP), cortisol 
binding  globulin,  transferrin  and  albumin,  which  represent  the  negative  APPs,  are 
decreased (Eckersall & Conner 1988; Gruys et al. 2005). The positive APPs, which are 
mainly glycoproteins synthesized by hepatocytes, include haptoglobin, C-reactive protein 
(CRP), SAA, ceruloplasmin, fibrinogen and α 1-acid glycoprotein (α1-AGP) (Murata et al. 
2004; Gruys et al. 2005).  
 
Overall, the released of APP during inflammatory condition helps to bind and remove 
harmful substances following tissue damage, to protect host from further damage and lastly 
to eliminate pathogenic organisms (Baumann & Gauldie 1994). Chapter 2, 85 
 
 
2.1.2  Bovine Haptoglobin 
Haptoglobin (Hp) is a major APP in bovine which strongly binds to haemoglobin, has anti-
inflammatory properties and binds to CD11b/CD18 receptor of effector cells (El Ghmati et 
al. 1996). It also reduces the oxidative damage associated with haemolysis (Yang et al. 
2003). Upon binding with haemoglobin (Hb), this stable complex of Hp-Hb is scavenged 
by phagocytes after recognition via CD 163, the specific surface receptor on macrophages 
(Schaer et al. 2002).  
 
Bovine plasma Hp was recognized by Liang (1957) and Neuhaus and Sogoian (1961). 
However, negligible levels of Hp are seen in healthy cows with physiological levels in the 
plasma being less than 0.1mg/ml (Ritcher 1974). Upon immune stimulation, its circulating 
level can increases up to 100-fold (Conner et al. 1988; Conner et al. 1989).  
 
Other  than  binding  to  haemoglobin,  Hp  also  has  an  inhibitory  effect  on  granulocyte 
chemotaxis, phagocytosis and bactericidal activity (Rossbacher et al. 1999). According to 
Xie et al. (2000), Hp is able to prevent spontaneous maturation of epidermal Langerhans 
cells or suppress T-cell proliferation (Baseler and Burrell 1983). 
 
Hp is often associated with inflammatory conditions in cows. Increased Hp levels were 
seen in cattle with mastitis (Spooner & Miller 1971; Conner et al. 1986), liver abscesses 
and  other  inflammatory  diseases  including  pyometra,  reticulitis,  traumatic  pericarditis 
(Panndorf et al. 1976; Makimura & Suzuki, 1982). Moreover, detection of Hp as a highly 
polymeric complex with Hb was found in cattle with acute inflammation (Morimatsu et al. 
1991). APP was not stimulated by viral diseases for example in inflammation by rinderpest 
virus (Spooner & Miller 1971) or in bovine leukosis (Panndorf et al. 1976). However, 
Eckersall et al. (1988) found smaller Hp response in some viral infections compared with 
bacterial infections. Just like any other APP, Hp concentration can be used to determine the 
severity status of the disease and the extent of tissue damage in affected cows (Murata et 
al. 2004). Thus, Hp has the potential on being a significantly useful parameter to measure 
the occurrence and severity of inflammatory responses. 
 
Apart  from  infection,  the  level  of  Hp  is  raised  in  cows  with  fatty  liver  syndrome 
(Yamamoto  et  al.  2000;  Katoh  2002),  by  starvation,  from  dexamethasone  treatment 
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with travelling (Murata & Miyamoto 1993). However, Skinner et al. (1991) found that in 
cows  with  normal  births,  there  was  no  significant  increase  in  Hp  indicating  that  Hp 
elevation at parturition is due to infection rather than trauma.  
2.1.3  Haptoglobin in bovine mastitis 
Bovine Hp has been demonstrated to be a selective indicator for the acute phase responses 
in  animals.  Skinner  et  al.  (1991) demonstrated that Hp can be used to diagnose early 
bacterial infection, particularly mastitis. The Hp test is also known to be accurate, can be 
performed  quickly  and  has  similar  sensitivity  as  other  major  bovine  APP;  the  SAA 
(Boosman  et  al  1989).    Skinner  et  al.  (1991)  concluded  that  the  concentration  of  Hp 
between 0.2g/litre-0.4g/litre and above was an indication of infection. 
 
Many studies have demonstrated that bovine Hp is one of the important APPs that could be 
used to diagnose bovine mastitis. It also has been proven that serum Hp levels raised with 
both experimental and naturally occurring diseases (Conners et al. 1986; Salonen et al. 
1996; Hirvonen et al. 1996; Skinners et al. 1991; Hirvonen and Pyorala 1998; Eckersall et 
al. 2001; Ohtsuka et al. 2001).  
 
Previously, serum bovine Hp was used to investigate its potential in diagnosing bovine 
mastitis. This is due to the fact that Hp is liver-derived protein (Koj 1974), synthesized by 
the hepatocytes in the event of acute phase reaction. As described previously, during the 
activation of acute phase reactions, the concentration of Hp can increase up to 100-fold 
from its normal level. Furthermore, its level in the normal serum is negligible and thus, the 
measurement of bovine Hp in serum has been used to analyse the effect of acute phase 
reaction during inflammatory processes. The increase of bovine serum Hp concentrations 
during mastitis is supported by various studies (Conner et al. 1986; Salonen et al. 1996; 
Horadagoda et al. 1999; Ohtsuka et al. 2001). 
 
However it is now known that Hp can be detected in milk during mastitis.  The first study 
that determined the presence of Hp in milk was performed by Eckersall  et al. (2001). 
Measuring Hp level in milk to investigate the presence of intramammary inflammation was 
suggested to provide a more readily and accessible indication of infection. According to 
Nielsen et al. (2004), the use of APP in milk to assess the APR following inflammatory 
processes provides a more specific and sensitive diagnostic method than bacteriology and 
it is less influenced by the physiological stage of the cow than SCC or EC (Sheldrake et al. 
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serum Hp occurred during mastitis, it was not specific as increases in serum APP can be 
due to other acute inflammatory conditions, but measuring Hp in milk provides specificity. 
 
It is first thought that an increased of Hp level in milk during bovine mastitis was due to 
transfer of these serum proteins synthesized largely by the hepatocytes into the mammary 
gland due to increased permeability of blood-milk barrier (Eckersall et al. 2001). This is 
based on the presence of other types of serum proteins such as serum albumin and protease 
inhibitor α-antitrypsin in the infected quarters as reported by Honkanen-Buzalski et al. 
(1981) and Honkanen-Buzalski & Sandholm (1981). Grӧnlund et al. (2003) also stated it 
was not clear whether APP found in the infected milk are locally produced or by an influx 
of  these  proteins  from  blood  due  to  the  change  in  the  permeability  of  the  blood-milk 
barrier. 
 
However, Nielsen et al. (2004) suggested that higher Hp concentrations in the milk from 
infected quarters could be due to the production of these proteins by the mammary tissues. 
They also suggested that increased serum Hp concentration in the cows with mastitis was 
due to the access of Hp synthesized by the mammary tissues to the blood serum. Hiss et al. 
(2004) confirmed that bovine mammary gland can be considered as another extrahepatical 
source of Hp based on the observed Hp mRNA in mammary gland tissues (the teat, the 
cisternal region, the glandular parenchyma). The authors also suggested that the migrated 
leukocytes might contribute or solely account for the detection of Hp mRNA. Thielen et al. 
(2005)  further  demonstrated  that  Hp  mRNA  was  present  in  bovine  peripheral  blood 
leukocytes  and  milk  somatic  cells  and  confirmed  that  leukocytes  are  another  cellular 
source of mammalian Hp mRNA expression.  
 
When comparing the increased level of Hp in milk to that of serum, it was found that the 
former occurred at 15h after experimentally induced mastitis by S. aureus while the earliest 
detection of increased serum Hp was at 24h postinfusion. Blood was therefore unlikely to 
be the source of immediate Hp elevation in milk (Eckersall et al. 2006). The probability of 
local production of Hp in the mammary gland was further supported by quantitative RT-
PCR. 
 
A study by Lai et al. (2009) proposed that Hp levels correlated well with SCC in bovine 
milk due to the fact that SCC >500 000 cells/ml indicated 10-fold increase in milk Hp 
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>500 000 cells/ml, are the major source of Hp synthesis. As the conclusion, Lai et al. 
(2009) suggested four combined pathways for the presence of Hp in milk during mastitis 
which were: activation and migration of neutrophils by inflammatory cytokines into the 
infected mammary gland where they secrete cellular Hp; direct entrance of plasma Hp into 
mammary  epithelial  cells  via  a  receptor-mediated  process  and  secreted  into  alveolus; 
passive diffusion of plasma Hp into udder; endogenous synthesis and expression of Hp by 
mammary epithelial cells. 
 
Åkerstedt et al. (2007) found the presence of Hp was significantly more common at higher 
SCC in quarter and composite milk samples but not in bulk tank milk samples due  to 
dilution that took place from quarter to bulk tank level.  
2.1.4  Quantification of bovine Hp 
The determination of bovine serum Hp was first demonstrated by Bremner (1964) but the 
concentrations were too low to be detected in healthy cattle but local inflammation induced 
by turpentine injection was able to increase the level of Hp in serum. Various types of 
assays  have  been  described  to  determine  Hp  levels  directly  or  indirectly.  There  were 
haemoglobin binding assay (Owen et al. 1960) modified by Jones & Mould (1984) using a 
microtitre plate format while Skinner et al. (1991) used an automated method based on an 
RA500  analyser.  Immuno  assay  has  also  been  described,  for  instance  single  radial 
immunodiffusion (Morimatsu et al. 1992). It is known that Hp binds with free Hb with 
high affinity. Measurement of the inherent Hb peroxidase activity which is protected from 
acid inactivation by formation of the Hb-Hp complex was used to determine Hp levels in 
plasma  (McNair  et  al.  1995).  Amongst  many  methods  Hb  binding  assay  is  the  most 
common method used to determine Hp level in cattle. 
 
Makimura  &  Suzuki  (1982)  determined  the  level  of  Hp  by  performing  the  modified 
method of Tarukoski 1966 based on the peroxidase activity of haptoglobin-haemoglobin 
(HpHb)  complex.  This  modified  method  provided  more  reliable  values  even  for 
haemolysed serum samples. Polyacrylamide gel disc electrophoresis (PAGE) employed in 
this study only provided a qualitative but simple and reliable method to determine Hp. 
 
However, due to bovine Hp being highly polymerised polymorphic protein (Eckersall & 
Conner 1990; Morimatsu et al. 1991), it can disturb both Hb-binding and immunochemical 
assays  (Salonen  et  al.  1996)  due  to  its  large  and  heterogeneous  molecular  sizes. Chapter 2, 89 
 
Depolymerisation of bovine haptoglobin with 2-mercaptoethanol produced homogenous 
haptoglobin with a high cyanmethaemoglobin (HbCN)-binding capacity.  
 
Hp can also be analysed photometrically based on the principal that cyanomethaemoglobin 
(HbCN) when bound to Hp was protected from denaturation in an acidic medium (formate 
buffer, pH 3-7) as described by Elson (1974). Studies by Salonen et al. (1996), Hirvonen et 
al. (1996) and Hirvonen et al. (1997) used this photometric assay to analyse serum Hp and 
the absorption of the acidified Hp-HbCN complex was measured at 405nm (Harvey 1976) 
and 380nm for the sample blank. The haemoglobin binding capacity was calculated in 
order to determine Hp concentrations. 
 
High performance liquid chromatography (HPLC) can also be used to analyse serum Hp 
by binding of depolymerised Hp by excess HbCN and separating Hp-HbCN complex and 
free HbCN by gel filtration on HPLC (Salonen et al. 1996). This method proved not to be 
influenced by haemolysis in the sample, haemoglobin is converted to HbCN by Drabkin’s 
solution and the excess did not interfere with the assay thus making it more sensitive and 
reproducible than that of photometric assay in detecting bovine serum Hp.  
 
Due to the development of monoclonal antibodies specific for bovine Hp (Sheffield et al. 
1994; McNair et al. 1995; Godson et al. 1996), antibody-based methods promised the 
advantages  of  direct  and  specific  measurement  of  Hp  (McNair  et  al.  1997).  Indeed, 
Sheffield et al. (1994) used monoclonal antibody against bovine Hp in ELISA to measure 
bovine Hp level in sera.  
 
Morimatsu  et  al.  (1992) developed a single radial immunodiffusion method  (SRID) to 
overcome  problems  of  measuring  bovine  serum  Hp  using  Hb-binding  assay.  Purified 
bovine Hp from acute phase bovine sera and specific antisera from rabbits were used in 
this method. Hp was treated with 20mM cysteine or glutathione (GSH) to partially reduce 
the Hp to smaller molecules or homogenous form.  
 
McNair et al. (1995) introduced a highly sensitive and specific competitive time resolved 
fluorimetric assay to determine bovine serum Hp. It was shown to enhance the level of 
detection using a solid phase competitive immunoassays in combination with lanthanide 
chelate labelling. This method used mouse monoclonal antibody (1D9) specific for bovine 
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superior  sensitivity  when  compared  with  Hp  binding  assay  since  there  was  a  direct 
measure of Hp by specific antibody while the Hp binding assay peroxidase activity may be 
affected by the presence of haemoglobin, active and inactive forms of Hp (Cerda & Oh 
1990) and other serum peroxidase inhibitors such as cysteine and glutathione. 
 
Young et al. (1995) further developed the immunoassay described by Sheffield (1994) 
using either three formats; (a) a direct binding format; (b) a direct Hb binding format and 
(c) a competitive inhibition Hp immunoassay. These three formats provide simple, rapid 
results  but  with  different  reproducibility.  Furthermore,  the  reagents  used  in  these 
immunoassays were inexpensive, non-hazardous and readily available. It was concluded 
that Format b gave a very good correlation with Hp levels determined by the standard 
peroxidase activity method with good precision and reproducibility as compared with other 
two formats. 
 
Immunoassay detected elevated Hp concentrations (62.5%) compared with binding assay 
(19.5%)  although  a  close  relationship  (r=0.94)  was  found  between  the  two  methods 
(McNair et al. 1997).  
 
However the majority of methods available relate to its measurement in serum and cannot 
be  used  to  measure  Hp  in  milk  due  to  lack  of  sensitivity  of  the  test  and  interfering 
substances present in the milk which can overestimated its concentration in milk (Eckersall 
et  al.  2001).  Milk  Hp  may  be  quantified  using  agarose  immunodiffusion  plates  as 
performed by Eckersall et al. (2001). 
 
Subsequently,  several  studies  have  employed  the  use  of  ELISA  to  measure  milk  Hp 
(Grӧnlund et al. 2003; Nielsen et al. 2004; Eckersall et al. 2006; Safi et al. 2009; Milica et 
al. 2010; Larsen et al. 2010; Haghkhah et al. 2010) but Hiss et al. (2004) claimed that the 
immunodiffusion assay and the sandwich ELISA were not sensitive enough to detect Hp 
level in milk from healthy cows. They eventually established an ELISA for bovine Hp that 
is highly sensitive to detect Hp levels in milk from healthy cows throughout lactation and 
physiologically increased Hp levels (e.g; colostrum) (Hiss et al. 2004). 
 
In contrast, ELISA measurement of bovine milk Hp was said to be unsuitable for routine 
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appeared to be rapid and sensitive based on the interaction between Hp and Hb using 
surface plasmon resonance (SPR) biosensor technology. 
2.1.5  Bovine Serum Amyloid A (SAA) 
The other major bovine APP is SAA which is an acute phase protein complexed to high 
density lipoprotein (HDL) as an apolipoprotein in serum (Benditt & Eriksen 1977; Skogen 
et al. 1979; Husebekk et al. 1988). In order to form a complex with HDL, it has to compete 
for the binding sites with other apoproteins (Husebekk et al. 1987). However, a study by 
Husebekk et al. (1988) found that no formation occurred of complexed amyloid A (AA) 
protein-HDL  which  suggested  removal  of  SAA  from  the  HDL  complexes  before 
degradation to amyloid A in amyloid deposits took place. Serum amyloid A (SAA) is 
thought to be a precursor protein for AA, a major constituent in bovine amyloid fibrils 
(Husebekk et al. 1985).  However, one of the most important features of SAA is that it can 
increase  more  than  one  hundred-fold  in  concentration  during  inflammatory  reactions 
(Horadagoda et al. 1999). 
 
The molecular weight of SAA in its native form is estimated at 18 kDa (Pepys & Baltz 
1983). SAA is involved in the transport of cholesterol from dying cells to hepatocytes 
(Liang & Sipe 1995), has an inhibitory effect on fever (Shainkin-Kestenbaum et al. 1991), 
on the oxidative burst of neutrophilic granulocytes (Linke et al. 1991) and on in vitro 
immune response (Aldo-Benson & Benson 1982; Benson & Aldo-Benson 1979). It has a 
chemotaxic effect on monocyte, polymorphonuclear leukocytes and T cells (Badolato et al. 
1994; Xu et al. 1995), induction of calcium mobilization by monocytes (Badolato et al. 
1995) and inhibition of platelet activation (Zimlichman et al. 1990)  
 
SAA  is  synthesized  predominantly  in  the  liver  with  an  induction  of  various  pro-
inflammatory cytokines such as IL-1, IL-6 and TNF-α (Jensen & Whitehead 1998; Sipe 
2000). It is also known to be produced extra-hepatically; by macrophages, endothelial cells 
and smooth muscle cells (Dibartola & Benson1989), intestinal epithelium (Vreugdenhill et 
al. 1999) as well as mammary epithelial cells (McDonald et al. 2001). 
 
According to Nazifi et al. (2008), several isotypes of SAA are found in bovine; type 1 and 
2 which represent positive acute phase proteins in bovine, while Jacobsen et al. (2004) also 
successfully determined different types of SAA isoforms in plasma/serum of cows with 
mastitis. The acute phase response also caused hepatic expression of SAA1 and SAA2 
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(1998).  Meanwhile,  in  a  range  of  human  tissues  which  include  breast,  pancreas  and 
intestine, the mRNA encoding SAA1, SAA2 and SAA 4 proteins has been detected by in-
situ hybridization (Urieli-Shoval et al. 1998).  
 
Amongst  many  isoforms,  SAA3  seems  to  be  the  predominant  SAA  isoform  in  most 
mammals which expressed the protein extra-hepatically (Ramadori et al. 1985; Meek and 
Benditt 1986; Benditt and Meek 1989). McDonald et al. (2001) discovered the mammary-
associated SAA3 (M-SAA3) isoform with a pI value of 9.6 was present in high levels in 
colostrum of equine, bovine and ovine. Although it is found in high concentrations in 
colostrum, M-SAA3 expression in the mammary gland is part of natural physiological 
process  that  is  not  only  limited  in  disease-associated  responses.  Its  presence  provides 
beneficial effects for the newborn as well as for the maintenance of mammary gland. 
2.1.6  Serum Amyloid A in Bovine Mastitis 
SAA as discussed previously can be used as a marker of tissue injury in cows (Horadagoda 
et al. 1999) and thus is considered to be a potential diagnostic marker due to its low level 
in normal animals but with a significantly increased concentration during an acute phase 
response and a later decrease in concentration with the resolution of the disease (Gruys et 
al. 1994).  
 
SAA response during inflammation/infection is known to be longer in duration when there 
were co-infections with virus and bacteria rather than in pure viral infections (Ganheim et 
al. 2003). Its magnitude and duration also depended on the severity of the clinical signs 
(Ganheim et al. 2003; Heegaard et al. 2000). 
 
The reliability of SAA in comparing between acute and chronic inflammation has been 
studied  by  Horadagoda  et  al.  (1999)  where  it  was  observed  that  SAA  levels  were 
significantly  higher  in  cows  with  acute  inflammation  than  in  cows  with  chronic 
inflammation. It was proved that SAA was the most reliable indicator in differentiating 
cattle  with  acute  and  chronic  inflammation  and  confirmed  that  the  use  of  APP 
measurement  was  better  than  a  haematological  test,  such  as  neutrophil  count  for  the 
presence of infection. 
 
Many studies have been done in order to investigate the potential of SAA as one of the 
important disease markers in bovine mastitis. Eckersall et al. (2001) first measured the 
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measurement of SAA in milk is able to discriminate between mild and moderate mastitic 
cows compared with SAA in serum. The ability of the SAA in providing sensitive results is 
due to the local synthesis of SAA in the mammary gland or milk which induces a greater 
response in moderate mastitis. The presence of different isoform of SAA in mammary 
gland  was  confirmed  by  McDonald  et  al.  (2001)  in  which  M-SAA3was  identified  in 
healthy bovine colostrum.  There is debate on the naming of the isoform in milk.  While it 
should be named M-SAA3 if it can be definitely identified as this isoform, most assays 
measure  all  isoforms  and  here  it  will  be  referred  to  as  M-SAA3  depending  on  the 
publication being cited. 
 
As shown by Grӧnlund et al. (2003), SAA levels in serum elevated dramatically during 
acute mastitis but these results can be due to other acute inflammatory conditions (Conner 
et al. 1988; Heegaard et al. 2000).  Compared with the results from Horadagoda et al. 
(1999), Grӧnlund et al. (2003) found much lower levels in serum APPs during chronic 
phase of mastitis than serum APP levels during acute mastitis. Milk serum amyloid A3(M-
SAA3)  however  provided  a  good  marker  in  chronic  subclinical  mastitis  as  it  was 
significantly higher in infected quarters than in pre-infected and healthy udder quarters 
(Grӧnlund et al. 2003). 
 
To be useful as a mastitis indicator, SAA needs to accumulate in milk during episodes of 
intramammary infection (Nielsen et al. 2004). Its high level in milk was found to coincide 
with  the  onset  of  clinical  signs  of  acute  mastitis  as  well  as  increases  in  SCC  in  milk 
(Grӧnlund et al. 2003).  However, in some cases, APPs in milk started to be elevated in 
concentration  in  milk  from  clinical  mastitic  cows  even  before  the  SCC  started  to  rise 
(Hogarth  et  al.  2002).  This  is  in  agreement  with  Pedersen  et  al.  (2003)  where  the 
concentration of M-SAA3 increased prior to increase in SCC in cows induced with S. 
uberis. 
 
High  levels  of  SAA  in  infected  quarters  can  be  attributed  to  its  local  production  in 
mammary gland as well as from leakage of serum proteins across the blood-milk barrier 
due to increased permeability during mastitis (Nielsen et al. 2004). According to Petersen 
et al. (2003), it can be assumed that SAA is produced locally in the mammary gland due to 
the lack correlation between SAA in milk and serum (Eckersall et al. 2001), the expression 
of serum amyloid protein homologue in the mammary gland (Molenaar et al. 2002) and the 
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SAA levels were also found to be increased during endotoxin-induced mastitis in both 
serum and milk of the cows (Lehtolainen  et al. 2004). However, serum SAA was not 
related to M-SAA3 as SAA seemed to peak earlier in milk than in serum. It was also 
thought in this study that some SAA that was present in serum may originate from milk 
due to changes in permeability of blood-milk barrier. However, Jacobsen et al. (2004) 
disagreed on this by saying that udder-specific SAA was unable to cross the blood-milk 
barrier and thus be present in the plasma.  Lehtolainen et al. (2004) also concluded that M-
SAA3 was less able to assess the severity of mastitis because of the slow rise of M-SAA3 
concentration during intramammary infection.  
 
In the study by Jacobsen et al. (2004) using E. coli-induced mastitis, they found several 
SAA isoforms in both plasma and milk of the cows. However, the presence of alkaline pI, 
tissue-specific  SAA3  isoforms  in  the  milk  did  not  appear  in  any  of  plasma  or  serum 
samples examined confirming the synthesis of SAA in the mammary gland. Furthermore, 
M-SAA3 levels in milk started to rise earlier at 12-hour post inoculation than SAA levels 
in  plasma  (between  12-hour  to  24-hour  post  inoculation).  Thus,  M-SAA3  became  a 
suitable  marker  for  early  mastitis  detection  as  well  as  an  indicator  of  tissue  damage 
severity. 
 
Larson  et  al.  (2005)  showed  that  bacterial  LPS  that  caused  a  severe  mammary  gland 
infection were able to  induce differential  expression of M-SAA3 by  bovine mammary 
epithelial  cells.  It  was  shown  that  inflammatory  cytokines  induced  by  LPS  played  an 
important  role  in  the  upregulation  of  M-SAA3  expression  in  the  mammary  gland  and 
initiate  a  cascade  of  events  during  the  acute  phase  response.  The  A-SAA  proteins 
expressed hepatically also present in the mastitic milk as part of leakage of serum proteins 
into the mammary gland from increased permeability of the blood-milk barrier.  
 
SAA levels also known to be increased both in serum and milk with repeated challenges of 
E.coli inoculation in udder quarters. However, serum SAA levels (24-hour post challenge) 
increased later than the levels of M-SAA3 in milk (12-hour post inoculation) but peaked at 
the  same  time  in  two  challenges.  They  further  confirmed  the  use  of  APP  as  mastitis 
indicator and to assess the severity of inflammation (Soujala et al. 2008). 
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and further promotes the spread of disease to other cows (Weber et al. 2005). Lipotechoic 
acid  (LTA)  from  gram-positive  bacterial  cell  wall  components  mimicked  a  mastitic 
episode as induced by Gram-positive bacteria (S. aureus) without having the confounding 
factors of bacterial growth as well as epithelial cell invasion. LTA was shown to be able to 
stimulate the differential production of SAA by mammary ductal cells with M-SAA3 (pI 
9.6) being the predominant SAA isoform produced (Weber et al. 2005). 
 
Another  experimental  study  of  S.  aureus  induced  mastitis  by  Eckersall  et  al.  (2006) 
supported  the  finding  that  increases  in  M-SAA3  level  in  milk  occurred  earlier  than 
increases of SAA in serum. The level of M-SAA3 was also greater in quarters that received 
2  infusions  of  bacteria  compared  with  quarters  that  only  received  single  infusion  of 
bacteria. Immunocytochemistry results revelead that M-SAA3 is present in the secretory 
epithelium,  gland cistern and at  significantly lower levels  in  the teat  canal  and it was 
concluded that the origin of M-SAA3 in milk was within the secretory epithelial cells and 
cells lining the gland cistern. Less M-SAA3 detected in the teat canal was probably due to 
infusion of bacteria directly into the gland cistern by-passing the teat canal. 
 
Milica et al. (2010) further demonstrated that the magnitude of both local and systemic 
APR in S. aureus mastitis was higher if more than 1 udder quarter were affected. Higher 
magnitude  of  local  tissue  response  was  observed  due  to  different  strain  of  S.  aureus 
(Dingwell  et  al.  2006),  number  of  S.  aureus  (Eckersall  et  al.  2006)  and  additional 
exudation of very high plasma SAA that leads to increased in concentration of MAA in 
milk. 
 
When comparing the reliability of APP measurement in diagnosing bovine mastitis with 
other mastitis diagnostic methods, APP showed significant correlations with ATP as in a 
study by Grӧnlund et al. (2005), about 52% of quarters of negative and positive ATP 
agreed  with  the  results  on  APP  level  in  udder  quarters  (ATP-Hp-SAA-  group  and 
ATP+Hp+SAA+). However, discrepancy in results was observed between APP level and 
SCC in affected udder quarters possibly due to different mechanisms of entry into the 
udder.  Leukocytes  migrate  actively  into  the  mammary  gland  by  means  of  adhesion 
molecules while APP is presumed to leak passively from blood into milk from altered 
membrane permeability or is produced locally by the mammary gland. 
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concentration  of  SAA  in  bovine  milk  and  established  cellular  indices  of  mastitis 
particularly the CMT and SCC. CMT in full and SCC have a strong correlation as both 
represent  the  cell  concentrations  in  milk.  However,  there  were  some  indications  that 
negative correlation happened between the level of milk SAA and SCC in a group of cows 
when the level of SAA was increased. Nevertheless, this study suggested that milk SAA as 
useful in detecting quarters with high SCC as serum SAA did not significantly influence 
the M-SAA3. 
 
Milk APP also showed high correlation with SCC as rise in milk APP concentrations was 
seen with increasing in SCC thresholds (Kovac et al. 2007). Thus, measurement of milk 
APP can be used in monitoring udder health as SCC was not suitable to be used alone as a 
marker to identify infected quarters (Zecconi & Piccini 2002). 
 
Åkerstedt et al. (2007) further confirmed the significant relationships between SAA and 
SCC at quarter, cow composite and bulk tank level of healthy milk samples. SAA was also 
detected more frequently than Hp regardless of the types of milk samples (quarter, cow 
composite and bulk tank) at higher SCC. 
 
The detectable level of M-SAA3 in milk can also be used to predict the protein quality of 
cow composite milk samples in which samples with detectable SAA level had lower casein 
number, lower lactose level and higher SCC. Casein number provided a good and specific 
milk quality parameter especially in cheese-making industry as total protein may include 
less valuable serum proteins that are known to increase in concentrations during mastitis. 
Reduced casein number could be contributed by proteolysis while reduced lactose content 
might be due to the regulation of lactose secretion by specific peptides released during 
casein hydrolysis by plasmin (Silanikove et al. 2000). 
 
Gerardi et al. (2009) revealed that by using milk a SAA ELISA kit to measure the level of 
SAA in milk, a significant correlation was found between SCC and M-SAA3 in lower SCC 
levels from quarter milk samples compared with the level of M-SAA3 in milk determined 
by serum SAA ELISA kit. Thus, M-SAA3 has been suggested as a physiological marker of 
subclinical mastitis as it provided statistically better response in distinguishing subclinical 
from clinical mastitis.  
2.1.7  Quantification of bovine SAA 
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difficulties because most of them require some form of plasma or serum denaturation by 
heat, acid or alkali so that complete dissociation of SAA from the HDL 3 fraction of 
lipoprotein occurred (Marhaug et al. 1983; Sipe et al. 1989). This resulted in considerable 
variation in the reproducibility of the assays. 
 
In one example, Horadagoda et al. (1993) purified amyloid A from acute phase bovine 
serum and quantified the SAA concentration in serum by an indirect ELISA using rabbit 
anti-human SAA and horseradish peroxidase conjugated donkey anti-rabbit IgG. However, 
this type of assay was considered to be laborious, time consuming and depended on the 
commercial availability of antisera to human amyloid A with cross-reactivity to the bovine 
protein (Horadagoda et al. 1999). They suggested that by using immunoturbidimetric or 
latex agglutination immunoassay it was quicker and based on antiserum to bovine SAA. 
Latex agglutination nephelometric immunoassay has been used to measure human SAA on 
an automated analyser in less than 6 minutes (Yamada et al. 1993). 
 
McDonald et al. (2001) then developed a monoclonal antibody sandwich immunoassay for 
SAA that did not require sample denaturation and can be performed in 3 hours. It also has 
other advantages such as the hybridomas producing the monoclonal antibodies are self-
renewing, inexpensive to maintain and yield a highly consistent, easily purified product, 
the microtitre plates can be coated and stored so that the assay is available within 3 hours, 
it provides an accurate and reproducible results and lastly requires equipments and skills 
that normally available in a research or a clinical laboratory.  
 
Later, a commercialized SAA ELISA (Tridelta Development plc, Ireland) was produced 
based on the assay first developed by McDonald et al. (1991). With that, studies of SAA 
measurement  whether  in  serum  or  milk  have  been  done  using  commercialized  SAA 
ELISA. 
 
In the subsequent chapters in this thesis, measurement of Hp and M-SAA3 in milk has 
been used to confirm the origin of milk samples from udder quarters with mastitis.  The 
immunoassay for bovine Hp used in previous studies (Eckersall et al. 2006) was no longer 
available and a novel ELISA was developed for this purpose.  While attempts were made 
to establish an ELISA for M-SAA3, this was not successful and a commercial assay for 
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2.1.8  Aims of study 
The aims of this chapter were to develop sandwich bovine Hp assay before validating and 
optimizing this assay to test its reliability to measure Hp. Commercialized SAA assay 
using Tridelta™ kit was used to measure bovine milk SAA. This type of SAA assay was 
used due to several problems encountered in developing an in-house bovine milk SAA 
assay especially in getting a good and acceptable standard SAA curve. After validating and 
optimizing these assays, they were used to measure APP in milk for the next three chapters 
to confirm the disease status of the animals. 
2.2  Materials and Methods 
 
2.2.1 Reagents 
General chemicals and other materials were obtained from Sigma Chem. Co, Poole, UK 
and Bio-Rad Laboratories Inc. for PAGE unless otherwise stated. Double distilled water 
was used throughout. 
2.2.2 Milk samples 
Milk samples were obtained from Cochno Farm, West of Scotland and Vale Veterinary 
Laboratory,  Dorset,  UK.  Samples  from  subclinical  mastitic  cases  (n=10)  were  chosen 
based on their previous somatic cell count records, no obvious clinical signs as the time of 
sampling  but  produced  positive  California  Mastitis  Test  (CMT)  results.  Samples  from 
clinical  mastitic  cases  (n=40)  were  chosen  based  on  their  clinical  signs  and  further 
confirmed  by  bacteriological  culture  results  which  mainly  identified  major  mastitis 
pathogens  such  as  E.  coli,  S.  aureus  and  Strep  uberis.  Samples  from  healthy  animals 
(n=25)  (SCC  <  100000  cells/ml)  were  used  in  comparison  with  animals  with  mastitis 
cases. Samples were stored at -20°C until required. 
2.2.3 California Mastitis Test 
The CMT procedure was conducted as discussed in the previous chapter on Section 1.2.2. 
The CMT reagent dissolved or disrupted the outer cell wall and the nuclear cell wall of any 
leukocyte and DNA was released from the nuclei. A stringy mass was developed and the 
amount of gel formation increased with an increase number of leukocytes (Mellenberger 
2001). The result was interpreted as presented in Table 1.1 in Chapter 1.  
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2.2.4.1  Biotinylation of antibody 
The biotinylated rabbit anti-bovine Hp was prepared using a biotinylation kit according to 
the  manufacturer’s  instructions  as  described  below.  Bovine  anti-haptoglobin  was 
purchased from Life Diagnostic
 Inc., USA. This antibody was stored at the concentration 
of 3.43mg/ml. Different biotinylation of antibody was made up at least for 4 times and the 
reason will be discussed in the discussion part (Section 2.4). 
2.2.4.1.1  Preparation of Elution buffer and Antibody Binding 
Solution 
Elution buffer was prepared by adding 50μl of 4M Imidazole stock solution to 950μl PBS. 
The Antibody Binding Solution (ABS) was prepared by adding 29μl of anti-bovine Hp to 
210μl of PBS. 
2.2.4.1.2  Antibody Binding 
The disc provided was put in the bottom of a 1.5ml microcentrifuge tube. The prepared 
ABS  was  added  to  the  tube  containing  the  disc.  To  hydrate  the  resin,  the  tube  was 
incubated at room temperature for 30 seconds. The tube was inverted several times to 
suspend  the  resin  and  further  10  minutes  incubation  at  room  temperature  with  gentle 
rocking motion on a rotating platform was performed (no vortex). It must be noted that the 
resin must remain suspended during binding and the tube was manually inverted every 2-3 
minutes to keep the resin in suspension. The tube was centrifuged at 500 x g for 30 seconds 
to pellet the resin. The liquid was carefully removed with a pipette to discard. 1mL of PBS 
was added to the tube and the tube was inverted several times to wash the resin. The tube 
was centrifuged at 500 x g for 30 seconds to pellet the resin and the liquid was carefully 
removed with a pipette to discard. To complete washing, 1mL of PBS was added to the 
tube as before and step was repeated. 300μl of PBS was then added to the tube containing 
antibody and resin and pipetting the liquid gently up and down to resuspend the resin. A 
Handee Spin Column was placed in a new 1.5ml microcentrifuge tube. The entire volume 
of resin slurry was pipetted into the spin column. The column was centrifuged at 500 x g 
for 30 seconds and the flow-through was discarded before placing the column back into the 
tube. 
2.2.4.1.3  Antibody Biotinylation 
A bottom plug was applied to the separation column. A No-Weigh NHS-PEO4 Biotin 
Microtube was punctured with a pipette tip and the tube contents were dissolved by adding 
200μl of PBS with gentle pipetting. 188μl of PBS was added to 12μl of biotin reagent Chapter 2, 100 
 
directly to the separation column. PBS was added to the column first before adding the 
biotinylation  reagent.  The  column  was  capped  with  a  screw  cap  and  gently  mixed  by 
flicking. The column was incubated for 1 hour at room temperature with the column being 
flicked occasionally during incubation to keep the resin from settling. The bottom cap of 
the column was removed and it was centrifuged at 500 x g for 30 seconds. The flow-
through was discarded and the column was placed back into the same tube. 400μl of PBS 
was added to the column and further centrifuged at 500 x g for 30 seconds. Again, the 
flow-through was discarded and the column was placed back into the same tube. The PBS 
was added as before and the step was repeated three times to wash the column. 
2.2.4.1.4  Antibody Elution 
The column was capped at the bottom and placed in a new 1.5ml microcentrifuge tube. 
200μl  of  Elution  buffer  was  added  to  the  column.  The  tube  was  incubated  at  room 
temperature for 10 minutes before centrifugation at 500 g for 30 seconds to elute antibody. 
After  elution,  some  antibody  will  remain  bound  to  the  column.  To  increase  yield  of 
biotinylated antibody, 200μl of Elution buffer was added and incubated for 10 minutes at 
room  temperature  and  elution  repeated.  The  resin  was  discarded  after  used.  The 
biotinylated antibody was stored at 4°C for up to one month. Biotinylated antibodies are 
generally  stable  when  stored  in  Elution  buffer  (0.2M  Imidazole  in  PBS)  at  4°C.  If 
biotinylated antibodies were not used within one month, they were stored in single-use 
aliquots at -20°C. 
2.2.4.2  Newly prepared biotinylated antibody  
To test  for the availability of newly prepared biotinylated antibody, serial dilutions  of 
standard  bovine  Hp  (3.43mg/ml,  Life  Diagnostics  Inc.,  USA)  were  prepared  in  1:100, 
1:200, 1:400, 1:800 and 1:1600. Standard bovine Hp at a different dilution was blotted 
onto a nitrocellulose membrane. 10% of Marvel milk in TBS Tween buffer was used to 
block the membrane for 60 minutes. The membrane was rinsed with wash buffer and the 
newly prepared biotinylated antibody at 1:1000 was blotted onto the membrane and further 
incubated at 60 minutes. 1:1000 of streptavidin peroxidise (Tridelta Development Ltd., 
Ireland) was blotted after rinsing and incubated for another 60 minutes. The membrane was 
rinsed and substrate (Opti-4CN
TM Substrate Kit, USA) was added to develop bands. Chapter 2, 101 
 
2.2.4.3  Assay Procedure 
The  assay  conditions  were  optimised  as  described  in  section  2.2.4  so  that  the  best 
performance from the assay is achieved. The following protocol described the finalised 
conditions. 
2.2.4.3.1  Coating  
The Life Diagnostic rabbit anti-bovine haptoglobin as described earlier was diluted to a 
final concentration of 1 µg/ml in 0.05M NaHCO3, pH 9.6. 100 µl was dispensed into each 
well of a Nunc-Maxisorp 96 MicroWell™ plate (Nunc International, Rochester, NY) and 
incubated at 4°C overnight. 
2.2.4.3.2  Washing 
Wells were washed using 0.02M Tris-HCl pH 7.4 with 0.05% Tween-20 by adding 250µl 
per well for 4 times. 
2.2.4.3.3  Blocking 
Unoccupied binding sites were blocked by adding 250µl of 10% (w/v) Marvel milk protein 
in wash buffer and incubated at 37ºC for 60 minutes. 
2.2.4.3.4  Washing 
Wells were washed again as above. 
2.2.4.3.5  Dilution and addition of Standard Bovine 
Haptoglobin and milk samples 
Standard bovine haptoglobin (0.845mg//ml, Life Diagnostics Inc., USA) was prepared at 
0.25µg/ml in washing buffer and double diluted until concentration reached 1.95ng/ml. 
Milk samples were also diluted at 1:10000 or 1:1000 in washing buffer. 100µl of each 
standard  bovine  haptoglobin  and  milk  samples  were  added  into  duplicate  wells  and 
incubated at 37 °C for 60 minutes.  
2.2.4.3.6  Addition of biotinylated antibody 
After washing, diluted biotinylated rabbit anti-bovine haptoglobin at 1:1000 in washing 
buffer was added at 100µl per well and incubated at room temperature for 60 minutes. 
2.2.4.3.7  Addition of secondary antibody 
After washing, diluted Streptavidin-peroxidase at 1:1000 in washing buffer was added at 
100µl per well and further incubated at room temperature for 60 minutes. Chapter 2, 102 
 
2.2.4.3.8  Addition of substrate 
After washing, Tetra methyl benzidine (TMB) peroxidise substrate was prepared according 
to manufacturer instruction (KPL, Inc., USA). The substrate was added at 100µl per well 
and developed for 5-10 minutes. The peroxidase-enzyme reaction was stopped by adding 
100µl per well of 1M hydrochloric acid. 
2.2.4.3.9  Absorbance reading 
The absorbance was read at 450 nm using Fluostar OPTIMA platereader (BMG Labtech 
Ltd.)  and the results  analysed and  calculated using the  associated FLUOstar OPTIMA 
Software V1.32 R2 using a 4 parameter-fit standard curve plotted on a linear scale. 
2.2.5 Haptoglobin Assay Optimisation 
During assay development a number of parameters were altered to come to the optimised 
assay.  A number of these variations are given below. 
2.2.5.1  Antibody concentrations 
The concentration of primary antibody (anti-rabbit bovine Hp) was varied to achieve the 
highest optical density (OD) value for the maximum standard while producing a steep 
standard curve, with low OD for blanks. Other variables were kept constant with varying 
antibody concentrations of 1µg/ml, 5µg/ml and 25µg/ml.  Though the curve for 1μg/ml of 
antibody gave the lower curve (Fig 2-2) it was chosen for the optimised assay due to its 
lower background reading. 
2.2.5.2  Varying batch of biotinylated antibodies 
With each batch of antibody prepared, different dilutions of antibody were tested so that a 
straight standard curve with low OD values for blanks were achieved.  
2.2.5.3  Biotinylated antibody concentrations 
The concentration of biotinylated antibody (anti-rabbit bovine Hp) was varied to achieve 
aims as previously described. Other variables were kept constant with varying antibody 
concentrations of 1:250 and 1:1000. Figure 2-4 shows the Hp standard curve for the first 
batch of biotinylated anti-bHp at 1:250 and 1:1000, the latter was chosen for the optimised 
assay due to a lower background.  Figure 2-5 shows the comparison between batch 1 and 
batch 2 of the biotinylated antisera at 1:1000.  With batch 3 and batch 4 of the biotinylated 
antibody a dilution of 1:500 was optimal. Chapter 2, 103 
 
2.2.5.4  Optimisation of Standard and Sample Dilution 
The standard bovine Hp was  diluted at  different  concentrations  and serially  diluted to 
achieve standard curves over different ranges, so that a steep standard curve over was 
produced.    Figure  2-6  shows  a  typical  standard  curve.  Milk  samples  were  diluted  at 
different concentrations until their reading were on the linear section (0-1000ng/ml) of the 
standard curve.  It shows that samples of milk with elevated Hp gave parallel dilution 
curves  with  the  standard  curve  giving  an  indication  that  the  assay  is  measuring 
haptoglobin. 
2.2.6 Haptoglobin Assay Validation 
2.2.6.1  Precision 
For  intra-assay  precision,  the  coefficient  of  variance  was  determined  as  the  mean  of 
coefficient of variance (CV) for of duplicate results. Inter-assay precision was determined 
where CVs were calculated from the mean and standard variation of the same milk samples 
(control samples) over 10 times during the use of the assay.   
2.2.6.2  Accuracy 
Linearity of dilution of 3 milk samples with varying Hp concentrations was assessed for 
accuracy of the assay. 
2.2.6.3  Limit of detection 
The limit of detection was determined as the lowest Hp concentration which could be 
distinguished from a zero value, and was taken as the mean +3 standard deviations of 4 
replicates of blank samples. 
2.2.6.4  Specificity 
The specificity of the assay was based on the commercial anti-bovine Hp anti-serum 
assessed by Ouchterlony immunodiffusion in agarose gel. 
 
2.2.7 Serum Amyloid A Assay 
The  concentration  of  SAA  in  milk  samples  were  quantified  using  a  commercial 
Multispecies SAA ELISA kit (PhaseTM Range, Tridelta Development Limited) according 
to the manufacturer’s instructions. Chapter 2, 104 
 
2.2.7.1  Reagents 
General chemicals and other materials were obtained from Sigma Chem. Co., (Poole UK) 
while Tridelta Development Ltd supplied the Phase™ Range SAA ELISA kit. 
2.2.7.2  Reagent Preparation 
All  buffers  should  be  prepared  beforehand  according  to  the  instruction  manual.  These 
include 1X  diluents buffer, 1X wash buffer, 1X biotinylated anti-SAA conjugate and 1X 
Streptavidin-peroxidase. 
The SAA calibrator provided in the kit was reconstituted by adding distilled water to the 
vial  and  vortexed  vigorously  for  3-4  times  for  3-5  seconds  to  dissolve  the  pellet 
completely. Top calibrator was prepared first before serially diluted. 
Quality controls from both with highest and lowest SAA values were diluted at 1:500 using 
1X diluent buffer. 
All milk samples were diluted in 1X diluents buffer before analysis. 
2.2.7.3  SAA Assay 
50 µl of diluted milk samples, diluted SAA calibrators and quality controls were added to 
duplicate wells. 50µl of 1X biotinylated antibody conjugate were also added to each well 
and incubated at 37ºC for 60 minutes. After incubation, the plate was washed 4 times using 
1X wash buffer before tapping the plate dry on absorbent paper. 100µl of 1X Streptavidin-
peroxidase was added to each of the wells and further incubated at room temperature in the 
dark for 30 minutes. The plate was washed as above. 100 µl of TMB Substrate were added 
before incubated at room temperature in the dark for 30 minutes. Finally, 50µl of Stop 
solution was added and the absorbance was read at 450nm. 
2.2.8 SAA Assay Validation 
The specificity and accuracy of the SAA ELISA was based on the data supplied with the 
commercial ELISA (Tridelta Development Ltd., Ireland). 
2.2.8.1  SAA Assay Precision 
For intra assay precision, the CV was calculated from the mean CV of duplicate samples 
(n=42).  Inter-assay precision was determined where CVs were calculated from the mean 
and standard variation of the same milk samples (control samples) over 10 times during the 
use of the assay Chapter 2, 105 
 
2.2.8.2  Limit of Dectection 
The limit of detection was determined as the lowest Hp concentration which could be 
distinguished from a zero value, and was taken as the mean +3 standard deviations of 15 
replicates of blank samples. 
2.2.9 Clinical Validation 
Milk samples were collected from two different locations; the Cochno Farm, University of 
Glasgow, Clydebank, UK and Vale Veterinary Group   Devon, UK. Milk samples acquired 
were  grouped  into  healthy  which  comprised  of  25  milk  samples  (Cochno  Farm), 
subclinical mastitis group which comprised of 10 milk samples (Cochno farm) and clinical 
mastitis group which were comprised of 40 milk samples (Vale Veterinary Group). Both 
healthy and subclinical mastitic milk samples were chosen based on their monthly SCC 
recording data whilst cows with clinical mastitis were chosen based on the general clinical 
signs of mastitis and further confirmed by bacteriological culture.  
2.2.10  Data Analysis 
Statistical analysis was carried out using Predictive Analytics Software (PASW) Statistics 
(SPSS) version 18 (IBM Corporation, NY, US). 
 
2.3  Results 
2.3.1  California Mastitis Test 
All subclinical mastitic milk samples (n=10) were subjected to CMT and all results 
revealed positive CMT reaction (2+ or 3+). 
2.3.2  Immuno dot blot of newly prepared biotinylated 
antibody  
The newly prepared biotinylated antibody was tested for cross reaction as shown in Figure 
2-1. The immuno dots developed with the greatest intensity at lowest dilution (1:100) of 
standard bovine Hp and decreased as the dilution of Hp increased. 
2.3.3  Haptoglobin Assay Optimisation 
2.3.3.1  Coating Antibody concentrations Chapter 2, 106 
 
During optimisation, varying concentrations of coating antibodies were assessed as shown 
in Figure 2-2. A final concentration of 1µg/ml of coating antibody was chosen due to its 
reasonably steep curve and covered a wide range of OD values whilst giving lower blank 
readings than other different dilutions. 
2.3.3.2  Biotinylated antibody concentrations 
The biotinylated antibody was optimised as the previous step with different dilutions of 
1:250 and 1:1000 using two different types of antibodies as shown in Figure 2-3. The final 
concentration of 1:1000 of biotinylated antibody was chosen as it resulted in a steep curve, 
provided  a  good  range  of  OD  values  with  lower  blank  readings  than  other  different 
dilutions. 
2.3.3.3  Varying batch of biotinylated antibodies 
For the Batch 1 of prepared biotinylated antibodies, several dilutions were tested (1:1000 
and 1:250). The chosen concentration was 1:1000 of as previously mentioned. An example 
of standard curve is shown in Figure 2-4. 
For the Batch 2 of prepared biotinylated antibody using anti-rabbit bovine Hp, the 1:1000 
dilution still give the best standard curve as shown in Figure 2-4. 
But for the Batch 3 and 4 of prepared biotinylated antibody using anti-rabbit bovine Hp, 
the  1:1000  dilution  did  not  produce  a  very  reasonable  standard  curve  thus  a  range  of 
different dilutions were tested (1:250, 1:500 and 1:1000). However, a good standard curve 
was not achieved. 
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Figure 2-1:  Immuno dot blot of biotinylated anti-bovine Hp reacting with bovine Hp 
at dilutions of 1:100, 1:200, 1:400, 1:800 and 1:1600. 
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Figure  2-2:  Optimisation  of  coating  antibodies  concentrations  using  different 
concentrations  for  the  developed  ELISA.  The  effect  of  anti-rabbit  bovine  Hp 
concentrations  at  1µg/ml,  5µg/ml  and  25µg/ml  on  bovine  Hp  ELISA.  The  1µg/ml 
concentration gave lower blanks and a steeper curve than others. 
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Figure 2-3: Optimisation of biotinylated antibody concentrations for the 
developed ELISA. The effect of the biotinylated antibodies at 1250 and 1:1000 on 
bovine Hp ELISA. The biotinylated antibody at 1:1000 provided lower blanks and a 
steeper curve than others. 
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Figure 2-4: Standard curve obtained from the optimised first and second batch of 
biotinylated antibodies (3.43mg/ml) diluted at 1:1000. 
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2.3.3.4  Optimisation of standard and sample 
dilution 
A working standard curve is needed as part of assay optimisation. This was achieved by 
diluting the standard bovine Hp (0.845mg/ml) in assay buffer to 0.25µg/ml and serially 
diluting the standards to achieve concentrations between 1.95-250ng/ml. An example 
of  working  standard  curve  is  given  on  Figure  2-5.  Milk  samples  were  diluted 
accordingly based on their Hp content until the readings were on the linear portion of 
the standard curve. 
2.3.4  Haptoglobin Assay Validation 
2.3.4.1  Precision 
The intra assay CV for the bovine Hp assay was 2.5% which was calculated as the 
mean CV of duplicate samples (n=36). Table 2-1 showed the values, means and the 
calculated CVs for the Hp ELISA assays which were 29.9% and 47.1% for mean milk 
Hp of 21 and 3.3μg/ml respectively. 
 
2.3.4.2  Accuracy 
Serial dilution of three milk samples as shown in Figure 2-6 was used to assess the 
assay accuracy. The three samples show linearity then plateau out at low dilution and 
are parallel to the standard curve. Diluted sample concentrations were taken from the 
linear portion of the curve as it is the most precise and accurate area of the curve. 
2.3.4.3  Limit of detection 
The minimum detection limit significantly different from the blank samples was taken 
as the Hp concentration at 3 standard deviations (SD) from the mean of blank sample 
(n=4). This resulted in a limit of detection of Hp in milk of 0.37ng/ml. 
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Figure 2-5: Standard curve obtained from optimised standard bovine Hp dilution. 
Standard bovineHp was diluted from 0.845mg/ml to 0.25µg/ml, then by 1:2 dilution. 
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Table 2-1: Inter-assay precision results obtained for ELISA with milk samples. 
The  CV  for  Hp  concentration  of  21.2μg/ml  was  29.9%  and  the  CV  for  Hp 
concentration of 3.31μg/ml was 47.1%. 
Sample ID  Hp Conc. (μg/ml)  Plate    Sample ID  Hp Conc. (μg/ml)  Plate 
92  15.4  1    41  6.5  1 
92  25.2  2    41  5.5  2 
92  15.2  3    41  3.3  3 
92  19.4  4    41  3.9  4 
92  11.8  5    41  2.5  5 
92  21.3  6    41  2  6 
92  32  7    41  2  7 
92  29.3  8    41  2.9  8 
92  20.1  9    41  2.3  9 
            10 
             
Mean  21.16      Mean  3.31   
SD  6.33      SD  1.56   
% CV  29.9      % CV  47.1   Chapter 2, 114 
 
 
Figure 2-6: Linearity of 3 bovine milk samples after serial dilution. Example of 
standard curve included for comparison. 
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2.3.4.4  Specificity 
The specificity of the assay was based on the commercial anti-bovine Hp anti-serum 
and was assessed by Ouchterlony immunodiffusion in agarose gel (Figure 2-7). 
 
2.3.5  SAA Assay Validation 
The specificity and accuracy of the SAA ELISA was based on the data supplied with 
the commercial ELISA (Tridelta Development Ltd., Ireland). In use the precision and 
limit of detection of the SAA ELISA for assessment of the protein in milk were as 
follows. 
2.3.5.1  Precision 
The intra assay CV for the SAA assay was 6.8% calculated from the mean CV of 
duplicate samples (n=42).  Results were from too few assays to calculate the inter assay 
just for this investigation but when included in a series of ELISAs run in the laboratory 
(n=35)  the  CVs  were  46%  at  a  concentration  of  7.2  +  3.3  ng/ml  and  30%  at  a 
concentration of 40.6 + 12.1 ng/ml. These values are for post dilution of samples and 
are equivalent to 1.44μg/ml and 8.12μg/ml in the undiluted milk samples respectively. 
While the CVs were high, they were deemed to be satisfactory in view of the large 
increased being measured between healthy and diseased samples. 
 
2.3.5.2  Limit of detection 
The limit of detection of the SAA was 4ng/ml being the value determined as 3 SD from 
the mean of replicate blank samples (n=15). 
 
2.3.6  Clinical Validation 
The descriptive statistics of all variables in each group are presented in Table 2-2 while 
the distribution of SAA, Hp concentrations and SCC measurement in all samples are 
presented  in  Figure  2-8,  2-9  and  2-10.  For  healthy  group,  the  range  of  SAA 
concentration  was  between  0.03-2.96μg/ml  with  a  median  of  0.36μg/ml,  mean  of 
0.54μg/ml and standard deviation of 0.61μg/ml. The range of Hp concentration fell Chapter 2, 116 
 
between 0.07-31.95μg/ml with the average of 9.17μg/ml with a median of 3.52μg/ml 
and standard deviation of 9.88μg/ml. The range of SCC measurement was between 12 
x 10
3 to 81 x 10
3 cells./ml with a median of 43 x 10
3 cells/ml, mean of 43 x 10
3 cells/ml 
and standard deviation of 19 x 10
3 cells/ml on at least one SCC recording one month 
before the sampling took place. 
For  subclinical  mastitic  group,  the  range  of  SAA  concentration  was  between  0.18-
14.05μg/ml with a median of 1.44μg/ml, mean of 3.19μg/ml and standard deviation of 
4.27μg/ml. The range of Hp concentration fell between 0.31-14.91μg/ml with a median 
of 7.41μg/ml, average of 7.49μg/ml and standard deviation of 5.13μg/ml. The range of 
SCC measurement was between 67 x 10
3 to 1224 x 10
3 cells/ml with a median of 268 c 
10
3 cells/ml with the average of 486 x 10
3 cells/ml and standard deviation of 447 x 10
3 
cells/ml on the SCC recording one month before the sampling took place. 
For  clinical  mastitic  group,  the  range  of  SAA  concentration  was  between  1.78-
1780.5μg/ml  with  a  median  of  63.55μg/ml,  average  of  422.14μg/ml  and  standard 
deviation  of  649.08μg/ml.  The  range  of  Hp  concentration  fell  between  1.95-
413.85μg/ml  with  a  median  of  86.52μg/ml,  average  of  99.36μg/ml  and  standard 
deviation of 90.16μg/ml. The cultured bacterial pathogens were amongst the common 
causal of bovine mastitis such as E. coli, S. aureus, S. uberis and S. dysgalactiae (Table 
2-3) 
As the data was not normally distributed, the Spearman’s correlation was performed to 
analyze  the  correlation  between  these  variables  (Table  2-4).  The  Spearman’s 
correlation  between  SAA  and  Hp  concentration  in  all  groups  of  milk  samples  was 
0.653.  The  Spearman’s  correlation  between  SAA  and  SCC  in  all  groups  of  milk 
samples  was  0.438  whilst  the  Spearman’s  correlation  between  Hp  and  SCC  in  all 
groups of milk samples was 0.08. 
Mann-Whitney’s test was used to analyze for significant differences between diseased 
groups on SAA, Hp and SCC measurements (Table 2-5). Healthy and clinical mastitic 
groups showed significantly difference in the SAA concentration (p<0.05) with the z 
value  of  -6.737and  healthy  and  subclinical  mastitic  groups  also  showed  significant 
difference in SAA concentration (p<0.05) with the z value of -2.41. Clinical mastitic 
and  subclinical  mastitic  groups  had  significant  differences  in  SAA  concentration 
(p<0.05) with the z value of -4.573. Chapter 2, 117 
 
Healthy  and  clinical  mastitic  groups  showed  significantly  difference  in  the  Hp 
concentration (p<0.05) with the z value of -5.437 whilst the Hp concentration between 
healthy and subclinical mastitic groups was not significantly different (p>0.05) with the 
z  value  of  -0.087.  Clinical  mastitic  and  subclinical  mastitic  groups  however  had 
significant difference in Hp concentration (p<0.05) with the z value of -4.131. 
Finally, healthy and clinical mastitic groups showed significantly difference in the SCC 
measurements (p<0.05) with the z value of -4.439. Chapter 2, 118 
 
 
 
 
 
 
 
 
Figure 2-7: Ouchterlony immunodiffusion gel of anti-bovine Hp. The centred well 
was anti-bovine Hp, well 1 was purified bovine Hp, well 2 was low Hp bovine serum, 
well 3 was low Hp bovine serum, well 4 was high Hp bovine serum, well 5 was high 
Hp bovine serum and well 6 was high Hp bovine serum. A single line of 
immunoprecipitate was observed showing that the antiserum was specific for bovine 
Hp and that there were no non-specific reactions with other proteins in the serum 
samples. 
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Group 
N  Minimum  Maximum  Mean 
 
Median 
Std. 
Deviation  Variance 
Healthy  SAA  25  .03  2.96  .5435  .3600  .60944  .371 
Hp  22  .07  31.95  9.1665  3.5150  9.88022  97.619 
SCC  25  12000  80500  42800.00  43000.00  19812.664  3.925E8 
Valid 
N 
22 
     
 
   
Subclinical  SAA  10  .18  14.05  3.1870  1.4350  4.27359  18.264 
Hp  9  .31  14.91  7.4848  7.4120  5.13332  26.351 
SCC  10  67000  1224000  485900.00  286000.00  446707.573  1.995E11 
Valid 
N 
9 
     
 
   
Clinical  SAA  40  1.78  1780.50  422.1374  63.5480  649.08256  421308.170 
Hp  40  1.95  413.85  99.3570  86.5200  90.16136  8129.070 
SCC  0             
Valid 
N 
0 
     
 
   
 
Table  2-2:  The  descriptive  statistics  for  the  Hp  concentration  (μg/ml),  SAA 
concentration (μg/ml) and SCC of milk samples taken from healthy, subclinical 
mastitic and clinical mastitic cows. The values for mean, maximum and minimum 
values, median, standard deviation and variance of each Hp, SAA and SCC for each 
group of milk samples were presented. 
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Sample IDs  Bacteriological culture 
475  E. coli 
76  E. coli 
1111  E. coli 
Star  Strep. uberis 
1510  Strep. dysgalactiae 
814  E. coli 
438  S. aureus 
940  Coryne. bovis 
74  NA 
669  Strep. uberis 
544  Strep. uberis 
708  Strep. uberis 
200  Strep. uberis 
185  Strep. uberis 
14  S. aureus 
692  E. coli 
1061  NA 
697  E. coli 
519  E. coli 
31  Strep. uberis 
980  S. aureus 
453  E. coli 
496  E. coli 
1222  E. coli 
828  NA 
49  Strep. dysgalactiae 
4493  Strep .uberis 
669  Strep. uberis 
708  S. aureus 
474  E. coli 
346  S .aureus 
7  Strep. uberis 
230  Strep. uberis 
1512  Strep. dysgalactiae 
715  S. aureus 
452  E. coli 
932  E. coli 
770  Strep. uberis 
656  Strep. uberis 
339  Strep. uberis 
Table 2-3: The bacteria causing mastitis cultured from the clinical mastitic milk 
samples. NA stands for not available. 
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Figure 2-8: The box-plot showed the distribution of SAA levels in bovine milk 
samples  between  healthy,  subclinical  mastitis  and  clinical  mastitis  groups.  The 
median of SAA concentration in healthy group was 0.36μg/ml whilst the maximum and 
minimum  values  were  2.96  and  0.03μg/ml  respectively.  The  median  of  SAA 
concentration in subclinical mastitic group was 1.435μg/ml whilst the maximum and 
minimum  values  were  14.05  and  0.18μg/ml  respectively.  The  median  of  SAA 
concentration  in  clinical  mastitic  group  was  63.55μgml  whilst  the  maximum  and 
minimum values were 1781 and 1.78μg/ml respectively. 
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Figure  2-9:  The  box-plot  showed  the  distribution  of  Hp  levels  in  bovine  milk 
samples  between  healthy,  subclinical  mastitis  and  clinical  mastitis  groups.  The 
median of Hp concentration in healthy group was 3.52μg/ml whilst the maximum and 
minimum  values  were  31.95  and  0.07μg/ml  respectively.  The  median  of  Hp 
concentration in subclinical mastitic group was 7.41μg/ml whilst the maximum and 
minimum  values  were  14.91  and  0.31μg/ml  respectively.  The  median  of  Hp 
concentration  in  clinical  mastitic  group  was  86.52μg/ml  whilst  the  maximum  and 
minimum values were 413.85 and 1.95μg/ml respectively. 
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Figure 2-10: The box-plot showed the distribution of SCC values in bovine milk 
samples  between  healthy  and  subclinical  mastitis  groups.  The  median  of  SCC 
measurement in healthy group was 43 x 10
3cells/ml whilst the maximum and minimum 
values were 80.5 x 10
3 and 12 x 10
3 cells/ml respectively. The SCC measurement in 
subclinical mastitic group was 286 x 10
3 cells/ml whilst the maximum and minimum 
values were 1224 x 10
3 and 67 x 10
3 cells/ml respectively 
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Correlations 
  SAA  Hp 
Spearman's rho  SAA  Correlation 
Coefficient 
1.000  .653
** 
Sig. (2-tailed)  .  .000 
N  75  71 
Hp  Correlation 
Coefficient 
.653
**  1.000 
Sig. (2-tailed)  .000  . 
N  71  71 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Correlations 
  SAA  SCC 
Spearman's rho  SAA  Correlation 
Coefficient 
1.000  .438
** 
Sig. (2-tailed)  .  .008 
N  75  35 
SCC  Correlation 
Coefficient 
.438
**  1.000 
Sig. (2-tailed)  .008  . 
N  35  35 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Correlations 
  SCC  Hp 
Spearman's rho  SCC  Correlation 
Coefficient 
1.000  .080 
Sig. (2-tailed)  .  .670 
N  35  31 
Hp  Correlation 
Coefficient 
.080  1.000 
Sig. (2-tailed)  .670  . 
N  31  71 
 
Table 2-4: Spearman’s correlation between SAA concentration, Hp concentration 
and SCC measurements in milk samples. The Spearman’s correlation between SAA 
and Hp was 0.653 whilst the Spearman’s correlation between SAA and SCC was 0.438. 
The Spearman’s correlation between SCC and Hp was 0.08.  
 Chapter 2, 125 
 
  Healthy vs. 
Clinical mastitis 
Healthy vs. 
Subclinical 
mastitis 
Clinical mastitis 
vs. Subclinical 
mastitis 
SAA Conc. 
(μg/ml) 
z= -6.737 
p=0.00 
z= -2.41 
p= 0.00 
z= -4.573 
p= 0.00 
Hp Conc. (μg/ml)  z= -5.437 
p= 0.00 
z= -0.087 
p= 0.931 
z= -4.131 
p= 0.00 
SCC (x 10
-3/cells)  NA  z= -4.439 
p= 0.00  
NA 
Table 2-5: Mann-Whitney’s Test was performed to test for differences in SAA 
concentration  and  Hp  concentration  as  well  as  SCC  measurements  between 
healthy, subclinical mastitic and clinical mastitic group. 
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2.4  Discussion 
Hp  and  SAA  have  been  studied  in  this  chapter  to  evaluate  their  effectiveness  in 
diagnosing bovine mastitis prior to use their use to confirm the status of samples used 
in the following chapters. After optimising and validating the developed assays for Hp 
and SAA, their concentrations in different groups of milk samples were then compared 
statistically.  Correlation  between  SCC  values  and  APP  concentrations  were  also 
analysed statistically. 
For the development of bovine Hp ELISA, several stages were optimised to make sure 
the assays were reproducible. A final concentration of 1μg/ml of 3.43mg/ml rabbit anti-
bovine Hp was chosen whilst 1:1000 or 1:500 (depending on batch) of biotinylated 
antibody  was  used  to  achieve  an  optimised  assay.  Both  gave  a  reasonably  steep 
standard  curve  and  covered  a  wide  range  of  OD  values  with  acceptable  low 
background.  Each  time  a  new  biotinylated  antibody  was  prepared,  a  series  of 
optimisation on the varying batch of biotinylated antibodies were done. Different batch 
of biotinylated antibodies at different dilutions (1:1000 or 1:500) were used due to the 
large  number  of  milk  samples  assayed  throughout  this  project.  The  amount  of 
biotinylated antibody was often less than 0.5ml after its preparation. 
The Hp assay was validated by determining the intra-assay CVs of 36 duplicates milk 
samples and inter-assay CVs of the internal controls. Inter-assay CVs were within the 
range of 29.9-47.1% with the highest value occurring for a control with lowest level of 
Hp in milk. In general, CV values for biochemical tests should be lower than 10%, but 
in the case of immunoassays, the value of 20-30% are generally acceptable, especially 
if the concentrations of the analyte are low (FDA, 2001). In this study, even though the 
CV value was above 20%, the large changes in Hp concentration meant that the assay 
could be used to identify samples with high concentrations of this APP in milk samples. 
The PhaseTM Range SAA Assay developed by Tridelta Development Limited, was 
used to detect the M-SAA3 in the milk samples. It had acceptable precision with an 
intra assay CV of 6.8% in 42 duplicate samples and a limit of detection adequate to 
measure M-SAA3 in the healthy milk samples.   
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2.4.1 Clinical Validation: Assessment of APP level in 
healthy, subclinical and clinical mastitic milk samples 
The final stage of validation of the Hp assay and demonstration of the SAA assay was 
by clinical validation on assays of the APPs in different groups of milk samples. Some 
of these samples were used in the following chapters. Hp and SAA assays as described 
in previous section were performed to assess any differences and correlations between 
these APP levels in three different groups of milk samples. 
2.4.2 Hp level in three different groups of milk samples 
Based on the quantification of Hp levels in this study, Hp was detected in milk samples 
regardless of its disease status. Statistically, it was found that the Hp concentration in 
healthy milk samples (n=22) was significantly different (p<0.05) from clinical mastitic 
milk samples. This was in agreement with many publications (Eckersall et al. 2001; 
Gronlund et al. 2003) on the ability of Hp as a disease marker in bovine mastitis. Hp 
level also showed significantly higher in concentrations (p<0.05) in clinical mastitic 
milk samples in comparison with subclinical mastitic milk samples. Thus, Hp may be 
able to discriminate between clinical and subclinical mastitic animals as reported by 
others (Gronlund et al. 2003; Ohtsuka et al. 2001). However, Hp levels in the milk 
examined  here  produced  no  significant  difference  between  healthy  and  subclinical 
mastitic milk samples (p>0.05). This is in an agreement with Gronlund et al. (2003) in 
which they only observed significantly higher level of SAA in infected quarters than 
pre-infection and healthy quarters but not Hp. The reason might be due to different 
types of cytokines produced which lead to variation in the secretion and synthesis of 
APP  (Horadagoda  et  al  1999)  in  milk  samples  with  different  disease  status. 
Furthermore, during subclinical mastitis, Hp production might not be as great as that 
produced during clinical mastitis.  The other possible reason is might be due to the 
immunoassay  which  is  not  sensitive  enough  to  detect  a  slight  elevation  of  Hp 
concentrations in sublinical mastitic group. Other factors such as pathogen virulence 
and host response of the cows can play a role in the production of APP in infected 
quarters (Gronlund et al 2004). Nevertheless the Hp ELISA developed in the project 
was able to identify milk samples from cows with clinical mastitis and its use will be 
demonstrated in subsequent chapters. 
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2.4.3 SAA level in three different groups of milk samples 
With  the  commercial  ELISA  to  measure  SAA  levels  in  this  study,  this  APP  was 
detected in all milk samples regardless of its disease status. This ELISA was sensitive 
enough to detect a low amount of SAA in healthy animals.    
Statistically,  SAA  levels  were  found  to  be  significantly  different  (p<0.05)  between 
healthy and clinical mastitic milk samples. The high concentration of SAA found in all 
clinically infected milk samples further confirmed the role of SAA as a biomarker in 
bovine mastitis.  SAA levels also showed significantly higher concentrations in clinical 
mastitic  milk  samples  compared  with  subclinically  infected  milk  samples  (p<0.05). 
Furthermore,  SAA  can  also  be  employed  to  discriminate  between  clinical  and 
subclinical mastitis and milk SAA concentrations  can also be used to differentiate 
between healthy and subclinical mastitis as it showed statistically significant difference 
in milk SAA levels between those two groups (p<0.05). These results are in agreement 
with several studies which have shown that SAA (or M-SAA3) are elevated in milk 
during mastitis (Eckersall et al 2001; Grönlund et al 2003; Nielsen et al 2004) and in 
particular  those  that  show  that  milk-SAA3  is  able  to  differentiate  healthy  from 
subclinical mastitis samples (Grönlund et al 2003; Grönlund et al 2005).  Thus use of 
the SAA ELISA was validated to monitor the concentration of this APP in milk for the 
investigations in the following chapters. 
2.4.4 Correlation between SAA and Hp levels in milk 
samples 
As the APP and SCC had been measured in multiple samples it was of interest to 
determine the correlations between the analytes.   In general, SAA level showed a 
strong  and  positive  correlation  (r=  0.653)  with  the  level  of  Hp  in  clinical  mastitic 
group. This finding confirmed that SAA and Hp can be used as good mastitis indicators 
in which they both present in a very low amount in healthy milk samples but can 
increase  significantly  after  induction  of  acute  phase  response.  This  finding  also 
supported the fact that the measurement of APP during intramammary infection can be 
done by using milk samples rather than serum/plasma due to the ease of sampling and 
sample preparation. It also showed that the ELISA used to measure these major bovine 
APP is reliable and sensitive enough to detect its concentration in milk samples. 
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2.4.5 Correlation between SCC and APP levels in milk 
samples 
Milk samples of healthy and subclinically infected cows were chosen on the basis of 
SCC  measurement.  Thus,  it  is  also  important  to  assess  the  relationship  observed 
between SCC values and APP measurements. SCC has been a common method for 
mastitis diagnosis and is still being widely used in most of commercial dairy farms as 
part of disease monitoring system.  
According to Hillerton (1999), the limit of SCC for a healthy quarter should be around 
100 000 cells/ml and the SCC for composite milk should not exceed 100 000 cells/ml 
(Laevens et al 1997). In this current study, the average of SCC in the healthy group is 
43 x 10
3 cells/ml. Statistiscally, the SCC measured between healthy and subclinical 
mastitic milk samples were significantly different (p<0.05). It proved that SCC is still 
reliably  trusted  to  diagnose  subclinical  mastitis  as  changes  of  milk  composition 
microscopically are the only signs of subclinical mastitis (Radostits et al 1994).  The 
SCC was not measured in the clinical group as measurement can be misleading in 
clinical mastitis due to the interference of milk protein clots distorting the cell counting 
results. 
The correlation between SCC and APP in was done and showed a positive but not very 
strong relationship. The correlation between SCC and SAA (r=0.438) gave a medium 
relationship whilst the correlation between SCC and Hp (r=0.08) gave a very small 
relationship. The interpretation was based on Cohen (1988).  
Previous  studies  showed  a  strong  and  positive  relationship  between  SCC  and  Hp 
(Thielen et al 2005; Lai et al 2009). They claimed that leukocytes of milk somatic cell 
act as one of the cellular source of mammary Hp mRNA expression and also that these 
circulating  bovine  leukocytes  might  be  able  to  synthesize  the  Hp  and  contribute 
towards the measurement of Hp in milk (Thielen et al 2005). It was also supported by 
Lai et al (2009) that somatic cells were responsible for the increase of milk Hp as Hp 
levels measured using ELISA were positively correlated with the SCC and also Hp 
mRNA levels in cells of high SCC groups were significantly elevated than in cells from 
normal group. 
Although the relationship between Hp and SCC was very low, it should be noted that 
this correlation was calculated based on all milk samples regardless of the type of milk 
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suggested  depending  on  the  conventions  used,  countries,  breed  and  type  of  milk 
samples (Mattila et al 1986; Holdaway et al 1996). 
As a summary, the ELISA developed for quantification of Hp in milk samples was a 
reliable and sensitive enough assay to investigate the Hp levels in milk samples of 
different groups being able to differentiate clinical mastitic samples from subclinical 
and healthy samples. Commercial SAA ELISA also proved to be able to analyse SAA 
concentration  in  all  milk  samples  studied.  The  measurement  of  APP  levels  in 
diagnosing bovine mastitis appears to be a useful tool in monitoring udder health for its 
ability to discriminate the healthy milk samples from infected milk samples.  However, 
at present SCC should also be used in detecting the presence of subclinical mastitis in a 
herd of cows, although various factors should be evaluated (e.g; stages of lactation, 
milk  production  level,  stress,  breed)  before  any  decision-making,  especially  on 
therapeutic  measures.  Furthermore,  SCC  and  APP  measurements  should  be  used 
together  as  part  of  udder  health  inspection  in  a  herd  of  dairy  cows.    For  the 
investigations in subsequent chapters, the ELISAs for M-SAA3 and milk Hp along with 
SCC and bacteriology were used to provide definitive characterisation of milk samples 
as being from healthy dairy cows or from udder quarters with subclinical or clinical 
mastitis 
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Chapter III: Proteomics in Bovine Mastitis 
3.1   Introduction 
Proteomics  has  come  forward  as  a  rapidly  maturing  essential  tool  in  the  omics  age 
following the huge success of genomic studies. As mentioned previously, proteomics is a 
study that involved in separation and identification of a set of proteins existing in a cell, 
organ or organism (Wang et al. 2007).  Studying proteins has been a subject of interest for 
many researchers as any cell responses to stimuli or stress are manifested by the alteration 
of  protein  expression  levels  (Lippolis  &  Reinhardt  2010).  Protein  information  is  also 
valuable  as  protein  acts as  structural  building  blocks, conveys information, controlling 
many chemical reactions as well as being involved in antimicrobial defence mechanisms. 
Proteomics can also be defined as a large-scale study of protein expression, protein-protein 
interactions or post-translational modifications (Cravatt et al. 2007; Lippolis & Reinhardt 
2010). Unlike other methodologies, proteomics is able to analyze thousands of proteins in 
a  single  study  and  thus  one  can  demonstrate  how  cells  dynamically  change  upon 
stimulation or changes in the environment. In particular, proteomics stands out in its ability 
for a high resolution and simultaneous analysis of the composition of milk. (O’Donnell et 
al. 2004). 
Previous  studies  on  the  milk  proteome  have  utilized  many  different  approaches  of 
proteomic analyses. Details on each study have been discussed earlier in chapter 1. By 
using various proteomic methods such as 2D gel electrophoresis and MALDI analyses 
(Anderson  et  al.  1982;  Galvani  et  al.  2000,2001;  Baeker  et  al.  2002),  2D  and 
microsequencing  (Murakami  et  al.  1998;  Yamada  et  al.  2002)  as  well  as  LC-MS/MS 
(Palmer et al. 2006), a complete milk proteome which also included low abundance milk 
proteins has been achieved. In this section, the technical aspects of proteomic analyses will 
be discussed further. 
3.1.1  Sample Collection and Preparation 
The protein level in any biological fluid is influenced by many factors such as normal 
metabolism,  circadian  rhythms  of  protein  production,  degradation  and  environmental 
conditions (Hale et al. 2003). Upon sampling, protein modifications may also occur which 
include proteolysis, protein aggregation and chemical modifications. Thus, to minimize 
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However, most biological fluids are dominated by relatively few proteins for example in 
blood, albumin and the immunoglobulins (Igs) predominate (Anderson & Anderson 2002). 
Thus, removal of these proteins is advantageous to retrieve other lower abundance proteins 
and to reduce sample complexity. For example, the use of columns containing Cibacron 
blue (Hale et al. 2003) and anti-albumin antibodies (Steel et al. 2003) or albumin-specific 
peptides (Pingali et al. 1996) can be applied to remove albumin. 
Despite the sensitivity of the mass spectrometers used in proteomics study, several factors 
concerning the complexity of the sample must be analyzed. These include the number of 
protein in a proteome, the diversity of protein expression, the degree of protein solubility 
and the copy number of protein classes to assess the changes (Reinhardt & Lippolis 2008; 
Graham et al. 2005).  
Thus,  various  fractionation  protocols  were  introduced  to  reduce  the  complexity  of  the 
mixtures  for  a  more  complete  identification  of  proteins.  This  can  be  achieved  via 
subcellular  fractionation,  enrichment  strategies,  chromatography  or  gel  electrophoresis 
(Stasyk & Huber 2004). The subcellular fractionation provides important information on 
the nuclear membrane proteome; for example the isolation of MFGM from bovine milk. 
With enrichment methods, antibodies or metal ions can be used to isolate the protein of 
interest from the cell or pathogens. Size exclusion filtration may be applied to separate 
peptides subsequently sequenced by mass spectrometry (Hunt et al. 1992; Lippolis et al. 
2002). Chromatography and gel electrophoresis will be discussed next in this section. 
 
3.1.2  Protein separation 
Protein separation is the first main technology in proteomic study and two most popular 
methods are two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) (O’Farrell 
1975;  Görg  et  al.  1998;  Rabilloud  2002)  and  the  gel-free  procedure;  liquid  phase 
separation (Isaaq 2001; Isaaq et al. 2002). 
2D-PAGE has  been utilized for many  years  and was first  established in the mid 70’s 
(O’Farrell 1975; Klose 1975). It is able to resolve thousands of proteins and the procedure 
consists  of  two  steps;  separation  of  proteins  based  on  their  isoelectric  points  (pI)  and 
finally separation based on their molecular weight (Mr). Basically, this method combines 
isoelectric focusing (IEF) and sodium dodecyl sulphate polyacrylamide gel electrophoresis 
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in  broad  or  narrow  pH  ranges  to  achieve  different  levels  of  resolution  (Lippolis  & 
Reinhardt 2008). 
Following gel electrophoresis, a spot pattern on a gel is generated and each spot represents 
a different protein or its modification form (Heindleder et al. 2005). These protein spots 
can be cut out and further analyzed by mass spectrometry (Lippolis & Reinhardt 2008). 
According to O’Donnell et al. (2004) the advantage of using 2D-PAGE includes higher 
resolution and ability to separate proteins of similar relative molecular mass (Mr) and pI. 
However, major drawbacks of this method limit its usage such as an inability to separate 
single polypeptide chains  of masses  greater than 150 kDa or less than 8 kDa, limited 
dynamic range and loading capacity of the immobilized pH gradient (IPG) strip while it is 
unable to resolve proteins with an extremely basic (pI >12) or acidic (pI < 3) in nature. 
To overcome the irreproducibility problem of 2DE, difference gel electrophoresis (DiGE) 
was developed to minimize the effects of gel-to-gel variation by labelling two samples 
with two different fluorescent dyes before running them on the same gel (Unlu et al. 1997). 
DiGE is extremely sensitive as it is able to detect over a >10 000-fold protein abundance 
range (Viswanathan et al. 2006; Lilley et al. 2002).  
In DiGE, equal amount of protein samples are differentially labelled using synthetic N-
hydroxysuccinimidyl (NHS) ester derivatives of the cyanine dyes Cy3 and Cy5 before 
being subjected to 2DE separation and finally scanned to produce two super-imposable 
images (Timms & Cramer 2008). In order to increase the accuracy of the results, standard 
can  be  included  and  labelled  with  a  third  fluorophore  through  internal  standardization 
(Hiendleder et al. 2005). 
Other protein separation methods are based on liquid phase separation such as capillary 
electrophoresis (CE) and liquid chromatography (LC). They are known to have greater 
sensitivity, provide a wide dynamic range, are easily automated and can be faster than 2D-
PAGE (O’Donnell et al. 2004). A number of separation mechanisms can be applied such 
as  size  exclusion,  reversed-phase  (RP)  and  ion  exchange  so  that  strongly  acidic/basic 
proteins  can  be  analysed.  Peptides  are  separated  into  fractions  based  on  their 
hydrophobicity  (RP-HPLC)  or  based  on  their  charge  state  (strong  cation  exchange 
chromatography) (Lippolis & Reinhardt 2008). 
A  rather  new  approach  to  provide  better  separation  is  multidimensional  protein 
identification  (Mud-PIT)  where  two  or  more  LC  techniques  (e.g.  ion  exchange 
chromatography and RP HPLC) are used with on-line MS (Washburn et al. 2001). Chapter 3, 134 
 
 
3.1.3  Protein characterization 
Protein  characterization  is  mainly  accomplished  by  mass  spectrometers.  Basically,  all 
current mass spectrometers can detect and identify peptides in the femtomole (10
-15) to 
attomole (10
-18) range (Moyer et al. 2003). After initial protein digestion with trypsin, 
peptides must be ionized upon entering the mass spectrometer. The two most frequently 
used ionization methods are electrospray ionization (ESI) (Fenn et al. 1989) and MALDI 
(Tanaka et al. 1988; Karas & Hillenkamp 1988).  
ESI  allows  direct  connection  between  LC  and  MS  due  to  the  volatility  of  the  HPLC 
solutions. MALDI requires mixing of the digested peptides with a UV-absorbing molecule 
to  form  a crystalline structure. A laser will strike  this  structure for sublimation  of the 
matrix  and  ionization  before  releasing  the  associated  peptides  (Lippolis  &  Reinhardt 
2008). 
After ionization, the peptide mass is determined by mass analyser. Peptide mass is usually 
expressed  as  a  ratio  of  mass  divided  by  the  charge  of  the  peptide  (m/z).  Mass 
spectrometers are completed by detectors which can range from simpler quadrupole (Q), 
time-of-flight (TOF) to more complex Fourier transform ion-cyclotron resonance (FTICR) 
analysers (O’Donnell et al. 2004). 
Information gained from mass spectrometers includes mass and sequence of the proteins. 
MALDI-TOF is used primarily for detecting only protein masses while quadruopole-time 
of flight tandem mass spectrometry (Q-TOF MS/MS) can be used to provide sequence 
information (Roepstorff & Fohlman 1984). Post-source decay (PSD) is another technique 
used to sequence proteins (Spengler et al. 1992). 
The next step is protein identification by matching the masses of digested tryptic petides 
with known masses from a non-redundant protein database (Beavis & Fenyo 2000). This 
technique is simply achieved by peptide mass fingerprinting (PMF). Peptide fingerprinting 
is often associated with 2D-PAGE and protein identification is based on the measurement 
of multiple peptides from one particular protein (Lippolis & Reinhardt 2008). The second 
method to identify proteins is by using tandem mass spectrometers when PMF data are 
inconclusive (O’Donnell et al. 2004; Lippolis & Reinhardt 2008). 
Generally, proteomics experiments can be either direct identification or characterization of 
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shotgun approach is to identify all proteins present in a sample. It can be divided into 
survey or expression proteomics (Lippolis & Reinhardt 2010). In survey proteomics, it 
gives an overview of types of proteins and grouped them based on their biological process, 
cellular compartment or molecular function (Lippolis & Reinhardt 2010) while expression 
proteomics involved with relative quantification where two or more samples are compared 
with one served as a reference (Bantscheff et al. 2007; Lippolis & Reinhardt 2008; Ong & 
Mann 2005). 
3.1.4  Quantitative proteomics 
The  next  stage  of  proteomics  is  quantification  for  estimates  of  differential  protein 
expression.  DiGE  is  one  of  the  techniques  which  represent  a  real  advance  in  protein 
quantification by 2DE electrophoresis as described above. Fluorescence characteristics of 
the CyDyes are used to determine the relative abundance of proteins from two different 
samples (Wu et al. 2009).  
The other two commonly used quantitative techniques use molecular tags to label peptides 
via  an  interaction  with  a  free  thiol  or  amine  group.  The  first  molecular  tags  is  called 
isotope-coded affinity tags (ICAT) that uses isotopic labelling of cysteine residues by light 
or heavy tag  containing  biotinylated reagents  (Lippolis  & Reinhardt 2008;  Gygi  et  al. 
1999). One sample is labelled with the light tag and the other is labelled with the heavy 
tag. They are combined and enzymatically cleaved before further analyzed by LC-MS/MS. 
A newer tag approach called iTRAQ has been commercially available since 2004 and uses 
a set of 4 tags that possess the same molecular weight but different fragmentation points. It 
permits relative quantification of many samples (up to 8 samples) at one time (Choe et al. 
2007). 
Other less commonly used methods to obtain metabolic information on bacterial growth 
are stable isotope from amino acids in cell culture (SILAC) (Ong et al. 2002; Couté et al. 
2007) and surface-enhanced laser desorption  ionization-time of flight (SELDI-TOF) to 
identify enzymes that change expression in response to the presence of substrates such as 
lactose, glucose and galactose (Gagnaire et al. 2009). 
3.1.5  Aims of study 
The aims of this study were to determine the changes of milk proteome during the presence 
of intramammary inflammation (subclinical and clinical bovine mastitis). For comparison, 
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DiGE  and  MALDI-MS  analyses.  The  discovery  of  new  biomarkers  especially  in 
subclinical mastitis was also an important objective of this study. 
3.2    Materials and Methods 
3.2.1 Reagents 
General  chemicals  and  other  materials  were  obtained  from  Bio-Rad  Laboratories  Inc. 
unless otherwise stated. Double distilled water was used throughout. 
3.2.2 Milk samples 
Milk samples used in this study were of subclinical mastitic cases from Cochno Farm of 
School of Veterinary Medicine, University of Glasgow, UK (n=5) and clinical mastitis 
cases from Vale Veterinary Laboratory, Devon, UK (n=12). Bacteriological culture was 
performed  for  clinical  mastitic  milk  samples  in  the  Bacteriology  Laboratory  of  Vale 
Veterinary  Laboratory to determine the bacterial  cause of bovine mastitis.  Meanwhile, 
control milk samples (n=12) came from healthy cows from the Cochno Farm of School of 
Veterinary Medicine, University of Glasgow. The healthy milk samples were confirmed by 
somatic cell counts (<100 000 cells/ml) (Kromker et al. 2001) obtained from the Cochno 
Farm of School of Veterinary Medicine, University of Glasgow, UK. Prior to proteomic 
analyses, SAA and Hp assays (Chapter 2) were performed to determine the concentration 
of both acute phase proteins in each milk sample as confirmation of the health status. 
Samples were stored at -20°C prior to analysis. California Mastitis Test (CMT) was carried 
out on the subclinical mastitic milk samples at the Cochno Farm. 
3.2.3  California Mastitis Test 
The California Mastitis Test (CMT) was performed as described in the previous chapter on 
Section 2.2.3. 
3.2.4 Removal of high abundance milk proteins 
3.2.4.1  Rennet Coagulation 
Casein, the most abundant milk protein can be coagulated with the enzyme rennin found in 
rennet (an extract from the stomach of calves) to split a specific bond in the amino acid 
chain of the κ-casein macromolecule and form para-κ-casein and a glycol-macropeptide 
(Leonil & Molle 1991). Thus, the removal of casein from milk can be performed by rennet 
coagulation to allow the investigation of low abundance proteins. A total of 10μl of 15% 
(w/v)  of  calcium  chloride  was  added  into  1ml  of  milk  sample  in  order  to  improve 
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hour before pre-heated at 30ºC using a water bath for 20 minutes. An aliquot of 5 µl of 
7.5mg/ml  rennet  (Sigma-Aldrich,  Dorset,  UK)  was  added  into  1ml  milk  sample  and 
incubated at 30ºC for 30 minutes. Finally, the sample was centrifuged at 21 000 x g for 10 
minutes and supernatant/whey was kept frozen until further analysis. 
3.2.4.2  Acid Precipitation 
 Acid precipitation was used to remove major milk proteins such as caseins as another 
approach to investigate the properties of noncasein milk proteins (Murakami et al. 1998; 
Baeker et al. 2002, Yamada et al. 2004). A 0.5ml aliquot of milk sample was used and its 
pH was  altered to  pH4 using 1M  acid  hydrochloric (HCl). After pH  adjustment, milk 
sample  was  centrifuged  at  21  000  g  for  10  minutes  to  remove  precipitates. 
Supernatant/whey was kept frozen until further analysis. 
3.2.4.3  Ammonium sulphate (NH4SO4) Fractionation 
Ammonium sulphate fractionation was employed as another method to remove major milk 
proteins such as caseins. It was thought that this method was able to reduce any potential 
for acid induced protein hydrolysis (Hogarth et al. 2004). Saturated NH4SO4 was prepared 
by dissolving NH4SO4 in ice cold distilled water till no more dissolved. NH4SO4 (100%) 
was added into milk sample to make up 35% of NH4SO4. The sample was incubated for 1 
hour in an ice bath before being centrifuged at 21 000 g for 10 minutes. Supernatant/whey 
was kept frozen until further analysis. 
3.2.5 One-dimensional gel electrophoresis 
Milk samples used for 1D GE were 5 from individual subclinical mastitic and another 6 
from individual healthy cases obtained from Cochno Farm, Glasgow, UK.  
3.2.5.1  Reagent Preparation and Stock Solutions 
All  stock  solutions  and  buffers  were  prepared  according  to  Mini-PROTEAN®  3  Cell 
Instruction Manual.  12% PAGE gels  were also prepared according to  the manual  (see 
method in Appendix 1, Chapter 3). 
3.2.5.2  Sample Preparation 
Prior to 1DE analysis, the protein content was measured using a BioRad Bradford Assay 
(see Appendix 2, Chapter 3). Milk samples were diluted to give a sample at 2-3mg/ml and 
mixed with SDS Reducing Buffer (10% (w/v) SDS containing 0.5M Tris-HCl, pH 6.8, 
2.5ml glycerol and 0.05% (v/v) bromophenol blue; Bio-Rad Laboratories, Inc. USA) at a 
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3.2.5.3  Running the gel electrophoresis 
After the assembly of the electrophoresis module, the sample was loaded into wells with a 
pipette  using  gel  loading  tips.  Power  was  applied  to  the  Mini-Protean®  3  cell  and 
electrophoresis was run at 200 volts for 40 minutes. 
3.2.5.4  Gel staining and Image Acquisition 
After  electrophoresis,  the  gels  were  stained  using  colloidal  Coomassie  blue  G  dye 
according to manufacturers’ instructions (Sigma-Aldrich, Dorset, UK) and de-stained  in 
10% (w/v) acetic acid in 25% (v/v) methanol overnight. Gel images were acquired using 
Umax Power Look III. 
3.2.5.5  In-gel trypsin digestion of Coomassie-stained proteins  
Chosen gel bands from 1D gel electrophoresis were excised and placed in 1.5ml Eppendorf 
tubes. These bands were then cut into several pieces using pipette tips. Gel pieces were 
washed for 45 minutes in 500µl of 100mM ammonium bicarbonate and the wash was 
discarded.  Gel  pieces  were  further  washed  in  50%  acetonitrile/100mM  ammonium 
bicarbonate for another 45 minutes. The wash was again discarded. For reduction, 150µl of 
100mM ammonium bicarbonate and 10µl of 45mM DTT were added and incubated at 
60ºC  for  30  minutes.  For  alkylation,  10µl  of  100mM  iodoacetamide  was  added  and 
incubated in the dark for 30 minutes. Solvent was discarded and gel pieces were washed in 
500µl 0f 50% (v/v) acetonitrile/100mM ammonium bicarbonate with shaking for 1 hour. 
The wash was discarded and 50µl of 100% (v/v) acetonitrile was added to shrink the gel 
pieces. After 10 minutes, solvent was removed and gel pieces were dried completely in a 
vacuum centrifuge for 30 minutes. The dried gel pieces were left at 4ºC for 15 minutes 
before adding 0.2µg/µl sequencing grade modified Porcine Trypsin (Promega #V111) in 
25mM ammonium bicarbonate to rehydrate each gel piece. Additional trypsin solution was 
added if trypsin was completely absorbed so that the gel band became fully rehydrated. 
Finally about 20µl of 25mM ammonium bicarbonate was added over the gel pieces which 
were incubated overnight to allow protein digestion at 37ºC. 30µl of 100% acetonitrile was 
then added to the gel pieces and incubated for 20 minutes. Each solution in each tube was 
transferred to separate wells in a 96-well plate and dried in the Speed Vac. About 20 μl of 
1%  (v/v)  formic  acid  was  added  into  each  Eppendorf  tubes  containing  gel  pieces  and 
incubate for another 20 minutes. Each solution was transferred to the corresponding wells. 
These two steps were repeated for better recovery. About 40µl of acetonitrile was added 
and  further  incubated  for  10  minutes  before  the  solution  was  transferred  to  the 
corresponding wells. This step was also repeated for one time. The plate was checked at 
least after 90 minutes to make sure the sample had been dried up. Chapter 3, 139 
 
3.2.5.6  Sample Plating 
The MALDI plate should be cleaned and rinsed before use. A saturated solution of cyano-
4-hydroxy cinnamic acid (CHCA) in 50% (v/v) acetonitrile and 0.1% (v/v) trifluoroacetic 
acid (TFA) was prepared in 1.5ml Eppendorf tube and covered with aluminium foil. The 
tube was vortexed for 5 minutes before being centrifuged for 5 minutes. The saturated 
solution of CHCA was diluted at 1:10 in 50% acetonitrile and 0.1% TFA. 10µl of 50% 
acetonitrile and 0.1% TFA was loaded into the plate and 1µl of dried peptide was dissolved 
into the same spot. 1µl of 90% (v/v) CHCA solution (matrix solution) was added to the 
peptide on the plate and was mixed well by pipetting up and down for 5-7 times. After 
sample loading, the plate was left to dry before being analysed by the MS which was 
supervised by Kamburapola Jayawardena of the Sir Henry Wellcome, Functional Genomic 
Facilities, University of Glasgow, UK. 
3.2.6 Two-dimensional gel electrophoresis 
Milk samples used for 2D GE were pooled together from six of subclinical mastitic milk 
samples to make up pooled subclinical mastitic sample and another six from healthy cases 
were pooled together to make up pooled healthy samples.  
3.2.6.1  Sample preparation 
Each  supernatant/whey  sample  from  rennet  coagulation  was  precipitated  with  acetone 
overnight for 500μg protein. To a sample volume containing 500 μg, a 10 times volume of 
ice cold acetone was added and incubated at -20°C overnight. The protein solution was 
then  centrifuged  at  14  000  x  g  for  10  minutes.  Supernatant  was  removed  after 
centrifugation. 1ml of 80% acetone was used for washing before suspending the pellet in 
80% acetone. The dissolved pellet was centrifuged at 14 000 x g for another 10 minutes. 
Supernatant was discarded before dissolving the pellet in 1ml of lysis buffer (see Appendix 
3, Chapter 3). To make sure the pellet did not stick to the centrifuge tube’s wall, another 
brief centrifugation was performed. For the pellet to fully dissolve, the tube was put on the 
vibrating platform. 
3.2.6.2  Isoelectric Focusing 
A protein concentration assay was run on each sample so that an equal amount (100μg) 
was present before adding 3-10 IPG buffer (0.5% v/v), DTT 0.001 g/μl (0.02% w/v) and 
rehydration buffer (6M urea, 2M thiourea, 4% CHAPS and 0.02% (w/v) bromophenol 
blue) for 100μg. Sample was centrifuged at maximum speed for 5 minutes. About 450 μl 
of prepared sample was applied on pH3-10, 24cm IPG strip. Isoelectric focusing was run 
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50μA per strip at 20°C 
S1: Step-and-hold 30V 12 hours 
S2: Step-and-hold 300V 1 hour 
S3: Gradient 1000V 2 hours 
S4: Gradient 8000V 2 hours 
S5: Step-and-hold 8000V 8 hours 
S6: Step-and-hold 1000V 24 hours 
S7: Step-and-hold 1000V 24 hours 
 
After the focusing finished, the strip was put in a plastic tube with the gel part facing 
upward and stored at -20°C before running the SDS-PAGE gel electrophoresis.  
3.2.6.3  SDS-PAGE Gel Electrophoresis 
Both IEF Equilibration Buffers (EB) I and II (see Appendix 4 and 5, Chapter 3) were 
prepared prior to gel electrophoresis. 10ml of EB I was added onto the strip and mixed for 
15 minutes. The strip was then washed with running buffer and then 10ml of EB II was 
added onto the strip and mixed for another 15 minutes. The strip was washed once again 
before 1ml of running buffer was added on top of the gel (large format SDS PAGE gel). 
The strip was placed horizontally on top of the precast Ettan DALT® gels (26 x 20cm) and 
added 1ml of 0.5% agarose (heated at 105°C at least 5 hours prior to gel electrophoresis) 
was placed on top of the gel. The prepared gel was placed in the tank and the remaining 
running buffer was added in the tank. The electrophoresis was run overnight at higher and 
constant power. 
3.2.6.4  Gel staining and Image Acquisition 
After electrophoresis, the gel was fixed for 1-2 hours using 10% methanol and 7.5% acetic 
acid. Gel was then stained with freshly prepared Colloidal dye solution and put on the 
rocker  overnight.  Gel  images  were  acquired  using  a  Typhoon™75  multicolour 
fluorescence and phosphor image scanner.  
3.2.7 Difference Gel Electrophoresis 
Milk samples used for DiGE comprised 12 clinical mastitic and 12 healthy milk samples 
which were then pooled together to make up a pooled clinical mastitic milk samples and Chapter 3, 141 
 
pooled healthy milk samples. Concentration of Hp and M-SAA3 were determined as in 
Section 2.2.3 and 2.2.6. 
3.2.7.1  Sample Preparation 
Cold acetone (-20ºC) at four times sample volumes was added to protein (i.e: 250µl of 
each sample into 1000µl of cold acetone). This mixture was incubated overnight and it was 
then centrifuged for 10 minutes at 13 000 x g. The supernatant was decanted and the pellet 
was washed with 4 times volume of 80% acetone. Centrifugation was performed again and 
supernatant  was  decanted.  Brief  centrifugation  was  done  and  residual  supernatant  was 
removed with pipette tip. The dry pellet was air dried for approximately 5 minutes at room 
temperature but was not overdried the pellet. The pellet was resuspended in 10µl of DiGE 
lysis  buffer  (see  Appendix  6,  Chapter  3)  with  protease  inhibitor  cocktail  with  brief 
spinning. The milk samples were solubilised by probe sonification for 3 times brief cycles 
(1-2 second each cycle). Between sonification, the sample was cooled on ice for 1 minute. 
Foaming and heating during sonifcation was avoided. After sonification, the samples were 
incubated  for  10  minutes  at  room  temperature  with  gentle  mixing.  Lastly,  to  remove 
insoluble  material,  the  samples  were  centrifuged  for  10  minutes  at  13  000  x  g.  The 
supernatant was transferred to a fresh microcentrifuge tube. 
3.2.7.2  CyDye Labelling 
1µl of CyDye was added into 10µl of sample and incubated in the dark for 30 minutes. To 
stop the reaction, 1µl of 10mM lysine was added and further incubated in the dark for 10 
minutes. The pooled milk samples from healthy cows were labelled with Cy3 and the 
pooled milk samples from cows with clinical mastitis were labelled with Cy5. 
3.2.7.3  Isoelectric focussing 
The samples (1 labelled Cy3 and 1 labelled Cy5; ~24μl of each) were mixed together and 
500µl of rehydration buffer was added into the sample mixture. Before centrifugation, the 
sample mixture was left at room temperature for 10 minutes.  450µl of sample mixed in 
rehydration buffer was pipetted along the length of the strip holder, avoiding any formation 
of bubbles. The IPG strip was put onto the strip holder before layering mineral oil over the 
top of the strip, just enough to cover the strip. The lid was placed on the strips which were 
placed on the IPGphor system (GE Healthcare UK) and isoelectric focussing was run for 
between 70-80000V hours on the IPGphor as described in Section 3.2.6.2 
3.2.7.4  SDS-PAGE 
After isoelectric focussing, the strips were taken out of the holders and put into the plastic 
tubes. 10ml of SDS Equilibration Buffer I (see Appendix 4, Chapter 3) were placed onto Chapter 3, 142 
 
the strips and the plastic tubes was put on a large flat rocker desk for 15 minutes. The 
buffer was poured off and SDS Equilibration Buffer II (see Appendix 5, Chapter 3) was 
added and was rocked gently for another 15 minutes. The buffer was poured off and the 
strip was placed on the gel.1ml of 0.5% agarose was added on top of the gel (precast Ettan 
DALT®  gels; 26 x 20cm) before putting the  gel  in  the tank. Electrophoresis was  run 
overnight at 1-2V/gel in the running buffer. 
3.2.7.5  Gel Scanning 
DiGE gels were fixed before scanning on a 3 Laser Typhoon 9400 scanner. A preliminary 
scan was performed with one DiGE gel at a low resolution (1000 microns). Spot saturation 
was checked on each of the resulting images, and the photomultiplier tube voltage adjusted 
so  that  the  most  intense  protein  spots  were  not  saturated  (see  DiGE  manual  GE 
Healthcare). Gels can be scanned in pairs. Each high resolution (100 microns) scan takes > 
1 hr to complete but it was found that DiGE gels can be stored wrapped in the fridge 
overnight without noticeable loss of resolution. Once satisfactory images were obtained, 
gels were discarded and plates cleaned. After staining and scanning, the gel was wrapped 
and stored at 4°C until spot picking. 
3.2.7.6  Image manipulation 
DiGE  images  were  cropped  using  Imagequant  software  on  the  Typhoon  scanner.  The 
cropping removed all edges of the gel image (gel spacers, IPG strip and dye front). Images 
were then loaded into DeCyder for processing.  
3.3   Results 
3.3.1 SCC  measurement  and  acute  phase  proteins 
concentration 
In  order  to  confirm  the  disease  status  of  milk  samples  used  in  this  study,  SCC 
measurement and acute phase proteins (SAA and Hp) concentrations were determined. 
Table  3-1  showed  the  SCC  measurement  and  CMT  scores  in  all  control  (n=6)  and 
subclinical  mastitic  (n=5)  milk  samples  used  in  this  study  for  1D  and  2D  gel 
electrophoresis. In control milk samples, the range of SCC measurement in control milk 
samples (n=6) was between 6 and 27 x 10
3 cells/ml with an average of 18 x 10
3 cells/ml 
and median of 19 x 10
3cells/ml.  The range of SCC measurement for subclinical mastitic 
milk samples (n=5) was between 211 and 4472 x 10
3 cells/ml with an average of 1355 x 
10
3 cells/ml and median of 389 x 10
3 cells/ml. The CMT scores for all subclinical mastitic Chapter 3, 143 
 
milk samples were 2+ and all control milk samples gave negative results on CMT score. 
Table 3-2 showed the SCC measurement concentrations in all control milk samples (n=12) 
and APP concentrations as well as bacteriological culture results in clinically infected milk 
samples  used  in  this  study  for  DiGE.  In  control  milk  samples,  the  range  of  SCC 
measurement in control milk samples (n=6) was between 6 and 105 x 10
3 cells/ml with an 
average  of  40  x  10
3  cells/ml  and  median  of  27  x  10
3  cells/ml.    The  range  of  Hp 
concentration was between 560 and 16803.62 μg/ml with an average of 5532μg/ml and 
median  of  40234μg/ml.  The  range  of  SAA  concentrations  in  clinically  infected  milk 
samples was between 16.57 and 10635μg/ml with an average of 1041μg/ml and median of 
107.7μg/ml. From the results of bacteriological culture of clinical mastitic milk samples, 
bacteria that had been successfully identified include S. uberis and E. coli although in 
some milk samples, no growth of bacteria was identified.  
 
3.3.2 Comparison  between  rennet  coagulation,  acid 
precipitation and salt precipitation (ammonium sulphate) 
to remove casein 
After each of casein precipitation methods, whey samples from normal milk were run on 
1D gel electrophoresis for protein separation. For comparison, whole milk without any 
casein precipitation was run on the 1D gel electrophoresis as a control. Based on Figure 3-
1, Lane 2, protein bands of casein were found between 25-37 kDa by comparing to Mr 
standard (Lane 1) showing the presence of major milk protein in the whole bovine milk. 
As for Lane 3, 4 and 5 where various methods of casein precipitation were applied, protein 
bands  of  casein  were  completely  absent  from  the  1D  gel.  Furthermore,  both  rennet 
coagulation (Lane 3) and acid precipitation (Lane 4) showed increased intensity of protein 
bands between 10-15 kDa of molecular weight. These protein bands are likely to be β-
lactoglobulin (15 kDa) and α-lactalbumin (10 kDa). However, more low intensity of higher 
molecular  weight  protein  bands  were  seen  between  50-250  kDa  on  both  rennet 
precipitation  (Lane  3)  and  acid  precipitation  (Lane  4).The  intensity  of  those  high  Mr 
protein bands was higher with rennet precipitation as compared with acid precipitation. 
The rennet coagulation do had a very big Mr protein band at Mr 250kDa. Ammonium 
sulphate precipitation gave a low yield of whey protein (Lane 5). 
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Healthy milk samples     
ID  SCC (x 10
3 cells/ml)  CMT Score 
31  24  Negative 
5  6  Negative 
4  27  Negative 
16  13  Negative 
73  27  Negative 
110  9  Negative 
Min  6   
Max  27   
Mean  17.67   
Median  18.5   
Subclinical mastitic milk samples     
ID  SCC  CMT Score 
78  4472  2+ 
75  211  2+ 
80  482  2+ 
27  255  2+ 
97  NA  2+ 
Min  211    
Max  4472   
Mean  1355   
Median  368.5   
 
Table 3-1: The SCC measurement in all control (n=6) and subclinical mastitic milk 
samples (n=5) and CMT scores in subclinical mastitic milk samples used in this study 
for 1D and 2D gel electrophoresis. The range of SCC measurement for healthy milk 
samples was between 6 and 27 x 10
3 cells/ml with an average of 18 x 10
3 cells/ml and 
median of 19 x 10
3 cells/ml.  The range of SCC measurement for subclinical mastitic milk Chapter 3, 145 
 
samples was between 211 and 4472 x 10
3 cells/ml with an average of 1355 x 10
3 cells/ml 
and  median  of  369  x  10
3  cells/ml.  The  CMT  scores  for  all  subclinical  mastitic  milk 
samples were 2+ and all control milk samples gave negative results on CMT score. NA 
means not available. 
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Control milk samples       
ID 
SCC  (x  10
3 
cells/ml)     
31  24     
5  6     
4  27     
16  13     
73  27     
110  9     
43  19     
60  80     
49  105     
110  46     
71  43     
95  75     
Min  6     
Max  105     
Mean  39.5     
Median  27     
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Clinical  mastitic  milk 
samples 
ID  Hp (μg/ml) 
SAA 
(μg/ml) 
Bacteriological 
culture 
24  16803.62  20.52  Strep. uberis 
9  11277.6  19.92  Strep. uberis 
17  559.5  10635.28  No growth 
18  6296.3  99.5  No growth 
3  2905.1  559.5  E. coli 
7  7980.4  115.81  Strep. uberis 
78  4419.15  16.57  No growth 
47  2815.77  131.34  No growth 
A94  1517.24  17.11  No growth 
2  4772.38  502.07  E. coli 
4  3411.28  42.47  Strep. uberis 
6  3628.2  336.46  No growth 
Min  559.5  16.57 
Max  16803.62  10635.28 
Mean  5532.211667  1041.37917 
Median  4023.675  107.655   
 
Table  3-2:  The  SCC  measurement  in  all  control  (n=12)  milk  samples  and  APP 
concentration in clinically infected milk samples (n=12) used in this study for DiGE. 
The range of SCC measurement for healthy milk samples was between 6 and 105 x 10
3 
cells/ml with an average of 40 x 10
3 cells/ml and median of 27 x 10
3 cells/ml.  The range of 
Hp  concentration  was  between  559.5  and  16803.62  μg/ml  with  an  average  of 
5532.21μg/ml and median of 4023.68μg/ml. The range of SAA concentrations in clinically 
infected  milk  samples  was  between  16.57  and  10635.28μg/ml  with  an  average  of 
1041.38μg/ml and median of 107.66μg/ml. From the results of bacteriological culture of Chapter 3, 148 
 
clinical mastitic milk samples, bacteria that had been successfully identified include  S. 
uberis and E. coli although in some milk samples, no growth of bacteria was identified.  Chapter 3, 149 
 
 
Figure  3-1:  1D  gel  electrophoresis  whey  samples  after  various  methods  of  casein 
precipitation  in  co3mparison  with  whole  milk  sample  without  any  treatment.  Mr 
standard on Lane 1, whole milk on Lane 2, whey sample after rennet coagulation method 
on Lane 3, whey sample after acid precipitation method on Lane 4 and whey sample after 
ammonium sulphate fractionation method on Lane 5. 
 
 
 
 
 
 
 
Lane 1  Lane 2  Lane 3  Lane 4  Lane 5 
250 kDa 
150 kDa 
100 kDa 
75kDa 
50 kDa 
37kDa 
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3.3.3 1D  gel  electrophoresis  on  individual  subclinical 
mastitic and healthy milk samples 
Rennet  precipitation  was  subsequently  used  to  remove  major  casein  protein  to  allow 
analysis of lower abundant protein in whey. At the concentration used, rennet did not give 
a protein band stainable with Coomassie blue (not shown). The separation of proteins from 
individual  subclinical  mastitic  and  healthy  milk  samples  on  1D  gel  electrophoresis  is 
shown in Figure 3-2a, 3-2b, 3-2c. In comparison of mastitic to healthy milk, no clear 
difference in terms of presence or absence of protein bands observed (Fig 3-2a). However, 
despite having no significant difference of protein bands, visualized protein bands in one 
individual sample of each group (subclinical mastitis in Lane 3; healthy in Lane 10) was 
digested with trypsin and identified by MALDI-MS. Upon, protein identification searched 
against Mascot database, only major milk proteins and some serum-derived proteins were 
successfully  identified  such  as  α-lactalbumin,  β-lactoglobulin,  albumin,  lactoferrin  and 
immunoglobulins (Fig 3-2b and Fig 3-2c). These results were similar between subclinical 
mastitic  and  healthy  milk  samples.  No  protein  was  successfully  identified  from  the 
database for high molecular protein bands such as band 1, 2, 11 and 12 or for low Mr 
protein  bands  such  as  10,  21,  22  (Fig  3-2b).  The  whole  list  of  successful  protein 
identification by Mascot database is presented on Table 3-3. 
3.3.4 2D gel electrophoresis on pooled subclinical mastitic 
and healthy milk samples 
The second dimension protein separation on both pooled subclinical mastitic and healthy 
milk samples after casein removal by rennet precipitation is shown in Figure 3-3a and 3-
3b. The IPG strip used was between pH 3 and pH 10. Upon colloidal Coomassie staining 
of the gel, there was no clear difference in terms of presence, absence, increase or decrease 
intensity of protein spots observed between these two pooled milk samples. There was 
only increased in the intensity of albumin protein spot (Spot 1) seen on 2D gel of pooled 
subclinical mastitic milk sample in comparison with pooled healthy milk sample. Based on 
previous study by Hogarth et al. (2004), it was concluded that protein spot 2 and 3 were 
the major whey proteins; β-lactoglobulin and α-lactalbumin respectively. Thus, no further 
mass spectrometry analysis was done on this 2D gel. 
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Figure  3-2a:  1D  gel  electrophoresis  of  5  individual  subclinical  mastitic  and  6 
individual healthy milk samples. Showing protein bands for each of milk samples and 
the Mr standard was on Lane 1. 
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150 kDa 
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75 kDa 
50 kDa 
37 kDa 
25 kDa 
20 kDa 
15 kDa 
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Figure  3-2b:  1D  gel  electrophoresis  of  a  subclinical  mastitic  and  a  healthy  milk 
sample. Showing protein bands used for MS analysis. Chapter 3, 153 
 
 
Figure  3-2c:  1D  gel  electrophoresis  of  a  subclinical  mastitic  and  a  healthy  milk 
sample. Showing all the proteins identified by the MS based on the Mascot database. 
 
 Chapter 3, 154 
 
 
Table 3-3: Proteins identified after in-gel trypsin digestion of protein bands on 1D gel 
electrophoresis. Mascot peptide database was used to identify the proteins. Mr and pI data 
were from Mascot database result. 
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Figure 3-3a: 2D gel electrophoresis of pooled subclinical mastitic whey sample. Showing 
major milk proteins such as albumin on Spot 1, β-lactoglobulin on Spot 2 and α-lactalbumin 
on Spot 3 (Hogarth et al. 2004). 
Spot 1 
Spot 2 
Spot 3 
pH 3 
250 kDa 
10 kDa 
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Figure 3-3b: 2D gel electrophoresis of pooled healthy whey sample.  Showing major milk 
proteins such as β-lactoglobulin on Spot 4 and α-lactalbumin on Spot 5 (Hogarth et al 2004). 
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3.3.5 Difference  gel  electrophoresis  (DiGE)  on  pooled 
clinical mastitic and healthy milk samples 
Difference gel electrophoresis was performed on clinical mastitic samples in comparison 
with healthy samples to increase the likelihood of identifiable difference and after casein 
removal by rennet precipitation to increase the sensitivity of lower-abundance proteins 
detection. The scanned gel of the overlay image where both samples labeled with Cy3 and 
Cy5 fluorescent dyes can be analyzed on the same image as shown in Fig 3-4a. The gel 
stained with Cy5 dye for the mastitic milk is shown in Fig 3-4b and with Cy3 dye for 
normal milk is shown in Fig 3-4c. No clear difference was observed in terms of presence, 
absence,  increase  or  decrease  intensity  of  protein  spots  between  the  pooled  two  milk 
samples  except  for  increase  in  the  intensity  of  protein  spot  of  albumin  and  reduced 
intensity of the protein spot of whey proteins in mastitic milk sample as compared with 
healthy milk sample. Otherwise, no other significant protein spot was detected on these 
gels.Chapter 3, 158 
 
 
Figure 3-4a: Difference gel electrophoresis on clinical mastitic and healthy milk 
samples.  Showing clinical mastitic milk sample was labeled with Cy5/red fluorescent dye 
and healthy milk sample was labeled with Cy3/green fluorescent dye.Chapter 3, 159 
 
 
Figure 3-4b: Difference gel electrophoresis on pooled clinical mastitic milk sample on 
Cye5 fluorescent dye. Increased in albumin and decreased in whey proteins spot intensities 
are shown by the arrows as compared with pooled healthy milk sample in Figure 3-4c. 
Albumin 
Whey proteins Chapter 3, 160 
 
 
Figure 3-4c: Difference gel  electrophoresis on pooled  healthy milk samples on Cye3 
fluorescent  dye.  Increased  in  whey  proteins  spot  intensity  is  shown  by  the  arrow  as 
compared with pooled healthy milk sample in Figure 3-4b. 
Whey 
proteins Chapter 3, 161 
 
3.4  Discussion 
The clinical mastitic milk samples chosen in this study had high concentrations of acute 
phase proteins for both SAA and Hp. The mean values for APP concentrations in clinically 
infected milk samples were 5532μg/ml and 1041μg/ml for Hp and SAA respectively. The 
range in values for APP concentrations in clinically infected milk samples were 560 to 
16804μg/ml and 16.6 to 10635μg/ml for Hp and SAA respectively. As the distribution of 
these  data  was  not  normally  distributed,  the  median  values  for  each  parameter  were 
obtained. The median values for APP concentrations in clinically infected milk samples 
were  4024μg/ml  and  107.7μg/ml  for  Hp  and  SAA  respectively.  Because  no  APP 
concentration was obtained for either the healthy or the subclinical mastitic milk samples 
as these analyses were carried out retrospectively after development of the Hp ELISA 
assay  and  the  specific  samples  were  no  longer  available,  no  significance  test  was 
performed.  However,  the  Spearman’s  correlation  test  was  performed  which  revealed  a 
negative and low relationship between SAA and Hp concentrations (r=  -0.364). It was 
surprising and interesting and may reflect different origins of Hp and SAA in milk, notable 
that recent evidence suggests that Hp in milk may be derived from neutrophils (ie somatic 
cells)  as  well  as  epithelial  tissue  (Cooray  et  al.  2007).  The  SCC  measurement  for  all 
healthy milk samples was less than 100 000 cells/ml (average was 40 000 cells/ml) which 
confirmed the healthy status of the cows. The Mann Whitney’s test revealed significant 
difference  (p<0.05)  in  the  SCC  measurement  of  control  and  subclinical  mastitic  milk 
samples with a significance level (p) of p=0.001. 
The objective of this study was to characterize the milk proteome associated with bovine 
mastitis on gel-based proteomic techniques and to characterize and identify low abundance 
protein in the milk proteome using mass spectrometry. Previous studies as described in 
chapter one clearly demonstrated that proteomic analyses have successfully characterized 
and identified several important milk proteins which might be served as protein biomarker 
of bovine mastitis (Yamada et al. 2002; Smolenski et al. 2007). Furthermore proteomics 
has also helped to study the physiological functions of those identified proteins in the 
maintenance  of  mammary  gland  in  terms  of  providing  nutrients  immunity  and 
development to the newborns.  
To examine changes in low abundance proteins, rennet coagulation was chosen over acid 
precipitation or ammonium sulphate fractionation. Based on 1D gel electrophoresis, rennet 
coagulation successfully removed the majority of milk casein. Furthermore, the intensity of Chapter 3, 162 
 
lower abundance proteins at 50kDa to 250kDa of molecular weight was increased when 
rennet coagulation was used. However, other major milk proteins such as α-lactalbumin 
and β-lactoglobulin were still present in the milk samples. Potential interference in protein 
pattern for the protein of the rennet enzyme was discounted. A rennet precipitation of a 
similar concentration to that used for casein precipitation was run on 1D SDS PAGE and 
gave no Coomassie blue stained band. 
For  a  preliminary  analysis,  1D  gel  electrophoresis  of  individual  milk  samples  was 
performed on subclinical mastitis in comparison with healthy cases. However, there was no 
distinctive difference in terms of protein bands between subclinical mastitic and healthy 
milk samples (Figure 3.2a, b, and c). Furthermore, no lower abundance protein bands were 
seen in milk samples after casein removal in the healthy or mastitic sample. Unfortunately, 
the high molecular weight protein bands but with lower intensity were not successfully 
identified by the MALDI-MS. 
Colloidal  Coomassie  blue  staining  might  not  be  sensitive  enough  to  detect  all  lower 
abundance  proteins  which  may  still  include  an  important  protein  biomarker  in  bovine 
mastitis. However, there was no significant difference in terms of protein levels that could 
differentiate subclinical mastitic from healthy milk sample in this study. Another possible 
reason was due to the limited usage of 1D gel electrophoresis as it only separates milk 
proteins based on their molecular weight so that 2DE may be more effective. Low intensity 
but high molecular weight protein bands (Band 1, 2 ,11 and 12) were not successfully 
identified due to very low level of proteins exist in those protein bands. Limited number of 
B. taurus database entries in the database used (Mascot) might contribute to no possible 
protein identification of these protein bands. 
However, for further characterization of milk proteins on 1DE, separated protein bands in a 
milk sample from each group were cut from the gel and sent for MS analysis. MALDI-
TOF  successfully  identified  more  of  these  protein  bands  though  it  appeared  that  the 
identified proteins were the normal milk proteins that can be found in bovine milk. These 
include  albumin,  α-lactalbumin  and  β-lactoglobulin.  This  result  was  in  accord  with 
previous proteomic analyses (Hogarth et al. 2004; Smolenski et al. 2007; Boehmer et al. 
2008; Boehmer et al. 2010). No casein was identified on the 1DE gel showing that rennet 
precipitation had successfully removed casein.  
Beta-lactoglobulin which comprises about 10% of the total milk protein was identified by 
MALDI-TOF with Mr of 18554 and pI value of 4.83 for subclinical mastitic milk sample Chapter 3, 163 
 
and slightly higher Mr of 18640 with the pI value of 4.76 for healthy milk sample. Beta-
lactoglobulin binds to retinol and thus implicates its function in the transport of vitamin A 
to newborns (Wong et al. 1996). Alpha-lactalbumin which accounts for about 13% of total 
whey protein was identified by MALDI-TOF in this study with a Mr of 11541.4 kDa with 
pI values of 4.61. It acts as a specifier protein which catalyzes the biosynthesis of lactose in 
addition  of  galactosyltransferase  (Wong  et  al.  1996).  During  intramammary  infection, 
there is a possible reduction in the levels of α-lactalbumin and β-lactoglobulin in milk has 
been reported due to depletion in the synthesis and secretion of these proteins following 
damage to the mammary epithelial cells by bacterial toxins or by the presence of infection 
in the mammary gland (McFadden et al. 1988). 
It is known that serum-derived proteins such as albumin, immunoglobulins, complement 
proteins (Ward et al. 2002) and lactoferrin are present in low levels in bovine milk (Lacy-
Hulbert  et  al.  1999;  Smolenski  et  al.  2007).  These  may  have  antimicrobial  properties 
(Ward et al. 2002). Albumin is also known to increase in concentration during mastitis as a 
result of leakage from blood circulation into the mammary gland (Hogarth et al. 2004). It 
has also been demonstrated that albumin can be synthesized and secreted in the bovine 
mammary gland as local expression of albumin in the mammary gland increased upon 
exposure to LPS as well as in mastitic condition (Shamay et al. 2005). However, because 
no quantification of specific protein levels in milk samples was made, it is not known 
whether the presence of albumin in subclinical mastitic milk was significantly different 
from its presence in healthy milk in this study. Other than albumin, immunoglobulins and 
lactoferrin  were  also  present  in  both  subclinically  infected  and  healthy  milk  samples. 
Epithelial  cells  of  the  mammary  gland  are  known  to  produce  lactoferrin  as  well  as 
cytokines  (IL-8  and TNF-α) in  response to  LPS stimulation (McClenahan  et  al.  2005; 
Pareek  et  al.  2005).Study  by  Chaneton  et  al.  (2008)  suggested  that  different  bacteria 
species may stimulate different mammary gland responses mediated by Lf secretion. On 
the other hand, immunoglobulins are one of the major proteins in colostrum which confer 
passive immunity to the newborn (Smolenski et al. 2007) which also serve as defence 
mechanism against microbial invasion of mammary gland. 
As no differences were observed on the gel pattern of 1D gel electrophoresis between 
subclinical  mastitic  and  healthy  milk  samples,  2D  gel  electrophoresis  was  applied  to 
similar samples. It was hope that lower abundance proteins would be identified because 2D 
electrophoresis is generally more effective in separating as in bovine milk. Further pools of Chapter 3, 164 
 
milk  samples  from  subclinical  and  healthy  groups  were  used  prior  to  2D  gel 
electrophoresis. 
Unfortunately,  there  was  again  no  observable  difference  in  low  abundance  proteins 
between the pooled subclinically infected milk and pooled healthy milk samples on the 2D 
gel.  Mass  spectrometry  analysis  was  not  undertaken  as  the  protein  spots  in  both  gels 
represent the same major milk proteins; albumin, α-lactalbumin and β-lactglobulin and 
have previously been identified (Hogarth et al. 2004). However, it was interesting to find 
that  albumin  was  not  observed  on  the  2D  gel  of  healthy  samples.  This  result  further 
supported the findings that albumin was increased in concentration during bovine mastitis 
as a result of either an increase in leakage from serum into the mammary gland or in 
albumin expression in the mammary gland. No reduction in the intensity of protein spots of 
other whey proteins in subclinical sample was shown in this 2D gel.  
In this study, no low abundance protein was seen on the 2D gel of subclinical mastitic 
sample  and  the  possible  explanation  may  derived  from  the    evidence  or  the  potential 
binding of other proteins  to  serum albumin.  Serum albumin  is  known to  bind  as  well 
transport long-chain fatty acids and other small molecules such as bradykinin, interferon 
and even acute phase proteins (SAA and α-1-acid glycoprotein) (Peters 1977; Gundry et al. 
2007). Furthermore, 2D gel electrophoresis was thought to have difficulty to separate low 
abundance proteins, acidic and basic proteins, proteins with very small or very large in size 
as well as hydrophobic proteins (Beranova-Giorgianni 2003). This can be explained of 
why  no low  abundant  protein  particularly APP  seen on 2D  gel  of subclinical  mastitic 
sample. 
In contrast to studies which have removed casein, it has been suggested that in order to 
increase  the  likelihood  of  the  detection  of  lower  abundance  proteins,  no  sample 
fractionation or depletion of high-abundance proteins should be performed (Boehmer et al. 
2008).  Although  several  other  studies  suggest  the  use  of  fractionation  or 
immunoprecipitation  (Yamada  et  al.  2002;  Hogarth  et  al.  2004)  to  selectively  remove 
casein, β-lactoglobulin, α-lactalbumin or other major milk proteins, the possibility of other 
lower-abundance  proteins  also  being  removed  might  occur.  To  investigate  subclinical 
mastitis,  more  milk  samples  should  also  be  examined  to  increase  the  potential  of 
discovering protein biomarkers important in bovine mastitis. Another way to improve and 
increase  the  separation  and  detection  of  lower  abundance  proteins  is  by  using  more 
sensitive staining methods than colloidal Coomassie including silver or sypro-ruby staining 
(Hogarth et al. 2004). As investigation of milk samples from sub clinical mastitis cases did Chapter 3, 165 
 
not give any significant difference in the levels of milk proteome, the examination of milk 
samples from clinical mastitis should be considered to find identity possible biomarker 
after which change in the subclinical mastitis could be determined. 
Therefore, milk samples from clinical mastitis cases were collected for comparison with 
healthy  milk  samples  and analyzed using difference  gel  electrophoresis  (DiGE). DiGE 
enables the visualization of multiple protein samples in one 2D gel. After labelling the 
milk samples with the differing fluorescent dyes and running on the same gel, spot patterns 
were visualized by alternately illuminating the gel with the excitation wavelengths of each 
dye. Overlay image was then analyzed using standard proteomics software (Van den Bergh 
et al. 2003).  
Unfortunately, although clear distinction were found between clinical mastitic and healthy 
samples  on  DiGE  gels  with  lower  abundance  proteins  and  increased  albumin  in  the 
mastitic sample, all of the changes had been observed before (Hogarth et al. 2004). Thus, 
no further mass spectrometry analysis was done and based on the previous study (Hogarth 
et al. 2004), the protein spots seen on the Cy dye stained gels were actually the major milk 
proteins (albumin, β-lactoglobulin and α-lactalbumin).  
The protein concentration of the non-casein but still high abundance proteins (albumin or 
whey proteins) of these milk samples might also contribute to failed detection in other 
lower abundance proteins. Thus, in order to increase the potential of using difference gel 
electrophoresis, several  important  factors must be taken into consideration. The use of 
more clinical mastitic milk samples may increase the sensitivity to detect lower abundance 
proteins. Milk samples should be handled more cautiously in terms of transporting the 
samples  from  farm  to  laboratory  as  well  as  minimizing  the  thawing  process  of  milk 
samples. This would ensure no depletion of important milk proteins should occur. 
In  conclusion,  among  milk  proteins  successfully  identified  by  MALDI-MS  on  1D  gel 
electrophoresis  were  albumin,  α-lactalbumin,  β-lactoglobulin,  lactoferrin  and 
immunoglobulins.  However,  no  clear  distinction  was  observed  between  the  2D  gel 
electrophoresis of subclinical mastitic and healthy milk samples. Additionally, from DiGE 
analysis, albumin was found increased in clinical mastitic sample whilst β-lactoglobulin 
was reduced in mastitic sample when compared with healthy sample. From this study, it 
was evident that gel-based proteomic techniques as used here were not able to identify 
novel  protein  biomarker  in  milk  in  bovine  mastitis  or  other  lower-abundance  proteins 
involved  in  inflammation  or  host  defence  mechanism.  The  technical  requirement  and Chapter 3, 166 
 
resource  implication  needed  for  consistent  analytical  result  in  a  gel-based  approach  to 
proteomic  analysis  of  milk  are  further  aspects  to  consider.  Accordingly,  non-gel 
approaches were undertaken to continue the investigation such as CE-MS and LC-MS/MS 
in the next chapters. 
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Chapter IV: Peptidomic Analysis on Bovine 
Mastitis 
4.1  Introduction 
Peptidomic  analysis  involves  extraction,  separation,  detection  and  identification  of 
peptides in samples. In earlier studies, less manipulation of the samples was employed to 
allow peptides to be analysed by mass spectrometry (Baggerman et al. 2004). Tissues were 
directly placed on the MALDI target plate together with the matrix solution (Clynen et al. 
2001; Verhaert et al. 2001; Uttenweiler-Joseph et al. 1998; Sweedler et al. 2000) although 
in the case of ESI, a simple extraction was performed in the spraying solvent (Kollisch et 
al.  2000).  However,  due  to  the  presence  of  multiple  biological  peptides  at  different 
concentrations in cells, tissues or body fluids, it is desirable that peptide extraction and 
separation are used prior to mass spectrometric analysis. Indeed, the aim of several studies 
is  to  enrich  the  low-abundance  peptide  composition  of  samples  (Chertov  et  al.  2005; 
Baggerman et al. 2002; Skold et al. 2002; Schulz-Knappe et al. 2001). 
As the main difference between protein and peptide is based on their molecular weights, 
the isolation of smaller peptides from higher concentration of larger proteins is essential 
(Hu et al. 2009). Several extraction steps for analysis of endogenous peptides have been 
employed to meet this aim. Some methods which have been applied include ultrafiltration, 
organic solvent precipitation, solid phase extraction, restricted-access material (RAM) - 
trap column-based extraction and others (Hu et al. 2009).  
In ultrafiltration, a membrane with an accurate molecular weight cut-off (MWCO) is used 
to  extract  peptides  of  interest  while  removing  other  high  molecular  weight  (HMW 
>20kDa)  peptides  and  proteins.  However,  in  this  method,  the  ultrafiltration  times  will 
increase dramatically if huge amount of sample is applied and also, other LMW (<20kDa) 
contaminants (e.g. salt) may also be concentrated which may affect the efficiency of the 
method (Hu et al. 2009). 
By using organic solvent precipitation, the electrostatic interactions between molecules are 
increased  and  the  smaller  peptides  are  dissolved  in  the  high  concentration  of  solvents 
(Polson et al. 2003). An example of an organic solvent that has been used is acetonitrile 
(Chertov et al. 2004). The use of solid-phase extraction (SPE) has also been employed as  Chapter 4, 168 
 
 
 
part of sample clean-up preparation while functionalized magnetic particles were used as 
adsorbents to enrich specific peptides in various studies (Villanueva et al. 2004; Fiedler et 
al.  2007;  Baumann  et  al.  2005).  In  addition,  conventional  chromatographic  packing 
materials  such  as  reversed-phase  polymers  and  nanomaterials  with  different  properties 
have been employed as part of this methodology (Aristoteli et al. 2007; Li et al. 2007; Tian 
et al. 2009).  
All  these  methods  are  examples  of  off-line  mode  sample  preparation  which  may  be 
laborious, time-consuming and have poor reproducibility (Hu et al. 2009). The use of a 
special  type  of  chromatographic  packing  materials  called  restricted  access  materials 
(RAMs) with two functions during chromatographic separation has been proposed. It was 
suitable for online extraction of smaller peptides and removal of other high abundance 
peptides (Boos & Grimm 1999). Other techniques including selective electrophoresis and 
continuous  elution  electrophoresis  have  similar  characteristics  in  their  ability  to 
concentrate LMW peptides (Camerini et al. 2007; Ly et al. 2008).  
The  next  step  of  peptidomics  involves  peptide  separation.  Baggerman  et  al.  (2004) 
reviewed several types of peptide separation methodologies that can be employed. One of 
them is the use of coupling an HPLC to electrospray sources. In this method, the peptides 
are separated by the use of reversed-phase chromatography (Schoofs et al. 1993) and by 
applying the voltage difference between the outlet of HPLC and the sample targets, ions 
can be transferred from solution into the gas phase. This method allowed sensitive peptide 
analysis and have been applied to various peptidomics studies (Schulz-Knappe et al. 2001).  
Recent  advances  have been developed to  detect lower concentrations  of peptides  from 
complex protein mixtures. When ultra low flow LC systems coupled to nanospray sources 
are  used,  the  flow  rates  employed  for  chromatographic  separation  has  been  as  low  as 
20nl/min  with  the  internal  diameters  of  columns  down  to  15μm  (Shen  et  al.  2002). 
However,  this  method  is  time  consuming  and  to  prevent  this,  column  switching  was 
introduced to separate the sample loading and the actual separation. A whole sample can 
be  analyzed  and  peptides  identified  can  be  selected  for  further  fragmentation  in  the 
collision cell of the MS instrument as they passed through the columns (Baggerman et al. 
2004).  When  analysing  more  complex  samples,  reducing  the  flow  rate  during  the 
separation can be performed to increase the time analysis of the mass spectra and thus, 
more peptides can be fragmented or fragmented longer in the case of LMW peptides.  Chapter 4, 169 
 
 
 
Another type of peptide analysis is multi-dimensional peptide separation. Reversed-phase 
LC is frequently used as the second separation stage which enables full separation of all 
the effluent material from the first step. It can be combined with size exclusion reversed-
phase  (Oosterkamp  et  al.  1998),  reversed  phase-reversed  phase  chromatography 
(Oosterkamp et al. 1998: Wall et al. 1999) or ion exchange-reversed phase (Oosterkamp et 
al. 1998; Davis et al. 2001). Multidimensional protein identification technology (MudPIT) 
using  a  strong  cation  resin  (SCX)  and  RP  columns  has  been  successfully  applied  for 
shotgun proteomic research (Hu et al. 2009). The individual peptides separated from SCX 
columns were eluted onto the RP columns before subsequently being sprayed into the ESI 
MS (Baggerman et al. 2004; Hu et al. 2009). 
Most peptidomes, unlike tryptic peptides, do not carry C-terminal Lys or Arg residues and 
SCX column separates peptides based on their charges (Hu et al. 2009).  Reversed phase 
(RP) on the other hand is pH stable, and by using RP-RP separation, peptides may be better 
separated  as  shown  by  Dowell  et  al.  (2008).  A  total  of  56  peptides  from  known 
neuropeptides  precursors  including  17  unidentified  peptides,  have  been  successfully 
separated using this method. A combination of sample ultrafiltration with size-exclusion 
chromatography prefractionation has been considered as a good method for comprehensive 
peptidomics analysis (Hu et al. 2007). It allows the investigation of HMW peptides and at 
the same time, identifying the LMW peptides which improved the sensitivity of LMW 
method of detection. The advances in the MS analysis in detecting HMW peptides have 
developed  with  the  use  of  quadrupole  TOF  MS  with  collision-induced  dissociation 
(Möhring et al. 2005), fourier transformion cyclotron resonance MS using electron capture 
dissociation and linear quadrupole ion-trap MS wit electron transfer dissociation (Hu et al. 
2009) which allowed sequencing of large and small peptides.  
Another  increasingly  popular  peptidomics  analysis  is  the  combination  of  capillary 
electrophoresis  (CE)  with  MS.  It  can  perform  a  separation  of  peptides  from  small 
molecules to large proteins in the same analysis. It has been chosen as a method of analysis 
due to the low amount of sample used and short analysis time (Baggerman et al. 2004). 
Pre-concentrating of the sample with hydrophobic media can be employed to increase the 
concentration of the sample. 
Quantitative  peptidomics  has  been  increasingly  important  especially  in  biomarker 
discovery when it is important to understand the relative difference of each protein/peptide 
in  different  conditions  (Hu  et  al.  2009;  Baggerman  et  al.  2004).  Direct  profiling  with  Chapter 4, 170 
 
 
 
MALDI/SELDI is most widely used to quantify peptides but another way is the by using a 
UV  detector  between  the  LC  system  and  the  MS  to  compare  the  peptide  relative 
abundances (Hu et al. 2009; Baggerman et al. 2004).  
Differential peptide display was introduced by Tammen et al. (2003) in which the sample 
was separated by RP-HPLC and each fraction eluted was analysed by MALDI-TOF MS. 
The  mass  spectra  were  transformed  into  1D  gel-like  pattern  and  the  patterns  were 
combined to generate a virtual 2D peptide map. To identify the peptides, individual HPLC 
fractions were subjected to nESI-qTOF-MS/MS or MALDI-TOF/TOF-MS sequencing. 
The SELDI-TOF MS technique is another method using the protein chip array technology 
with a modified surface target (Huchens & Yip 1993). The target surface can be modified 
with chemical functionality such as RP, ion exchange chromatography (IEX), immobilized 
metal affinity chromatography, antibodies, proteins and DNA. This binding activity was 
considered as a pre-fractionation step to allow easier analysis. Different expressed peptides 
can  be  identified  from  different  groups  of  sample  using  advanced  bioinformatic  tools 
(Issaq et al. 2003; 2002).  
However, these methods described above (MALDI/SELDI profiling) which were thought 
to  provide semi-quantitative analyses  of peptides  as  ion  patterns, could  be affected by 
ionization efficiency, ion suppression effects and sample preparation process (Hu et al. 
2009). Furthermore, ion intensities in the mass spectrum did not correlate to the relative 
amounts  of  the  corresponding  compounds  (Baggerman  et  al.  2004).  To  overcome  this 
problem,  mass  labelling  was  employed  in  which  a  known  concentration  of  a  „mass 
labelled‟  analogue  of  the  peptide  of  interest  was  used  as  internal  reference.  A  perfect 
example of mass labelling was by incorporating stable isotopes in which two different 
samples had the same ionization efficiency but with a slight difference in masses (Hu et al. 
2009; Baggerman et al. 2004).  
An iTRAQ approach with amine reactive isobaric tagging and tandem MS to quantify the 
peptides has been employed in both proteomics and peptidomics analyses. Peptides with 
the same sequence appeared to be identical in masses but produced as a single ion signal in 
MS (Hu et al. 2009). It may be used in complementary studies with MALDI profiling for 
both clinical diagnosis and biomarker discovery as performed by Hu et al. (2009). 
Another isotope labelling method used for cysteine containing peptides/proteins is isotope-
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with an isotopically light form of the ICAT reagent. By comparing their relative signal 
intensities, the relative quantification of samples in different conditions can be determined 
(Gygi et al. 1999). 
In a previous discussion about peptide analysis in bovine mastitis, most of the studies 
identified proteolytic activities yielding peptides in milk (Wedholm et al. 2008; Larsen et 
al.  2010).  Many  diseases  are  associated  with  proteolytic  processes  (Hu  et  al.  2009). 
Proteases reflect the response of the host towards the different physiological conditions. 
Different  disease states  will lead to  different  degradation pattern of proteins  and these 
degradation products may be of useful as disease biomarkers (e.g. cancer) as described by 
Villanueva  et  al.  (2006).  The  activity  of  proteases  in  the  biological  samples  can  be 
quantified  by  the  use  of  activity-based  probes  (ABPs)  coupling  to  MS.  ABP  work  by 
targeting specific proteases based on their enzymatic mechanisms such as serine proteases, 
cysteine proteases, threonine proteases, aspartyl proteases and metalloproteases (Kidd et 
al. 2001; Greenbaum et al. 2000, Greenbaum et al. 2002, Kessler et al. 2001, Chun et al. 
2004; Saghatelian et al. 2004). Affinity chromatography can also be used to characterize 
proteases as performed by Tian et al. (2006). 
Peptidomic analysis allows full visualization and characterization of the whole peptidome 
in  given  cells,  tissues  or  bodily  fluid  and  even  their  post-transitional  modifications 
peptides. With the use of nanoscale LC coupled with MS, one can identify peptides  at the 
acid amino sequence level however, the use of tandem MS can only provide partial amino 
acid  sequences  of  peptides.  This  can  be  resolved  by  using  certain  bioinformatic 
programmes to identify peptides from protein database or analogue gene from the genomic 
database (Choudhary et al. 2001). Peptidomics analysis can be applied in complementary 
with other protein characterization methodologies to discover novel disease biomarkers as 
well as to identify newly discovered peptides for therapeutic purposes. 
4.1.1 Aims of study 
Overall,  the  objective  of  this  chapter  is  to  apply  a  peptidomic  approach  to  study  the 
presence of polypeptides that may be used to discriminate normal milk samples from milk 
samples from quarters infected with bacteria causing bovine mastitis. It was hoped that by 
using this sensitive and high-throughput methodology, significant results can be achieved 
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from healthy cows were compared to samples from cows with clinical mastitis caused by 
either S. aureus or E. coli. Initially samples were analyzed by CE-MS to detect positive 
biomarkers and then by LC-MS/MS to sequence putative biomarkers. 
4.2  Materials and Methods 
 
4.2.1 Milk Samples and Reagents 
Milk samples from clinical mastitic cases were obtained from Vale Veterinary Laboratory, 
Devon, UK. Bacteriological culture was performed in the Bacteriology Laboratory of Vale 
Veterinary Laboratory to determine the bacterial cause of bovine mastitis. Milk samples 
from mastitis caused by either E. coli (n=10) or S. aureus (n=6) infection were selected for 
further analysis. Control milk samples (n=10) from healthy cows from the Cochno Farm of 
School of Veterinary Medicine, University of Glasgow were also used in this study as 
comparison to those clinical mastitic cases. The healthy milk samples were confirmed by 
somatic cell counts (<100 000 cells/ml). Prior to peptidomics analysis, SAA and Hp assays 
(Chapter 2) were performed determine the concentration of both acute phase proteins in 
each milk sample. Samples were stored at -20°C prior to analysis. 
Buffers and reagents for both sample preparation and CE-MS analysis are presented as in 
Appendix. 
4.2.2 Milk sample preparation for CE-MS using PD-10 
Desalting Column 
4.2.2.1  Preparation of fresh ammonium (NH4OH) and urea buffer 
An aliquot of 25% NH4OH (400μl) was added into 1 litre of deionised water to make up 
NH4OH buffer. The solution was mixed by inversion and pH value was checked (pH 10.5-
11.5). Urea buffer was prepared by mixing 5ml of 8M urea, 0.4ml of 5M NaCl, 10μl of 
25% (v/v) NH4OH solution and 100μl of 2% (w/v) SDS solution. 
4.2.2.2  Sample Preparation 
Milk samples were defrosted at room temperature prior to centrifugation at 14 000 x g for 
10 minutes at 4ºC to remove the fat. Two aliquots of 1ml milk samples were prepared. An 
aliquot  of  700μl  of  centrifuged  milk  was  added  to  700μl  of  urea  buffer,  placed  in  a 
centrisart tube (Sartorius, Goettingen, Germany) and mixed well by pipetting up and down.  Chapter 4, 173 
 
 
 
The filter was put on top of the centrisart tube and centrifuged at 3400 rpm for 80 minutes 
at 4ºC. During centrifugation, a PD-10 column (GE Healthcare, Sweden) was equilibrated 
with 25ml of NH4 solution. After centrifugation, 1.1ml of centrisart filtrate was added into 
the columns until the column was dry. Next, 1.9ml of NH4 buffer was added into columns 
until the column was dry. The column was then placed on 15ml collecting tubes and the 
sample  was  eluted  with  2ml  of  NH4  buffer.  The  2ml  of  flow-through  was  distributed 
between three Eppendorf tubes (2 tubes containing 900 µl  to  be used for CE and  LC 
analysis and 1 tube for protein determination containing 150 µl). Tubes to be used for CE 
and LC analysis were freeze-dried until further use. 
4.2.3  Protein concentration 
Protein  concentration  in  milk  extracted  samples  was  checked  using  the  BCA 
(bicinchoninic acid) assay Uptima from  Interchim (Montluçon, France), About 25μl of 
each standard and milk extracted samples were pipetted into microplate wells in duplicates. 
The BCA assay reagent was then added at 200μl and further mixed. The sample mixtures 
were incubated at 37°C for 30 minutes or 2 hours at room temperature. Prior to reading the 
results  at  the  optical  absorbance  of  562  nm,  the  microplate  was  cooled  at  room 
temperature. The standard curve was plotted and the protein concentration in the sample 
was interpolated. Freeze-dried aliquots have to be resuspended in appropriate volume of 
Milli Q water to reach a concentration of 2μg/μl before running in the CE.  
4.2.4 CE-MS Analysis 
4.2.4.1  Preparation of buffers for CE-MS analysis 
All  buffers  were  freshly  prepared  every  week.  1M  sodium  hydroxide  (NaOH)  was 
prepared in deionised water. Ammonium hydroxide buffer was prepared by adding 3.76 
ml of ammonium solution (25%) to deionised water and the volume adjusted to 50 ml 
with deionised water. Running buffer was prepared by adding 10 ml of acetonitrile and 
472 μl of formic acid to a final volume of 50 ml with deionised water. The sheath flow 
liquid was prepared by mixing 15 ml of 2-propanol and 200 μl of formic acid with the 
volume adjusted to 50 ml with deionised water. The standard protein/peptide solution (0.5 
pmol/μl) for the calibration of CE-MS analysis contains Lysozyme (14,303 Da, L4919, 
Sigma-Aldrich, Dorset,  UK), ribonuclease (13,681 Da, R5500, Sigma-Aldrich, Dorset, 
UK), aprotinin (6,513 Da, A1153, Sigma-Aldrich, Dorset, UK) and 4 synthetic peptdies : 
ELMTGELPYSHINNRDQIIFMVGR (2,832 Da), TGSLPYSHIGSRDQIIFMVGR (2,333 
Da), GIVLYELMTGELPYSHIN (2,048 Da), REVQSKIGYGRQIIS (1,733 Da).  Chapter 4, 174 
 
 
 
4.2.4.2  CE-MS Analysis for peptide fingerprint 
The capillary  was  carefully installed into the CE system  (Beckman Coulter, Fullerton, 
USA). The capillary was first conditioned with NaOH (pressure 50 psi) for 15 minutes. 
The  capillary  was  then  washed  with  NH4OH  solution  (50  psi)  for  15  minutes  and  20 
minutes with running buffer (50 psi). The capillary was not connected to the MS until the 
conditioning procedure has been completed The Beckman CE was set to run in “reverse 
mode” when connected to the MS system using the external detector adapter. Running 
buffer (pressure applied 50 psi) was used to rinse the capillary prior to each injection. 
Freeze dried samples  were re-suspended to  achieve a final  concentration 2 µg/µl  with 
HPLC water and centrifuged at 14,000 x g for 10 min at 4 ºC shortly before analysis. The 
samples were then injected at a pressure of 2.0 psi for 99 s resulting in a loading volume of 
290 nl of sample volume. Separation was done with +25kV at the injection site for 30 
minutes with a capillary set temperature of 35°C. In addition to the +25kV, pressure is 
applied as followed ( 0.1 psi for 1 min, 0.2 psi for 1 min, 0.3 psi for 1 min, 0.4 psi for 1 
min and 0.5 psi for the following 30 min). The sheath liquid was applied coaxially at a 
running speed of 0.02 ml/h. The capillary was rinsed with deionised water (50 psi) for 1 
minute after each run followed by a washing step with NH4OH solution (50 psi) for 3 
minutes and lastly by a flushing step with deionised water (50 psi for 3 min). ESI sprayer 
was grounded to achieve electric potential zero and the electrospray interface potential was 
set between -4 000 and -5 000 V. The MS spectra were accumulated every 3 s, over a 
mass-to-charge  range  from  400  to  3000  m/z  for  about  60    minutes  depending  on  the 
analysis requirements. The mass calibration of the MS was performed on a weekly basis 
using  the  standard  protein/peptide  solution  (0.5pmol/μl)  for  CE-MS  analysis.  CE-MS 
analysis was performed under supervision of Dr. Bill Mullen and Dr. Amaya Albalat of 
Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK. 
4.2.5  CE-MS Data processing 
Mass  spectral  ion  peaks  were  deconvoluted  into  single  masses  using  MosaiquesVisu 
software (www.proteomiques.com). Only signals observed in a minimum of 2 consecutive 
spectra with a signal-to-noise ratio of at least 4 were considered. Signals with a calculated 
charge  of  +1  were  automatically  excluded  to  minimize  interference  with  matrix 
compounds or drugs. MosaiquesVisu uses a probabilistic clustering algorithm and both 
isotopic distribution and conjugated masses for charge-state determination of the entities. 
CE migration time and ion signal intensity were normalized because migration time and 
ion-counts showed significant variability between samples mainly due to different salt and  Chapter 4, 175 
 
 
 
peptide concentrations. Reference signals of over 380 milk entities or „milk housekeeping 
polypeptides‟ were used for CE-time calibration by local regression. The same peptides 
were used for ion signal intensity normalization by a applying a global linear regression. 
The resulting peak list contained the molecular mass (Da) and normalized CE migration 
time (min) for each feature. Normalized signal intensity can be used as a measure of 
relative abundance. Data sets were accepted only if the following quality control criteria 
were met: A minimum of 950 chromatographic features (mean number of features minus 
one standard deviation) must be detected with a minimal MS resolution of 8000 (required 
resolution to resolve ion signals with z=6) in a minimal migration time interval (the time 
window, in which separated signals can be detected) of 10 min. After calibration, the 
mean deviation of migration time (compared to reference standards) must be below 0.35 
min. 
Control  and  disease-specific  polypeptide  patterns  were  generated  using  support  vector 
machine (SVM)-based MosaCluster software.  
4.2.6 Statistical analysis 
Only polypeptides that were found in more than 70% of the samples in at least one of the two 
groups (controls or cases) were considered for biomarker definition. The pre-defined set of 
polypeptides should be further validated by randomly excluding 30% of available samples. 
This was repeated (bootstrapping procedure) up to 10 times. For multiple testing corrections, P 
values  were  corrected  using  the  stringent  maxT  test  or  using  false  discovery  rate 
adjustments  of  Benjamini-Hochberg  (BH).  Two  models  were  generated  for  the 
classification of the samples depending on their CE-MS profile. The first model was used 
to classify the milk sample as control (healthy) or bacteria (infected) and the second one to 
discriminate the infectious microorganism (E .coli or S. aureus). 
4.2.7  LC-MS/MS Analysis for Peptide Sequencing 
4.2.7.1  LC-MS/MS analysis  
LC-MS  analysis  was  performed  using  an  Ultimate3000  nano-LC  pump  (Dionex, 
Sunnyvale, CA, USA) coupled to a LTQ-Velos (Thermo Corp.). Five μL from each sample 
were loaded onto a Dionex 100μm x 2 cm 5 μm C18 nano trap column at a flowrate of 5 
μl/min by a Ultimate 3000 RS autosampler (Dionex, Camberley UK) and separated on a 
C18 reverse phase column (75 µm ID × 150 mm, 100 Å, Acclaim PepMap RSLC C18, 
Dionex). Peptides were eluted using a gradient of 1-5-40% B (80% ACN, 0.2% formic 
acid) in 0-5-60 min at a flow rate of 300 nL / min. The eluant from the column was  Chapter 4, 176 
 
 
 
directed to a Proxeon nano spray ESI source (Thermo Fisher, Hemel, UK) operating in 
positive ion mode then into an Orbitrap Velos FTMS. The ionisation voltage was 2.5 kV 
and the capillary temperature was 200 ºC. The mass spectrometer was operated in MS/MS 
mode scanning from 2=380 to 2000 amu. The top 20 multi charged ions were selected 
from  each full  scan for MS/MS analysis, the fragmentation method was  HCD at  35% 
collision energy. The ions selected for MS2 using data dependent method with a repeat 
count of 1 and repeat and exclusion time of 15 s. Precursor ions with a charge state of 1 
were rejected. The resolution of ions in MS1 was 60,000 and 7,500 for HCD MS2. LC-
MS/MS analysis was performed under supervision  of Dr.  Bill  Mullen  and Dr. Amaya 
Albalat of Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK. 
4.2.7.2  LC-MS/MS – Data analysis 
Raw spectral data from LC-MS/MS analysis of the samples were uploaded to Thermo 
Proteome Discoverer 1.2. Peak picking was performed under default settings for Fourier 
transform mass analyzers (FTMS) analysis i.e. only >+2 peptides were considered with 
signal to noise ratio higher than 1.5 and belonging to precursor peptides between 700 – 
8000 Da. Peptide and protein identification was performed with SEQUEST algorithm. An 
in house compiled database containing proteins from the latest version UniProt SwissProt 
database was compiled to include only  Bos taurus, E. coli and S. aureus entries. This 
concatenated  database  was  selected  to  facilitate  peptide  identification  and  reduce  the 
probability for false positive identifications upon making searches against 3 differently 
sized FASTA databases. No enzyme cleavage was selected and oxidation of methionine 
and proline were chosen as variable modifications. Precursor tolerance was set at 20 ppm 
and 0.1 Da for MS/MS fragment ions. Resulting peptides and protein hits were further 
screened  by  excluding  peptides  with  an  error  tolerance  higher  than  10  ppm  and  by 
accepting only those hits listed as high confidence by Proteome Discoverer software. 
4.3  Results 
4.3.1  SCC measurement and acute phase proteins 
concentration 
In order to confirm the disease status of milk samples used in this study, SCC measurement 
and acute phase proteins (SAA and Hp) concentrations were determined. Table 4-1 showed 
the SCC measurement and APP concentrations in all control milk samples used in this 
study. In control milk samples, the range of SAA concentration was between 0.079 and  Chapter 4, 177 
 
 
 
2.96μg/ml. The average of SAA concentration was 0.71μg/ml and the median of SAA 
concentration  was  0.48μg/ml  in  control  milk  samples.  Meanwhile,  the  range  of  Hp 
concentration  was  between  1.95  and  32μg/ml.  The  average  of  Hp  concentration  was 
12.8μg/ml  and  the  median  of  Hp  concentration  was  12.64μg/ml.  The  range  of  SCC 
measurement in control milk samples was between 10 and 96 x 10
3 cells/ml. The average 
was 45 x 10
3 cells/ml and the median was 46 x 10
3 cells/ml. Table 4-2 (a and b) showed 
the bacteriological culture results and the concentration of both SAA and Hp for mastitic 
milk samples caused by E. coli and S. aureus. For E. coli infected group, the range of SAA 
concentration was between 4.18 and 1500μg/ml. The average of SAA concentration was 
626.6μg/ml  and  the  median  of  SAA  concentration  was  90.79μg/ml  in  E.  coli  infected 
group milk samples. Meanwhile, the range of Hp concentration was between 16.03 and 
354.26μg/ml. The average of Hp concentration was 112.5μg/ml and the median of Hp 
concentration  was  98.85μg/ml.  For  S.  aureus  infected  group,  the  range  of  SAA 
concentration was between 16 and 1500μg/ml. The average of SAA concentration was 
526.1μg/ml  and  the  median  of  SAA  concentration  was  51.54μg/ml  in  E.  coli  infected 
group milk samples. Meanwhile, the range of Hp concentration was between 22.15 and 
118.83μg/ml. The average of Hp concentration was 71.44μg/ml and the median of Hp 
concentration was 78.49μg/ml. The Statistical analysis (Mann Whitney) showed that both 
SAA and Hp were significantly higher (p=0.00; p<0.05) in the infected group (E. coli and 
S. aureus) but not significantly different between two bacterial groups (p=0.958; p>0.05 
for SAA and p=0.428; p>0.05 for Hp). 
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Control milk samples       
       
Sample Ids  SAA Conc.(ng/ml)  Hp conc. (ng/ml)  SCC (x10
3) 
102  0.36  7.78  13 
66  0.57  16.38  14 
3  0.55  27.98  48 
62  0.079  1.95  31 
72  1.21  7.24  96 
109  0.65  13.21  10 
80  0.28  24.61  54 
100  0.48  15.36  38 
16  0.9  2.86  58 
58  0.34  1.95  56 
111  0.13  21.94  28 
48  0.39  31.95  85 
4  2.96  4.17  63 
2  1.43  1.95  32 
29  0.29  12.64  46 
Min  0.08  1.95  10 
Max  2.96  31.95  96 
Mean  0.71  12.8  45 
Median  0.48  12.64  46 
 
Table  4-1:  The  acute  phase  proteins  (SAA  and  Hp)  concentrations  and  SCC 
measurement  in  all  control  milk  samples  used  in  this  study.  The  range  of  SAA 
concentrations  was between 0.08 and 2.96 μg/ml with  an average of  0.71μg/ml  and  a 
median of 0.48μg/ml. The range of Hp concentrations was between 1.95 and 32μg/ml with 
an average of 12.8μg/ml and a median of 12.64μg/ml. The range of SCC measurement was 
between 10 and 96 x 10
3 cells/ml with an average of 45 x 10
3 cells/ml and a median of 46 x 
10
3 cells/ml.  Chapter 4, 179 
 
 
 
Mastitic milk 
samples       
Sample Ids 
SAA Conc. 
(ng/ml) 
Hp conc. 
(ng/ml) 
Bacteriological 
results 
475  72.13  89.68  E. coli 
76  1500  115.18  E. coli 
?  1500  78.51  E. coli 
814  1500  141.26  E. coli 
692  9.48  60.27  E. coli 
697  1500  144.89  E. coli 
519  109.44  108.02  E. coli 
453  4.18  16.63  E. coli 
496  24.31  16.03  E. coli 
1222  46.02  354.26  E. coli 
Min  4.18  16.03    
Max  1500  354.26   
Mean  626.56  112.47   
Median  90.79  98.85   
 
Table 4-2a: The acute phase proteins (SAA and Hp) concentrations and bacterial 
causing mastitis in infected milk samples caused by E. coli used in this study. The 
range  of  SAA  concentrations  was  between  4.18  and  1500μg/ml  with  an  average 
626.6μg/ml and a median of 90.79μg/ml. The range of Hp concentrations was between 
16.03  and  354.26μg/ml  with  an  average  of  112.5μg/ml  and  a  median  of  98.85μg/ml. Chapter 4, 180 
 
 
 
Mastitic milk 
samples       
Sample Ids 
SAA Conc. 
(ng/ml) 
Hp conc. 
(ng/ml) 
Bacteriological 
results 
438  48.12  70.77  S. aureus 
14  37.21  42.69  S. aureus 
980  1500  111.83  S. aureus 
708  54.96  95  S. aureus 
346  1500  86.2  S. aureus 
715  15.99  22.15  S. aureus 
Min  15.99  22.15   
Max  1500  111.83   
Mean  526.05  71.44   
Median  51.54  78.49   
 
Table 4-2b: The acute phase proteins (SAA and Hp) concentrations and bacterial 
causing mastitis in infected milk samples caused by S. aureus used in this study. The 
range  of  SAA  concentrations  was  between  15.99  and  1500μg/ml  with  an  average  of 
526.1μg/ml and a median of 51.54μg/ml. The range of Hp concentrations was between 
22.15 and 111.8μg/ml with an average of 71.44μg/ml and a median of 78.49μg/ml. 
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4.3.2  Polypeptide Fingerprinting for control and infected 
groups 
Initially in this work the possibility of differences existing in the milk proteome of healthy 
cows (n=10) when compared to mastitic cows, regardless of their bacterial cause (n=16) 
was examined. The polypeptide fingerprints of these groups were very different as shown 
in Figure 4-1. The y-axis represents the molecular mass (kDa) on a logarithmic scale and 
the x-axis represents the CE migration time (min) whilst the z-axis represents the mean 
signal intensity. From the figure, higher molecular mass of peptides appeared to be in 
higher  signal  intensity  eluting  between  25  and  40  minutes  in  control  milk  samples 
compared with infected milk samples. Lower molecular mass of peptides were found to be 
present in infected milk samples eluting between 50 and 60 minutes although in low signal 
intensity as compared in control milk samples. Peptides with molecular mass between 1.5 
and 4 kDa at 30 to 45 minutes were found to be in higher abundance with higher signal 
intensity in infected milk samples compared with control milk samples. The next step was 
to investigate the differences in milk proteome of infected samples caused by two different 
bacterial pathogens (E. coli and S. aureus). The polypeptide profiles of these 2 different 
groups  were  almost  similar  in  pattern  as  shown  in  Figure  4-2  except  in  their  signal 
intensities. Peptides with molecular mass between 2.5 and 3.0 kDa at 25 to 30 minutes 
were found to be in higher signal intensity in E. coli infected milk samples as compared 
with S. aureus infected milk samples. Peptides with molecular mass between 2.0 and 4 
kDa at  35 and 40 minutes were also  found to  be in  higher signal  intensity in  E.  coli 
infected milk samples as compared with S. aureus infected milk samples. 
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Figure 4-1: The polypeptide fingerprints of both non-infected and infected groups. 
From these fingerprints, they clearly showed a significant differences in the pattern of 
polypeptide peaks between non-infected and infected groups. X-axis referred to the CE 
migration  time  in  minutes  whilst  y-axis  referred  to  the  molecular  mass  (kDa)  on  a 
logarithmic scale and z-axis referred to mean signal intensity. 
 
 
 
Figure 4-2: The polypeptide fingerprints of both E. coli and S. aureus groups. From 
these  fingerprints,  they  clearly  showed  differences  in  the  pattern  of  polypeptide  peaks 
between E. coli and S. aureus groups. 
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4.3.3  Model Generation of the polypeptide fingerprints for 
control and infected groups 
Based  on  the  polypeptide  fingerprints  described  above,  multiple  testing  of  statistical 
analysis was performed to identify peaks which discriminate between control and infected 
groups.  In  the  first  model,  discriminatory  peptides  were  selected  that  were  able  to 
differentiate between the control and infected groups with the area under curve (AUC) set 
at more than 0.99, Benjamini-Hochberg (BH) was set at less than 0.05 and Tmax less than 
0.05. With these very stringent conditions a group of 31 peaks were identified that can be 
used to discriminate between control and infected groups. From the statistical analysis, this 
model possessed 100% value for its sensitivity, specificity and accuracy. The peptides that 
from this model could be used to discriminate between non-infected and infected group is 
presented in Figure 4-3. 
Based  on  the  polypeptide  fingerprints  described  above,  multiple  testing  of  statistical 
analysis was performed to discriminate peaks between two infected groups caused by E. 
coli and S. aureus. There were three models generated with different values of sensitivity, 
specificity and accuracy. For Model 1 (Figure 4-4), the area under curve (AUC) was set at 
more than 0.99, Benjamini-Hochberg (BH) was set at less than 0.05 and Tmax at less than 
0.05 and 6 peaks were identified that can be used to discriminate between E. coli and S. 
aureus groups. The sensitivity value for this model was 100% whilst the specificity value 
was 91.67% and the accuracy value was 96.3%. For Model 2 (Figure 4-5), with the area 
under curve (AUC) set at more than 0.8, Benjamini-Hochberg (BH) was set at less than 
0.05 and Tmax less than 0.05, 3 peaks were identified that can be used to discriminate 
between E. coli and S. aureus groups. The sensitivity value for this model was 100% whilst 
the specificity value was 83.3% and the accuracy value was 92.52%. For the Model 3 
(Figure 4-6), with the area under curve (AUC) set at more than 0.9, Benjamini-Hochberg 
(BH) was set at less than 0.1 and Tmax less than 0.05, 13 peaks were identified that can be 
used to discriminate between E. coli and S. aureus groups. The sensitivity value for this 
model  was  100%  whilst  the  specificity  value  was  83.3%  and  the  accuracy  value  was 
92.52%.  These  three  models  with  different  number  of  polypeptides  were  used  to 
discriminate between E. coli and S. aureus infected groups. All polypeptides generated 
from all three models were tabulated in Table 4-3. It should be noted that a total of 13 
polypeptides appeared in at least one of the models (Table 4-4). 
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Figure  4-3:  The  model  of  polypeptide  fingerprint  after  multiple  testing  of  non-
infected  and  infected  groups.  This  model  has  successfully  identified  31  polypeptide 
peaks that can be used to discriminate between non-infected and infected groups. 
E. coli            S. aureus 
 
Figure 4-4: The first model of polypeptide fingerprint after multiple testing of E. coli 
and S. aureus groups. This model has successfully identified 6 polypeptide peaks that can 
be used to discriminate between E. coli and S. aureus groups. 
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E. coli           S. aureus   
 
Figure 4-5: The second model of polypeptide fingerprint after multiple testing of E. 
coli and S. aureus groups. This model has successfully identified 3 polypeptide peaks that 
can be used to discriminate between E. coli and S. aureus groups. 
E. coli             S. aureus 
 
Figure 4-6: The third model of polypeptide fingerprint after multiple testing of E. coli 
and S. aureus groups. This model has successfully identified 13 polypeptide peaks that 
can be used to discriminate between E. coli and S. aureus groups. 
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Model 1    Model 2    Model 3 
Peptide ID    Peptide ID    Peptide ID 
8093    9662    9662 
8098    8093    8093 
9092    6503    6503 
9662        8098 
13428        9092 
14889        13428 
        14889 
        9960 
        13328 
        4865 
        7557 
        13101 
        3255 
 
Table 4-3: Polypeptides that were identified from 3 models generated to discriminate 
E. coli from S. aureus infected groups. These peptides appeared in at least one of the 
models Chapter 4, 187 
 
 
 
Peptide 
ID 
Models from where the peptide was 
found 
9662  1,2,3 
8093  1,2,3 
6503  1,2 
8098  2,3 
9092  2,3 
13428  2,3 
14889  2,3 
9960  3 
13328  3 
4865  3 
7557  3 
13101  3 
3255  3 
 
Table 4-4: A total of 13 polypeptides generated from 3 models that discriminate E. 
coli from S. aureus infected groups. Models from where the peptide was found were also 
listed. 
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4.3.4  CE-MS Analysis 
A total of 31 discriminatory polypeptides were identified from CE-MS analysis and were 
significant on the basis of comparison between control and infected groups (S. aureus and 
E.  coli)  and  are  presented  in  Table  4-5.  Meanwhile,  a  total  of  14  discriminatory 
polypeptides were identified from CE-MS analysis and were significant on the basis of 
comparison between two infected groups (S. aureus and E. coli) and are presented in Table 
4-6. A total of 45 discriminatory polypeptides were presented in Table 4-7 based on the 
sample type comparison (e.g: control vs infected; E. coli vs. S. aureus). These polypeptides 
were found in more than 70% of the samples in at least one of the two groups (controls or 
cases) in order to be considered as disease biomarkers. 
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Peptide ID  Peptide Mass  CE Migration time 
386  914.5  32.3 
895  1013.5  32.1 
963  1028.6  28.9 
2367  1275.7  32.3 
2664  1335.7  37.8 
2739  1350.7  25.1 
2740  1350.7  27.6 
2757  1352.8  21.1 
2759  1353.7  29 
3422  1481.8  39.2 
3728  1554.8  39.2 
3913  1597.8  28 
4226  1667.9  40 
5064  1893  30.8 
5217  1933.1  30.2 
5263  1947.1  30.8 
6017  2153.2  24.4 
6178  2197.3  26.7 
6465  2277.3  27.6 
6891  2390.2  33.1 
7095  2440.4  24.8 
7323  2490.4  29.7 
7333  2493.4  24.8 
11937  3720  40.5 
14110  4498.4  36.9 
14701  4780.6  26.4 
16632  6376  41.9 
16728  6517.8  29.7 
17239  7687.5  40 
19020  15873.3  26.6 
19046  16123.3  27.8 
 
Table 4-5: The discriminatory polypeptides identified from CE-MS analysis that were 
significant in the basis of comparison between control and infected groups. A total of 
31 polypeptides are presented with their mass values and CE migration times. 
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Peptide ID  Peptide Mass  CE Migration time 
3255  1451.8  21.4 
4865  1839  27.7 
6503  2285.2  33.1 
7557  2552.3  27.7 
8093  2676.5  34.4 
8098  2677.4  34.2 
9092  2896.5  41.4 
9094  2896.6  59.4 
9662  3028.5  39.5 
9960  3113.6  27.7 
13101  4120.2  37.5 
13328  4205.2  28.3 
13428  4237.2  37.5 
14889  4882.5  38.4 
 
Table 4-6: The discriminatory polypeptides identified from CE-MS analysis that were 
significant in the basis of comparison between two infected groups (E. coli and S. 
aureus). A total of 14 polypeptides are presented with their mass values and CE migration 
times. Chapter 4, 191 
 
 
 
Peptide ID  Peptide Mass  CE Migration Time  Type of comparison 
386  914.486  32.3  Control vs Infected 
895  1013.55  32.1  Control vs Infected 
963  1028.58  28.9  Control vs Infected 
2367  1275.67  32.2  Control vs Infected 
2664  1335.7  37.8  Control vs Infected 
2739  1350.71  25.1  Control vs Infected 
2740  1350.71  27.6  Control vs Infected 
2757  1352.76  21.1  Control vs Infected 
2759  1353.69  29.0  Control vs Infected 
3422  1481.8  39.2  Control vs Infected 
3728  1554.82  39.2  Control vs Infected 
3913  1597.81  28.0  Control vs Infected 
4226  1667.9  40.0  Control vs Infected 
5064  1893.01  30.8  Control vs Infected 
5217  1933.11  30.2  Control vs Infected 
5263  1947.07  30.8  Control vs Infected 
6017  2153.17  24.4  Control vs Infected 
6178  2197.26  26.7  Control vs Infected 
6465  2277.28  27.6  Control vs Infected 
6891  2390.21  33.1  Control vs Infected 
7095  2440.39  24.8  Control vs Infected 
7323  2490.36  29.7  Control vs Infected 
7333  2493.36  24.8  Control vs Infected 
11937  3720.03  40.5  Control vs Infected 
14110  4498.43  36.9  Control vs Infected 
14701  4780.55  26.4  Control vs Infected 
16632  6376.03  41.9  Control vs Infected 
16728  6517.75  29.7  Control vs Infected 
17239  7687.52  40.0  Control vs Infected 
19020  15873.3  26.6  Control vs Infected 
19046  16123.3  27.8  Control vs Infected 
3255  1451.843  21.4  E. coli vs S. aureus 
4865  1838.965  27.7  E. coli vs S. aureus 
6503  2285.208  33.1  E. coli vs S. aureus 
7557  2552.311  27.7  E. coli vs S. aureus 
8093  2676.482  34.4  E. coli vs S. aureus 
8098  2677.406  34.2  E. coli vs S. aureus 
9092  2896.512  41.4  E. coli vs S. aureus 
9094  2896.564  59.4  E. coli vs S. aureus 
9662  3028.54  39.5  E. coli vs S. aureus 
9960  3113.574  27.7  E. coli vs S. aureus 
13101  4120.18  37.5  E. coli vs S. aureus 
13328  4205.192  28.3  E. coli vs S. aureus  Chapter 4, 192 
 
 
 
13428  4237.227  37.5  E. coli vs S. aureus 
14889  4882.521  38.4  E. coli vs S. aureus 
 
Table 4-7: The discriminatory polypeptides identified from CE-MS analysis that were 
significant in the basis of both comparison (between control and infected groups as 
well as between E. coli and S. aureus). These polypeptides are presented with their mass 
values and CE migration times. 
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4.3.5  Peptide sequencing 
In order to identify the discriminatory peptides of the models by their sequences, samples 
were  analysed  using  LC-MS/MS.  Twelve  of  the  45  polypeptides  identified  with  high 
confidence are listed in Table 4-8.  Based on their masses from the CE-MS analysis and 
the number of basic amino acids in the sequence (H, R, K or histidine, arginine and lysine), 
these parameters (peptide mass and number of amino acids) were used to link the peptides 
obtained  in  both  systems  (CE-MS  and  LC-MS).  Figure  4-7  showed  a  scatterplot  of 
polypeptides in all milk samples from CE-MS analysis based on the number of basic amino 
acids  found  in  the  sequence.  The  y-axis  represents  the  molecular  mass  (kDa)  of  milk 
polypeptides  whilst  the  x-axis  represents  the  CE  migration  time  (min).  Based  on  the 
molecular mass and the CE migration time of certain polypeptides, the number of amino 
acids found in the sequence can be determined from Figure 4-7. The number of basic 
amino  acids  can  be  used  in  the  process  of  determining  the  peptide  sequence  for  each 
polypeptide identified from CE-MS analysis. From Thermo Proteome Discoverer software 
and SEQUEST algorithm, the potential amino acids sequences were obtained according to 
these  polypeptide  masses  and  number  of  basic  amino  acid  present  in  the  sequence  as 
presented in Table 4-8. In this table, other important parameters are presented such as the 
amino  acid  sequence,  protein  accession,  probability/XCorr/scores,  charge,  mass-charge 
ratios (m/z), the protonated mass of the peptide (MH +), DM (ppm), LC migration time 
(RT in minutes) and number of ions matched. As the methionine and proline oxidations 
were set as variable modifications you, the lower cases were presented (e.g. p and m) 
instead  of  their  upper  cases  (e.g.  P  and  M)  in  the  amino  acid  sequence.  The  protein 
accessions obtained from the software programme are the coded name for the protein from 
which  the  peptide  belongs  and  this  information  was  used  to  search  for  protein 
identification using protein database (e.g. UniProt or NCBI; see section 4.3.6 below). The 
probability, XCorr and score values were the statistical values provided by the Proteome 
Discoverer  and  SEQUEST  algorithm  that  depict  the  validity  of  the  identification. 
Meanwhile, the charge column in the table referred to the charge state in which the peptide 
was detected by the mass spectrometer and DM (ppm) means the error difference between 
the theoretical mass value of the peptide and the experimental mass value from the mass 
spectrometer. Theory mass was the mass deviation of the peptide which was calculated 
from the sequence whilst ions matched referred to the produced peptide fragments from air 
collision in the MS and were recorded in a new mass spectrum to produce the amino acid 
sequence.  Chapter 4, 194 
 
 
 
It  should  be  noted  that  not  all  the  identified  polypeptides  from  CE-MS  analysis  were 
successfully sequenced. Furthermore, even with the same peptide sequence, the statistical 
values (probability, XCorr, score values) and other parameters appeared to be different as 
the respective peptide originated from different type of samples  (control,  E. coli  or S. 
aureus) as happened in Peptide ID 2367, 3728, 3913, 4226, 4865, 6017, 6178 and 6465.  
4.3.6  Protein identification 
As described above, protein identity was determined from a protein database based on their 
amino acid sequences. The identified and named proteins are presented as in Table 4-9. 
The UniProt Knowledgebase (UniProtKB) database was used to determine the name of 
protein by using the protein accession information of each amino acid sequence. These 
identified proteins will be discussed further in the discussion section.  Chapter 4, 195 
 
 
 
ID 
Peptide Sequence 
Protein 
Accessions  Pb  XC  Sc  C  m/z [Da]  MH+ [Da] 
Theory 
Mass 
ΔM 
[ppm]  RT [min] 
Ions 
Matched 
Origins of 
polypeptides 
2367  PFPEVFGKEKV  P02662  2.92  3.00  1.00  2  638.85034  1276.69341  1275.68613  -0.21  64.93  11/20  Found in S. aureus 
sample 
  PFPEVFGKEKV  P02662  6.16  3.97  1.00  3  426.23605  1276.69361  1275.68633  -0.05  51.09  17/40  Found in E. coli 
sample 
2757  SKVKEAMAPKHK  P02666  23.81  4.33  1.00  3  451.92667  1353.76545  1352.75817  -1.29  8.26  22/44  Found in  S. aureus 
sample 
3728  YQEPVLGPVRGPFP  P02666;E1BIM4  25.84  3.73  1.00  2  778.41815  1555.82903  1554.82175  1.42  59.97  14/26  Found in E. coli 
sample 
  YQEPVLGPVRGPFP  P02666;E1BIM4  32.84  3.07  1.00  2  778.41870  1555.83013  1554.82285  2.13  64.93  12/26  Found in S. aureus 
sample 
3913  HKEMPFPKYPVEP  P02666  1.41  3.31  1.00  3  533.60522  1598.80112  1597.79384  -1.57  41.45  16/48  Found in Control 
sample 
  HKEMPFPKYPVEP  P02666;E1BIM4  1.00  4.11  0.20  3  533.60553  1598.80204  1597.79476  -1.00  39.71  17/48  Found in E. coli 
sample 
  HKEMPFPKYPVEP  P02666;E1BIM4  1.00  3.93  1.00  3  533.60577  1598.80277  1597.79549  -0.54  38.86  18/48  Found in S. aureus 
sample 
  pNpKTpSSKRQVDP  A5D7N6  1.00  3.34    3  533.60590  1598.80313  1597.79586  -6.39  39.22  13/52  Found in E. coli 
sample 
4226  YQEPVLGPVRGPFPI  P02666;E1BIM4  18.74  3.76  1.00  2  834.95844  1668.90959  1667.90232  -0.77  64.55  15/28  Found in E. coli 
sample 
  YQEPVLGPVRGPFPI  P02666;E1BIM4  4.48  3.16  1.00  2  834.95856  1668.90984  1667.90256  -0.63  66.70  12/28  Found in S. aureus 
sample 
  LYQEPVLGPVRGPFP  P02666;E1BIM4  8.54  3.56  1.00  2  834.95856  1668.90984  1667.90256  -0.63  61.65  13/28  Found in S. aureus 
sample 
4865  RGPGGAWAAKVISNARET  Q8SQ28;Q56J78  16.53  3.75  1.00  3  614.33032  1840.97641  1839.96914  -0.73  38.82  21/68  Found in E. coli 
sample 
  RGPGGAWAAKVISNARET  Q8SQ28;Q56J78  28.50  5.18  1.00  4  460.99957  1840.97646  1839.96919  -0.71  38.01  24/102  Found in S. aureus 
sample 
5217  SRQPQSQNPKLPLSILK  P80195  31.69  4.53  1.00  4  484.28540  1934.11977  1933.11250  0.79  42.73  26/96  Found in Control 
sample 
5263  QPQSQNPKLPLSILKEK    1.00  3.54  1.00  4  487.78638  1948.12368  1947.11640  0.52  41.88  22/96  Found in Control 
sample 
6017  RGSKASADESLALGKPGKEPR    10.05  3.87  1.00  5  431.63834  2154.16257  2153.15530  -0.05  15.95  27/160  Found in Control 
sample 
  RGSKASADESLALGKPGKEPR  Q4VS17  9.18  3.77  1.00  5  431.63849  2154.16334  2153.15606  0.30  16.34  24/160  Found in Control 
sample 
  RGSKASADESLALGKPGKEPR    6.92  3.92  1.00  5  431.63867  2154.16425  2153.15698  0.73  15.54  28/160  Found in E. coli 
sample 
  RGSKASADESLALGKPGKEPR    9.66  4.66  1.00  5  431.63867  2154.16425  2153.15698  0.73  15.71  27/160  Found in S. aureus  Chapter 4, 196 
 
 
 
 
 
 
 
 
 
Table 4-8: The amino acid sequences of potential biomarkers from the LC-MS/MS analysis. Various other parameters are also presented to help 
better understanding of each of the polypeptides. 
sample 
6178  QPQSQNPKLPLSILKEKHL  P80195  22.10  4.59  1.00  5  440.45886  2198.26521  2197.25793  -0.20  44.31  24/144  Found in E. coli 
sample 
  QPQSQNPKLPLSILKEKHL  P80195  9.81  4.05  1.00  5  440.45926  2198.26719  2197.25991  0.70  44.51  21/144  Found in Control 
sample 
6465  SSRQPQSQNPKLPLSILKEK  P80195  53.89  6.33  1.00  5  456.46353  2278.28855  2277.28127  0.31  34.79  31/152  Found in E. coli 
sample 
  SSRQPQSQNPKLPLSILKEK  P80195  22.40  6.44  1.00  5  456.46353  2278.28855  2277.28127  0.31  35.85  29/152  Found in S. aureus 
sample 
  SSRQPQSQNPKLPLSILKEK  P80195  49.13  5.28  1.00  5  456.46356  2278.28870  2277.28143  0.37  36.94  28/152  Found in Control 
sample 
7095  SRQPQSQNPKLPLSILKEKHL  P80195  1.00  3.96  1.00  5  489.08575  2441.39967  2440.39239  0.35  39.30  25/160  Found in Control 
sample  Chapter 4, 197 
 
 
 
 
Figure 4-7:  Milk polypeptides detected in CE-MS analysis based on the number of 
basic amino acids found in the amino acid sequence. Y-axis represents the molecular 
mass (kDa) and x-axis represents the CE migration time (min). The red line is specific for 
the number of basic amino acids in the sequence. Up to five basic amino acids can be 
found in certain amino acid sequence. The higher number of basic amino acids found in the 
sequence, the shorter migration time for the CE-MS analysis. This diagram can be used to 
match the sequence from LC-MS/MS analysis for each polypeptides identified from CE-
MS analysis. 
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Peptide 
ID  Sequence  Protein Identity 
Fq in 
contro
l 
Fq in 
infected 
Fq in 
E. 
coli 
Fq in S. 
aureus 
2367  PFPEVFGKEKV  αS1-casein  0.80  1.00       
2757  SKVKEAMAPKHK  β-casein  0.50  1.00       
3728  YQEPVLGPVRGPFP  β-casein  0.30  1.00       
3913  HKEMPFPKYPVEP  β-casein  0.10  1.00       
4226  YQEPVLGPVRGPFPI  β-casein  0.20  1.00       
4865  RGPGGAWAAKVISN
ARET 
serum amyloid 
A 
      1.00  0.58 
5217  SRQPQSQNPKLPLSIL
K 
Glycosylation-
dependent cell 
adhesion 
molecule 1 
1.00  0.07 
     
5263  QPQSQNPKLPLSILKE
K 
Protein 
accession not 
available 
1.00  0.48 
     
6017  RGSKASADESLALGK
PGKEPR 
Fibroblast 
growth factor 
binding protein 
1.00  0.59 
     
6178  QPQSQNPKLPLSILKE
KHL 
Glycosylation-
dependent cell 
adhesion 
molecule 1 
1.00  0.15 
     
6465  SSRQPQSQNPKLPLSI
LKEK 
Glycosylation-
dependent cell 
adhesion 
molecule 1 
1.00  0.74 
     
7095  SRQPQSQNPKLPLSIL
KEKHL 
Glycosylation-
dependent cell 
adhesion 
molecule 1 
1.00  0.07 
     
 
Table 4-9: The protein identities obtained from the UniProtKB database 
(www.uniprot.org/uniprot). The frequency of each of the identified protein was also 
presented according to the respected groups. 
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4.4  Discussion 
The  mastitic  milk  samples  chosen  in  this  study  had  significantly  higher  acute  phase 
proteins concentrations for both SAA and Hp as compared with the healthy milk samples 
(p<0.05). However, the concentrations for both SAA and Hp were not significant between 
E. coli and S. aureus infectedgroup (p>0.05). The SCC measurement for all healthy milk 
samples was less than 100 000 cells/ml which confirmed the healthy status of the cows 
(average of 46 x 10
3 cells/ml). 
The  chosen  peptidomic  method  of  capillary  electrophoresis  (CE)  coupled  with  the 
electrospray mass spectrometry is known as a rapid (approximately 45 min per sample), 
sensitive method using its automated approach (Kolch et al. 2005). It was used in this 
study  to  detect  differences  in  the  milk  peptidome  between  healthy  cows  (control)  and 
mastitic cows caused by two different bacterial pathogens (E. coli and S. aureus). 
All milk samples were analyzed by CE-MS and only polypeptides present at a frequency 
>70% in at least one of the two groups (control and cases) were chosen for analysis. The 
compiled data for all test groups (control, all infected, E. coli and S. aureus) are shown in 
Figure 4-1 and 4-2. It was found that the milk polypeptide patterns of infected cows were 
markedly different from control cows (Figure 4-1). However, the milk polypeptide patterns 
of both bacterial groups (E. coli and S. aureus) were more similar (Figure 4-2). 
For identification of potential biomarkers for bovine mastitis, milk polypeptides of healthy 
cows were compared with those of cows with mastitis regardless of its bacterial pathogen. 
This  analysis  identified  31  polypeptides  of  statistical  significance  after  correction  for 
multiple  testing  (p  <  0.05  in  max  T  testing)  with  100%  sensitivity,  specificity  and 
accuracy. The distribution of the polypeptides in these groups is shown in Figure 4-3. It is 
observed that the identified polypeptides significantly higher in the infected than control 
group were of lower molecular mass (y-axis) and appeared at much later time of migration 
(x-axis) which is an indicator of containing a lower proportion of basic amino acids. 
To identify biomarkers that could discriminate between two mastitic groups caused by E. 
coli and S. aureus, the analysis successfully generated three different models with different 
values of sensitivity, specificity and accuracy. Model 1 appeared to have 100% sensitivity, 
91.67% specificity and 96.3% accuracy. Six peaks of discriminatory polypeptides were 
found in this model. In Model 2, the sensitivity was 100% with the specificity of 83.3% 
and accuracy of 92.52%. Three peaks of discriminatory polypeptides were found in this  Chapter 4, 200 
 
 
 
model. Finally, Model 3 appeared to have 100% sensitivity, 83.3% specificity and 92.52% 
accuracy. 13 peaks of discriminatory polypeptides were found in this model. In conclusion, 
a total of 13 discriminatory polypeptides were identified from these three models generated 
(Table 4-4). 
The previous step is known as the learning phase in which the „training set‟ was used to 
generate  a  polypeptide  pattern  with  significant  biomarkers  (Zürbig  et  al.  2009).  To 
complete biomarker identification exercise, after this training, the model should be able to 
characterize further unknown data sets so that a correct classification can be confirmed. 
There are only a few studies on peptide analysis of milk from cows with bovine mastitis 
using milk samples (Wedholm et al. 2008; Larsen et al. 2010). Both studies employed the 
same method in separating the peptides by RP-HPLC with further protein characterization 
by MALDI-TOF/MS/MS. These studies  were also  focused on the result of proteolysis 
caused by different types of proteolytic enzymes. Wedholm et al. (2008) have successfully 
identified 10 peptides from milk with high SCC (16 000 000 cells/ml) while Larsen et al. 
(2010) on the other hand identified approximately 20 different peptides in milk samples 
infused with LTA of S. aureus as a result of proteolysis.  
However,  the  objective  of  these  studies  was  to  gain  better  understanding  in  the  milk 
proteinase activities during mastitis and in comparison, this present study is focused on 
how the peptide profile of the milk samples can be changed in the presence of bovine 
mastitis. In addition, the discovery of significant peptide biomarker in bovine mastitis was 
also one of the important objectives in this present study. 
Although further model validation will be needed as discussed above, protein identification 
of these discriminatory polypeptides should be done to provide an initial insight on the 
change of peptide profiles in milk samples infected with bovine mastitis. It was interesting 
to see the presence of peptide ID 9094 as one of the discriminatory polypeptides detected 
from the generated model that can be used to discriminate E. coli from S. aureus infected 
group (Table 4-3 and 4-4). However, this polypeptide was not detected from the CE-MS 
analysis that discriminate E. coli from S. aureus infected group (Table 4-6). Although it 
was not a statistically significant polypeptide that discriminated very well between E. coli 
and S. aureus infected group, this shouldn‟t be a problem because we were interested in 
determining the peptide sequencing in the LC-MS system. Thus, it would have been a good 
idea to be able to identify this polypeptide by sequencing in the LC-MS/MS analysis.  Chapter 4, 201 
 
 
 
 A total of 45 discriminatory polypeptides (31 polypeptides which discriminate healthy 
from mastitis cases and 14 polypeptides which discriminate E. coli from S. aureus infected 
cases) from CE-MS analysis were then analysed for their amino acid sequence by LC-
MS/MS As the only parameters used to link the peptides obtained in both systems (CE-MS 
and LC-MS/MS) were peptide mass and the number of basic amino acids, it can lead to 
mass  ambiguities  due  to  the  highly  complex  peptide  mixtures  which  complicate  the 
assignment of sequences obtained from different separation methods. A further factor was 
the fact that the mass spectrometers used in the two systems were different. For peptide 
identification, the LC-MS was used but it was not possible with 100% certainty to correlate 
the results from the CE-MS with the results from the LC-MS/MS data.  
Despite having a problem with mass ambiguity, the results from the LC-MS/MS analysis 
can be used to determine the protein identity for each of the sequences. However, not all of 
these 45 polypeptides identified by CE-MS were able to be sequenced by the LC-MS/MS. 
This occurred as the peptide mass calculated from the CE-MS analysis was not matched 
with the peptide mass calculated from the LC-MS/MS analysis. It should also be noted that 
the peptide mass calculated from the LC-MS/MS was based on the mass of peptide plus 
one  proton  which  made  them  one  unit  more  than  the  mass  calculated  from  CE-MS 
analysis.  
Due to the problem in sequencing, a total of 12 polypeptides were able to be sequenced by 
LC-MS/MS (Table 4-8). From the total of 12 successfully sequenced polypeptides, 11 
were used to discriminate control milk samples from the infected milk samples. Only 1 
sequenced polypeptide in the set was used to discriminate E. coli infected milk samples 
from S. aureus infected milk samples. The origin of the milk peptides from which the 
sequenced  polypeptides  was  found  is  presented  in  Table  4-8.  Based  on  their  protein 
accession information, these polypeptides were identified by their amino acid sequences. 
UniProtKB  database  was  searched  for  each  of  the  protein  identity.  Amongst  the  12 
peptides  that  were  successfully  identified  were  sequences  from  α  S1-casein,  β-casein, 
serum  amyloid  A  protein  (SAA),  glycosylation-dependent  cell  adhesion  molecule  1 
(GlyCAM-1) and fibroblast growth factor binding protein (FGFBP) which were mostly on 
the bovine protein database as showed in Table 4-9. 
As the focus was on discriminatory polypeptides, the discussion will be presented based on 
the polypeptides/proteins that were able to discriminate between control, infected and two 
different bacterial pathogens groups. Statistically, α S1-casein, β-casein, GlyCAM-1 and  Chapter 4, 202 
 
 
 
FGFBP were the proteins that can be used to discriminate the infected group (regardless of 
its causing bacterial pathogen) from the control group.  
During mastitis, the proteolytic activity in milk can be increased substantially (Verdi et al. 
1987). Apart from β-casein, plasmin can also  hydrolyses α S2-casein  and α S1-casein 
(Larsen et al. 2006) which explain the presence of peptides of α S1-casein in the infected 
group higher compared with the control group from the hydrolytic activity in milk. 
Statistically, peptides from glyCAM 1 and FGFBP were the peptides that can be used to 
discriminate the control from the infected groups. The presence of glyCAM 1 protein in 
bovine milk has been reported previously by Smolenski et al. (2007) and Boehmer et al. 
(2010). Smolenski et al. (2007) have identified it as one of the minor milk protein that 
present in all peak lactation, colostrums and mastitic whey and MFGM whilst Boehmer et 
al. (2010) considered it as one of the host defence proteins. Again, it was also surprising to 
observe this minor milk protein which acts in the host defence mechanism to appear in the 
control group in higher frequency compared with the infected group. 
The fibroblast growth factor-binding protein (FGFBP) is a secreted carrier protein that 
releases fibroblast growth factors (FGFs) from the extracellular matrix storage and thus 
enhancing  the  FGF  activity  (Xie  et  al.  2006).  Kawakami  et  al.  (2006)  concluded  that 
FGFBP  may  be  tightly  associated  with  lactoferrin  in  bovine  milk.  Plath  et  al.  (1998) 
successfully examined the expression and localization of FGFBP in the bovine mammary 
gland and it may be important in the local regulation of the bovine mammary gland.  
Peptides from SAA (protein ID 4865) were the only discriminatory peptides that were 
sequenced that were significantly that can be used to differentiate E. coli infected group 
from S. aureus infected group. Serum amyloid A protein was one of the important acute 
phase protein in bovine mastitis and it can be produced locally in the mammary gland 
making it a more reliable indicator of bovine mastitis (Eckersall et al. 2001, 2006) but not 
a single previous study that able to determine if SAA can significantly discriminate E. coli 
from S. aureus infected milk samples.  
No other identified peptides could be used to discriminate S. aureus infected group from E. 
coli infected group. Perhaps the use of sample size calculation is needed so that more 
polypeptides can be sequenced that are able to significantly discriminate between these two 
groups.  Chapter 4, 203 
 
 
 
Although several  proteins  were successfully identified as  the precursor of the peptides 
using the protein database based on their sequences, those proteins cannot be used per se as 
the  potential  markers  in  each  group.  The  reason  is  that,  it  is  the  peptides  of  specific 
fragments of the proteins identified as biomarkers. The protein identity only provided with 
an insight into which protein were affected and played role in the disease mechanism. It is 
possible that specific peptides  resulted from  proteases  of the cow rather than bacterial 
proteases. Thus, no ultimate conclusion can be made based on the protein identity that has 
been identified in each of the group. 
The results discussed above can provide an initial insight on how the milk peptide profiles 
can  change  as  result  of  bovine  mastitis.  However,  these  results  can  be  improved  by 
applying further improvements. First, validation of SVM models is needed to demonstrate 
that these milk peptidomes really are able to differentiate healthy cows from mastitic cows 
with  different  bacterial-causing  pathogens.  More  milk  samples  without  knowing  their 
infection status (blinded samples) should be tested to validate these models.  By validating 
these models, the status of each marker in each group (control, infected,  E. coli or S. 
aureus infected milk groups) can be confirmed and may eventually be used to determine 
the presence of bovine mastitis in the cows or even to predict the type of bacterial pathogen 
that lead to inflammation of the mammary gland. 
Second, it was not possible with 100% certainty to correlate the results from the CE-MS 
with the results from the LC-MS/MS data based on peptide masses, this situation can lead 
to  mass  ambiguities  due  to  the  highly  complex  peptide  mixtures  involved  which 
complicates the assignment of sequences obtained from different separation methods and 
also due to the fact that the mass spectrometers used after CE-MS and LC-MS/MS were 
different. Therefore, further work should be conducted in order to resolve this ambiguity 
issue by running samples with internal standards of known mass in both systems. In this 
way, an internal mass calibration of each sample can be done that would allow a more 
correct cross-correlation of results between both systems. 
It would also be interesting to propose a time-course of infection study for future work and 
determine the earliest time that can be applied to diagnose an infected cow based on the 
proposed polypeptide biomarker of bovine mastitis and if the putative biomarkers would be 
able to discriminate subclinical mastitis from clinical mastitis and healthy group. More 
information  on  peptide  sequencing  can  lead  to  a  better  understanding  of  the  Chapter 4, 204 
 
 
 
pathophysiology of bovine mastitis and eventually could help in improving the bovine 
mastitis detection. Chapter 5, 205 
 
Chapter V: Metabolomics Analysis in Bovine 
Mastitis 
5.1  General Metabolomics 
Being one of the most newly emerged “-omics” sciences, metabolomics is becoming one 
of the most significant field of study in system biology which complements the other “-
omics” and proving to have unique advantages. It was first proposed by Oliver (1998), and 
seeks to characterize and quantify the whole collection of both intra and extra-cellular 
metabolites. The metabolome is defined as the qualitative and quantitative collection of all 
low molecular weight of molecules that are present in biological fluid, organism or cell 
under a different set of physiological conditions (Tyagi et al. 2010; Banderas et al. 2011).  
These  metabolites  include  a  diverse  range  of  endogenous  and  exogenous  chemical 
molecules  such  as  peptides,  amino  acids,  nucleic  acids,  carbohydrates,  organic  acids, 
vitamins,  polyphenols,  alkaloids  and  any  other  chemical  that  is  used,  ingested  or 
synthesized  by  a  given  cell  or  organism  (Wishart  2008).  Some  of  the  metabolites  are 
acquired  externally  but  most  are  products  or  intermediates  from  metabolic  reactions 
(Tomita and Nishioka 2005). 
Metabolomic analyses involve two basic methodologies (Nielsen and Jewett 2007). First is 
metabolite profiling which allows qualitative screening of a large number of metabolites 
(usually  more  than  100)  and  the  pattern  of  metabolites  produced  via  high-throughput 
detection  can  be  used  to  find  discriminatory  elements  followed  by  data  deconvolution 
methods. This method covers metabolic fingerprinting (analysis of endometabolome) and 
metabolic footprinting (analysis of exometabolome). According to Álvarez-Sáchez et al. 
(2010), global metabolomics profiling involved detection of metabolites by using a single 
analytical platform or a combination of complementary analytical platforms (GC-MS, LC-
MS,  CE-MS  or  NMR).  The  second  method  is  target  analysis  which  aims  to  produce 
absolute or semi-quantitative detection of metabolites. Previously, only small numbers of 
metabolites were able to be analyzed but with new development on quantitative analysis, 
more expanded metabolite coverage can be performed. 
However, the comprehensive analysis of a wide range of metabolites is only possible with 
the use of recent technological advancements in separating and identifying these molecules 
(Wishart 2008). The most widespread analytical platforms include robust, high-resolution 
mass spectrometry (MS) instruments, nuclear magnetic resonance (NMR) spectrometers, Chapter 5, 206 
 
capillary electrophoresis (CE) and ultra-high pressure liquid chromatography (UPLC and 
HPLC). Many investigations have used an integration of various analytical methods such 
as  gas  chromatography  combined  with  mass  spectrometry  (GC-MS)  and  liquid 
chromatography  combined  with  mass  spectrometry  (LC-MS)  to  improve  metabolite 
identification and coverage (Álvarez-Sáchez et al. 2010). 
There are many advantages to studying the metabolome in comparison with transcriptome 
and  proteome.  According  to  Dunn  &  Ellis  (2005)  and  Álvarez-Sáchez  (2010) 
metabolomics is often seen more useful because the number of metabolites is smaller than 
the  number  of  proteins  and  genes  in  a  cell  which  reduces  the  sample  complexity. 
Furthermore, the concentration of metabolites can significantly change during biochemical 
reaction  even  though  the  concentration  of  enzyme  and  metabolic  flux  may  not  be 
significantly  altered  (Kell  and  Mendes  1999).  As  the  downstream  product  of  gene 
expression, the metabolome reflects the functional level of the cell more appropriately and 
is  thought  to  be  amplified  in  physiological  changes  as  compared  to  proteome  and 
transcriptome. Furthermore, metabolic fluxes are more influenced by environmental stress 
than gene expression, making the measurement of metabolites more appropriate. Finally, 
metabolic profiling is less expensive than proteomic and transcriptomic experiments. 
Despite having many benefits for the analysis of smaller molecules, one major problem in 
metabolomics  is  the  lack  of  standardized  methods  especially  in  the  analysis  of  global 
metabolomics  (Álvarez-Sáchez  et  al.  2010).  A  standard  metabolomic  experimental 
approach is needed from sample collection through chemical analysis to data processing. 
Metabolomics has been applied to various investigations such as determining the metabolic 
biomarkers that act as indicators to the presence of a disease or as a response towards drug-
based intervention.  Other than that, various metabolomic studies have been performed on 
plants and microbes (Le Gall et al. 2003) and on bacterial characterisation (Vaidyanathan 
et al. 2002). For the past few years, metabolomic analyses has gained an interest in food 
and nutrition fields to give a more comprehensive molecular picture on food composition 
as well as food consumption.(Wishart 2008). 
5.1.1 Metabolites in milk and serum found during bovine 
mastitis 
Metabolomics provide a very important tool to analyse changes in milk metabolome during 
the presence of bovine mastitis because of its rapid and high throughput characterization of 
small molecule metabolites found in milk or serum.  Chapter 5, 207 
 
There have been many studies on the metabolites in milk and serum in relation to mastitis 
from the era when metabolism study used traditional methodologies. An early study by 
Peter  et  al.  (1990)  investigated  the  metabolites  of  prostanoids  in  milk  of  heifers  after 
intramammary  infusion  of  E.  coli  organisms.    Prostanoids  are  known  to  be  important 
mediators  in  the  inflammatory  processes  associated  with  endotoxin-induced  mastitis. 
Increases  of  arichidonic  acid  metabolites  such  as  thromboxane  A2,  prostaglandin  E2 
(PGE2) as well as milk prostacyclin (PCM) were seen in milk from infected quarters. The 
increased concentrations of these metabolites showed that they have an important role in 
the  pathophysiologic  process  of  coliform  mastitis  released  as  the  mediators  during 
inflammation. 
The presence of change in metabolites during mastitis is also associated with other factor 
such as dietary selenium (Se). A study by Maddox et al. (1991) showed that cows with Se 
deficiency  (-Se)  contained  significantly  higher  concentrations  of  PGE2,  6-keto-
prostaglandin  F1α  and  leukotriene  B  4  (LTB4)    in  milk  after  E.  coli  inoculation  as 
compared  with  milk  from  cows  with  Se  sufficiency  (+Se).  The  higher  eicosanoid 
concentration in milk was associated with higher number of bacteria. This is may be due to 
impaired killing abilities of selenium deficiency polymorphonuclear leukocytes (PMNL) as 
during non-specific immune response such as in coliform mastitis, the function and activity 
of PMNL are highly influenced by eicosanoids. Greater concentration of these eicosanoid 
levels in milk of –Se cows is due to the increase of substrate availability and enzyme 
activity  from  the  activation  of  cyclooxygenase  and  lipoxygenase  enzymes  in  the  Se-
glutathione peroxidase (Se-GSH-Px) depleted state. The severity of clinical signs seen in –
Se cows could be at least partially caused by the higher eicosanoid concentrations in the 
milk  as  they  have  play  an  important  role  in  the  pathogenesis  of  inflammatory  and 
endotoxin-induced diseases. 
Serum trace minerals were also studied (Erskine and Bartlett 1993) during E. coli-induced 
mastitis in which a transient depression in both plasma zinc (Zn) and iron (Fe) was seen 
during intramammary challenge with E. coli. High number of bacteria (E. coli) secreted in 
milk over time was correlated with the severity of clinical signs of infection as well as with 
decreased plasma Zn and Fe concentrations. These divalent cations are important in the 
growth of gram-negative bacteria such as E. coli and reduced concentrations of both Zn 
and Fe may be part of defence mechanism to limit the bacterial growth. As for copper (Cu) 
concentration, this study did not show any increase during the inflammatory process but in 
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accordance with the previous study by Conner et al. (1986) in which they found increased 
ceruloplasmin during the acute phase response in cattle as well as studies by Barber et al. 
(1988) and Etzel et al. (1982) where they found increased in serum ceruloplasmin in both 
rats  and  hamster.  Ceruloplasmin  is  the  Cu-binding  protein  which  plays  a  role  as  a 
scavenger  for  superoxide  anion  radicals.  The  difference  might  be  due  to  species 
differences.  
Gram  negative  mastitis  in  early  lactation  may  also  influenced  the  ovarian  and  certain 
endocrine functions and metabolism in dairy cows. Huszenicza et al. (1998) found that 
during lipopolysaccharide (LPS) loading, various events occurred that might impair the 
ovarian functions such as delay in the resumption of cyclicity or even causing premature 
luteolysis if sensitive corpus  luteum is  present  simultaneously on the ovary caused by 
prostaglandin F2α. However, based on individual progesterone (P4) profiles in the blood of 
the affected cows, gram negative mastitis influenced the ovarian function during the 3
rd up 
to 10
th weeks of lactation. During early puerperal (<14 days) mastitis, its prevalence was 
not  influenced  by  the  concentration  of  acetoacetone,  β-  OH  butyrate  (BHB)  or  non-
esterified fatty acids. Cows affected with different forms of early puerperal mastitis did not 
show any delay in the onset of cyclicity either. 
Interesting  metabolites  that  exist  in  the  milk  are  the  reactive  oxygen  metabolites  that 
include superoxide anion (O2
-), hydroxyl radical (OH), hydrogen peroxide (H2O2) and fatty 
acid  radicals  (Lindmark-Månsson  and  Åkesson  2000).  These  reactive  metabolites  are 
released by PMN after phagocytising foreign particles or bacteria and discharging their 
granules’ contents. Although they are harmful to bacteria, these oxidants are known to be 
cytotoxic and can induce tissue damage by destroying host cells. To control these reactive 
oxygen  radicals,  anti-oxidants  are  also  present  in  the  milk  during  the  inflammatory 
processes which include natural vitamins (vitamin E and C), beta-carotene and enzymatic 
systems  mainly  represented  by  superoxide  dismutase  (SOD),  catalase  and  glutathione 
peroxidase (GSHPx). A study by Hamed et al. (2008) investigated the level of these anti-
oxidants in association with the bulk milk somatic cell counts (BMSCC). Because oxidants 
released by PMN induce cellular damage (Weiss 1989; Van Asbeck 1990) and antioxidants 
are needed to control these reactive oxygen metabolites, the relationship between milk 
somatic  cells  and  antioxidant  activities  was  studied.  SOD  activity  was  found  to  be 
unaffected by BMSCC. SOD activity was weakly dependent upon BMSCC and suggested 
that SOD incorporation did not prevent the cytotoxic effect of the oxygenated radicals and 
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activity in high BMSCC samples probably playing a central role in milk redox control 
especially during mastitis. It also could be used as an indicator in mastitis. This study also 
showed a positive correlation between GHSPx activity with the BMSCC especially with 
the neutrophil content but its role in bovine milk was thought to be limited. However, it 
was concluded that catalase and GSHPx are the principal enzymatic defence that neutralize 
the harmful free radicals.  
Metabolic activity is able to influence the health of the udder.  Near parturition and in the 
period of early lactation, there is a large nutrient demand in which nutrients are mobilized 
from tissue reserves. This results in changes in blood concentration of both hormones and 
metabolites (Ingvartsen and Friggens, 2005). In general, primiparous cows have a greater 
prevalence of mastitis as several important immune factors are impaired around calving. 
Thus,  one  study  by  Nyman  et  al.  (2008)  revealed  that  blood  concentration  of  β-
hydroxybutyrate  (BHBA),  nonesterified  fatty  acids  (NEFA),  glucose  and  α-tocopherol 
around calving were associated with the SCC at first test-milking of primiparous cows. 
Immune  variables  such  as  the  collectins  which  consist  of  collectin-43  (CL-43)  and 
conglutinin as well as haptoglobin (Hp) were also seen to be correlated with Box-Cox 
transformed SCC (bcSCC) and these correlations must be based from a direct breed effect. 
It  is  also  known  that  age  and  breed  factors  were  significantly  associated  with  several 
metabolites and immunological variables. For example, heifers calving at an older age had 
greater concentrations of serum BHBA and NEFA but lower glucose, insulin and urea 
nitrogen values compared with heifers calving at a younger age (Nyman et al. 2008). This 
has shown that older heifers were in more severe negative energy balance in the period 
around calving and in early lactation than younger heifers. 
Another study that investigated various metabolites in serum and their variation during the 
transition period in dairy cows was performed by Moyes et al. (2009). This study is in 
agreement with Nyman et al. (2008) in which there was an increased NEFA concentration 
in cows that developed clinical mastitis at calving and during early lactation. Thus, higher 
circulating NEFA was shown to inhibit immune responses that lead to the development of 
mastitis  especially  during  early  lactation.  Clinical  mastitic  cows  also  showed  higher 
circulating BHBA concentrations during the transition period. This result was in contrast 
with that of Nyman et al. (2008) in which high BHBA concentrations were associated with 
lower bcSCC at the first test-milking during early lactation. According to Nyman et al. 
(2008), this increase may be associated with microbial butyrate production from rumen 
carbohydrate fermentation, which is then converted to BHBA in the rumen epithelium. As Chapter 5, 210 
 
for glucose levels, the results were inconclusive. Higher glucose levels were seen during 
pre-partum period in cows that developed clinical mastitis as compared to cows that did 
not developed mastitis during early lactation period.  This can be explained by the lack of 
difference in insulin concentration in clinical mastitic cows and this might suggested a 
lower  efficiency  of  glucose  clearance  from  circulation  for  these  cows  compared  with 
subclinical  mastitic  and  healthy  cows.    This  study  also  suggested  that  aspartate 
aminotransferase  (ASAT)  has  no  association  with  the  development  of  clinical  and 
subclinical mastitis during the first week of lactation making it a less useful marker to 
evaluate the risk of mastitis due to low specificity of ASAT in lactation. Overall, NEFA 
was the most consistent with least conflicting positive association with the development of 
mastitis and making it the most useful marker for the risk of mastitis during early lactation. 
The use of metabolites as the risk factors of mastitis is promising but further investigations 
are needed. 
Melendez et al. (2009) studied a relationship between NEFA at calving with the incidence 
of many periparturient diseases including mastitis in Holstein dairy cattle. The authors 
agreed that increased in NEFA concentrations in serum have been associated with impaired 
immunity which predisposed cows to periparturient diseases. Thus the NEFA values at 
calving  can  be  used  to  monitor  the  nutritional  management  as  well  as  to  be  used  as 
indicators in the risk factors in many periparturient diseases including mastitis. 
Metabolites can also be produced by the mastitis-causing pathogens. These metabolites 
have  been  used  to  determine  the  pathogen.  This  is  based  on  the  fact  that  all 
microorganisms produced their own range of often volatile metabolites. Hettinga  et al. 
(2008) identified a wide range of volatile metabolites that were produced by different types 
of  microorganisms  using  a  solid-phase  microextraction  (SPME)  coupled  to  gas 
chromatography/mass  spectrometry  (GC/MS).  In  this  study,  they  found  that  volatile 
metabolites found in milk from uninfected quarters differed significantly from those found 
in milk from infected quarters. Lower numbers and amounts of metabolites were found in 
the samples from uninfected quarters compared to the samples from mastitis quarters. For 
example, S. aureus and E. coli both formed a large amount of ethyl acetate and acetic acid. 
It was confirmed that different microorganisms produced different types of metabolites 
which means that the presence of certain volatile metabolites in infected milk samples 
could be used to detect and identify mastitis-causing pathogens. 
A  further  study  on  volatile  metabolites  in  mastitis  milk  samples  by  the  same  authors 
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that  pathogens  are  responsible  to  the  presence  of  volatile  metabolites  in  mastitic  milk 
samples, some of these detected metabolites may also be formed by enzymes, present in 
the blood of the animals but which travel into the milk due to the disruption of blood-milk 
barrier during inflammatory process. Around 20% of metabolites identified in this study 
were found to be different between inoculated milk (milk from healthy animals inoculated 
with  the  same  bacteria)  and  mastitic  milk  samples.  Nevertheless,  most  of  the  volatile 
metabolites detected in mastitis samples are mainly formed by the pathogens except for 
ethyl esters of free fatty acids (FFA) which were absent or significantly lower in inoculated 
samples. These metabolites are formed by the esterase enzymes found in cow’s blood. 
During mastitis, due to increase leaking of the barrier between blood and udder, esterase 
enzymes can be found in the mastitic milk (Raulo et al. 2002). Thus, during mastitis, this 
enzyme can probably transfer from the blood to the milk due to disruption of the blood-
milk barrier. Furthermore, dimethyl sulphide may be useful for E. coli identification as it 
was found that dimethyl sulphide concentrations is increased in samples inoculated with E. 
coli. 
Another type of metabolite which is seen to have an effect in milk production are the 
metabolites of nitric oxide (NO). Bouchard et al. (1999) have investigated the nitric oxide 
production  during  endotoxin-LPS  induced  bovine  mastitis.  In  this  study,  a  significant 
three- to five-fold of increase in nitrate and nirite contents (metabolites of nitric oxide) 
were formed in milk samples upon LPS infusion. Nitric oxide is produced from L-arginine 
by the enzymes termed as nitric oxide synthase (NOS). Inducible isoforms of NOS (iNOS) 
are also thought to be cause overproduction of nitric oxide. It is known that somatic cells 
are responsible for the production of nitric oxide although in this study, it did not establish 
of which cell type(s) that is (are) involved. They have also studied the effect of co-infusion 
of LPS with an inhibitor of iNOS; aminoguanidine which successfully prevented the nitric 
oxide production upon LPS infusion. These results confirmed the activity of iNOS during 
the endotoxin-induced inflammatory reaction.  
During lactation, nitric oxide synthase plays a role in generating nitric oxide contained in 
the mammary gland tissues (Lacasse et al. 1996). Nitrate and nitrite are the end products of 
nitric oxide oxidation in aqueous solutions (Moncada et al. 1991). Milk also contains S-
nitrosothiols (RSNO) which are also metabolites of short-lived NO. Because milk contains 
lactoperoxidase, nitrite can be oxidized to toxic nitrogen dioxide (Silanikove et al. 2005). 
A study by Titov et al. (2010) revealed by using an enzyme sensor method that in healthy 
milk and colostrums, no nitrite compounds were found. Thus, its presence in milk can be Chapter 5, 212 
 
an indicator of mastitis. However, the occurrence of these compounds was accompanied 
with a lower content of RSNO which possibly occurs under the effect of reactive oxygen 
species. Nitrite also can be produced by leukocytes. As said earlier, the oxidation of nitrite 
by lactoperoxidase can lead to the production of toxic nitrogen dioxide, a powerful oxidant 
that could cause the oxidative breakdown of milk lipoprotein. To avoid this toxic effect, 
the presence of high concentrations of other compounds that are able to compete with 
nitrite for lactoperoxidase is important (thiocyanate and ascorbate). 
5.1.2 Aims of Study 
In conclusion, the aim of this study is to apply metabolomic study by the use of LC-
MS/MS  analysis  to  study  the  presence  of  important  metabolites  that  can  be  used  to 
discriminate normal milk samples from milk samples from quarters infected with bacteria 
causing bovine mastitis.  It was hoped that by using this sensitive and high-throughput 
methodology, significant results could be achieved and lead to the discovery of important 
and significant mastitis biomarkers and that differences may be found in samples of milk 
from infected quarters caused by different pathogens. 
5.2  Materials and Methods 
5.2.1 Animals and Samples 
Milk  samples  from  clinical  mastitic cases  were  sent  from  Vale Veterinary  Laboratory, 
Devon, UK and bacteriological culture was performed in the Bacteriology Laboratory of 
Vale  Veterinary  Laboratory  to  determine  the  bacterial  cause  of  bovine  mastitis.  Milk 
samples from mastitis caused with either E. coli (n=10) or S. aureus (n=6) infection were 
collected for further analysis. Control milk samples (n=10) from healthy cows from the 
Cochno Farm of School of Veterinary Medicine, University of Glasgow were also used in 
this study as comparison to those clinical mastitic cases. The healthy milk samples were 
confirmed by somatic cell counts (<100 000 cells/ml). Prior to metabolomic analysis, SAA 
and Hp assays (Chapter 2) were performed determine the concentration of both acute phase 
proteins  in  each  milk  sample  for  further  confirmation  of  disease  status.  Samples  were 
stored at -20°C prior to analysis. 
5.2.2 Chloroform and methanol Extraction 
5.2.2.1  Reagent preparation 
A mixture (1:3) of chloroform: methanol was prepared by adding 20ml of chloroform into 
60ml methanol.  Chapter 5, 213 
 
5.2.2.2  Extraction method 
An aliquot of 500µl of each milk sample was added to 2ml of 1:3 chloroform: methanol 
solution and mixed vigorously in the cold room at 4ºC for 2 hours. Next, the sample was 
centrifuged at 13 000 x g for 3 minutes at 4ºC. The supernatant was aspirated and was then 
stored at -80ºC until analysis by LC-MS. 
5.2.3 LC-MS Analysis 
LC/MS was carried out using a Dionex UltiMate 1 coupled to an Orbitrap Exactive. The 
separation  of  metabolites  was  performed  using  a  4.6  x  150mm  ZIC-HILIC  column  at 
300μl/min. The gradient ran from 80% acetonitrile (ACN) to 20% ACN in 30 minutes, 
with a step to 5% ACN for 9 minutes. Re-equilibration was then performed for 6 minutes 
at 80% ACN. 10μl of each sample was used per run. The MS acquisition was performed in 
both negative and positive ionisation modes with full scan modes. The MS was set at 
50,000  resolution  with  the  scan  range  from  70-1400  amu.  The  LC-MS  analysis  was 
performed  under  supervision  of  Dr.  Karl  Burgess  of  Sir  Henry  Wellcome  Functional 
Genomic Functional, University of Glasgow, UK. 
5.2.4 Data Acquisition 
The  LC/MS  data  was  analyzed  using  MzMine  software  (version  2.0) 
(http://mzmine.sourceforge.net/index.shtml; Finland and Japan). For the peak detection, a 
noise threshold of 5000 and m/z tolerance of 0.0005 Da was performed. An alignment with 
a mass tolerance of 0.0005 and a retention time tolerance was 15 seconds. 
5.2.5  Analysis of Individual Metabolites 
Output from the LC/MS for both positive and negative modes was obtained as spreadsheet 
of mass-to-charge ratio peaks for each sample and with m/z values providing molecular 
formula by comparison to metabolite database and a putative identification was based on 
the formula. Not all m/z peaks gave identified metabolites. For each peak, the mean and 
SD of the m/z intensities for all samples in the group (control; E. coli; S. aureus) were 
automatically determined. Inspection of the results and manipulation of the spreadsheet 
allowed analysis in a variety of criteria. 
For both positive and negative modes, the metabolites were sorted to identify those with 
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Numerous metabolites were not present in the control group but were present in either or 
both the E. coli and S. aureus groups. These were identified and the 20 metabolites with 
largest difference in mean m/z intensities determined by substraction. 
Numerous metabolites had large difference between the mean of control group and the 
mean of either E. coli or S. aureus groups. They were determined by calculation of the 
total increase or decrease by dividing the mean of the m/z intensities of the infected groups 
by the mean of the control group and the 15 metabolites with greatest fold increase or 
decrease were identified. 
Metabolites showing significant difference between the E. coli and S. aureus groups were 
identified by calculation of the fold change by dividing the median of the m/z intensities of 
the S. aureus group by the median m/z intensities of the E. coli group. The 15 metabolites 
with the highest fold change between groups increased in either S. aureus or in E. coli were 
identified and the Mann Whitney test for significant differences applied for non-parametric 
data. The metabolites were listed in order of increasing probability of the significance of a 
difference (P-value). 
5.2.6 Metabolites Analysis – Pathway Analysis 
Bioinformatic analysis of the metabolomics data performed using tools provided by the 
Scottish  Metabolomics  Facility.  An  in-house  web  facility,  known  as  PATHOS 
(http://motif.gla.ac.uk/Pathos/index.html), has the ability to display metabolites identified 
based on the metabolic pathways in which they occur. By listing areas of metabolism and 
by generating a Kyoto Encyclopaedia of Genes and Genomes (KEGG) map, the data of 
experimental m/z values or refined lists of metabolites generated by the MS data by other 
means  was  analysed.  PATHOS  also  provides  quantitative  data  for  the  metabolites 
identified and these changes are indicated by colour-coding on KEGG map. 
For  preliminary  analyses,  changes  in  metabolites  were  grouped  based  on  different 
metabolism; lipid, protein and carbohydrate metabolisms. In each group, the analysis was 
focussed on six metabolic pathways showing most changes for both positive and negative 
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5.3   Results 
5.3.1  SCC measurement and acute phase proteins 
concentration 
In order to confirm the disease status of milk samples used in this study, SCC measurement 
and acute phase proteins (SAA and Hp) concentrations were determined. Table 5-1 showed 
the SCC measurement and APP concentrations in all control milk samples used in this 
study. The results were as the same as in Chapter 4, Section 4.3.1. Table 5-2 (a and b) 
showed the bacteriological culture results and the concentration of both SAA and Hp for 
mastitic milk samples caused by E. coli and S. aureus. The results were also as the same as 
in Chapter 4, Section 4.3.1. The Statistical analysis (Mann Whitney) showed that both 
SAA and Hp were significantly higher (p=0.00; p<0.05) in the infected group (E. coli and 
S. aureus) but not significantly different between two bacterial groups (p=0.958; p>0.05 
for SAA and p=0.428; p>0.05 for Hp). Chapter 5, 216 
 
Control milk samples       
       
Sample Ids  SAA Conc.(ng/ml)  Hp conc. (ng/ml)  SCC (x10
3) 
102  0.36  7.78  13 
66  0.57  16.38  14 
3  0.55  27.98  48 
62  0.079  1.95  31 
72  1.21  7.24  96 
109  0.65  13.21  10 
80  0.28  24.61  54 
100  0.48  15.36  38 
16  0.9  2.86  58 
58  0.34  1.95  56 
111  0.13  21.94  28 
48  0.39  31.95  85 
4  2.96  4.17  63 
2  1.43  1.95  32 
29  0.29  12.64  46 
Min  0.08  1.95  10 
Max  2.96  31.95  96 
Mean  0.71  12.8  45 
Median  0.48  12.64  46 
 
Table  5-1:  The  acute  phase  proteins  (SAA  and  Hp)  concentrations  and  SCC 
measurement  in  all  control  milk  samples  used  in  this  study.  The  range  of  SAA 
concentrations  was between 0.08 and 2.96 μg/ml with  an average of  0.71μg/ml  and  a 
median of 0.48μg/ml. The range of Hp concentrations was between 1.95 and 32μg/ml with 
an average of 12.8μg/ml and a median of 12.64μg/ml. The range of SCC measurement was 
between 10 and 96 x 10
3 cells/ml with an average of 45 x 10
3 cells/ml and a median of 46 x 
10
3 cells/ml. Chapter 5, 217 
 
Mastitic milk 
samples       
Sample Ids 
SAA Conc. 
(ng/ml) 
Hp conc. 
(ng/ml) 
Bacteriological 
results 
475  72.13  89.68  E. coli 
76  1500  115.18  E. coli 
?  1500  78.51  E. coli 
814  1500  141.26  E. coli 
692  9.48  60.27  E. coli 
697  1500  144.89  E. coli 
519  109.44  108.02  E. coli 
453  4.18  16.63  E. coli 
496  24.31  16.03  E. coli 
1222  46.02  354.26  E. coli 
Min  4.18  16.03   
Max  1500  354.26   
Mean  626.56  112.47   
Median  90.79  98.85   
 
Table 5-2a: The acute phase proteins (SAA and Hp) concentrations and bacterial 
causing mastitis in infected milk samples caused by E. coli used in this study. The 
range  of  SAA  concentrations  was  between  4.18  and  1500μg/ml  with  an  average 
626.6μg/ml and a median of 90.79μg/ml. The range of Hp concentrations was between 
16.03  and  354.26μg/ml  with  an  average  of  112.5μg/ml  and  a  median  of  98.85μg/ml.Chapter 5, 218 
 
Mastitic milk 
samples       
Sample Ids 
SAA Conc. 
(ng/ml) 
Hp conc. 
(ng/ml) 
Bacteriological 
results 
438  48.12  70.77  S. aureus 
14  37.21  42.69  S. aureus 
980  1500  111.83  S. aureus 
708  54.96  95  S. aureus 
346  1500  86.2  S. aureus 
715  15.99  22.15  S. aureus 
Min  15.99  22.15   
Max  1500  111.83   
Mean  526.05  71.44   
Median  51.54  78.49   
 
Table 5-2b: The acute phase proteins (SAA and Hp) concentrations and bacterial 
causing mastitis in infected milk samples caused by S. aureus used in this study. The 
range  of  SAA  concentrations  was  between  15.99  and  1500μg/ml  with  an  average  of 
526.1μg/ml and a median of 51.54μg/ml. The range of Hp concentrations was between 
22.15 and 111.8μg/ml with an average of 71.44μg/ml and a median of 78.49μg/ml. Chapter 5, 219 
 
5.3.2  Metabolites found in milk 
Upon LC-MS analysis, the identified metabolites were analyzed by MzMine software, the 
data  was  presented  based  on  the  individual  metabolites  found  according  to  their  m/z 
values, retention times, numbers of detected peaks, molecular names and their abundances 
in each of the milk samples. The data was divided into positive and negative ionisation 
modes based on the MS acquisition. A total of 9904 were detected in the milk samples 
using positive mode detection of which 814 were identified using the MzMine software. 
For the negative ion  detection the equivalent figures  were a total of 5551 metabolites 
detected  with  512  being  identified.  Numerous  metabolites  were  present  with  both  ion 
detection systems and inspection of the data showed that 221 metabolites were in both the 
positive and negative mode so that a total 1105 metabolites were detected across the milk 
samples analysed (Table 5-3). The mean values of m/z intensities of metabolites in each 
group were then determined. The full excel files with the identified and non-identified 
metabolites are presented in the supplementary information.  The following examination of 
the metabolites and their variation between milk from healthy cows and that from udder 
quarters with mastitis caused by E. coli or S. aureus are focused on the metabolites that 
were identified in the samples by LC-MS-MS and the MzMine software programme. 
With the large data set generated by the study, the results were examined by scrutiny of the 
individual  metabolites  and  their  variation  in  mean  m/z  intensity  between  control  and 
infected groups. In order to reduce the complexity of the interpretation, the metabolites are 
discussed in relation to the m/z intensity and the mean of the peaks obtained with the 
discussion  focused  on  the  metabolites  with  the  highest  intensity  or  on  those  with  the 
greatest relative value between bacterially infected groups.   Thereafter the major possible 
metabolic  pathway  alterations  that  produce  the  identified  changes  in  metabolites  are 
described. Chapter 5, 220 
 
 
 
Table  5-3:  The  total  number  of  metabolites,  identified  and  unidentified  in  both 
positive  and  negative  ionisation  modes.  The  number  of  common  and  individual 
identified metabolites was also presented. A total of 15 455 metabolites were identified 
from  the  LC-MS/MS  analysis.  However,  only  1326  metabolites  were  successfully 
identified  by  the  MzMine  software.  About  221  of  common  metabolites  and  1105 
individual metabolites were identified from this software. 
  Positive 
Mode 
Negative 
Mode 
Total of 
metabolites 
Number of metabolites  9904  5551  15455 
Number of identified metabolites  814  512  1326 
Number of unidentified metabolites  9090  5039  14129 
Number of common identified  
metabolites 
    221 
Number of individual identified 
metabolites 
    1105 Chapter 5, 221 
 
5.3.3  Effect of mastitis on the metabolites of milk 
The first 20 metabolites with highest m/z intensities in each three groups of milk samples; 
control,  E.  coli  and  S.  aureus  groups  were  tabulated  in  each  positive  and  negative 
ionisation modes as presented in Table 5-4 and 5-5. From the positive mode MS, it was 
found that the metabolites with greatest intensity differed between the groups although 
most of the highest  metabolites  in  the control were still within the top group.  The 3 
metabolites with highest intensity in the control group (Table 5-6) were L-acetylcarnitine, 
choline and sn-glycero-3-phosphocholine. The fourth metabolite was lactose, the primary 
carbohydrate of milk. However, the Pathos analysis programme identified this as 1-alpha-
D-Galactosyl-myo-inositol which has an identical molecular formula of C12H22O11. On 
tables, the form given is maintained with lactose identified in bracket. In the group with E. 
coli infection (Table 5-7) choline was the metabolite with highest m/z intensity but L-
carnitine and the amino acid, L-valine were also at the top of the metabolites detected 
while lactose had the fourth highest intensity.  In the group with S. aureus infection (Table 
5-8), L-valine had the highest intensity and it was noticeable that 11 of the top 20 were 
amino acids, di-peptides or tri-peptides, compared to 6 in the E. coli group and only one, 
glutamate in the milk samples from the control group.  Lactose was detected in the S. 
aureus group but was tenth of the twenty metabolites with the highest m/z intensity.   
With the negative ion detection, all three groups had the same metabolites with the two 
highest m/z intensities, being citrate (though incorrectly identified as 5-dehydro-4deoxy-D-
glucarate) and lactose (Tables 5-9 to 5-11), which reflect their high concentration in milk.  
In the samples for both the E. coli and S. aureus infections the third highest m/z intensity 
was  lactate, which was  not  in  the top  20 in the control  group and its  presence in  the 
samples  from  mastitic milk  would indicate the alteration in  metabolism  caused by the 
bacteria.  Also noticeable was that that glucose/galactose (identified as myo-inositol) was 
detectable in milk from the control group and that from the E. coli infected but not the S. 
aureus infected groups.  It was noticeable that the metabolites in the top 20 of the negative 
ion detection were mostly small molecular weight acidic metabolites while those in the 
positive ion detection had a higher proportion of basic metabolites. 
Metabolites which were absent in control milk samples but present in both infected groups 
(E. coli and S. aureus) were examined in both positive and negative ion modes. Twenty 
metabolites with the largest difference between intensities in E. coli and S. aureus infected 
groups were tabulated in Table 5-12, 5-13, 5-14, 5-15. From the positive mode analysis, of 
the  20  metabolites  which  were  higher  in  the  S.  aureus  group  than  E.  coli  18  were Chapter 5, 222 
 
tripeptides, with Leu-Val-Ser being the metabolite with greatest difference from that in the 
E. coli group (Table 5-12). In contrast ten different tripeptides had higher intensities in the 
samples from the E. coli   group compared to the S. aureus group (Table 5-13).  However 
also detected in this group were other metabolites such as calligonine, harmolol (both are 
alkaloids) and lincomycin.  From the negative mode analysis, of the 20 metabolites which 
were higher in the S. aureus group than E. coli, 12 were tripeptides with Leu-Gln-Ser being 
the metabolites with greatest difference from that in the E. coli group (Table 5-14).  In 
contrast, eight different tripeptides had higher intensities in the samples from the E. coli 
group compared to the S. aureus group (Table 5-15).  Chapter 5, 223 
 
 
Name  Control  Name  E. coli  Name 
S. 
aureus 
L-Acetylcarnitine  5.3E+08  Choline  6.9E+08  L-Valine  4.7E+08 
Choline  4.6E+08  L-Carnitine  3.3E+08  Choline  4.6E+08 
sn-glycero-3-Phosphocholine  4.6E+08  L-Valine  3.2E+08  L-Phenylalanine  4.2E+08 
1-alpha-D-Galactosyl-myo-inositol 
(lactose)  4.1E+08 
1-alpha-D-Galactosyl-myo-inositol 
(lactose)  3E+08  L-Acetylcarnitine  3.5E+08 
L-Carnitine  4E+08  L-Acetylcarnitine  3E+08  Piperidine  3.2E+08 
[FA methyl(4:2/18:2)] methyl 9-
butylperoxy-10_12-octadecadienoate  2.3E+08  L-Phenylalanine  2.2E+08  Leucyl-leucine  3E+08 
Methyl acetyl ricinoleate  1.9E+08 
[ST] (5Z_7E)-9_10-seco-5_7_10(19)-
cholestatriene  2.1E+08  L-Carnitine  2.8E+08 
Methacholine  1.7E+08  Piperidine  1.9E+08 
[ST] (5Z_7E)-9_10-seco-
5_7_10(19)-
cholestatriene  2.7E+08 
L-Glutamate  1.5E+08 
[FA methyl(4:2/18:2)] methyl 9-
butylperoxy-10_12-octadecadienoate  1.8E+08  L-Proline  2.5E+08 
N-Acetyl-D-glucosamine  1.5E+08  Methyl acetyl ricinoleate  1.6E+08 
1-alpha-D-Galactosyl-
myo-inositol (lactose)  2.5E+08 
Glycogen  1.5E+08  Methacholine  1.4E+08  L-Glutamate  2.4E+08 
[ST] (5Z_7E)-9_10-seco-5_7_10(19)-
cholestatriene  1.4E+08  Glycogen  1.3E+08 
sn-glycero-3-
Phosphocholine  2.3E+08 
1-O-(1Z-Tetradecenyl)-2-(9Z-
octadecenoyl)-sn-glycerol  1.2E+08  L-Tyrosine  1.2E+08  L-Tyrosine  2.1E+08 
[FA oxo(19:0)] 10-oxo-nonadecanoic 
acid  1.1E+08  Leu-Tyr  1.1E+08 
[FA oxo(19:0)] 10-oxo-
nonadecanoic acid  1.6E+08 Chapter 5, 224 
 
 
 
Table 5-4: The first 20 of metabolites with the highest m/z intensity of positive ionisation mode from the total of 814 metabolites identified using 
the MzMine software in control, E. coli infected and S. aureus infected groups. 
 
 
 
 
 
 
[FA methoxy_hydroxy(18:2)] 8-
methoxy-13-hydroxy-9_11-
octadecadienoic acid  1.1E+08  L-Proline  1.1E+08  Leu-Phe  1.5E+08 
O-Propanoylcarnitine  9.3E+07 
[FA oxo(19:0)] 10-oxo-nonadecanoic 
acid  1.1E+08  Leu-Tyr  1.5E+08 
[FA (17:1/2:0)] 8E-Heptadecenedioic 
acid  8.8E+07  L-Glutamate  1E+08  Leu-Val-Ser  1.5E+08 
Mercaptoethanol  7.6E+07 
[FA methoxy_hydroxy(18:2)] 8-
methoxy-13-hydroxy-9_11-
octadecadienoic acid  9.7E+07  Leu-Leu-Val  1.4E+08 
1_3_8-Naphthalenertriol  7E+07  sn-glycero-3-Phosphocholine  8.7E+07  Leu-Thr  1.3E+08 
O-Butanoylcarnitine  6.6E+07 
[FA (17:1/2:0)] 8E-Heptadecenedioic 
acid  7.8E+07  Methacholine  1.3E+08 Chapter 5, 225 
 
Table 5-5 : The first 20 of metabolites with the highest m/z intensity of negative ionisation mode from the total of 512 metabolites identified using 
the MzMine software in control, E. coli infected  and S. aureus infected groups. 
Name 
Control  Name  E. coli  Name  S. aureus 
5-Dehydro-4-deoxy-D-glucarate (citrate)  1.8E+09  5-Dehydro-4-deoxy-D-glucarate (citrate)  1.4E+09  5-Dehydro-4-deoxy-D-glucarate (citrate)  1.7E+09 
1-alpha-D-Galactosyl-myo-inositol (lactate)  1.5E+09  1-alpha-D-Galactosyl-myo-inositol (lactate)  1.2E+09  1-alpha-D-Galactosyl-myo-inositol (lactose)  1.2E+09 
N-Acetyl-D-glucosamine 6-phosphate  2.6E+08  (R)-Lactate  8.1E+08  (R)-Lactate  9.2E+08 
cis-Aconitate  1.7E+08  myo-Inositol (glucose/galactose)  1.8E+08  L-Glutamate  1.6E+08 
myo-Inositol (glucose/galactose)  1.1E+08  Succinate  1.8E+08  cis-Aconitate  1.2E+08 
Hippurate  9.9E+07  cis-Aconitate  1.1E+08  myo-Inositol (glucose/galactose)  1.2E+08 
Urate  9E+07  2-C-Methyl-D-erythritol 4-phosphate  9.2E+07  (S)-Malate  1E+08 
2_5-Dioxopentanoate  8.4E+07  2-Dehydro-3-deoxy-L-arabinonate  8.6E+07  Urate  9.4E+07 
Miserotoxin  7.9E+07  Pyruvate  8.2E+07  2-C-Methyl-D-erythritol 4-phosphate  8.5E+07 
2-C-Methyl-D-erythritol 4-phosphate  7.8E+07  Creatine  7.3E+07  L-Erythrulose  7.5E+07 
L-Erythrulose  7.5E+07  Hippurate  7.2E+07  N-Acetyl-D-glucosamine  7.4E+07 
N-Acetyl-D-glucosamine  7.4E+07  (S)-Malate  7.1E+07  Miserotoxin  7.1E+07 
Creatine  7.4E+07  2-C-Methyl-D-erythritol 4-phosphate  6.3E+07  2_5-Dioxopentanoate  6.9E+07 
(S)-Malate  7.4E+07  Urate  6.1E+07  Taurine  6.2E+07 
L-Glutamate  7.4E+07  L-Glutamate  6E+07  (R)-3-Hydroxybutanoate  6.2E+07 
sn-glycero-3-Phospho-1-inositol  6.6E+07  2_5-Dioxopentanoate  6E+07  Pyruvate  5.8E+07 
D-Glucose 6-phosphate  5.2E+07  N-Acetyl-D-glucosamine 6-phosphate  5.9E+07  Creatine  5.7E+07 
2-Dehydro-3-deoxy-L-arabinonate  4.4E+07  Glycerol 2-phosphate  5.2E+07  Hippurate  5.4E+07 
2-Butyne-1_4-diol  4.4E+07  2-Oxoglutarate  4.8E+07  2-Dehydro-3-deoxy-L-arabinonate  4.5E+07 
Pantothenate  4.3E+07  (2S)-2-Isopropylmalate  4.6E+07  Mesaconate  4.3E+07 Chapter 5, 226 
 
Controls       
row m/z  Molecular formula  Name  m/z intensity 
204.12288  C9H17NO4  L-Acetylcarnitine  532069651.6 
104.10717  C5H14NO  Choline  459631082.1 
258.10994  C8H21NO6P  sn-glycero-3-Phosphocholine  455789062.4 
343.12334  C12H22O11  1-alpha-D-Galactosyl-myo-inositol (lactose)  410172949.4 
162.11236  C7H16NO3  L-Carnitine  404013964.3 
383.31543  C23H42O4  [FA methyl(4:2/18:2)] methyl 9-butylperoxy-10_12-octadecadienoate  233919160.6 
355.28412  C21H38O4  Methyl acetyl ricinoleate  190471829.2 
160.1331  C8H18NO2  Methacholine  165776723.1 
148.06034  C5H9NO4  L-Glutamate  151091045.9 
222.09705  C8H15NO6  N-Acetyl-D-glucosamine  148793168.2 
667.22894  C24H42O21  Glycogen  146868998.2 
369.35138  C27H44  [ST] (5Z_7E)-9_10-seco-5_7_10(19)-cholestatriene  137976616.2 
551.50347  C35H66O4  1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycerol  121462416.9 
313.27353  C19H36O3  [FA oxo(19:0)] 10-oxo-nonadecanoic acid  112684801.4 
327.25284  C19H34O4  [FA methoxy_hydroxy(18:2)] 8-methoxy-13-hydroxy-9_11-octadecadienoic acid  108737293.9 
218.13858  C10H19NO4  O-Propanoylcarnitine  93016510.12 
299.22155  C17H30O4  [FA (17:1/2:0)] 8E-Heptadecenedioic acid  87738450.94 
79.02126  C2H6OS  Mercaptoethanol  75530497.29 
177.05456  C10H8O3  1_3_8-Naphthalenertriol  69725634.82 
232.15421  C11H21NO4  O-Butanoylcarnitine  66011561.24 
Table 5-6: The top 20 metabolites by m/z intensity of positive ionisation mode analysis in control group. The mass-to-charge ratio, formula and the 
m/z intensity of each named metabolites are presented as well.Chapter 5, 227 
 
 
E. coli       
row m/z  Molecular formula  Name  m/z intensity 
104.1071682  C5H14NO  Choline  688544094.3 
162.1123612  C7H16NO3  L-Carnitine  328583661.3 
118.0865562  C5H11NO2  L-Valine  323402732.5 
343.1233364  C12H22O11  1-alpha-D-Galactosyl-myo-inositol (lactose)  302781524.5 
204.1228806  C9H17NO4  L-Acetylcarnitine  301572172.6 
166.0861809  C9H11NO2  L-Phenylalanine  220244923.1 
369.3513767  C27H44  [ST] (5Z_7E)-9_10-seco-5_7_10(19)-cholestatriene  208831576.3 
86.09644175  C5H11N  Piperidine  191708498.1 
383.315431  C23H42O4  [FA methyl(4:2/18:2)] methyl 9-butylperoxy-10_12-octadecadienoate  179797044.2 
355.2841233  C21H38O4  Methyl acetyl ricinoleate  156590246.4 
160.1331034  C8H18NO2  Methacholine  144540343 
667.2289361  C24H42O21  Glycogen  125929094.7 
182.08111  C9H11NO3  L-Tyrosine  119735739.5 
295.16499  C15H22N2O4  Leu-Tyr  113966956.8 
116.070917  C5H9NO2  L-Proline  113953650.9 
313.2735285  C19H36O3  [FA oxo(19:0)] 10-oxo-nonadecanoic acid  106969595.2 
148.0603401  C5H9NO4  L-Glutamate  99580277.45 
327.2528422  C19H34O4  [FA methoxy_hydroxy(18:2)] 8-methoxy-13-hydroxy-9_11-octadecadienoic acid  97136487.65 
258.1099366  C8H21NO6P  sn-glycero-3-Phosphocholine  86502311.46 
299.2215456  C17H30O4  [FA (17:1/2:0)] 8E-Heptadecenedioic acid  77637189.42 
Table 5-7: The top 20 metabolites by m/z intensity of positive ionisation mode analysis in E. coli group. The mass-to-charge ratio, formula and the 
m/z intensity of each named metabolites are presented as well. Chapter 5, 228 
 
S. aureus       
row m/z  Molecular formula  Name  m/z intensity 
118.09  C5H11NO2  L-Valine  474193023 
104.11  C5H14NO  Choline  459760192 
166.09  C9H11NO2  L-Phenylalanine  420899486 
204.12  C9H17NO4  L-Acetylcarnitine  353171406 
86.10  C5H11N  Piperidine  317818082 
245.19  C12H24N2O3  Leucyl-leucine  304379656 
162.11  C7H16NO3  L-Carnitine  275815803 
369.35  C27H44  [ST] (5Z_7E)-9_10-seco-5_7_10(19)-cholestatriene  266427751 
116.07  C5H9NO2  L-Proline  253743805 
343.12  C12H22O11  1-alpha-D-Galactosyl-myo-inositol   248665608 
148.06  C5H9NO4  L-Glutamate  244795489 
258.11  C8H21NO6P  sn-glycero-3-Phosphocholine  231299639 
182.08  C9H11NO3  L-Tyrosine  214276582 
313.27  C19H36O3  [FA oxo(19:0)] 10-oxo-nonadecanoic acid  161755798 
279.17  C15H22N2O3  Leu-Phe  154149870 
295.16  C15H22N2O4  Leu-Tyr  153060034 
318.20  C14H27N3O5  Leu-Val-Ser  151748149 
344.25  C17H33N3O4  Leu-Leu-Val  139384457 
233.15  C10H20N2O4  Leu-Thr  132935813 
160.13  C8H18NO2  Methacholine  131531174 
Table 5-8: The top 20 metabolites by m/z intensity of positive ionisation mode analysis in S. aureus group. The mass-to-charge ratio, formula and 
the m/z intensity of each named metabolites are presented as well.Chapter 5, 229 
 
 
Control       
row m/z  Molecular formula  Name  m/z intensity 
191.02  C6H8O7  5-Dehydro-4-deoxy-D-glucarate (citrate)  1750330040 
341.11  C12H22O11  1-alpha-D-Galactosyl-myo-inositol (lactose)  1513754934 
300.05  C8H16NO9P  N-Acetyl-D-glucosamine 6-phosphate  261652267 
173.01  C6H6O6  cis-Aconitate  166893330 
179.06  C6H12O6  myo-Inositol  106110746 
178.05  C9H9NO3  Hippurate  98680533 
167.02  C5H4N4O3  Urate  89863389 
129.02  C5H6O4  2_5-Dioxopentanoate  84341727 
266.09  C9H17NO8  Miserotoxin  78910119 
215.03  C5H13O7P  2-C-Methyl-D-erythritol 4-phosphate  78482788 
119.03  C4H8O4  L-Erythrulose  75351299 
220.08  C8H15NO6  N-Acetyl-D-glucosamine  74489145 
130.06  C4H9N3O2  Creatine  74407132 
133.01  C4H6O5  (S)-Malate  73918031 
146.05  C5H9NO4  L-Glutamate  73661846 
333.06  C9H19O11P  sn-glycero-3-Phospho-1-inositol  66333040 
259.02  C6H13O9P  D-Glucose 6-phosphate  52176193 
147.03  C5H8O5  2-Dehydro-3-deoxy-L-arabinonate  44090003 
85.03  C4H6O2  2-Butyne-1_4-diol  43558519 
218.10  C9H17NO5  Pantothenate  43488200 
Table 5-9: The top 20 metabolites by m/z intensity of negative ionisation mode analysis in control group. The mass-to-charge ratio, formula and the 
m/z intensity of each named metabolites are presented as well. Chapter 5, 230 
 
E. coli     
row m/z  Molecular formula  Name  m/z intensity 
191.02  C6H8O7  5-Dehydro-4-deoxy-D-glucarate (citrate)  1375581553 
341.11  C12H22O11  1-alpha-D-Galactosyl-myo-inositol (lactose)  1163878111 
89.02  C3H6O3  (R)-Lactate  812425519 
179.06  C6H12O6  myo-Inositol  182735001 
117.02  C4H6O4  Succinate  179764837 
173.01  C6H6O6  cis-Aconitate  105428739 
215.03  C5H13O7P  2-C-Methyl-D-erythritol 4-phosphate  91564904 
147.03  C5H8O5  2-Dehydro-3-deoxy-L-arabinonate  86395991 
87.01  C3H4O3  Pyruvate  81948401 
130.06  C4H9N3O2  Creatine  73380634 
178.05  C9H9NO3  Hippurate  72131854 
133.01  C4H6O5  (S)-Malate  71188741 
215.03  C5H13O7P  2-C-Methyl-D-erythritol 4-phosphate  63327089 
167.02  C5H4N4O3  Urate  60860379 
146.05  C5H9NO4  L-Glutamate  60367636 
129.02  C5H6O4  2_5-Dioxopentanoate  59941285 
300.05  C8H16NO9P  N-Acetyl-D-glucosamine 6-phosphate  59306858 
171.01  C3H9O6P  Glycerol 2-phosphate  51930002 
145.01  C5H6O5  2-Oxoglutarate  47839083 
175.06  C7H12O5  (2S)-2-Isopropylmalate  46199319 
Table 5-10: The top 20 metabolites by m/z intensity of negative ionisation mode analysis in E. coli group. The mass-to-charge ratio, formula and the 
m/z intensity of each named metabolites are presented as well.Chapter 5, 231 
 
 
S. aureus     
row m/z  Molecular formula  Name  m/z intensity 
191.02  C6H8O7  5-Dehydro-4-deoxy-D-glucarate (citrate)  1713079641 
341.11  C12H22O11  1-alpha-D-Galactosyl-myo-inositol (lactose)  1246746397 
89.02  C3H6O3  (R)-Lactate  921868860 
146.05  C5H9NO4  L-Glutamate  155669416 
173.01  C6H6O6  cis-Aconitate  124042799 
179.06  C6H12O6  myo-Inositol (glucose/galactose)  116014627 
133.01  C4H6O5  (S)-Malate  100377602 
167.02  C5H4N4O3  Urate  94020844 
215.03  C5H13O7P  2-C-Methyl-D-erythritol 4-phosphate  85004997 
119.03  C4H8O4  L-Erythrulose  74942006 
220.08  C8H15NO6  N-Acetyl-D-glucosamine  73840064 
266.09  C9H17NO8  Miserotoxin  70788430 
129.02  C5H6O4  2_5-Dioxopentanoate  69476176 
124.01  C2H7NO3S  Taurine  62376397 
103.04  C4H8O3  (R)-3-Hydroxybutanoate  62310337 
87.01  C3H4O3  Pyruvate  58442163 
130.06  C4H9N3O2  Creatine  56614851 
178.05  C9H9NO3  Hippurate  53708833 
147.03  C5H8O5  2-Dehydro-3-deoxy-L-arabinonate  45261272 
129.02  C5H6O4  Mesaconate  42718964 
Table 5-11: The top 20 metabolites by m/z intensity of negative ionisation mode analysis in S. aureus group. The mass-to-charge ratio, formula and 
the m/z intensity of each named metabolites are presented as well. Chapter 5, 232 
 
row 
m/z 
Molecular formula  Name  m/z intensity (E. coli; EC)  m/z intensity (S. aureus; SA)  Difference in m/z intensity, 
SA - EC   
318.20  C14H27N3O5  Leu-Val-Ser  7169464  1.52E+08  144578685 
392.25  C21H33N3O4  Leu-Leu-Phe  2515770  62511479  59995709 
347.19  C14H26N4O6  Leu-Gln-Ser  66451.19  37865683  37799232 
378.20  C19H27N3O5  Val-Pro-Tyr  77005.78  20353927  20276921 
373.24  C17H32N4O5  Leu-Leu-Gln  68299.4  15413856  15345557 
321.14  C11H20N4O7  Gln-Ser-Ser  24894.88  15198151  15173256 
253.12  C12H16N2O4  Ala-Tyr  7303190  22111654  14808464 
333.21  C14H28N4O5  Lys-Val-Ser  262397  13470687  13208290 
496.22  C25H29N5O6  Trp-Gln-Tyr  381281.3  4664604  4283322 
300.19  C14H25N3O4  Leu-Ala-Pro  139108.5  3942298  3803190 
332.18  C14H25N3O6  Val-Val-Asp  1028657  4747132  3718476 
318.17  C13H23N3O6  Leu-Ala-Asp  6637.732  3344439  3337801 
423.22  C20H30N4O6  Leu-Gln-Tyr  338654.2  3321623  2982969 
361.24  C16H32N4O5  Leu-Lys-Thr  5150.919  2567885  2562734 
294.14  C14H19N3O4  Phe-Ala-Gly  1376626  3563815  2187189 
409.21  C19H28N4O6  Leu-Asn-Tyr  3618.938  2079692  2076073 
333.16  C16H20N4O4  Trp-Ala-Gly  115248  1737862  1622614 
303.18  C11H22N6O4  Ala-Gly-Arg  213576.7  1810903  1597326 
287.24  C14H30N4O2  N1_N12-Diacetylspermine  3925092  5423238  1498145 
290.17  C12H23N3O5  Leu-Ala-Ser  17054.07  944656.8  927603 
Table 5-12: Metabolites identified from positive ionisation mode analysis which were absent in control group but found greater in S. aureus 
infected group by means of m/z intensity than E. coli infected group. The m/z intensity for each of metabolites identified in both infected groups and 
the difference in m/z intensity were as presented. The difference in m/z intensity was equal to the m/z intensity of S. aureus infected group minus the m/z 
intensity of E. coli infected group Chapter 5, 233 
 
row m/z  Molecular formula  Name  m/z intensity 
(E. coli; EC) 
m/z intensity 
(S. aureus; 
SA) 
Difference in 
m/z intensity, 
SA - EC   
187.12  C12H14N2  Calligonine  7135922  2485802  4650121 
376.22  C20H29N3O4  Leu-Phe-Pro  15054435  11700662  3353774 
181.07  C7H8N4O2  Theophylline  4655026  1465804  3189222 
306.17  C12H23N3O6  Leu-Ser-Ser  1107760  283639  824122 
407.22  C18H34N2O6S  Lincomycin  1197998  434791  763207 
199.09  C12H10N2O  Harmalol  591018  108776  482242 
408.25  C21H33N3O5  Leu-leu-tyr  1228049  841475  386574 
350.21  C18H27N3O4  Leu-Phe-Ala  490555  130928  359627 
468.34  C23H50NO6P  [PC methyl(14:2)] 2-methyl-3-tetradecyl-sn-glycero-1-
phosphocholine 
731979  412006  319973 
295.18  C19H22N2O  Eburnamonine  597554  286885  310669 
334.16  C13H23N3O7  Leu-Asp-Ser  380049  88191  291859 
286.18  C13H23N3O4  Leu-Gly-Pro  324809  36711  288099 
165.07  C8H8N2O2  Ricinine  243149  4239  238910 
458.25  C22H31N7O4  Trp-Pro-Arg  641744  451644  190100 
140.03  C6H5NO3  4-Nitrophenol  171175  5689  165486 
366.17  C17H23N3O6  Pro-Ser-Tyr  163275  14072  149204 
296.12  C13H17N3O5  Asn-Tyr  655710  512128  143582 
451.16  C20H26N4O6S  Met-Trp-Asp  126010  1722  124289 
393.14  C14H24N4O7S  Met-Asp-Gln  164428  40184  124244 
407.22  C18H34N2O6S  Lincomycin  201509  80887  120622 
Table 5-13: Metabolites identified from positive ionisation mode analysis which were absent in control group but found greater in E. coli 
infected group by means of m/z intensity than S. aureus infected group. The m/z intensity for each of metabolites identified in both infected groups Chapter 5, 234 
 
and the difference in m/z intensity were as presented. The difference in m/z intensity was equal to the m/z intensity of S. aureus infected group minus the 
m/z intensity of E. coli infected group.Chapter 5, 235 
 
row m/z  Molecular formula  Name  m/z intensity (E. coli; EC)  m/z intensity (S. aureus; SA)  Difference in m/z intensity, SA - EC   
345.18  C14H26N4O6  Leu-Gln-Ser  46782  18858881  18812099 
331.20  C14H28N4O5  Lys-Val-Ser  640021  18012351  17372329 
231.14  C10H20N2O4  Leu-Thr  189543  14873123  14683580 
390.24  C21H33N3O4  Leu-Leu-Phe  258374  6241107  5982733 
359.23  C16H32N4O5  Leu-Lys-Thr  34118  5490747  5456629 
244.13  C10H19N3O4  Leu-Asn  145972  5592910  5446938 
354.18  C15H25N5O5  Thr-Val-His  337  4768081  4767744 
342.17  C15H25N3O6  Leu-Asp-Pro  50023  4469062  4419038 
201.12  C9H18N2O3  Leu-Ala  303533  3822614  3519082 
247.09  C9H16N2O6  Glu-Thr  618714  3901821  3283106 
329.18  C14H26N4O5  Leu-Ala-Gln  11706  3261910  3250204 
251.10  C12H16N2O4  Ala-Tyr  1199633  4388952  3189320 
373.17  C15H26N4O7  Leu-Asp-Gln  27874  2290843  2262968 
217.12  C9H18N2O4  Leu-Ser  1781005  3651567  1870562 
311.14  C18H20N2O3  Phe-Phe  1020478  2422191  1401713 
364.19  C18H27N3O5  Leu-Ala-Tyr  105095  1312711  1207616 
345.21  C15H30N4O5  Leu-Lys-Ser  207570  1389000  1181430 
205.08  C7H14N2O5  Thr-Ser  14626  1171204  1156578 
350.17  C17H25N3O5  Leu-Gly-Tyr  147416  1294531  1147114 
301.16  C11H22N6O4  Ala-Gly-Arg  204285  1220662  1016377 
Table 5-14: Metabolites identified from negative ionisation mode analysis which were absent in control group but found greater in S. aureus 
infected group by means of m/z intensity than E. coli infected group. The m/z intensity for each of metabolites identified in both infected groups and 
the difference in m/z intensity were as presented. The difference in m/z intensity was equal to the m/z intensity of S. aureus infected group minus the m/z 
intensity of E. coli infected group.Chapter 5, 236 
 
 
row 
m/z 
Molecular 
formula 
Name  m/z intensity (E. coli; 
EC) 
m/z intensity (S. aureus; 
SA) 
Difference in m/z intensity, SA - 
EC   
270.15  C12H21N3O4  Val-Gly-Pro  1214191  445816  768374 
304.15  C12H23N3O6  Leu-Ser-Ser  399260  61590  337670 
197.07  C7H10N4O3  5-Acetylamino-6-amino-3-
methyluracil 
340796  54974  285821 
277.12  C14H18N2O4  Pro-Tyr  520743  281163  239580 
374.21  C20H29N3O4  Leu-Phe-Pro  1167418  987379  180040 
147.01  C5H8O3S  4-Methylthio-2-oxobutanoic acid  154641  1714  152927 
294.11  C13H17N3O5  Asn-Tyr  469728  328468  141260 
355.20  C16H28N4O5  Leu-Gln-Pro  160771  42431  118340 
281.11  C13H18N2O5  Thr-Tyr  408989  315714  93275 
373.21  C16H30N4O6  Leu-Lys-Asp  903396  851149  52247 
91.06  C7H8  Toluene  52963  996  51967 
221.09  C11H14N2O3  Phe-Gly  95534  44609  50925 
344.18  C15H27N3O6  Leu-Val-Asp  47648  16611  31037 
217.12  C9H18N2O4  Leu-Ser  33732  11357  22375 
395.20  C17H28N6O5  Leu-Gln-His  19559  3891  15667 
284.16  C13H23N3O4  Leu-Gly-Pro  28598  17983  10615 
Table 5-15: Metabolites identified from negative ionisation mode analysis which were absent in control group but found greater in E. coli 
infected group by means of m/z intensity than S. aureus infected group. The m/z intensity for each of metabolites identified in both infected groups 
and the difference in m/z intensity were as presented. The difference in m/z intensity was equal to the m/z intensity of S. aureus infected group minus the 
m/z intensity of E. coli infected group. Chapter 5, 237 
 
5.3.4  Relative changes 
In  order  to  identify  the  metabolites  in  both  modes  that  showed  differences  between 
bacterial  infection  groups  and  control  group,  the  median  of  the  m/z  intensities  were 
calculated for each metabolite in each group. Fifteen metabolites that were either increased 
or  decreased  in  both  bacterial  infection  groups  from  control  group  in  both  modes  are 
presented in Table 5-16, 5-17, 5-18 and 5-19. Most of the metabolites that increased in 
both bacterial infection groups were tripeptides or dipeptides (Val-Pro-Pro, Leu-Leu-Ser, 
Lys-Ala-Pro, Leu-Ala-Gln, Val-Arg, Leu-Val, etc).  
The relative change in intensity for each identified metabolite between the sample groups 
from the infections was also calculated by dividing the median m/z intensity from the S. 
aureus samples by the median m/z intensity determined for the E. coli group.  Fifteen 
metabolites that either increased or decreased when comparing between bacterial infection 
groups (Table 5-20 and 5-21). As the majority of the group data was non-parametric, the 
Mann-Witney test used to test for the significance of the difference between the bacterial 
groups.  The tables (5-20 and 5-21) are arranged in increasing value of P as determined by 
the  Mann-Witney  test  which  shows  the  change  observed  in  m/z  intensity  for  the 
metabolites with the most significant difference in each of the categories. (Positive mode: 
significantly increased in S. aureus or increased in E. coli; Negative mode; significantly 
increased in S. aureus or in E. coli.) In positive mode, the p-values increased from 0 to 
0.0439 in group of metabolites increased in E. coli and the p-values increased from 0.0001 
to 0.037 in group of metabolites increased in S. aureus. In negative mode, the p-values 
increased from 0 to 0.0419 in group of metabolites increased in E. coli and the p-values 
increased from 0 to 0.0489 in group of metabolites increased in S. aureus. Chapter 5, 238 
 
Reduced in .E coli         
row m/z  Molecular formula  Name   m/z intensity (Control)  m/z intensity (E. coli)  Fold increase/decrease 
221.09  C11H12N2O3  5-Hydroxy-L-tryptophan  396487.6  0  0 
261.06  C14H12O3S  Suprofen  235737.3  0  0 
345.18  C14H24N4O6  Thr-Gln-Pro  405720.5  0  0 
223.10  C12H14O4  Dillapiole  14979735  23468.75  0.002 
177.05  C10H8O3  1_3_8-Naphthalenertriol  69725635  211373.6  0.003 
419.32  C26H42O4  Diisononyl phthalate  14710838  45524.96  0.003 
75.09  C3H10N2  1_3-Diaminopropane  469562.7  2367.125  0.005 
79.02  C2H6OS  Mercaptoethanol  75530497  1880468  0.025 
160.10  C7H13NO3  (-)-Betonicine  1187418  31450.85  0.026 
126.13  C8H15N  gamma-Coniceine  284401.3  9156.271  0.032 
208.10  C11H13NO3  Cantleyine  246641.8  8702.787  0.035 
85.10  C6H12  Cyclohexane  1094320  42105.6  0.038 
165.09  C10H12O2  Isoeugenol  661742.4  39724.09  0.060 
268.10  C10H13N5O4  Deoxyguanosine  7124045  462562  0.065 
142.03  C2H8NO4P  Ethanolamine phosphate  505132.3  33286.07  0.066 
           
           
Increased in E. coli         
329.15  C18H20N2O4  Phe-Tyr  71  3960112  55932 
283.13  C13H18N2O5  Thr-Tyr  48  1374349  28406 
312.19  C15H25N3O4  Val-Pro-Pro  235  3696719  15739 
188.18  C9H21N3O  N1-Acetylspermidine  171  2211589  12931 
313.15  C18H20N2O3  Phe-Phe  744  8893432  11959 Chapter 5, 239 
 
274.19  C11H23N5O3  Val-Arg  855  9403370  10995 
332.22  C15H29N3O5  Leu-Leu-Ser  78  753642  9678 
315.20  C14H26N4O4  Lys-Ala-Pro  35  304693  8789 
249.13  C10H20N2O3S  Met-Val  103  867833  8393 
217.12  C9H16N2O4  Thr-Pro  91  651287  7184 
264.10  C9H17N3O4S  Ala-Ala-Cys  115  492733  4274 
366.20  C18H27N3O5  Leu-Ala-Tyr  227  801312  3524 
272.16  C12H21N3O4  Val-Gly-Pro  2911  8509340  2923 
175.11  C7H14N2O3  N-Acetylornithine  2353  5549482  2359 
262.14  C10H19N3O5  Lys-Asp  25  55845  2267 
Table 5-16: A relative change of metabolites in positive ionisation mode analysis in E. coli infected group in comparison to control group. The 
relative change in intensity for each identified metabolite between the sample groups was calculated by dividing the mean m/z intensity from the E. coli 
infected samples by the mean m/z intensity determined for the control group.Chapter 5, 240 
 
 
Reduced in S. aureus           
row m/z  Molecular formula  Name  m/z intensity (Control)  m/z intensity (S.aureus)  Fold increase/decrease 
221.09  C11H12N2O3  5-Hydroxy-L-tryptophan  396487.6  0  n/a 
261.06  C14H12O3S  Suprofen  235737.3  0  n/a 
232.17  C15H21NO  Metazocine  230323.2  0  n/a 
142.03  C2H8NO4P  Ethanolamine phosphate  505132.3  0  n/a 
212.04  C4H10N3O5P  Phosphocreatine  20806449  0  n/a 
152.06  C5H5N5O  8-Hydroxyadenine  7285295  0  n/a 
183.09  C6H14O6  Mannitol  257290.9  0  n/a 
174.02  C6H7NO3S  2-Aminobenzenesulfonate  6894.951  0  n/a 
240.11  C9H13N5O3  Dihydrobiopterin  298827  0  n/a 
223.10  C12H14O4  Dillapiole  14979735  25325.15  0.002 
268.10  C10H13N5O4  Deoxyguanosine  7124045  17460.44  0.002 
75.09  C3H10N2  1_3-Diaminopropane  469562.7  1188.912  0.003 
131.13  C5H14N4  Agmatine  238399.8  813.1191  0.003 
160.10  C7H13NO3  (-)-Betonicine  1187418  4261.909  0.004 
177.05  C10H8O3  1_3_8-Naphthalenertriol  69725635  273655.9  0.004 
           
           
Increased in S .aureus       
329.15  C18H20N2O4  Phe-Tyr  71  6899649  97449 
344.18  C15H25N3O6  Leu-Asp-Pro  370  24766005  66964 
366.20  C18H27N3O5  Leu-Ala-Tyr  227  8501998  37387 Chapter 5, 241 
 
 
Table 5-17: A relative change of metabolites in positive ionisation mode analysis in S. aureus infected group in comparison to control group. The 
relative change in intensity for each identified metabolite between the sample groups was calculated by dividing the mean m/z intensity from the S. aureus 
infected samples by the mean m/z intensity determined for the control group.
331.20  C14H26N4O5  Leu-Ala-Gln  599  22347998  37289 
274.19  C11H23N5O3  Val-Arg  855  30879290  36106 
313.15  C18H20N2O3  Phe-Phe  744  25542108  34345 
332.22  C15H29N3O5  Leu-Leu-Ser  78  2561617  32895 
246.14  C10H19N3O4  Leu-Asn  290  8706973  30007 
249.13  C10H20N2O3S  Met-Val  103  2856985  27630 
292.13  C14H17N3O4  Trp-Ser  188  4827665  25732 
312.19  C15H25N3O4  Val-Pro-Pro  235  5247047  22340 
302.21  C14H27N3O4  Leu-Leu-Gly  92  2001246  21736 
283.13  C13H18N2O5  Thr-Tyr  48  1023145  21147 
401.29  C18H36N6O4  Leu-Leu-Arg  213  3979172  18697 
288.20  C12H25N5O3  Leu-Arg  1262  21946148  17391 Chapter 5, 242 
 
Reduced in E. coli         
row m/z  Molecular formula  Name  m/z intensity 
(Control) 
m/z intensity 
(E. coli) 
Fold increase/decrease 
219.01  C7H8O8  4-Carboxy-4-hydroxy-2-oxoadipate  528160  2379  0.005 
141.06  C7H10O3  4-Oxocyclohexanecarboxylate  129673  1436  0.011 
112.99  C4H2O4  Acetylenedicarboxylate  143871  2380  0.017 
275.02  C13H9N2O3Cl  GW 9662  324140  12136  0.037 
95.01  C5H4O2  Protoanemonin  59718  2432  0.041 
155.03  C7H8O4  2-Hydroxy-6-keto-2_4-heptadienoate  231762  10357  0.045 
210.03  C4H10N3O5P  Phosphocreatine  1659260  89840  0.054 
373.10  C18H18N2O7  PortulacaxanthinII  27781  1508  0.054 
188.99  C6H6O5S  3-Sulfocatechol  88004  5368  0.061 
113.02  C5H6O3  2-Hydroxy-2_4-pentadienoate  11126302  756437  0.068 
153.02  C7H6O4  3_4-Dihydroxybenzoate  965175  99451  0.103 
194.05  C9H9NO4  Salicyluric acid  1409008  163048  0.116 
104.04  C3H7NO3  L-Serine  161750  19405  0.120 
266.12  C17H17NO2  (-)-Caaverine  87469  10795  0.123 
140.01  C2H8NO4P  Ethanolamine phosphate  1079475  135707  0.126 
           
           
Increased in E. coli         
187.11  C8H16N2O3  N6-Acetyl-L-lysine  45  2013370  44736 
259.13  C11H20N2O5  Glu-Leu  398  2881723  7249 
327.14  C18H20N2O4  Phe-Tyr  37  263896  7187 
195.05  C7H8N4O3  1-3-Dimethyluricacid  92  634581  6865 
272.17  C11H23N5O3  Val-Arg  857  5143175  6004 
339.09  C12H20O11  3-Ketosucrose  92  343018  3746 Chapter 5, 243 
 
277.16  C15H22N2O3  Leu-Phe  132  392424  2962 
466.33  C23H50NO6P  [PC methyl(14:2)] 2-methyl-3-tetradecyl-
sn-glycero-1-phosphocholine 
255  730878  2861 
229.16  C11H22N2O3  Leu-Val  341  743738  2183 
313.19  C14H26N4O4  Lys-Ala-Pro  151  310677  2060 
181.04  C6H6N4O3  1-Methyluric acid  1359  2723161  2004 
203.08  C11H12N2O2  L-Tryptophan  187  320534  1714 
261.12  C14H18N2O3  Phe-Pro  525  855177  1628 
243.10  C10H16N2O5  Glu-Pro  364  556272  1527 
175.06  C7H12O5  (2S)-2-Isopropylmalate  31248  46199319  1478 
Table 5-18: A relative change of metabolites in negative ionisation mode analysis in E. coli infected group in comparison to control group. The 
relative change in intensity for each identified metabolite between the sample groups was calculated by dividing the mean m/z intensity from the E. coli 
infected samples by the mean m/z intensity determined for the control group.Chapter 5, 244 
 
 
Reduced in S. aureus         
row m/z  Molecular 
formula 
Name  m/z intensity 
(Control) 
m/z intensity 
(S.aureus) 
Fold increase/decrease 
210.03  C4H10N3O5P  Phosphocreatine  1659260  0  n/a 
150.04  C5H5N5O  8-Hydroxyadenine  216939  0  n/a 
219.01  C7H8O8  4-Carboxy-4-hydroxy-2-oxoadipate  528160  1524  0.003 
140.01  C2H8NO4P  Ethanolamine phosphate  1079475  7703  0.007 
179.03  C9H8O4  3-(4-Hydroxyphenyl)pyruvate  53543  477  0.009 
229.01  C5H11O8P  D-Ribose 5-phosphate  655172  10906  0.017 
155.03  C7H8O4  2-Hydroxy-6-keto-2_4-heptadienoate  231762  6764  0.029 
259.02  C6H13O9P  D-Glucose 6-phosphate  52176193  1588423  0.030 
171.01  C3H9O6P  Glycerol 2-phosphate  15741286  539478  0.034 
141.06  C7H10O3  4-Oxocyclohexanecarboxylate  129673  5551  0.043 
112.99  C4H2O4  Acetylenedicarboxylate  143871  6429  0.045 
104.04  C3H7NO3  L-Serine  161750  9620  0.059 
289.03  C7H15O10P  D-Sedoheptulose 7-phosphate  1368021  81751  0.060 
175.02  C6H8O6  D-Glucuronolactone  5130855  368321  0.072 
298.07  C9H18NO8P  D-4'-Phosphopantothenate  1604867  128723  0.080 
           
           
Increased in S. aureus         
187.11  C8H16N2O3  N6-Acetyl-L-lysine  45  8264384  183632 
277.16  C15H22N2O3  Leu-Phe  132  13157998  99319 Chapter 5, 245 
 
259.13  C11H20N2O5  Glu-Leu  398  9024354  22699 
327.14  C18H20N2O4  Phe-Tyr  37  594526  16192 
286.19  C12H25N5O3  Leu-Arg  304  4349308  14315 
272.17  C11H23N5O3  Val-Arg  857  10020592  11697 
243.17  C12H24N2O3  Leucyl-leucine  2334  23052455  9879 
229.16  C11H22N2O3  Leu-Val  341  2683365  7875 
233.08  C8H14N2O6  Glu-Ser  233  1236984  5305 
203.08  C11H12N2O2  L-Tryptophan  187  786619  4207 
241.09  C9H14N4O4  Ser-His  311  1043698  3360 
321.24  C20H34O3  2alpha-(Hydroxymethyl)-5alpha-androstane-
3beta_17beta-diol 
496  1658760  3343 
345.24  C22H34O3  Taxa-4(20)_11(12)-dien-5alpha-acetoxy-10beta-ol  561  1687503  3010 
232.13  C9H19N3O4  Lys-Ser  305  800527  2627 
466.33  C23H50NO6P  [PC methyl(14:2)] 2-methyl-3-tetradecyl-sn-
glycero-1-phosphocholine 
255  669343  2620 
Table 5-19: A relative change of metabolites in negative ionisation mode analysis in S. aureus infected group in comparison to control group. The 
relative change in intensity for each identified metabolite between the sample groups was calculated by dividing the mean m/z intensity from the S. 
aureus infected samples by the mean m/z intensity determined for the control group. 
 
 Chapter 5, 246 
 
 
Row m/z  Molecular formula  Name  Control  E. coli (EC)  S. aureus (SA)  SA/EC  P value for EC.>SA 
E. coli > S. aureus 
268.10  C10H13N5O4  Deoxyguanosine  7393670  246102  2422  0.010  0 
360.17  C17H21N5O4  Phe-Gly-His  74624  147797  19243  0.130  0 
131.13  C5H14N4  Agmatine  7274  25157  678  0.027  0.0001 
262.13  C11H19NO6  Mycosporine  2215241  1490476  73639  0.049  0.0002 
662.48  C35H68NO8P  [PC (11:0/16:0)] 1-(10E-undecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine  807946  1369890  82201  0.060  0.0004 
395.32  C24H42O4  [ST (4:0)] 5alpha-Cholane-3alpha_7alpha_12alpha_24-tetrol  675090  237003  28238  0.119  0.0007 
347.17  C14H26N4O4S  Lys-Cys-Pro  0  14053  2309  0.164  0.0008 
302.15  C16H19N3O3  Trp-Pro  3722  60648  6427  0.106  0.001 
690.51  C37H72NO8P  [PC (18:0/11:0)] 1-octadecanoyl-2-(10E-undecenoyl)-sn-glycero-3-phosphocholine  6104185  6834848  1086403  0.159  0.0012 
122.10  C8H11N  Phenethylamine  332351  366314  28392  0.078  0.0013 
136.06  C5H5N5  Adenine  15149  25308  2037  0.080  0.0015 
170.08  C8H11NO3  Pyridoxine  10690  43702  4123  0.094  0.0035 
292.10  C11H17NO8  2_7-Anhydro-alpha-N-acetylneuraminic acid  392316  242233  30159  0.125  0.0061 
341.27  C20H36O4  [FA (20:2)] 15S-hydroperoxy-11Z_13E-eicosadienoic acid  3284897  1757064  278653  0.159  0.0077 
415.23  C22H30N4O4  Tentoxin  4205  873662  59028  0.068  0.0185 
247.11  C10H18N2O3S  Met-Pro  83543  3674935  453681  0.123  0.0307 
291.12  C11H18N2O7  N-Succinyl-LL-2_6-diaminoheptanedioate  132015  45106  6421  0.142  0.0371 
452.28  C21H42NO7P  LysoPE(0  22523  429336  70584  0.164  0.0439 Chapter 5, 247 
 
 
Row m/z  Molecular formula  Name  Control  E. coli (EC)  S. aureus (SA)  SA/EC  P value for EC.>SA 
S. aureus > E. coli   
               
288.20  C12H25N5O3  Leu-Arg  882  106405  2643318  24.8  0.0001 
295.18  C19H22N2O  Eburnamonine  0  7322  911037  124.4  0.0001 
204.13  C8H17N3O3  Lys-Gly  0  4545  105894  23.3  0.0002 
275.17  C11H22N4O4  Lys-Ala-Gly  0  7408  259091  35.0  0.0007 
288.22  C15H29NO4  L-Octanoylcarnitine  32223  21165  882738  41.7  0.0011 
217.13  C8H16N4O3  N-a-Acetyl-L-arginine  17622  6593  251098  38.1  0.0012 
316.25  C17H33NO4  O-Decanoyl-L-carnitine  6766  11711  528729  45.1  0.0012 
233.15  C10H20N2O4  Leu-Thr  1694  599153  13755161  23.0  0.0042 
93.05  C3H8O3  Glycerol  948  2760  301366  109.2  0.0049 
262.10  C9H15N3O6  Ala-Asp-Gly  0  2511  527607  210.1  0.0062 
243.11  C9H14N4O4  Ser-His  0  3427  111584  32.6  0.0067 
246.16  C9H19N5O3  beta-Alanyl-L-arginine  0  595  21148  35.5  0.0086 
304.16  C11H21N5O5  Glu-Arg  0  1208  57459  47.6  0.0102 
246.14  C10H19N3O4  Leu-Asn  0  6124  1226699  200.3  0.0139 
220.09  C7H13N3O5  1D-1-Guanidino-1-deoxy-3-dehydro-scyllo-inositol  0  401  116297  290.2  0.0162 
400.34  C23H45NO4  L-Palmitoylcarnitine  0  49632  1440263  29.0  0.0166 
300.29  C18H37NO2  Sphingosine  10283  11327  975206  86.1  0.0185 Chapter 5, 248 
 
 
Table 5-20: A relative change of metabolites in positive ionisation mode analysis in E.coli and S. aureus infected groups in comparison to control 
group. The relative change in intensity for each identified metabolite between the sample groups from the infections was also calculated by dividing the 
median m/z intensity from the S. aureus samples by the median m/z intensity determined for the E. coli group. 
 
428.37  C25H49NO4  Stearoylcarnitine  3663  31932  870431  27.3  0.0203 
241.03  C6H12N2O4S2  L-Cystine  233951  15219  1219633  80.1  0.0228 
320.12  C15H17N3O5  Trp-Asp  0  1689  186229  110.2  0.037 Chapter 5, 249 
 
 
Row m/z  Molecular formula  Name    Control  E. coli (EC)  S. aureus (SA)  P- value SA/EC 
E. coli > S. aureus             
377.11  C13H22N4O7S  Met-Asn-Asp  6890577.34  8802326.18  214344.33  0.024  0 
421.22  C23H34O7  Picrasin C  14239.19  41027.42  3517.35  0.086  0 
181.05  C9H10O4  3-Methoxy-4-hydroxyphenylglycolaldehyde  62009.99  529282.74  39401.15  0.074  0.0001 
149.02  C8H6O3  2-Carboxybenzaldehyde  1776.99  19169.73  3885.44  0.203  0.0002 
208.06  C7H15NO4S  MOPS  463757.13  674283.55  55062.11  0.082  0.0003 
413.22  C22H30N4O4  Tentoxin  0.00  9914.58  684.99  0.069  0.0006 
227.14  C11H20N2O3  Leu-Pro  0.00  586049.23  103807.18  0.177  0.0012 
175.06  C7H12O5  (2S)-2-Isopropylmalate  28034.31  484537.27  16910.05  0.035  0.0013 
185.09  C8H14N2O3  Ala-Pro  0.00  110493.93  4949.62  0.045  0.0015 
225.05  C9H10N2O5  3-Nitrotyrosine  16030.61  64844.81  8919.53  0.138  0.0015 
191.06  C7H12O6  Valiolone  459049.45  836759.32  142111.11  0.170  0.0022 
464.28  C22H44NO7P  [PC (14:0)] 1-(9Z-tetradecenoyl)-sn-glycero-3-phosphocholine  6635.16  61018.85  9555.26  0.157  0.0026 
240.05  C10H11NO6  N-(2_3-Dihydroxybenzoyl)-L-serine  4933.71  12066.26  1245.97  0.103  0.0031 
241.01  C6H11O8P  D-myo-Inositol 1_2-cyclic phosphate  126772.78  268187.98  18729.54  0.070  0.0037 
138.02  C6H5NO3  4-Nitrophenol  2779.26  266216.76  18730.86  0.070  0.0068 
157.05  C7H10O4  2-Isopropylmaleate  9008.42  120032.46  18651.52  0.155  0.0077 
163.04  C9H8O3  Phenylpyruvate  4799.75  188677.58  36508.59  0.193  0.0077 
304.15  C12H23N3O6  Leu-Ser-Ser  0.00  77330.97  9092.19  0.118  0.0108 
166.04  C5H5N5O2  8-Hydroxyguanine  284694.89  163094.08  17370.75  0.107  0.0166 
181.04  C6H6N4O3  1-Methyluric acid  1341.04  237648.75  1724.51  0.007  0.0302 
171.01  C3H9O6P  Glycerol 2-phosphate  12866412.16  3984791.07  350936.16  0.088  0.0339 
91.06  C7H8  Toluene  0.00  3206.91  574.50  0.179  0.0419 Chapter 5, 250 
 
 
 
Row m/z  Molecular formula  Name    Control  E. coli (EC)  S. aureus (SA)  P-value SA/EC 
S. aureus > E. coli             
111.01  C5H4O3  3-Furoicacid  144280.02  37867.85  1270896.79  33.6  0 
241.09  C9H14N4O4  Ser-His  0.00  5983.68  404950.12  67.7  0.0007 
315.20  C14H28N4O4  Leu-Lys-Gly  0.00  2223.93  50059.68  22.5  0.0015 
237.09  C11H14N2O4  Gly-Tyr  0.00  7716.76  145858.86  18.9  0.0024 
339.25  C20H36O4  [FA (20:2)] 15S-hydroperoxy-11Z_13E-eicosadienoic acid  5925.74  7410.93  161970.79  21.9  0.0025 
302.15  C11H21N5O5  Glu-Arg  0.00  1449.54  51160.10  35.3  0.0028 
246.15  C10H21N3O4  Lys-Thr  203.59  72670.00  2556646.63  35.2  0.0042 
260.09  C9H15N3O6  Ala-Asp-Gly  0.00  4508.99  1183200.27  262.4  0.0042 
227.20  C14H28O2  Tetradecanoic acid  1803.83  7008.93  176840.89  25.2  0.0048 
360.14  C14H23N3O8  Leu-Asp-Asp  0.00  1015.08  78304.48  77.1  0.0094 
255.23  C16H32O2  Hexadecanoic acid  24943.22  57428.79  1014884.73  17.7  0.0108 
203.07  C7H12N2O5  Ala-Asp  0.00  10488.46  522376.69  49.8  0.0145 
239.02  C6H12N2O4S2  L-Cystine  85659.22  2122.87  560196.97  263.9  0.0161 
260.13  C10H19N3O5  Lys-Asp  0.00  1026.23  56647.44  55.2  0.0185 
301.24  C17H34O4  MG(0  3153.57  4636.33  93332.57  20.1  0.0278 
278.05  C8H14N3O6P  Cidofovir  655109.72  136903.56  2662709.08  19.4  0.0283 
231.10  C9H16N2O5  N2-Succinyl-L-ornithine  0.00  1513.78  46034.74  30.4  0.0293 
233.08  C8H14N2O6  Glu-Ser  0.00  7358.12  491377.73  66.8  0.0303 
253.03  C7H14N2O4S2  L-Djenkolic acid  0.00  762.58  15942.83  20.9  0.0324 
218.08  C7H13N3O5  1D-1-Guanidino-1-deoxy-3-dehydro-scyllo-inositol  0.00  738.01  101885.03  138.1  0.038 
353.31  C22H42O3  [FA oxo(22:0)] 10-oxo-docosanoic acid  1592.50  6321.76  113698.29  18.0  0.0489 Chapter 5, 251 
 
201.12  C9H18N2O3  Leu-Ala  0.00  32485.10  869131.79  26.8  0.0644 
258.15  C11H21N3O4  Leu-Ala-Gly  0.00  38433.25  666891.94  17.4  0.083 
205.08  C7H14N2O5  Thr-Ser  0.00  3997.60  199953.30  50.0  0.0963 
300.05  C8H16NO9P  N-Acetyl-D-glucosamine 6-phosphate  250003647.30  373727.48  19134245.55  51.2  0.2508 
 
Table 5-21: A relative change of metabolites in negative ionisation mode analysis in E.coli and S. aureus infected group in comparison to control 
group. The relative change in intensity for each identified metabolite between the sample groups from the infections was also calculated by dividing the 
median m/z intensity from the S. aureus samples by the median m/z intensity determined for the E. coli group. Chapter 5, 252 
 
5.3.5  Metabolic Pathways Altered by Bovine Mastitis 
 
 Pathos web facility provided by the Scottish Metabolomics Facility was used to further 
analyze the metabolites identified in each group of milk samples. The file was downloaded 
and this website (http://motif.gla.ac.uk/Pathos/index.html) allowed an investigation of the 
metabolites  found  in  certain  group  of  samples  according  to  corresponded  metabolic 
pathways. The pathways were listed starting from the greatest changes in the metabolites 
abundances in mastitic samples to the least changes in the metabolites abundances in both 
groups of mastitic as presented in Figure 5-1 and 5-2. The colour-coding scale indicator at 
each of the metabolites showed their abundances from increase to decrease in the milk 
samples.  According  to  the  website,  light  blue  colour  is  an  indication  of  decreased  of 
metabolites in mastitic milk samples whilst the dark red colour is an indication of increased 
of metabolite in mastitic milk samples. 
 
On each of the metabolic pathway, all metabolites involved in the particular metabolic 
pathway can be analyzed with the presented histogram showing the abundances in three 
different  groups of milk samples  as shown in  Figure  5-3. A KEGG  map was  also  be 
generated to highlight the potential metabolites involved in a particular metabolic pathway 
as showing in Figure 5-4 for the arachidonic acid pathway. 
The next step involved was dividing the metabolic pathways identified into three different 
groups;  lipid,  protein  and  carbohydrate  metabolisms.  Six  metabolic  pathways  with  the 
most  apparent  changes  in  each  metabolism  from  both  positive  and  negative  ionisation 
modes were chosen based on the abundances values provided by the Pathos website. For 
the  lipid  metabolism  (Table  5-22),  the  arachidonic  acid  metabolic  pathway  was  the 
pathway with most apparent changes with icosatetraenoic acid, prostaglandin F2 alpha, 
prostaglandin A2, leukotrienes A4 and B4 were increased in mastitic samples whilst no 
metabolites related to this pathway was found decreased in mastitis. Linoleic acid and α-
linolenic acid metabolic pathways were the next pathways with the most changes with 
increased in icosatetraenoic and stearidonic acids in mastitic samples. Hexadecanoic acid 
was also found to increase in mastitic milk which derived from fatty acid-related metabolic 
pathways.  The  majority  of  these  metabolites  were  the  main  precursors  of  eicosanoids 
involved  in  inflammatory  activity  in  a  host.  Thus,  it  is  not  surprising  to  see  these 
metabolites increased in mastitic samples. Chapter 5, 253 
 
For  carbohydrate  metabolism  (Table  5-23),  galactose,  pentose  and  glucuronate 
interconversions, fructose and mannose, starch and sucrose metabolic pathways were the 
pathways  with  the  most  apparent  changes  in  carbohydrate  metabolism  apart  from 
glycolysis/gluconeogenesis pathway. Glycerol, glycerone phosphate, fructose and glucose 
were  the  metabolites  found  increased  in  mastitic  samples,  whilst  fructose-6-phosphate, 
mannose-6-phosphate and glucose-6-phosphate were among the metabolites decreased in 
mastitic samples. 
Protein  metabolism  was  analyzed  and  the  metabolic  pathways  with  the  most  apparent 
changes were arginine, tryptophan, tyrosine, phenylalanine, cysteine and methionine, as 
well as glycine, serine and threonine metabolic pathways (Table 5-24). The metabolites 
found  to  be  increased  in  mastitic  samples  were  tryptophan,  ornithine,  methionine  and 
tyrosine. Glutamine, phosphocreatine, acetoacetate, propanoate and serine were among the 
protein metabolites decreased in mastitic milk samples. 
Di- and tri-peptides were also found to increase in both groups of mastitic samples. A table 
of peptides identified by Pathos programme is presented in Table 5-25 and includes Asn-
His, Asp-Arg, Gln-Ser-Ser and Leu- Gly- Ser. Chapter 5, 254 
 
 
Figure 5-1: An example of various metabolic pathways generated by PATHOS website.  In this example, the data from negative ionisation mode 
was used and the metabolic pathway was listed starting with the most apparent changes of metabolites to the least apparent changes of metabolites. Chapter 5, 255 
 
 
Figure 5-2: An example of metabolic pathway (Arachidonic acid metabolism) which listed down the metabolites with greatest changes of 
abundances (dark red colour) to the least changes of abundances in both groups of mastitis (light blue colour; not showing). Chapter 5, 256 
 
 
Figure 5-3: An example of histogram of prostaglandin F2 alpha showing abundances in control, E. coli infected and S. aureus infected groups. It 
shows here that prostaglandin F2 alpha increased in abundances in both mastitis groups but present in the lowest abundances in control group. 
 Chapter 5, 257 
 
 
Figure 5-4: An example of KEGG map generated from arachidonic acid metabolism to highlight the potential metabolites involved in a 
particular metabolic pathway. A dark red dot shows metabolite which was increased in mastitic milk samples. Further click on the dot revealed a 
histogram as showed in Figure 5.2. Chapter 5, 258 
 
 
Table 5-22: Six metabolic pathways in lipid metabolism with the most apparent changes of metabolites from both positive and negative ionisation 
mode analyses. The abundances values were provided by the Pathos website.
Lipid Metabolic Pathways  Metabolites Increased in Mastitis  Metabolites Decreased in Mastitis 
Arachidonic acid Met.  Icosatetraenoic acid, Prostaglandin F2α, 
Leukotriene A4, Leukotriene B4, Prostagladin 
A2 
None 
Linoleic acid Met.  Icosatetraenoic acid,   Linoleate  
α-linolenic acid Met.  Stearidonic acid  Heptadecatrienal  
Biosynthesis of unsaturated fatty acid  Hexadecanoic acid  Icosatetraenoic acid 
Fatty acid biosynthesis  Hexadecanoic acid  None 
Fatty acid Met.  Hexadecanoic acid  None Chapter 5, 259 
 
 
Carbohydrate Metabolic Pathways  Metabolites Increased in Mastitis  Metabolites Decreased in Mastitis 
Galactose Met.  Glycerol  D-Glucose-1-Phosphate, α-D-Galactose 
1-phosphate 
Pentose & Glucuronate 
interconversions 
Glycerone phosphate, D-Xylonolactone  D-Fructose-6-Phosphate 
Fructose & Mannose Met  D-Fructose  D-Mannose-6-Phosphate 
Starch & Sucrose Met.   Reduced acceptor D-Glucose  D-Glucose-6-phosphate 
Glycolysis/Gluconeogenesis  None  Acetate 
Table 5-23: Six metabolic pathways in carbohydrate metabolism with the most apparent changes of metabolites from both positive and negative 
ionisation mode analyses. The abundances values were provided by the Pathos website.Chapter 5, 260 
 
 
Protein Metabolic Pathways   Metabolites Increased in Mastitis   Metabolites Decreased in Mastitis  
ArginineMet.  N-Acetylornithine, L-Ornithine   L-Glutamine, Phosphocreatine  
Tryptophan Met.   L-Tryptophan   Anthranilate, 2-Oxoadipate  
Tyrosine Met.   L-Tyrosine, 4-
Hydroxyphenylacetate  
Acetoacetate  
Phenylalanine Met.   L-Phenylalanine, Succinate   Propanoate, 2-Hydroxy-2,4-
pentadienoate  
Cysteine and Methionine Met.   L-Methionine   2-Oxobutanoate, L-Serine  
Glycine, Serine and Threonine Met.   L-Tryptophan   L-Serine,D-serine  
Table 5-24: Six metabolic pathways in protein metabolism with the most apparent changes of metabolites from both positive and negative 
ionisation mode analyses. The abundances values were provided by the Pathos website. Chapter 5, 261 
 
 
 
 
Amino acid/Peptides   Examples  
Di-peptides   Asn-His, Asp-Arg, Lys-Asn, Leu-Met, Ala-Tyr, 
Trp-Gly  
Tri-peptides   Gln-Ser-Ser, Leu-Gly-Ser, Met-Ala-Ser, Ala-
Gly-Arg, Leu-Asp-Gly, Leu-Asn-Gly  
Table 5-25: Examples of di- and tri-peptides which were found increased in both 
mastitic groups from both positive and negative ionisation mode analyses. The 
abundances values were provided by the Pathos website. Chapter 5, 262 
 
5.4  Discussion 
From positive ion mode analysis, the 3 metabolites with highest intensity in the control 
group (Table 5-4) were L-acetylcarnitine, choline and sn-glycero-3-phosphocholine which 
are related to lipid metabolism and the choline content of phopsholipids in the milk fat 
globule membrane. Citrate, lactose, glucose and galactose were found high in intensity 
from negative ion mode in both control and E. coli infected group but the monosaccharides 
were  not  at  the  top  in  S.  aureus  infected  group,  possibly  indicative  that  these 
monosaccharides are more rapidly absorbed for use in metabolism by the latter bacterium 
Identification of the metabolites which show the most significant differences between the 
infections  caused  by  the  bacteria  provide  valuable  indications  for  demonstration  of 
differences in the metabolic effects of the infections and also reveal potential targets for 
biomarkers to identify the type of bacteria causing the mastitis.  Notable in the evaluation 
of metabolite changes on infection are the increase in identification of di-and tripeptides in 
in both infections with particular tripeptides being associated with both of the bacteria, 
though with S. aureus infection causing more of these peptides to be present.  The source 
of  the  peptides  in  the  infected  samples  is  likely  to  be  breakdown  products  from  milk 
proteins caused by bacterial or immune cell protease activity.  The finding that there are 
differences  between bacterial causative agent  could  be either due to  differences  in  the 
specifity of action of the bacterial proteases or that the bacteria have differing efficiencies 
in absorbing the peptides after they are released by hydrolysis.  As S. aureus infection 
caused the greater degree of di and tripeptide in the metabolite pool, the bacteria either 
have more active proteolytic enzymes or are less efficient at absorbing the peptides for 
their own metabolism. 
An attempt was made to find the origin of the tripeptides by comparison to the bovine 
genome of those found in either infection group. Although 40% of the tripeptides present 
in the mastitis milk could be identified in the amino acid sequence of the milk proteins: 
caseins, α-lactalbumin, β-lactoglobin, albumin and lactoferrin it was found by scanning the 
bovine protein database, that the tri-peptides were identified in over 5000 proteins in the 
bovine  proteome  so  that  no  definitive  conclusion  could  be  made  on  the  origin  of  the 
peptides.   
 
Of the 100 metabolites investigated, with the largest differences in m/z intensity between 
S.  aureus  and  E.  coli,  there  was  a  mix  of  metabolites,  with  lipid,  nucleotide  and 
carbohydrate  related  metabolites  being  identified.    There  were  also  non-host  and  non-Chapter 5, 263 
 
pathogen  metabolites  identified  such  as  tentoxin,  ricinine,  quinate,  toluene  and  others. 
When these occurred in the infected groups and not in the control group it is possible that 
the metabolites are derived from therapeutic reagents.  A number had metabolite database 
hits as either drugs (for infection or inflammation) or of compounds used in herbal or 
chinese medicine.  As mentioned above the identification by the computer database of a 
number of metabolites were questionable, and while a number of these were identified and 
corrected  (1-alpha-D-galactosyl-myo-inositol  =lactose;  myo-inositol  =  glucose  or 
galactose)  it  is  possible  that  the  molecules  are  incorrectly  named  and  these  identified 
agents may be erroneously named.  Confirmation of molecular identity would be a major 
task in following up this initial investigation.  
 
5.4.1  Lipid Metabolism 
As  part  of  the  analysis,  the  effect  of  mastitis  on  lipid  metabolism  was  assessed  by 
examination  of  the  metabolites  in  the  6  metabolic  pathways  with  the  most  apparent 
changes from both positive and negative ion modes. From these six metabolic pathways, 
the 6 metabolites greater in both diseased and control groups were selected for discussion. 
The method reported in this chapter revealed increases in arachidonic acid metabolites in 
both  two  mastitic  group  caused  by  E.  coli  and  S.  aureus.  Examples  of  increased 
metabolites  are  icosatetraenoic  acid,  prostaglandin  F2α  (PGF2α),  prostaglandin  E2 
(PGE2),  leukotriene  A4  (LKA4),  leukotriene  B4  (LKB4),  thromboxane  A2  (TXA2), 
thromboxane B2 (TXB2) and others.  
These metabolites are the main precursors of eicosanoids which are the fatty acid-derived 
mediators involved in a wide-range of inflammatory activity in the host cell (Bannerman 
2009). Thromboxanes and prostaglandins are formed by the catabolism of arachidonic acid 
mediated  by  cyclooxygenase  while  the  formation  of  leukotrienes  is  mediated  by 
lipoxygenase (Kuehl Jr. and Egan 1980; Williams and Higgs 1988). Each eicosanoids has a 
differing  role  in  inflammatory  processes  and  may  have  antagonizing  effects  to  other 
eicosanoids. Thromboxane A2 for example is most potent of the eicosanoids in contracting 
aortic  tissue  and  can  trigger  platelet  aggregation  whereas  other  prostaglandins  (e.g, 
prostacyclin) and PGI2 cause vasodilation and inhibit platelet aggregation (Kuehl Jr. and 
Egan 1980; Ball et al. 1986; Feuerstein and Hallenbeck 1987). Meanwhile, leukotrienes 
are involved in inducing leukocyte recruitment and promoting leukocyte respiratory burst 
activity  and  cytokine  production  (Zipser  and  Laffi  1985;  Williams  and  Higgs  1988; 
Bottoms and Adams 1992).  According to Bannermann (2008), leukotriene B4 is the most Chapter 5, 264 
 
potent  endogenous  chemoattractant.  Thus,  eicosanoids  are  responsible  in  mediating 
inflammatory response with a wide-range of activities on the immune response towards 
infection and injury.  
With their important role as mediators in inflammatory responses, it is not surprising that 
increases in concentrations of these eicosanoids happen in bovine mastitis. These results 
were in accordance with Giri et al. (1984) in which they also found a greater concentration 
of both PGF1α and PGF2α in milk after 50μg infusion of LPS. However, they did not find 
any increase in other eicosanoids such as TXB2 or LKB4. Anderson et al. (1985) on the 
other hand, revealed only an increase of TXB2 milk level after 10μg of LPS infusion. 
According to  Anderson  et  al. (1985), the reason of an absence of PGF2α in  the milk 
samples following infusion in their study is because of the reduced concentration of LPS 
infused into the quarters as compared to the former study. 
In this present study, both of the different pathogen-causing mastitis; E. coli and S. aureus 
are able to induce the release of these eicosanoids. One experimental intrammary infection 
study on E. coli by Peter et al. (1990) showed increases in prostacyclin (PCM), PGE2 and 
TXB2. However, no PCM was detected in this present study. However, Anderson et al 
(1985) also failed to show any increased in both PGF2α and TXB2 in experimental study 
of E.Coli. These differences are due to large biological and individual variability observed 
in milk eicosanoids concentrations in cows with acute coliform mastitis.  
Furthermore, studies by Atroshi et al. (1986, 1987) which involved naturally occurring 
cases of mastitis caused by S. uberis, S. aureus, S. dysgalactiae or Micrococcus species 
revealed  increases  in  PGE2,  PGF2α  and  TXB2.  In  this  present  study,  milk  samples 
infected with S. aureus showed greater concentrations of both TXA2 and TXB2 than milk 
samples infected with E. coli. Similarly, study by Boutet et al. (2003) on chronic mastitis 
caused by coagulase-negative staphylococci such as S. uberis, S. agalactiae or S. aureus 
showed increases in LTB4. Based on these results, it is indicated that different types of 
pathogen elicit increases in releasing eicosanoids during bovine mastitis.  
Apart from increased level of eicosanoids in all mastitic milk samples, there was also an 
increased  in  fatty  acids  metabolites  seen  in  both  groups  of  mastitic  samples  such  as 
hexadecanoic acid, icosatetraenoic acid, linoleate, octadecenoic acid, octadecanoic acid, 
tetradecanoic acid etc.  
Fatty  acids  in  the  blood  play  an  important  role  in  modulating  inflammatory  reactions 
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especially during negative energy balance (NEB) period. During this period, in a lactating 
cow  the  majority  of  available  glucose  is  directed  to  the  mammary  gland  for  lactose 
synthesis  (Herdt  2000).  Thus,  lipid  mobilization  from  body  reserve  occurs  and  as  a 
consequence, there is a release of non-esterified fatty acids (NEFA) into the blood stream. 
However an excess  in  the levels  of circulating  NEFAs could  contribute to  increase in 
disease susceptibility dairy cows especially in periparturient inflammatory-based diseases 
including mastitis, ketosis and metritis (Bernabucci et al. 2005; Goff 2006; Douglas et al. 
2007).  
Fatty acids can either provide benefit or have detrimental effects on the host through its 
regulating  mechanisms  in  inflammatory  reactions  (Sordillo  et  al.  2009).  For  example, 
saturated fatty acids including lauric, palmitic and oleic acids can activate the toll-like 
receptor  4  (TLR4)  through  activation  of  NK-κB  which  leads  to  activation  of  innate 
immune response of the host. Thus, the presence of hexadecanoic acid or palmitic acid; a 
saturated fatty acid in both groups of mastitic samples could play an important role in 
activation  of  host  innate  immune  response  which  provide  the  initial  protection  against 
invading pathogens before the acquired immune response is activated. 
During inflammation of the udder, milk composition is known to change and this includes 
the fat content in the milk. Previous studies showed that the levels of free fatty acids (FFA) 
is increased during mastitis (Randolph & Erwin, 1979; Salih & Anderson 1979; Needs & 
Anderson  1984;  Atroshi  et  al.  1989).  These  events  were  contributed  to  a  high  lipase 
activity which leads to lipolysis and increase in the permeability of the mammary gland to 
blood lipids (Randolph & Erwin 1979). According to Salih & Anderson (1979), lipoprotein 
lipase (LPL) is an enzyme that responsible for lipolysis in milk. Furthermore, the transfer 
of an increased amount of LPL activator from blood to milk may contribute to partly 
caused rise of the FFA in mastitic milk.  
However,  a  study  by  Fitz-Gerald  et  al.  (1981)  did  not  agree  on  the  role  of  LPL  in 
increasing the level  of  FFA in  mastitic milk.  It might  be explained by  other mastitis-
influenced  factors  (e.g;  presence  of  blood-serum  activators  or  changes  in  substrate 
susceptibility).  Lower  LPL  activity  in  mastitic  milk  is  due  to  impaired  biosynthetic 
capability of mammary gland through permanent tissue damage or the action of proteolytic 
enzymes which are also present in the milk during mastitis. This was also supported by 
Anderson and Needs (1983) who observed high levels of FFA from lipolysis in mastitic 
milk  but  these  increases  were  not  necessarily  due  to  LPL  activators.  Blood  serum  or 
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(1979) previously. According to Murphy et al. (1989), increase in lipolysis was contributed 
from the susceptibility of the milk fat substrate to lipolysis in mastitic milk and not from 
the high level of lipase acitivity. 
A number of factors can influence the level of FFA in milk such as above-normal FFA 
levels on secretion, LPL activator, cell lipase, proteolytic enzymes, anions, heparin-like 
substances and fat globule membrane (Salih & Anderson 1979; Fitz-Gerald et al. 1981). 
Other than that, the variation occurred in individual cows on the levels of FFA in milk are 
also influenced by factors such as diet, oestrus and stage of lactation (Anderson & Needs 
1983).   
In this present study, both linoleic and α-linolenic acid metabolism were increased in both 
mastitic  groups.  This  is  with  an  agreement  with  Hogan  et  al.  (1987)  in  which  they 
observed high content of unsaturated linoleic and linolenic acid in mastitic milk which 
might be important in the killing of bacteria. Linoleic acid is a precursor of archidonic acid 
and both could be released from the cell membrane phospholipids by phospholipase-like 
enzymes. Futhermore, according to Atroshi et al. (1989), α-linolenic acid was positively 
correlated with PGE2 and PGF2α which were also found in higher levels in mastitic milks 
in this present study than in healthy milk. 
In this present study, high levels of long-chain fatty acids were observed in both groups of 
mastitic milk. However, it is not an agreement with studies by Kisza & Batura (1969), 
Randolph & Erwin (1974) and Karijord et al. (1982) only reported the highest content of 
18:0 and C 18:1 in milk during early lactation but not during mastitis.  
In contrast, other previous studies argued with the high fat content observed in mastitic 
milk (Bartsch et al. 1981; Massart-Leen et al. 1994). They assumed that during mastitis, 
the low level in milk yield could lead to reduce synthesis of the total amount amount of 
milk fat as the mammary gland epithelium does not retain its normal integrity for synthesis 
of major milk components.  
5.4.2  Carbohydrate Metabolism 
Carbohydrates are one of the most important sources of energy in all living organisms. In 
cows, carbohydrate is fermented by microorganisms in the rumen to produce volatile fatty 
acids such as acetic acid, butyric acid and propionic acid. Gluconeogenesis in the cows 
occurs in the liver and glucose is produced from metabolites such as propionate, valerate, 
amino acids, lactate and glycerol (Nafikov & Beitz 2007). Chapter 5, 267 
 
The mammary gland takes up glucose from the liver via circulatory system to be used in 
lactose  synthesis.  Glucose  is  also  important  for  lipid  metabolism  as  it  serves  as  the 
backbone of milk fat synthesis in which glucose is converted to glycerol. Glycerol is then 
being attached to the fatty acids produced by acetate and ß-hydroxybutyrate. About 70% of 
net uptake of glucose from blood by lactating bovine udders is used to synthesize lactose 
and the remainder is oxidized in pentose and TCA cycles (Qiao et al. 2005). 
Following mass spectrometry of metabolomics, six carbohydrate metabolic pathways were 
chosen and in each metabolic pathway, metabolites that increased or decreased in mastitis 
in relation to control animals were assigned in both positive and negative ion modes.   
It was apparent that some carbohydrate metabolites were less evident in both groups of 
mastitis compared to control animals. Among these metabolites are glycerol, D-fructose, 
and  others,  while  D-glucose  or  its  isomer  D-galactose  and  identified  by  the  PATHOS 
programme as myo-inositol was still in the top 4 in E. coli and top 6 in S. aureus groups. 
Marschke & Kitchen (1984) agreed that levels of glucose were negatively correlated with 
both  log  somatic  cell  counts  (logSCC)  and  log  N-acetyl-beta-D-glucosaminidase 
(logNAGase). However, the reason for low levels of glucose found in mastitic milk is 
unknown. Several hypotheses have been made on how this event occurred. According to 
Linzell & Peaker (1971), during mastitis, reduced blood flow to the udder result in reduced 
in the supply of blood glucose to the secretory cells of mammary gland. It is also possible 
that glucose would move out of milk during mastitis by a paracellular pathway as Na
+ and 
Cl
-  increased  in  milk.  This  would  to  help  in  maintaining  the  osmolarity  between 
extracellular fluid and milk (Marschke & Kitchen 1984). 
A study by Cecil et al. (1965) revealed that glycogen concentrations were greatly increased 
in mastitic milk compared with normal milk. As leukocytes contain high glycogen levels, 
there  is  a  possibility  that  high  glucose  levels  in  mastitic  milk  are  due  to  leukocyte 
infiltration during the inflammatory processes. However, the results in this present study 
showed that the end-products of glycogen breakdown such as glucose-1-phosphate and 
glucose-6-phosphate are lower in  mastitic milk than in  control  milk.  It seems  that the 
influence of somatic cells in mastitis milk samples used in the present study was not great 
enough to release glycogen in the milk. Futhermore, because glycogen is only available 
from the liver as glucose for it to become accessible to other organs, reduced blood flow to 
the mammary gland during mastitis was the reason why glycogen levels are reduced in 
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Giesecke  &  Heever  (1981)  observed  a  fluctuation  in  glucose  levels  in  milk  from 
artificially-induced  mastitis  by  human  strains  Group  B  Streptococci  intracisternally.  In 
certain conditions, low levels of glucose may occur relative to its supply and demand even 
in normal udder quarters. Reduced concentration of glucose in mastitic milk can affect the 
abilities of PMN-leukocytes by affecting the efficiency of phagocytosis and the killing of 
bacteria (Giesecke & Heever 1981). 
Low levels of glucose contribute to cessation of milk secretion implying the importance of 
glucose  in  milk  secretion  (Rook  et  al.  1965).Thus,  a  reduced  blood  perfusion  to  the 
mammary gland and less glucose uptake by the mammary cells may occur in mastitis. In 
turn, depressed milk yield is seen which could explain one of the important clinical sign in 
mastitis. 
5.4.3  Protein Metabolism 
Ruminant animals require two types of digestible proteins; the one which escapes rumen 
degradation which is digested in the small intestine to be used by the animals itself and the 
one  is  a  degradable  protein  in  the  rumen  used  by  the  micro-organisms  to  synthesize 
microbial  protein.  Proteins  are  important  sources  for  maintenance  of  vital  functions, 
reproduction, growth and lactation. Within the mammary gland, large amounts of amino 
acids are needed to synthesize milk proteins. Amino acids can also be converted into other 
non-essential amino acids or oxidized into energy in the mammary gland (Wattiaux and 
Karg 2004). 
In this study, the six protein metabolic pathways with greatest change were chosen for 
discussion and in each metabolic pathways, six metabolites were identified that increased 
or  decreased  in  mastitis  compared  to  control  animals.  However,  breakdown  of  milk 
proteins such as casein is most likely to be responsible for much of the amino acid and di-, 
tri- peptides formed in this study. 
Amongst  these  metabolites,  it  is  apparent  that  methionine  (Met)  is  increased  in  both 
mastitic groups. As mentioned previously, amino acids in milk are absorbed from blood 
but  also  synthesized  and  degraded  in  the  mammary  gland  (Bequette  et  al.  1998). 
According  to  Pinotti  et  al.  (2002),  healthy  dairy  ruminants  produce  large  amounts  of 
methionine or a combination of Met and lysine (Lys) (Schwab et al. 1992). But in the 
present study, no increase in free Lys was observed in mastitic groups. These amino acids 
are the first limiting amino acids for milk protein synthesis and Met particularly is required 
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milk  and  milk  fat  productions.  However,  the  level  of  amino  acids  in  milk  is  greatly 
influenced by the quality and quantity of amino acids in basal diets (Klein et al. 2010). 
Glycine (Gly) level is increased in milk from both mastitic groups in this present study and 
this  increased  has  been  observed  during  the  early  lactation  due  to  increased  Gly 
metabolism during this period (Klein et al. 2010). Phosphocholine levels showed a positive 
correlation (r=0.81) with the levels of Gly which is also increased during early stage of 
lactation (Klein et al. 2010). In this present study, phosphocholine is also increased in 
mastitic milk samples. Phosphocholine acts as a precursor of Gly and serves as its storage 
form within the cytosol. It is therefore possible that the increased levels of both Gly and 
phosphocholine found in this study are due to mastitic milk collected at an early stage of 
lactation and that the ability of mammary gland to synthesize these amino acids are not 
impaired by udder infection. 
High levels of both tyrosine and isoleucine amino acids are seen in the present study in 
mastitic milk samples. These amino acids are seen to increase in organic milk compared to 
conventional whole milk as studied by Boudonck et al. (2009). High tyrosine levels in 
mastitic milks can be explained by the extensive proteolysis in milk. Proteolysis can result 
in accumulation of small peptides which contribute to the bitterness in the milk. According 
to Murphy et al. (1989), casein proteolysis products can be measured by the determination 
of tyrosine level. Thus, these authors agreed that high values on tyrosine during infection 
period are due to high milk protease activity during mastitis.  
 Bacterial  fermentation  in  the  milk  can  produced  milk  products  which  contained 
considerably  amounts  of  D-amino  acids  (Man  and  Bada  1987)  and  bacteria  can  be 
regarded as a biological source of D-amino acids (D-AA). Study by Pohn et al. (2009) 
revealed greater increases of free amino acids are seen in milk with different scores of 
CMT especially Ile, Ala, Asp, Pro and Leu. This is in accordance with the present study in 
which Ile, Pro and Leu were increased in mastitic milk samples. Study by Pohn  et al. 
(2009) also observed high free D-AA as CMT score increased for all nine free D-AA (D-
Asp, D-Ser, D-Glu, D-Pro, D-Ala, D-Val, D-allo-Ile, D-Leu and D-Lys). In this present 
study, D-Pro and D-Cys did increase in mastitic milk samples. Thus, it can be concluded 
the  presence  of  D-AA  content  is  associated  with  mastitis  and  related  to  the  bacterial 
activity in the udder. However, the MS analysis cannot differentiate D- from L- amino aicd 
as they have identified m/z and retention time, so that identification as D- amino acid is not 
definitive. Chapter 5, 270 
 
It can be concluded that increase in many amino acids in mastitic milk samples is due to 
proteolytic activity caused by proteases from pathogens and also from immune cells such 
as plasmin caused by the presence of microorganisms during udder infection. End products 
of major milk proteins degradation by proteases contribute to a wide-range of amino acids 
present in the mastitic milk samples. Thus, certain amino acids can be used to indicate the 
activity of pathogenic bacteria which lead to inflammation of mammary gland. 
In  conclusion,  there  was  an  increase  in  identification  of  di-and  tripeptides  in  both 
infections with particular tripeptides being associated with either of the bacteria, though 
with S. aureus infection causing more of these peptides to be released. Differences that 
present  between  bacterial  causative  agents  could  be  either  due  to  differences  in  the 
specificity  of  action  of  the  bacterial  proteases  or  that  the  bacteria  have  differing 
efficiencies in absorbing the peptides after they are released by hydrolysis. Amongst other 
metabolites changes in lipid, nucleotide and carbohydrate metabolism have been identified, 
there  were  also  non-host  and  non-pathogen  metabolites  identified  such  as  tentoxin, 
ricinine, quinate, toluene and others and it was possible that the metabolites are derived 
from therapeutic reagents though mis-classification is also possible. 
To differentiate between E. coli and S. aureus infected milk samples, certain metabolites 
may  have  potential  as  biomarkers  such  as  pyridoxine,  N-acetyl-L-glutamate, 
isopropylmalate  and  pyruvate.  These  metabolites  were  seen  in  E.  coli  infected  milk 
samples as compared with S. aureus infected milk samples. The majority of increased 
metabolites in S. aureus infected milk samples were comprised of di- or tri-peptides such 
as Gln-Ser-Ser, Leu-Asn-Tyr, Leu-Thr and others. 
Mastitis  had  an  effect  on  lipid,  protein  and  carbohydrate  metabolic  pathways.  In  lipid 
metabolic pathway, there was an increased in arachidonic acid metabolites in mastitis. As 
for protein metabolic pathway, arginine metabolites were seen increased in mastitis whilst 
galactose  metabolites  from  carbohydrate  metabolic  pathway  were  increased  in  mastitic 
milk samples.  
From this study, it can be concluded that metabolomic analysis has successfully studied the 
presence  of  important  metabolites  or  even  determined  the  changes  of  metabolites  that 
occurred in milk samples of dairy cows during the course of intramammary inflammation. 
Further analysis is needed with more milk samples being studied to confirm the status of 
these important metabolites and also to assess their appearance in subclinical as well as the 
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Chapter VI. General Discussion 
The aims of this thesis were outlined in chapter 1 and the relevant conclusions have been 
detailed  in  the  appropriate  chapters.  This  chapter  will  summarise  the  important  and 
significant findings and highlight the areas which have been recognised as worthy of future 
research. 
Despite the numerous researches that have been undertaken to control bovine mastitis, this 
disease  still  poses  one  of  the  most  prevalent  and  costly  diseases  in  dairy  cows.  The 
negative  impacts  of  bovine  mastitis  include  reduction  in  milk  production  and  quality 
because  of  changes  in  milk  composition  which  in  turn  affects  the  economy  of  dairy 
industry.  Other  factors  such  as  costs  of  treatment,  veterinary  services,  diagnostics  and 
culling were also contribute to the detrimental effect on dairy industry worldwide (Halasa 
et al. 2007). 
In chapter 1, various traditional and common bovine mastitis diagnostic methods have 
been discussed. Somatic cell counts (SCC) is still widely used as one of the most useful 
diagnostic techniques to detect the level and occurrence of bovine mastitis especially for 
bovine subclinical mastitis (Dohoo & Meek 1982; Schukken et al. 2003). However, in 
order to avoid false-positive or false-negative results, several factors should be taken into 
consideration before any conclusion can be made. These factors include mastitis causing 
pathogens, number of infected quarters, previous mastitis history, age, stage of lactation, 
milking  frequency  as  well  as  the  type  of  samples  taken  for  SCC  analysis  (quarter, 
composite or bulk tank). 
Other important diagnostic methods that have been discussed in detecting the presence of 
bovine mastitis are California Mastitis Test (CMT), enzyme levels, electrical conductivity 
(EC)  and  infrared  thermography  (IRT).  CMT  which  was  developed  by  Schalm  & 
Noorlander (1957) is the main cow-side test used to diagnose bovine mastitis and is based 
on the formation of gel formation which reflects the cell count of the milk (Barnum & 
Newbould 1961). Previous studies have been shown the relationship of CMT results with 
the leukocyte content of milk, the level of subclinical mastitis as well as bacteriological 
analyses (Barnum & Newbould 1961; Daniel et al. 1966; Wesen et al. 1967). 
Several types of enzymes may be useful as mastitis indicators but one enzyme that is 
considered  reliable  and  sensitive  is  N-acetyl-β-D-glucosaminidase  (NAGase)  (Kitchen 
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of bovine mastitis so that the level and extent of infection can be controlled (Pyörälä & 
Pyörälä  1997).  Other  important  enzymes  include  β-glucuronidase,  milk  antitrypsin,  L-
lactate dehydrogenase (LDH) and myeloperoxidase (MPO).  
The use of EC has been one of the most popular methods in diagnosing bovine mastitis. 
The concentration of NaCl is often measured as milk electrical conductivity and many 
studies have been performed to  assess the ability of EC in diagnosing bovine mastitis 
particularly subclinical mastitis (Linzell et al. 1974; Fernando et al. 1982, 1985). 
Finally, another popular bovine mastitis diagnostic method is IRT. It has been shown that 
IRT has strong correlation with CMT and a high predictive diagnostic ability making it a 
sensitive tool in detecting early onset of subclinical mastitis (Berry et al. 2003; Polat et al. 
2010) although several cow factors should be consider before analysing the reliability of 
IRT in diagnosing bovine mastitis. 
However, these traditional methods of bovine mastitis diagnosis may have their technical 
drawbacks such as less sensitive, less specific, lacking in speed, very labour-intensive and 
expensive. Their results can also be mis-interpreted which then lead to false positive or 
negative (Chagunda et al. 2006). 
Recently, much research interest has been focused on analysing the presence of bovine 
mastitis biomarkers that can be used to predict the progress and outcome of a disease. 
Biomarkers are important analytes which can be used to predict changes in any biological 
and  pathological  processes  so  that  any  disease  states  can  be  revealed  (Biomarkers 
Definitions Working Group 2001). Because of the limitations in traditional methods of 
diagnosing bovine mastitis that had been discussed previously (Chagunda et al. 2006; Le 
Roux  et  al.  2003;  Labohm  et  al.  1998;  Nielen  et  al.  1995),  the  discovery  of  specific 
mastitis  biomarkers  is  needed  for  an  early  diagnosis  of  bovine  mastitis.  Thus,  several 
bovine  mastitis  biomarkers  have  been  proposed  including  the  use  of  combinations  of 
several  bovine  mastitis  indicators  such  as  enzymes,  SCC,  prostanoids,  bacteriological 
culture and others (Mattila et al. 1986; Zank & Schlatterer 1998; Barta et al. 1990; Baeker 
et al. 2002; Bannikov et al. 2010). 
Two important APPs that are known to increase in response to disease are SAA and Hp 
(Conner  et  al.  1986;  Eckersall  et  al.  2001).  Hp  and  SAA  are  also  known  to  rise 
substantially in serum or milk as indicators of bovine mastitis (Pyörälä et al. 2011). In 
chapter 2, the reliability of both SAA and Hp was assessed by validating and optimising 
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The aim of chapter 2 was to develop sandwich ELISA by using rabbit anti-bovine antibody 
to measure Hp level in bovine milk and used commercialized Phase
TM Range SAA Assay 
to quantify the level of milk SAA so that the concentrations of the APPs in different types 
of  milk  samples  could  be  compared  statistically.  To  group  milk  samples  into  healthy, 
subclinical and clinical mastitis, the estimation of SCC and bacteriological culture were 
used before APP assays were performed in order to confirm the disease status.  It was 
shown in this chapter that Hp concentrations showed to be statistically increased in clinical 
mastitic samples when compared between healthy and clinical mastitic cases as well as 
between  subclinical  and  clinical  mastitic  cases.  However,  Hp  showed  no  significant 
difference between healthy and subclinical mastitic milk samples (p>0.05). Several factors 
were  discussed  which  may  contribute  to  this  reason  which  include  different  types  of 
cytokines produced during bovine mastitis, less Hp production during subclinical mastitis, 
insensitive immunoassay to detect a slight elevation of Hp concentrations in subclinical 
mastitic milk samples as well as different types of pathogen virulence and host responses. 
Milk serum amyloid A3 (M-SAA3) has also been shown to have an important role as 
biomarker in bovine mastitis (Eckersall et al. 2001; Grönlund et al. 2003, 2005; Nielsen et 
al. 2004; Pyörälä et al. 2011). This study successfully confirmed the use of M-SAA3 in 
diagnosing bovine mastitis in which M-SAA3 concentrations were significantly different 
between healthy, subclinical and clinical mastitic milk samples (p<0.05). 
SAA levels showed a relatively strong relationship with Hp levels further confirming that 
SAA and Hp can be used together as good mastitis indicator. It has also been shown that 
these APP measurements can be performed using milk samples instead of serum/plasma 
samples for an ease of sampling and sample preparation. 
Somatic cell counts (SCC) were measured in both healthy and subclinical mastitic milk 
samples and the relationship between SCC values and APP measurements was determined. 
SCC  measurement  was  significantly  different  between  healthy  and  subclinical  mastitic 
samples (p<0.05) which proved the reliability of SCC to diagnose subclinical mastitis. The 
correlation between SCC and APP showed positive relationship although the relationship 
was not strong. The correlation between SCC and SAA gave a medium relationship with 
the value of r was 0.438 while here was no correlation between SCC and Hp as the value 
of  r  was  0.08.  The  reason  for  this  difference  could  be  that  these  correlations  were 
calculated based on all milk samples regardless of the type of milk samples (control vs. 
infected) and various cut-off values for SCC have been suggested depending on several 
factors (countries, breeds, types of milk samples) (Mattila et al. 1986; Holdaway et al. Chapter 6, 274 
 
1996).  The  use  of  log  transformed  SCC  can  be  considered  when  analysing  their 
relationship to achieve good correlation between APP and SCC. 
The application of advances in proteomics has been a major recent area of research in 
studying  the  protein  changes  in  bovine  milk  during  mastitis.  In  chapter  3,  several 
proteomics methods were applied, such as 1DE, 2DE, DiGE and MALDI-MS analyses, to 
investigate  the  changes  of  milk  proteome  during  the  presence  of  intramammary 
inflammation.  Milk  samples  from  subclinical  and  clinical  mastitic  cases  were  used  in 
comparison with healthy milk samples as comparison. It was hoped that by applying these 
methods, discovery of new biomarkers of bovine mastitis can be achieved. 
Prior to the use of proteomic methods, SCC and APP measurements were used to confirm 
the disease status of the milk samples investigated. In initial studies rennet coagulation was 
performed to  remove the majority of milk  casein  in  order to examine  changes  in  low 
abundance proteins. In the first phase of this study, subclinical mastitic milk samples were 
analysed in comparison with healthy milk samples using 1D gel electrophoresis and the 
protein  bands  developed  on  the  gel  were  analysed  by  the  MALDI-MS  for  protein 
identification.  Unfortunately,  no  clear  difference  was  seen  on  the  gel  although  lower 
intensity bands but with high molecular weight were not successfully identified by the 
MALDI-MS analysis.  
Because no clear difference was observed on the gel pattern of 1D gel electrophoresis, 2D 
gel  electrophoresis  was  applied  to  similar  samples.  Unfortunately,  there  was  again  no 
observable difference in low abundance proteins between pooled subclinical mastitic and 
pooled healthy milk samples. However, it was evident that albumin was not present in 
healthy milk samples which further supported the idea that albumin concentrations was 
increased during bovine mastitis as a result of either an increase in leakage from serum into 
the mammary gland or in albumin expression in the mammary gland.  
Due  to  these  limitations,  clinical  mastitic  milk samples  were  analysed  by  using  DiGE 
which enables the visualization of multiple protein samples in one 2D gel. However, the 
only  findings  observed  were  increases  in  albumin  concentration  and  decreased  whey 
protein concentrations (β-LG and α-LA) in clinical mastitic milk samples as compared 
with healthy milk samples. Due to lack of significant findings in this chapter, non-gel 
proteomic approaches were recommended to continue the investigation of bovine mastitis 
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Peptidomic  approach  was  applied  next  to  investigate  the  presence  of  polypeptides  in 
bovine milk that may be used to discriminate normal from bovine mastitic milk samples 
and also to determine if peptide biomarkers could discriminate between mastitis caused by 
two different types of bacterial pathogens. It was hoped that by using this sensitive and 
high-throughput methodology, significant results can be achieved and lead to the discovery 
of important and significant bovine mastitis biomarkers by employing CE-MS and LC-
MS/MS analyses. 
Milk samples used in this study were from clinical mastitic cases, caused by two common 
bacterial pathogens which were E. coli and S. aureus, and were assessed in comparison to 
healthy milk samples. Two different types of comparison were analysed to determine the 
ability of peptidomics to compare between healthy and clinically infected milk samples as 
well  as  the  ability  of  peptidomics  to  compare  between  E.  coli  infected  and  S.  aureus 
infected milk samples. SCC and APP measurements were used as previously to confirm 
the disease status of the milk samples used.  
From CE-MS analysis, polypeptide fingerprinting was performed for different groups of 
milk samples to generate disease models. However, these models need to be validated so 
that the status of each marker in each group (control, infected, E. coli or S. aureus) can be 
confirmed and may eventually used to determine the presence of bovine mastitis or even 
predict the type of bacterial pathogens that caused bovine mastitis.  
A  total  of  45  discriminatory  polypeptides  were  identified  by  CE-MS  analysis  with  31 
polypeptides  used  to  discriminate  healthy  from  mastitis  cases  and  14  polypeptides 
discriminating E. coli from S. aureus infected cases. These polypeptides were then further 
analysed for their amino acid sequence by LC-MS/MS, although not all polypeptides were 
successfully  sequenced.  The  reason  was  because  the  only  parameters  used  to  link  the 
peptides obtained in both systems (CE-MS and LC-MS/MS) were peptide mass and the 
number  of  basic  amino  acids.  Thus,  mass  ambiguities  occurred  which  complicate  the 
assignment of sequences obtained from these two different methods.  
However, a total of 12 sequenced polypeptides were identified using UniProtKB database. 
Amongst the proteins identified from the peptide sequences were α S1-casein, β-casein, 
serum  amyloid  A  protein  (SAA),  glycosylation-dependent  cell  adhesion  molecule  1 
(GlyCAM-1) and fibroblast growth factor binding protein (FGFBP). Although GlyCAM-1 
was characterized as one of the host defence mechanism proteins (Boehmer et al. 2010; 
Smolenski  et  al.  2007),  it  was  interesting  to  see  the  presence  of  these  peptides  from 
GlyCAM-1 in healthy milk samples. Peptides from SAA were also seen in both E. coli and Chapter 6, 276 
 
S. aureus infected milk samples but they were not able to discriminate E. coli infected milk 
samples from S. aureus infected milk samples. The results from this chapter provided an 
initial  insight  on how  milk  peptide profiles can change  as  a result of bovine mastitis. 
Further  improvements  have  been  discussed  but  it  was  confirmed  that  peptidomic 
methodology able to identify significant biomarkers in bovine mastitis. 
Finally,  a  metabolomic  approach  was  applied  to  further  investigate  the  presence  of 
important metabolites that can be used to discriminate normal from mastitic milk samples 
by  the  use  of  LC-MS/MS  analysis.  As  previously,  SCC  and  APP  measurements  were 
performed to confirm the disease status of the samples used. Individual metabolites were 
analysed in both positive and negative ionisation modes in each different types of milk 
sample. Metabolites which were absent in control milk samples but present in both infected 
groups (E. coli and S. aureus) were also examined in both ionisation modes. Among the 
many metabolites detected, a variety of tri-peptides were seen with higher intensities in S. 
aureus group compared with E. coli group regardless of the type of ionisation modes. The 
relative change in intensity for each identified metabolites between two infected groups 
was determined and Mann-Whitney test was performed to show the significant difference 
in  each of the categories.  Amongst  the identified metabolites which were significantly 
increased in the E. coli infected group regardless of the type of ionisation modes were 3-
nitrotyrosine, deoxyguanosine and 3-methoxy-4-hydroxylphenyl. Whilst Leu-Arg, Ser-His 
and Lys-Ala-Gly were amongst the identified metabolites found significantly increased in 
S. aureus infected group. 
Metabolic pathways were also analysed to allow an investigation of the metabolites found 
in different group of milk samples according to their corresponding metabolic pathways. In 
lipid  metabolic  pathway,  arachidonic  acid  metabolites  were  seen  increased  in  mastitis 
while in protein metabolic pathway, arginine metabolites were found to be increased in 
mastitis.  Finally,  galactose  metabolites  from  carbohydrate  metabolic  pathways  were 
increased in mastitic milk samples. 
In chapter 4 and 5, several significant findings were found which could be proposed as 
bovine mastitis biomarkers. It was also apparent that some of the milk indicators could be 
applied to differentiate clinical mastitis caused by different type of bacterial pathogens (E. 
coli  and  S.  aureus).  This  would  be  of  especial  value  in  allowing  the  appropriate 
antibacterial treatment.  However, further experiments with more milk samples should be 
performed to validate and confirm these results so that they can be used to diagnose bovine 
mastitis. Furthermore it is important to investigate the differentiation of subclinical and Chapter 6, 277 
 
clinical bovine mastitis, so that subclinical mastitic milk samples should be used in both 
peptidomic  and  metabolomics  methodologies  in  comparison  with  clinical  mastitic  and 
healthy milk samples as it was apparent that the use of proteomic methodology in this 
study was not able to differentiate between subclinical and clinical bovine mastitis. It is 
also  hoped  that  changes  in  bovine  milk  proteome,  peptidome  or  metabolome  can  be 
perceived efficiently.  
In summary of this thesis, with a prior knowledge of known acute phase proteins during 
bovine  mastitis,  various  ‘-omics’  studies  such  as  proteomics,  peptidomics  and 
metabolomics can be applied to study the presence of other lower abundance proteins, 
peptides and metabolites which may serve as important mastitis biomarkers. 278 
 
Appendices 
Appendix Chapter 3 
1.  Preparation of 12% PAGE gels 
The monomer solution was prepared by mixin APS. The mixture was degassed for 15 minutes. 
Percent Gel  DDI water (ml)  30%  Degassed 
Acrylamide/Bis 
(ml) 
  Gel 
buffer 
(ml) 
10%  w/v  SDS 
(ml) 
12%  3.4  4.0  2.5  0.1 
  Resolving Gel Buffer – 1.5M Tris-HCl, pH 8.8 
  Stacking Gel Buffer – 0.5M Tris-HCl, pH 6.8 
Immediately prior to pouring the gel, for 10 ml monomer solution, these solutions were added: 
Resolving Gel: 50μl 10% APS and 5μl TEMED 
Stacking Gel: 50μl 10% APS and 10μl TEMED 
The mixed solution was gently swirled to initiate polymerization 
2.  Bradford Assay 
The Bradford reagent which consists of Brillian Blue G in phosphoric acid and methanol as well as 
Protein Standard (BSA) Solution (2mg/ml) were purchased from Sigma-Aldrich.Inc. 
a)  Protein Standard preparation 
Bovine serum albumin at 2mg/ml was used as the protein standard in performing Bradford assay. The 
standard was further diluted using MilliQ water into 1.5mg/ml, 1.0mg/ml and 0.5mg/ml to produce a 
standard curve. 
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Milk samples were used from both healthy and mastitic cows. All samples were kept at -20°C before 
analysis. After thawed, all samples were further diluted in 1:2, 1:4, 1:6 and 1:8 using MilliQ water. This 
dilution procedure was not necessary to perform in all assays. 
c)  Assay 
250μl of Bradford reagent was added into 5μl of each standard and sample at different dilutions. The 
sample was incubated for a few minutes at room temperature and the absorbance was measure at 595nm 
using [name]. 
d)  Protein Concentration Analysis 
The net absorbance values against the protein concentration of each standard were plotted automatically 
after the measurement. The protein concentration of each sample was determined by comparing the Net 
A595 values against the standard curve. 
3.  Lysis buffer 
6M urea  
2M thiourea  
4% CHAPS  
25mM tris base 
4.  Equilibration buffer I  
 pH8.8, 1.5M Tris HCl  
216.21 g urea 
180ml glycerol 
12g SDS 
100mg DTT 
5.  Equilibration buffer II 
pH8.8, 1.5M Tris HCl 
216.21 g urea 
180ml glycerol 
12g SDS 280 
 
250mg iodoacetamide 
 
6.  DiGE Lysis Buffer 
7M urea 
2M Thiourea 
4% CHAPS 
25mM Tris HCl 
 
Appendix Chapter 4 
1.  Preparation of Standards for microplate assay 
Standard  BSA standard  Water or buffer  Final protein 
concentration 
Standard A  75 µL stock  
(2 mg/ml) 
225 µl  500 µg/ml 
Standard B  200 µL of A  200 µl  250 µg/ml 
Standard C  200 µL of B  200 µl  125 µg/ml 
Standard D  80 µL of C  120 µl  50 µg/ml 
Standard E  60 µL of D  140 µl  15 µg/ml 
Standard F  60 µL of E  120 µl  5 µg/ml 
Standard G  80 µL of F  120 µl  2 µg/ml 
Blank  0  200 µl  0 µg/ml 
2.  Preparation of BC Assay reagent 
Prepare the required amount of BC Assay reagent by adding: 
1 part of reagent B to 50 parts of reagent A. 
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1.  Disposable de-salting PD10-columns (GE Healthcare Biosciences AB, Bedford, USA). 
2.  Centristart ultrafilter tubes 20 kD, 0.62 cm
2 tubes (Sartorius Stedim Limited, UK). 
3.  BCA protein quantification kit (Uptima, Interchim, Montluçon, France). 
4.  Lyophilisation Christ Speed-Vac RVC 2-18/Alpha 1-2 (Christ, Osterode am Harz, Germany). 
 
4.  Components for CE-MS analysis 
1.  P/ACE MDQ capillary electrophoresis system (Beckman Coulter, Crea, CA, USA)  
2.  Micro-TOF (time-of-flight) mass spectrometer (Bruker Daltonics, Bremen, Germany). 
3.  Electro-ionisation sprayer (Agilent Technologies, Santa Clara, USA) (see Note 3). 
4.  Capillary 90 cm, 50 µm I.D. fused silica capillary non-coated (New Objective, Woburn, USA) 
5.  Cole-Parmer single-syringe infusion pump (Cole-Parmer Instrument Company, USA). 
6.  Hamilton syringe 2.5 ml  
 
5.  Software for Data processing and Statistical Analysis 
a) Software for peak detection: MosaiquesVisu (Biomosaiques, Hannover, Germany). 
b)  Commercial statistical packages: SAS (www.sas.com) and MedCal (www.medcalc.be). 
c)  Multitest R-package available at www.bioconductor.org 
d)  SVM-based program for multiparametric data classification: MosaCluster (Biomosaiques, 
Hannover, Germany). 
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